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SUMMARY 
In the mammalian genome, cytosine methylation (5mC) plays a central role in the epigenetic 
regulation of gene expression and has been implicated in a variety of biological processes, 
including genome stability, imprinting or differentiation. Compared to other epigenetic marks, 
DNA methylation has been thought to be relatively stable. However, genome-wide loss of 5mC, 
or DNA demethylation, has been observed in specific developmental stages and in various types 
of cancer. The discovery of the TET family of enzymes in 2009 was a watershed moment in 
comprehending the mechanisms of DNA demethylation. TET proteins oxidize 5mC to 5-
hydroxymethylcytosine (5hmC), 5-formlycytosine (5fC) and 5-carboxylcytosine (5caC), which not 
only serve as key intermediates in active DNA demethylation pathways, but can also act as 
independent epigenetic marks. In this study, various aspects of TET-mediated DNA 
demethylation have been intensively investigated. 
Using quantitative mass-spectrometry-based proteomics readers for the different cytosine 
derivatives in mouse embryonic stem cells (ESCs), neuronal progenitor cells, and adult mouse 
brain tissue were identified. Readers for these modifications are only partially overlapping and are 
dynamic during differentiation. Moreover, the oxidized derivatives of 5mC recruit distinct 
transcription regulators as well as a large number of DNA repair proteins, implicating DNA 
damage response as the main pathway contributing to active DNA demethylation. 
To identify additional non-canonical DNA bases, highly sensitive quantitative mass-spectrometry 
led to the discovery of 5-hydroxymethyluracil (5hmU) in ESCs. Genomic 5hmU is not generated 
via deamination of 5hmC, as widely suggested, but through direct oxidation of thymine by TET 
proteins. In addition, screening for specific 5hmU readers identified different transcriptional and 
epigenetic factors, implicating that this mark has a specific function in ESCs. 
So far, only little is known how TET enzymes are regulated and how they are modified by 
posttranslational modifications (PTMs). Mapping TET phosphorylation and glycosylation sites at 
amino acid resolution revealed that these PTMs are interdependent and mostly occur at regulatory 
protein regions.  
Finally, a reporter gene based assay could demonstrate that in vitro methylation causes gene 
silencing while subsequent oxidation, resulting in DNA demethylation, leads to gene reactivation 
in vivo. Different knockout and rescue experiments clearly show that oxidation of methylcytosine 
by TET proteins and subsequent removal by TDG or NEIL glycosylases and the base excision 
repair pathway results in reactivation of epigenetically silenced genes. 
In conclusion, this work provides new insights how TET proteins can set DNA modifications, 
how these oxidized bases are read by various factors and how TET proteins can be 
posttranslationally modified. Furthermore, removal of 5mC is achieved through TET-mediated 
oxidation and depends on the activity of specific glycosylases, which leads to gene reactivation. 
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1 INTRODUCTION 
1.1 Epigenetic regulation 
DNA is the essential macromolecule that stores all genetic information and it propagates this 
information to the next generation through the germ line [Avery et al., 1944]. Determining the 
structural details of the DNA double helix, which is considered as one of the landmark discoveries 
in biology and other findings gave rise to the “central dogma” of modern molecular biology 
[Watson and Crick, 1953]. This dogma describes the processes and mechanisms involved in 
maintaining and translating the genetic template required for life. The principal steps are the self-
propagation of DNA by semiconservative replication, unidirectional transcription of the DNA 
into an intermediary messenger RNA (mRNA) and the translation of mRNA into chains of amino 
acids, the building blocks of proteins [Crick, 1970]. 
Cells of multicellular organisms contain the same genetic information, however, they differ 
dramatically in morphology and function. These differences are based on complex and dynamic 
changes of gene expression patterns that cannot be explained by alterations in the DNA sequence 
[Jaenisch and Bird, 2003]. This additional layer of information is termed epigenetic and 
responsible for the identity of every single cell [Waddington, 1957]. The structure and composition 
of chromatin are generally modulated by heritable epigenetic modifications, which result in the 
establishment and maintenance of stable chromatin signatures. These so called “epigenetic 
landscapes” are highly organized systems of information storage on the genome and mediate a 
response to environmental signals that lead to changes in gene expression [Goldberg et al., 2007].  
Epigenetic mechanisms include DNA methylation, posttranslational histone modifications, 
histone variants, nucleosome remodeling, as well as regulation by non-coding RNAs and ensure 
long-term stability of transcriptional states (Figure 1). In recent years, it has become apparent that 
epigenetic modifications do not stand on their own, but are connected in various combinations to 
cross talk with each other in a sense that manifolds their functions [Bannister and Kouzarides, 
2011; Ponting et al., 2009; Reik, 2007].  
 
 
Figure 1 Epigenetic mechanisms 
Epigenetic regulation of gene expression is mediated by the crosstalk between DNA methylation and various posttranslational histone 
modifications. The replacement of canonical histone proteins by histone variants and nucleosome remodeling can additionally alter the 
structural composition and accessibility of chromatin. Further factors contributing to epigenetic regulation are long non-coding RNAs. 
Ac
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The establishment, the reading and the removal of these epigenetic marks control the pluripotency 
of embryonic stem cells and other key developmental processes such as imprinting, neurogenesis 
as well as X inactivation in female cells [Augui et al., 2011; Kacem and Feil, 2009; Tee and 
Reinberg, 2014]. 
 
 
1.2 Chromatin structure and histone modifications 
In eukaryotic cells, DNA is not present as a naked double helix, but rather organized into complex 
higher order chromatin structures. 146 base-pair long DNA strands are wrapped around an 
octamer of histone proteins to form nucleosomes, representing the basic level of chromatin 
compaction [Richmond and Davey, 2003]. One histone octamer contains the four core histone 
proteins H2A, H2B, H3 and H4, which pairwise interact to form the barrel-shaped histone 
particle. Moreover, each histone also harbors a 20-35 amino acid long N-terminal peptide that 
extends from the surface of the nucleosome [Luger et al., 1997]. These so called histone tails and 
to a lower extent the core histone itself are subject to a large number and variety of 
posttranslational modifications. The modifications include methylation and acetylation of lysines 
and arginines, phosphorylation of serines and threonines, ubiquitination and sumoylation of 
lysines, as well as ribosylation and proline isomerization [Kouzarides, 2007]. Additionally, 
methylated and unmethylated arginines undergo deimination, resulting in their conversion to 
citrulline [Cuthbert et al., 2004].  
In general, histone modifications can act via two different mechanisms to control chromatin 
structure and thus gene expression. First, the modifications can alter the electrostatic charge of the 
histone resulting in a structural change and disturbed binding to DNA. Of all known 
modifications, acetylation shows the highest potential to decondense chromatin, since it 
neutralizes the basic charge of histone proteins. Second, the composition of histone modifications 
can promote or inhibit the binding of non-histone proteins to chromatin. One example is HP1  
(heterochromatin protein 1) that specifically binds to histone H3 trimethylated on lysine 9 
(H3K9me3), a predominant mark for heterochromatin and transcriptionally inactive regions 
[Jacobs et al., 2001]. The release of HP1 from its binding sites during mitosis is regulated by a 
transient phosphorylation of H3 on serine 10 [Fischle et al., 2005].  
Moreover, these histone marks can regulate each other, providing dynamic epigenetic crosstalk. 
One modification can influence the occurrence of one or more subsequent modifications on the 
same histone molecule, or between different histone molecules and across nucleosomes. Histone 
modifications may even form a code that is read by the binding of specific proteins to regulate 
distinct downstream functions [Latham and Dent, 2007; Strahl and Allis, 2000].  
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1.3 DNA methylation 
DNA methylation was the first epigenetic mechanism known to directly correlate with gene 
expression [Razin and Riggs, 1980]. In eukaryotes, DNA methylation implies the addition of a 
methyl group to the C5 position of cytosine, which results in the formation of 5-methylcytosine 
(5mC). This modification has been intensively studied and is well conserved among most plant, 
animal and fungal species. 5mC is almost exclusively found in a symmetric CpG dinucleotide 
context, however, small amounts of non-CpG methylation were observed [Patil et al., 2014; 
Ramsahoye et al., 2000]. Mammalian genomic landscapes are overall CpG-poor and global 
methylation occurs at 70-80% of all CpG sites [Ehrlich et al., 1982]. The remaining unmethylated 
CpGs were first detected as a DNA fraction that was cleaved frequently by DNA methylation 
sensitive restriction enzymes [Cooper et al., 1983]. These dense clusters termed CpG islands 
(CGIs) are on average 1000 base pairs in length and show an elevated CpG content [Suzuki and 
Bird, 2008]. As 5mC can be converted to thymine by enzymatic or spontaneous deamination, the 
evolutionary loss of genomic CpGs is thought to have occurred due to deamination of methylated 
sequences in the germline. Therefore, the existence of CGIs can be explained as they are never or 
probably only transiently methylated in the germline [Smallwood et al., 2011]. Approximately 70% 
of gene promoters are associated with a CGI, making this the most common promoter type in the 
mammalian genome [Saxonov et al., 2006]. Almost all housekeeping genes, as well as a large 
number of tissue-specific and developmental genes are characterized by CGI promoters, which 
outline the strong correlation between CGIs and transcription initiation [Larsen et al., 1992; Zhu 
et al., 2008]. However, a large class of CGIs that are remote from annotated transcription start 
sites were recently identified, but they nevertheless fulfill promoter function [Zhu et al., 2008]. 
The majority of CGIs is found in a hypomethylated state, but a small percentage acquires 
methylation during normal development leading to a stable transcriptional repression. Some of 
these examples are known to play a key role in X inactivation and genomic imprinting [Edwards 
and Ferguson-Smith, 2007; Payer and Lee, 2008].  
DNA methylation is not only restricted to promoters where it is associated with transcriptional 
repression. The generally CpG-poor gene bodies are highly methylated and contain multiple 
repetitive and transposable elements. Methylation of the CpG sites in gene exons is a major reason 
for cytosine to thymine transition mutations, resulting in disease-causing mutations in the germline 
and cancer-causing mutations in somatic cells [Rideout et al., 1990]. It has been known from the 
early days that gene body methylation is a feature of transcribed genes [Wolf et al., 1984]. In line 
with that, extensive positive correlations between gene body methylation and active transcription 
have been confirmed on the active X chromosome, as well as on whole animal and plant genomes 
[Feng et al., 2010; Hellman and Chess, 2007; Lister et al., 2009].  Furthermore, exons show higher 
INTRODUCTION  
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5mC levels than introns and transitions in the degree of methylation are predominantly found at 
exon–intron boundaries, possibly suggesting a role for methylation in regulating cotranscriptional 
splicing [Laurent et al., 2010; Maunakea et al., 2013].  
 
 
1.4 Setting the methylation mark 
The addition of the methyl group to cytosine is catalyzed by the protein family of DNA 
methyltransferases (DNMTs). In vertebrates four different DNMT members have been described, 
which all apart from DNMT3L comprise an N-terminal regulatory and a catalytically active C-
terminal domain (Figure 2). In the first step of the methylation reaction, DNMTs bind to the 
DNA and flip out the target base. Subsequently, they form a covalent complex by a conserved 
cysteine nucleophile with the C6 position of cytosine. This results in the activation of the C5 atom 
and the methyl group is transferred from the cofactor S-adenosyl-L-methionine (SAM), which 
serves as the common cellular methyl group donor. In the last reaction step, the covalent bond is 
resolved by β-elimination and the enzyme released from the DNA [Cheng and Blumenthal, 2008]. 
 
Figure 2 Domain structure of the 
mammalian DNMT family 
All DNMTs except DNMT3L contain a 
regulatory N-terminal and a highly conserved 
catalytically active C-terminal domain. PBD: 
PCNA binding domain; TS: Targeting sequence; 
ZnF: zinc finger domain; BAH: bromo-adjacent 
homology domain; PWWP: Pro-Trp-Trp-Pro 
motif containing domain; PHD: plant homeo-
domain; MTase: methyltransferase domain. 
Numbers indicate the length of the murine 
proteins in amino acids. 
 
 
DNMT1 
DNMT1 was the first mammalian DNA methyltransferase to be characterized and numerous 
genetic and biochemical studies demonstrated its role in maintaining methylation patterns during 
semiconservative replication [Bestor et al., 1988]. Initial studies showed that targeted mutations in 
the Dnmt1 gene result in global hypomethylation in murine embryonic stem cells (ESCs) and 
homozygous embryos deficient in DNMT1 are delayed in development and died during mid-
gastrulation [Li et al., 1992]. Dnmt1 compound heterozygous mice display chromosomal instability 
and develop severe T cell lymphomas with a high frequency of chromosome 15 trisomy [Gaudet 
et al., 2003]. DNMT1 was also shown to be essential for X chromosome inactivation and 
maintenance of genomic imprints [Howell et al., 2001]. Furthermore, mouse embryos lacking 
DNMT1 exhibit increased transcription of intracisternal A particle (IAP) retrotransposons, 
DNMT1
DNMT3A
DNMT3B
DNMT3L
TS BAH1PBD ZnF BAH2 MTase
PWWP PHD
1620
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suggesting that DNMT1 also contributes to suppression of retroviral and transposable elements 
[Gaudet et al., 2004].  
Based on bioinformatic studies, mammalian DNMT1 evolved by fusion of at least three ancestral 
genes [Margot et al., 2000]. Its large N-terminal regulatory part contains a PCNA (Proliferating cell 
nuclear antigen) binding domain (PBD), a targeting sequence (TS domain), a zinc finger domain 
(ZnF), two bromo adjacent homology domains (BAH1 and BAH2) and is linked to the C-terminal 
catalytic domain by several lysyl-glycyl dipeptide repeats [Goll and Bestor, 2005; Rottach et al., 
2009]. The PBD is responsible for the interaction with PCNA, which serves as a loading platform 
and processivity factor for proteins contributing to DNA replication and repair [Chuang et al., 
1997; Maga and Hubscher, 2003; Mortusewicz et al., 2005; Sporbert et al., 2005]. The highly 
conserved TS domain triggers the accumulation at pericentric heterochromatin from late S phase 
until early G1 phase [Easwaran et al., 2004; Leonhardt et al., 1992; Schneider et al., 2013]. 
Moreover, structural insights proposed a potential autoinhibitory effect of the TS domain on the 
catalytic activity of DNMT1 [Syeda et al., 2011]. The two BAH domains are likely involved in 
protein-protein interactions and the CXXC zinc finger mediates binding to DNA [Nicolas and 
Goodwin, 1996; Oliver et al., 2005]. On the one hand, it has been shown that the ZnF of DNMT1 
prefers unmethylated CpG sites [Fatemi et al., 2001; Frauer et al., 2011b; Pradhan et al., 2008].  
On the other hand, new structural details support a preference of the ZnF for hemimethylated 
DNA and an inhibitory role of binding to unmethylated CpG sites during maintenance 
methylation [Song et al., 2011; Song et al., 2012]. The catalytic domain of DNMT1 contains all 
conserved motifs for the methyl group transfer but additional intramolecular interactions with the 
N­terminal regulatory domain are required for allosteric activation [Fatemi et al., 2001; Margot et 
al., 2000].  
Numerous posttranslational modifications can additionally modulate DNMT1: the abundance and 
stability of DNMT1 during cell cycle is controlled by ubiquitination and acetylation [Du et al., 
2010; Felle et al., 2011; Qin et al., 2011]. Phosphorylation with subsequent methylation of 
DNMT1 regulates stability and sumoylation was shown to enhance the catalytic activity in vivo 
[Esteve et al., 2011; Lee and Muller, 2009]. 
 
DNMT3 family 
DNMT3A and DNMT3B are closely related and they show activity on unmethylated DNA and 
are responsible for establishing de novo methylation during embryogenesis and gametogenesis. 
While Dnmt3a/Dnmt3b double-knockout ESCs are unable to methylate newly introduced retroviral 
elements, the maintenance methylation of imprinted regions is not affected [Kaneda et al., 2004; 
Okano et al., 1999]. Accordingly, both DNMT3A and DNMT3B are highly expressed in ESCs as 
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well as germ cells and down-regulated in differentiated cells and tissues [Watanabe et al., 2002]. 
Knockout mice lacking either DNMT3A or DNMT3B die at different stages during embryonic 
development. Dnmt3b-/- mice are not viable and display several developmental defects, whereas 
Dnmt3a-/- mice die four weeks after birth. This indicates an essential role for DNMT3B during 
early developmental stages, while DNMT3A is important for methylation in later development 
[Okano et al., 1999]. Human patients with mutations in DNMT3B suffer from the ICF 
(immunodeficiency, centromere instability and facial abnormalities) syndrome and display 
methylation defects at pericentric heterochromatin and at CpG islands on the inactive X 
chromosome [Ehrlich et al., 1982; Miniou et al., 1994]. Recent studies revealed that mutations in 
the functional domains of the human DNMT3A gene cause overgrowth syndromes, intellectual 
disabilities and facial dysmorphism. The associated mutations are likely to disrupt histone binding 
and intramolecular interactions within DNMT3A [Tatton-Brown et al., 2014]. In addition, 
DNMT3A was shown to catalyze non-CpG methylation especially during neuronal maturation. 
First studies proposed a potential role in transcriptional repression for this special case of DNA 
methylation, but the exact mechanisms and functions are not fully understood [Aoki et al., 2001; 
Guo et al., 2014]. 
Both DNMT3A and DNMT3B contain an N-terminal regulatory domain linked to a C-terminal 
catalytic domain. The PWWP (Pro-Trp-Trp-Pro) domain was shown to bind H3K36me3, thus, 
enhancing methyltransferase activity and heterochromatin targeting [Dhayalan et al., 2010; Fuks et 
al., 2001; Ge et al., 2004]. The PHD (plant homeodomain) is essential for multiple interactions 
with chromatin-associated proteins including HP1, HDAC1 (histone deacetylase 1) and the 
histone methyltransferase SUV39H1 [Fuks et al., 2001; Fuks et al., 2003].  
The third member of the DNMT family, DNMT3L, lacks some essential catalytic motifs and has 
no methyltransferase activity. However, DNMT3L serves as a cofactor for DNMT3A and 
DNMT3B and stimulates their activity via direct interaction [Chedin et al., 2002; Gowher et al., 
2005; Jia et al., 2007]. 
 
 
1.5 New aspects of DNA methylation 
DNMT1 is involved in de novo  methylation 
The classical model implies that 5mC is introduced de novo at both DNA strands at CpG sites by 
DNMT3A and DNMT3B, which results in a pattern of either fully methylated or unmethylated 
sites. After each round of DNA replication, methylation is still present in the parental strands 
generating a pattern of hemimethylated and unmethylated CpG sites. For this reason, methylation 
can be maintained by DNMT1 that specifically remethylates hemimethylated CpG sites (Figure 3). 
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During the past decade compelling experimental evidence indicated that the classical site-specific 
methylation model needs to be revised and expanded [Jeltsch and Jurkowska, 2014; Jones and 
Liang, 2009]. 
The de novo methylation only by the DNMT3 enzymes during embryogenesis is challenged by the 
fact that both methyltransferases show distinct and selective flanking sequence preferences, which 
surrounds the targeted CpG site. This sequence-specific activity leads to the generation of 
hemimethylated sites, which represent ideal substrates for DNMT1 [Handa and Jeltsch, 2005; Lin 
et al., 2002; Wienholz et al., 2010]. Additionally, DNMT3A binds to DNA in a tilted manner and, 
thus, cannot methylate both strands of one CpG site during one binding event [Jia et al., 2007]. As 
DNMT1 preferentially methylates hemimethylated CpGs, de novo methylation of unmethylated 
DNA can be accomplished more efficiently by a cooperation of DNMT3 enzymes with DNMT1 
[Kim et al., 2002]. Furthermore, de novo methylation activity of DNMT1 was confirmed in vitro and 
in vivo as residual DNA methylation was observed in DNMT3A/DNMT3B double-knockout 
embryos [Goyal et al., 2006; Okano et al., 1999]. Recent genome-wide DNA methylation analysis 
compared wildtype to Dnmt1-/- cells and provided evidence that DNMT1 has considerable de novo 
methylation activity at single copy sequences and certain repetitive elements [Arand et al., 2012]. 
 
Maintenance methylation is not site-specific 
The classical maintenance methylation model is based on two important requirements: DNMT1 
has to work as a perfect copy machine and the methylation state of each CpG site has to be stably 
inherited, which would imply that all cells of the same tissue exhibit identical 5mC patterns.  
Indeed, genome wide methylation analysis at single base pair resolution revealed that the average 
methylation levels of DNA regions are maintained. However, no exact CpG site-specific 
methylation patterns could be observed, thus, changes in methylation densities occur through 
stochastic processes [Landan et al., 2012; Zhang et al., 2009]. Various biochemical studies 
determined that DNMT1 has a 10-40-fold preference for hemimethylated substrates [Bashtrykov 
et al., 2012; Bestor, 1992; Fatemi et al., 2001; Song et al., 2012]. Nevertheless, this preference is 
not nearly sufficient to guarantee accurate and site-specific copying of methylation patterns at all 
CpG sites in the genome during DNA replication. 
 
DNMT3A and DNMT3B are involved in maintenance methylation 
Knockout studies imply that DNMT1 alone is only capable of maintaining DNA methylation at 
CpG-poor regions but DNMT3A or DNMT3B are additionally required for methylation at 
repetitive elements such as the LINE1 promoter [Liang et al., 2002]. Furthermore, depletion of 
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DNMT3A and DNMT3B leads to a loss of methylation at repetitive elements, despite the 
presence of DNMT1 [Chen et al., 2003]. Together with recent genome wide studies [Arand et al., 
2012], these findings clearly indicate that cooperation between DNMTs is crucial for the 
maintenance methylation during replication. 
 
Complex regulation of DNMTs controls DNA methylation 
The activity of DNMTs is affected by targeting to and regulation of these enzymes at particular 
genomic regions rather than to individual CpG sites. Thus, DNA methylation is more complex 
than previously assumed by the classical site-specific methylation model (Figure 3). 
DNMT3 enzymes are predominantly enriched at heterochromatic regions and this recruitment is 
mediated by specific histone tail modifications. The PHD domain of DNMT3A and DNMT3B 
and their cofactor DNMT3L prevents binding of the complex to H3K4me2/3, a mark for active 
chromatin [Otani et al., 2009; Zhang et al., 2010c]. In addition, DNMT3A is targeted to 
H3K36me2/3 found inside gene bodies and heterochromatic regions via the PWWP domain 
[Dhayalan et al., 2010]. Lacking the catalytic domain, DNMT3L also has the potential to 
antagonize DNMT3A and DNMT3B activity and reduce DNA methylation at promoters of 
bivalent genes [Neri et al., 2013]. Since DNMT1 is associated with the replication fork and with 
hemimethylated sites, this targeting reduces its activity on other regions of the genome [Sharif et 
al., 2007]. Recently, the inhibition of DNMT1 activity by long non-coding RNAs has been shown 
as well [Di Ruscio et al., 2013]. 
 
Figure 3 Classic versus stochastic 
methylation model  
Left: In the classic methylation model fully 
methylated CpGs are generated by the de novo 
methyltransferases DNMT3A/B and their 
cofactor DNMT3L. This methylation pattern is 
maintained throughout DNA replication by 
DNMT1 in a site-specific manner.  
Right: No strict separation into de novo and 
maintenance DNMTs. DNMT activity and 
recruitment is controlled by the interaction with 
other proteins such as transcription factors (1). 
DNMT3L can activate or repress DNMT3A/B 
activity (2) and the access to DNA is achieved by 
chromatin remodeling complexes (3). Long non-
coding RNA represses DNMT1 function (4) and 
posttranslational modifications alter the enzymatic 
activity (5). Targeting of DNMTs is regulated by 
modifications on histone tails (6). The complex 
control of DNMT activity and epigenetic crosstalk 
leads to a more stochastic setting of methylation 
patterns with instructions of other epigenetic 
pathways. 
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Moreover, structural and in vitro methylation studies revealed that DNA wrapped around 
nucleosomes does not provide an ideal substrate for DNMTs [Jia et al., 2007; Takeshima et al., 
2006]. This suggests that in addition to DNMT recruiting, nucleosomes have to be removed or 
shifted by chromatin remodeling complexes in order to allow DNA methylation in the 
nucleosomal core region. Maintenance methylation occurs rapidly after replication, when 
nucleosomes are not yet assembled and not in later stages and during de novo methylation. Indeed 
the LSH (lymphoid specific helicase) protein, which belongs to the family of SWI/SNF (switch 
sucrose non fermentable) chromatin remodelers, plays an important role in de novo DNA 
methylation in mice [Dennis et al., 2001; Zhu et al., 2006], supporting the cooperation between 
chromatin remodeling and DNA methylation. 
In summary, DNA methylation is controlled by regulation and targeting of DNMTs, which 
include interaction with chromatin marks, posttranslational modifications, long non-coding RNAs 
and other factors. Furthermore, chromatin remodeling processes influence the accessibility of 
DNA for DNMTs. Together with the complex epigenetic crosstalk and non-CpG methylation, a 
more stochastic methylation model can be established, meaning that only the combined 
methylation density levels of larger DNA regions rather than site-specific methylation events is 
stably inherited. 
 
  
1.6 Reading the methylation mark 
How can DNA methylation in promoter regions lead to gene silencing? One possibility is that the 
presence of 5mC in the major groove of the DNA interferes with the binding of transcription 
factors that usually regulate gene expression [Choy et al., 2010; Watt and Molloy, 1988]. The 
second mode of repression involves proteins that are recruited to methylated CpG sites. 
 
Methyl-CpG-binding domain (MBD) proteins 
The MBD family has five known members in mammals: MBD1, MBD2, MBD3, MBD4 and 
MECP2 (Figure 4). MECP2 was the first characterized methyl-CpG binding protein and genomic 
sequencing projects and homology searches led to the identification of the other members [Becker, 
2006; Hendrich and Bird, 1998; Lewis et al., 1992]. 
They all contain a conserved MBD, which, except for MBD3, preferentially binds to methylated 
DNA substrates. MECP2 is highly expressed in the nervous system and sporadic mutations of the 
X chromosome linked MECP2 gene cause the neurodevelopmental Rett syndrome [Amir et al., 
1999]. Recent genome wide studies revealed that MBD2 is mainly recruited to CpG island 
promoters that are highly methylated, whereas MBD3 localizes at promoters, gene bodies and 
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enhancers of active genes [Menafra et al., 2014; Shimbo et al., 2013]. Interestingly, MBD1 
localization to certain chromatin regions is controlled by long non-coding RNAs [Monnier et al., 
2013]. 
 
Figure 4 Domain structure of the 
methyl-CpG-binding domain 
(MBD) proteins 
All MBD family members share a 
conserved MBD domain, which is essential 
for DNA binding. MBD1, MBD2 and 
MBD3 contain a transcriptional repression 
domain (TRD). MBD2 harbors glycine-
arginine-rich (GR-rich) and MBD3 
glutamine-rich (E-rich) repeats. MBD4 
contains a glycosylase domain at the C-
terminal end. Numbers indicate the length 
of the murine proteins in amino acids. 
 
All members regulate transcriptional repression by indirect HDAC interactions and all except 
MBD4 associate with nucleosome remodeling complexes such as the NuRD complex, which 
generates repressive chromatin states [Jones et al., 1998; Morey et al., 2008; Nan et al., 1998]. 
Furthermore, MBD1 and MECP2 were shown to directly recruit histone methyltransferases like 
SUV39H1, which methylates lysine 9 on histone H3, thereby creating a binding site for HP1. In 
this manner, a dynamic connection between DNA methylation and repressive histone 
modifications is established by MBD proteins [Agarwal et al., 2007; Lachner et al., 2001; Sarraf 
and Stancheva, 2004]. 
Additionally, MBD1, MBD2 and MECP2 comprise a non­conserved transcription repressor 
domain (TRD), which in the case of MECP2 was described to mediate interaction with DNMT1 
[Kimura and Shiota, 2003]. MBD2 and MBD3 were also identified to associate with DNMT1 and 
proposed to contribute to maintaining DNA methylation during DNA replication [Tatematsu et 
al., 2000]. Notably, MBD1 and MECP2 also bind to unmethylated DNA and were shown to 
generate condensed secondary and tertiary chromatin structures, which act as a physical barrier 
preventing the binding of activating transcription factors at these sites [Georgel et al., 2003; 
Jorgensen et al., 2004; Nikitina et al., 2007]. Interestingly, MBD4 is the only member harboring a 
thymine DNA glycosylase domain at the C-terminal end, which has been shown to be involved in 
the repair of TŊG mismatches generated by deamination of 5mC [Hendrich et al., 1999].  
 
UHRF protein family 
The UHRF family, comprising the multi-domain proteins UHRF1 and UHRF2, contain an N-terminal 
ubiquitin-like domain (Ubl), a tandem Tudor domain (TTD), a plant homeodomain (PHD), a SET-
and-RING-finger associated domain (SRA) and a C-terminal RING domain (Figure 5, top).   
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Figure 5 Domain structure of the 
UHRF family proteins 
Top: The multi-domain proteins UHRF1 
and UHRF2 contain a terminal ubiquitin-
like domain (Ubl), a tandem Tudor 
domain (TTD), a plant homeodomain 
(PHD), a SET-and-RING-finger 
associated domain (SRA) and a RING 
domain. Numbers indicate the length of 
the murine proteins in amino acids. 
Bottom: UHRF1 links histone modifi-
cations with DNA methylation. Crystal 
structure of the UHRF1-TTD (pink, PDB 
3DB3) bound to an H3K9me3 histone 
peptide (brown) and SRA domain (green) 
bound to hemimethylated DNA (blue, 
PDB 3FI).  5mC (red) is flipped out from 
the DNA helix and inserted into a 
conserved pocket on the inner concave 
surface of the SRA domain. 
 
 
UHRF1 colocalizes with PCNA during S phase, indicating a function during cell cycle 
progression, DNA replication or DNA damage repair [Fujimori et al., 1998; Muto et al., 2002; 
Uemura et al., 2000]. Furthermore, UHRF1 was shown to interact with DNMT3A, DNMT3B and 
several histone-modifying enzymes like HDAC1 or the histone methyltransferase G9A [Achour et 
al., 2009; Kim et al., 2009; Meilinger et al., 2009]. UHRF1 binds and flips out hemimethylated 
DNA via the SRA domain and targets DNMT1 to its substrate for maintenance DNA 
methylation (Figure 5, bottom) [Arita et al., 2008; Avvakumov et al., 2008; Bostick et al., 2007; 
Hashimoto et al., 2008]. The SRA domain of UHRF1 was described to also mediate direct 
interaction with DNMT1, thus, stimulating the methyltransferase activity by an allosteric 
mechanism. Consistently, UHRF1 not only increases the accessibility for DNA inside the catalytic 
center of DNMT1 but also the specificity for hemimethylated CpG sites [Bashtrykov et al., 2014; 
Berkyurek et al., 2014]. Additionally, UHRF1 deficient embryos display a phenotype very similar 
to Dnmt1­/­ embryos, including genome wide DNA hypomethylation and early embryonic lethality 
[Sharif et al., 2007]. 
The involvement of UHRF1 in maintenance DNA methylation is also based on its ability to 
recognize H3K9me2/3 through the TTD (Figure 5, bottom), thus, connecting DNA methylation 
with repressive histone marks [Nady et al., 2011; Rothbart et al., 2012; Rottach et al., 2010]. The 
adjacent PHD of UHRF1, previously implicated in transcriptional regulation and heterochromatin 
organization, was shown to bind the unmodified N-terminus of histone H3 and also target 
DNMT1 to hemimethylated sites [Hu et al., 2011; Papait et al., 2007; Rajakumara et al., 2011; 
Wang et al., 2011a]. Crystal structures of the linked TTD–PHD bound to H3K9me3 peptides 
revealed that UHRF1 can simultaneously bind the unmodified H3 N-terminus and H3K9me3 on 
a single histone H3 tail through this connected recognition module [Arita et al., 2012; Cheng et al., 
2013]. However, the UHRF1 TTD and PHD are also able to bind histone peptides independently 
UHRF1
UHRF2
Ubl TTD PHD SRA RING
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of one another in vitro [Hu et al., 2011; Rajakumara et al., 2011; Wang et al., 2011a]. Moreover, the 
UHRF1 dependent ubiquitination at H3K27 in Xenopus egg extracts was proposed to serve as an 
additional platform for the recruitment of DNMT1 to DNA replication sites [Nishiyama et al., 
2013]. 
The second member of the UHRF family, UHRF2, shares a high structural similarity to UHRF1 
[Bronner et al., 2007]. However, both members show opposite expression patterns: while UHRF1 
is mainly expressed in ESCs, UHRF2 is upregulated during differentiation and highly abundant in 
differentiated tissues. UHRF2 displays a preference for hemimethylated DNA only in 
combination with binding to H3K9me3 heterochromatin marks mediated by the TTD. 
Interestingly, the localization and in vivo binding characteristics of UHRF2 were described to 
require an intact TTD and depend on H3K9me3 recognition but not on DNA methylation. It was 
therefore postulated, that the cooperative interplay of UHRF2 domains might regulate gene 
expression in differentiated cells. Notably, ectopic expression of UHRF2 in Uhrf1-/- ESCs was not 
able to restore DNA methylation at major satellites arguing that the proteins are not functionally 
redundant [Pichler et al., 2011]. 
UHRF2 was also identified to take part in the intranuclear degradation of polyglutamine 
aggregates and recently it was found to interact with cell cycle proteins including cyclins, cyclin-
dependent kinases, retinoblastoma 1 protein (RB1), tumor protein p53 (P53), and PCNA [Iwata et 
al., 2009; Mori et al., 2012]. Therefore, UHRF2 might play an essential role in connecting the cell 
cycle with the epigenetic network. 
 
 
1.7 Erasing the methylation mark 
Compared with the highly dynamic histone modifications, DNA methylation is a relatively stable 
epigenetic mark. However, reversed DNA methylation has been observed in different biological 
contexts and this so-called demethylation process can occur actively or passively. Active DNA 
demethylation refers to the enzymatic removal or modification of the methyl group from 5mC. In 
contrast, passive DNA demethylation describes the loss or dilution of 5mC after repeated rounds 
of DNA replication in the absence or inhibition of the functional maintenance DNA methylation 
machinery. Although passive DNA demethylation is generally understood, the evidence for active 
DNA demethylation and how it is regulated has been controversial and incomplete. However, a 
number of recent discoveries shed new light onto the understanding of these complex processes 
and the underlying mechanisms. 
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Suggested DNA demethylation mechanisms independent of oxidation 
Direct removal of the methyl group 
The simplest mechanism leading to DNA demethylation is the direct enzymatic removal of the 
methyl group from 5mC. MBD2 was the first reported enzyme to catalyze this reaction. It was 
proposed that no specific cofactors were necessary and elimination of the methyl group resulted in 
the release of methanol [Bhattacharya et al., 1999]. To date, no compelling evidence supports that 
this thermodynamically unfavorable reaction could take place in vivo. As MBD2 can stably bind to 
methylated CpGs, it is unlikely that binding could occur if MBD2 was so efficient at removing the 
methyl group. Furthermore, MBD2 knockout mice show normal genomic methylation patterns 
and the paternal pronucleus of Mbd2-/- zygotes still undergoes normal demethylation [Hendrich et 
al., 2001; Santos et al., 2002]. Since no other laboratories were able to reproduce this specific 
MDB2 activity, serious doubts have been raised whether this protein is really involved in active 
demethylation. 
 
Radical SAM mechanism 
ELP3 (elongator complex protein 3) was described to be involved during active demethylation of 
the paternal genome in mouse zygotes [Okada et al., 2010]. Immunostaining and bisulphite 
sequencing of selected retrotransposons showed a potential role for ELP3 in demethylation. It 
was suggested that the radical SAM domain of ELP3 may be involved in the direct removal of the 
methyl group but clear biochemical evidence confirming this activity is still missing. 
 
Nucleotide excision of 5mC 
The repair of short genomic regions that contain methylated CpG sites can indirectly lead to active 
removal of 5mC. Nucleotide excision repair (NER) is mainly involved in repairing DNA 
containing bulky lesions, which result from exposure to radiation or chemicals. After the damaged 
DNA site is recognized, dual incisions flanking the lesion are made by specific glycosylases and a 
24–32 oligonucleotide is excised. The resulting gap on the single-stranded DNA is then filled in by 
polymerases and sealed by a ligase. The GADD45 (growth arrest and DNA-damage-inducible 
protein 45) family of proteins was reported to stimulate active DNA demethylation via NER. 
Overexpression of GADD45A in mammalian cell lines resulted in loci-specific as well as global 
demethylation, whereas knockdown led to DNA hypermethylation [Barreto et al., 2007]. Since 
GADD45A has previously been implicated in NER, loss of DNA methylation could be 
accompanied by DNA synthesis and requires the NER endonuclease XPG (xeroderma 
pigmentosum group G-complementing protein), which directly interacts with GADD45A 
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[Barreto et al., 2007; Zhan, 2005]. However, it is not fully understood how this NER-based 
demethylation pathway is initiated and whether GADD45A is directly involved during this 
process. Furthermore, two independent studies have raised doubts on the role of GADD45A 
since a more detailed analysis of the Gadd45a-/- mice showed neither loci-specific nor global effects 
on DNA methylation levels [Engel et al., 2009; Jin et al., 2008].  
 
 
Base excision of 5mC or TŊG mismatches  
Active DNA demethylation could also be accomplished by direct removal of 5mC by base 
excision repair (BER). Strong genetic and biochemical evidence support the use of this pathway in 
plants [Bauer and Fischer, 2011; Zhu, 2009]. This type of repair is initiated by a DNA glycosylase 
that recognizes and excises the target base resulting in an abasic (apurinic and apyrimidinic (AP)) 
site. The DNA backbone is subsequently nicked by an AP endonuclease, which removes the 3′ 
sugar group leaving a single nucleotide gap that is ultimately filled in by DNA polymerase β and 
DNA-Ligase III [Fortini and Dogliotti, 2007]. Although it is clear that plants use BER to directly 
remove 5mC, evidence for a similar mechanism in vertebrates has been less compelling. The first 
indication that BER could contribute to DNA demethylation came from chicken embryo extracts, 
showing 5mC glycosylase activity against hemimethylated DNA [Jost, 1993; Jost et al., 1995]. 
Subsequent purification of this activity revealed that a homologue of mammalian thymine DNA 
glycosylase (TDG) was important for this process [Jost et al., 1999; Zhu et al., 2000b]. However, 
its excision activity towards 5mC is about 40-fold lower compared with that towards T and 
although TDG can flip C and T analogues into its active site, it is not able to lyse the N-glycosidic 
bond [Bennett et al., 2006]. In addition to TDG, MBD4 was also proposed to show glycosylase 
activity against 5mC, but again this activity is about 40-fold lower than towards TŊG mismatches 
[Zhu et al., 2000a]. In accordance, Mbd4-/- zygotes display normal demethylation of the zygotic 
paternal pronucleus and Mbd4 knockout mice are viable and show normal DNA methylation 
pattern during development [Millar et al., 2002]. In contrast, TDG knockout mice die during 
embryonic development and exhibit modestly increased 5mC levels at some CpG-rich gene 
promoters [Cortazar et al., 2011; Cortellino et al., 2011]. 
Spontaneous deamination of cytosine generates uracil and the resulting mismatch can also be 
repaired by BER. The APOBEC family of cytidine deaminases are known to directly participate in 
generating mutations in RNA, which contribute to antibody diversification in B cells [Conticello, 
2008]. Previous in vitro studies showed that the APOBEC member AID (activation-induced 
deaminase) additionally converts 5mC to T in DNA [Morgan et al., 2004]. However, AID is only 
active on single-stranded DNA and displays up to 20-fold lower activity on 5mC relative to 
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cytosine, its canonical substrate [Bransteitter et al., 2003; Nabel et al., 2012]. AID knockout mice 
exhibit the expected B cell and immunological defects, but are viable and fertile [Morrison et al., 
1996]. Nevertheless, studies in mouse primordial germ cells (PGC), mouse ESC/human fibroblast 
fused heterokaryons and induced pluripotent stem cells (iPSCs), support a potential role of AID-
mediated 5mC deamination in DNA demethylation [Bhutani et al., 2010; Kumar et al., 2013; Popp 
et al., 2010].  
Notably, DNMT3A and DNMT3B have been proposed to deaminate 5mC in vitro in the absence 
of the cofactor SAM [Metivier et al., 2008]. As SAM is abundant in vivo the DNMT-mediated 
deamination of 5mC remains elusive. 
 
TET proteins and oxidized cytosines 
In 1972, the presence of 5-hydroxymethylcytosine (5hmC), an oxidized derivative of 5mC, was 
detected in the mammalian genome [Penn et al., 1972]. However it took almost 40 years until the 
Ten-eleven-translocation (TET) family of Fe(II)-2-oxoglutarate dependent dioxygenases were 
identified as the enzymes that convert 5mC to 5hmC [Kriaucionis and Heintz, 2009; Tahiliani et 
al., 2009]. Subsequent studies showed that TET proteins can further oxidize 5hmC to 5-
formylcytosine (5fC) and 5-carboxylcytosine (5caC, Figure 6 and Figure 8) [Ito et al., 2011; 
Pfaffeneder et al., 2011]. These groundbreaking discoveries have highly contributed to the 
understanding of the molecular mechanisms leading to active DNA demethylation in mammals. 
TET1 was initially discovered as a fusion partner of the histone H3 lysine 4 methyltransferase 
MLL1 (Mixed lineage leukemia 1) in acute myeloid leukemia [Lorsbach et al., 2003; Ono et al., 
2002]. First experiments revealed that overexpression of TET1 leads to decreased genomic 5mC 
levels and recombinant TET1 protein can oxidize 5mC in vitro generating 5hmC [Tahiliani et al., 
2009]. Similar enzymatic activity was also demonstrated for TET2 and TET3, the two other 
members of the TET protein family [Ito et al., 2010]. The three TET proteins are expressed 
differently in a developmental-stage- and cell-type-specific manner. Whereas TET1 is specific for 
ESCs, the inner cell mass of blastocysts, and developing PGCs, TET2 and TET3 are broadly 
expressed in various adult tissues [Ito et al., 2010; Szwagierczak et al., 2010; Yamaguchi et al., 
2012]. Interestingly, TET3 is the only member present in mouse oocytes and zygotes at one-cell 
stage [Iqbal et al., 2011; Wossidlo et al., 2011].  
All TET family members contain a C-terminal catalytic domain, which includes a cysteine-rich 
(Cys-rich) domain and the double-stranded beta helix (DSBH) with the binding sites for the 
cofactors Fe(II) and 2-oxoglutarate (2-OG). An unstructured insert that shows great variation 
between TET family members separates the DSBH domain, but its exact function remains elusive 
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(Figure 6, top). A recent crystal structure of the TET2 catalytic domain in complex with DNA 
shows that the Cys-rich domain stabilizes the DNA above the DSBH core. Furthermore, TET2 
specifically recognizes CpG dinucleotides with 5mC inserted into the catalytic cavity using a base-
flipping mechanism (Figure, 6 bottom). As the methyl group is not involved in the TET2-DNA 
interaction, the composition of the catalytic cavity allows TET2 to accommodate 5mC-oxidized 
derivatives for further oxidation [Hu et al., 2013]. In addition, Tet1 and a long splicing variant of 
Tet3 encode a CXXC-zinc finger domain at their N-termini [Iyer et al., 2009; Liu et al., 2013b]. 
The CXXC domain is present in many chromatin-associated proteins and has a strong preference 
for unmethylated CpGs [Long et al., 2013]. Although TET2 lacks a CXXC domain, a neighboring 
gene Idax (inhibition of the Dvl and axin complex) encodes for a CXXC domain similar to those 
in TET1 and TET3. IDAX is thought to have been originally part of an ancestral Tet2 gene that 
underwent a chromosomal inversion, which separated the CXXC domain from the catalytic 
domain. It was shown that IDAX directly interacts with TET2 and is enriched at unmethylated 
CpG sites [Iyer et al., 2009; Ko et al., 2013].  
The isolated CXXC domain of TET1 was first described to have no DNA binding activity on its 
own and dispensable for catalytic activity in vivo [Frauer et al., 2011b]. However, further 
biochemical and structural analyses indicate that an extended TET1 CXXC domain may also 
recognize methylated cytosines and the TET3 CXXC domain can target unmethylated cytosines 
within both CpG and non-CpG contexts [Xu et al., 2011b; Xu et al., 2012; Zhang et al., 2010a]. 
Thus, unlike other CXXC domains that only bind to unmethylated CpG sites, CXXC domains of 
TET1 or TET3 and IDAX are more flexible in sequence selectivity and might recruit TET 
enzymes to their specific genomic targets.  
 
Figure 6 Domain composition of TET 
proteins and crystal structure of human 
TET2 catalytic domain bound to DNA 
Top: The C-terminal catalytic domain of the 
three TET proteins contains a cysteine-rich 
domain (Cys) and a double-stranded beta-helix 
(DSBH) domain, which includes a large insert. 
TET1 and a long splicing variant of TET3 also 
inherit a N-terminal CXXC domain. During 
evolution a chromosomal inversion detached the 
catalytic domain of TET2 from its CXXC 
domain, which became a separate gene encoding 
IDAX. Numbers indicate the length of the 
murine proteins in amino acids. 
Bottom: Crystal structure of human TET2 
catalytic domain bound to a methylated CpG 
containing substrate (PDB 4NM6). The target 
cytosine is flipped out of the DNA helix (blue) 
inside the core of the DSBH consisting of eight 
antiparallel beta-sheets (purple).  The Cys-rich 
region (yellow) wraps around the DSBH. 
Crystallization was preformed with the 2-OG 
analog N-oxalylglycine  (green) and iron 
(orange). Due to its low-complexity the insert 
was not crystallized and the two parts of the 
DSBH domain directly connected by a linker. 
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5hmC can be detected in most cell-types (1%-5% of 5mC) and is particularly enriched in the 
genome of adult neurons (up to 40% of 5mC) [Globisch et al., 2010; Kriaucionis and Heintz, 
2009; Szwagierczak et al., 2010]. With improved detection methods, TET proteins have been 
shown to be capable of further oxidizing 5hmC to 5fC and 5caC. Mass spectrometry analysis 
revealed that 5fC is present in various tissue types and 5caC is detectable in mouse ESCs, although 
their levels are at least an order of magnitude less than that of 5hmC [Ito et al., 2011; Pfaffeneder 
et al., 2011].  
 
Passive demethylation by replication-dependent dilution of oxidized cytosines 
The presence of oxidized 5mC bases at CpG sites may contribute to passive replication-dependent 
loss of 5mC. While there are conflicting results whether UHRF1 can specifically recognize 
hemihydroxymethylated CpG sites, DNMT1 has been shown to be less efficient in methylating 
hemihydroxymethylated CpGs than hemimethylated sites in vitro [Frauer et al., 2011b; Hashimoto 
et al., 2012b]. Thus, TET proteins may initiate a two-step demethylation process in dividing cells: 
The initial oxidation of 5mC could be subsequently followed by a replication-dependent passive 
dilution of 5hmC or potentially 5fC and 5caC. This mode of active DNA demethylation is distinct 
from simple passive dilution of 5mC, as this oxidation-based loss may be effective even in the 
presence of a functional methylation maintenance machinery.  
 
Figure 7 Passive DNA demethylation after oxidation by TET proteins 
TET proteins oxidize methylated CpG sites (mCpG) to generate symmetrically oxidized CpGs (oxCpG). During DNA 
replication, the oxidized cytosines may interfere with maintenance methylation by inhibiting UHRF1 binding or DNMT1 
activity. Thus, the CpG sites progressively lose methylation through successive DNA replication cycles. 
 
 
Active demethylation by base excision repair 
Two replication-independent demethylation mechanisms have been proposed, which couple 
iterative oxidation of methylcytosine with BER (Figure 8). In the first mechanism, TET proteins 
further oxidize 5hmC to generate 5fC or 5caC, which can be excised by TDG and their 
oxidation replication
DNMT1TETmCpG oxCpGCpG
UHRF1
replication
replication
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subsequent replacement with unmodified cytosine results in demethylation [He et al., 2011; Maiti 
and Drohat, 2011]. TDG is not able to efficiently remove 5mC or 5hmC and structural analyses 
indicate that TDG binds 5fCŊG or 5caCŊG mismatches with higher affinity than TŊG mismatches. 
Depletion of TDG causes 2–10-fold increased 5fC and 5caC levels in ESCs, consistent with the 
fact that these bases are demethylation intermediates that can be excised by TDG [Shen et al., 
2013; Song et al., 2013; Zhang et al., 2012]. However, even in TDG-deficient cells, 5fC is rare 
compared with 5mC (0.2% - 0.3% of 5mC), and 5caC is even less abundant indicating that there 
might be additional active demethylation mechanisms using other glycosylases. 
In the second proposed mechanism, 5hmC is deaminated to 5-hydroxyuracil (5hmU) by AID. 
Subsequently, 5hmU could be removed by single-strand-selective monofunctional uracil DNA 
glycosylase 1 (SMUG1), TDG or MBD4 and ultimately replaced by cytosine (Figure 8) [Guo et al., 
2011a]. In support of such mechanisms, TDG and MBD4 can excise 5hmUŊG mismatches in vitro. 
Furthermore, PGCs derived from AID- or TDG-deficient mice exhibit modestly increased levels 
of methylation at some CpG island promoters [Cortazar et al., 2011; Cortellino et al., 2011; 
Hashimoto et al., 2012c; Nabel et al., 2012]. Against a deamination based mechanism argues that 
the AID enzyme primarily acts on single-stranded DNA and APOBEC enzymes display no 
detectable activity on 5hmC [Nabel et al., 2012; Rangam et al., 2012]. Therefore, it seems unlikely 
that AID and APOBEC enzymes play a role in 5hmC-dependent demethylation pathways, 
although their involvement under specific conditions cannot be ruled out.  
 
 
 
Figure 8 Oxidized cytosines and potential active demethylation pathways 
The cytosine modification pathway starts with DNMTs, which use SAM as a methyl donor to catalyze methylation at the 5-
position of cytosine, yielding S-adenosylhomocysteine (SAH). TET proteins subsequently oxidize 5mC to 5hmC, 5fC and 
5caC using Fe(II), 2-OG and O2. 5fC and 5caC can be removed by TDG and replaced by cytosine via BER. Deamination of 
5hmC leads to the formation of hydroxymethyluracil (5hmU). 5hmU:G mismatches are proposed to be excised by SMUG1, 
TDG or MBD4 glycosylases. Other direct mechanisms are less well established, including dehydroxymethylation by 
DNMT3A and DNMT3B or decarboxylation.  
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Enzymatic removal of the oxidized methyl group 
Decarboxylation of 5caC 
Direct decarboxylation of 5caC to cytosine without BER was described in ESC lysates. This 
observation is based on oligonucleotides containing 5caC, isotopically labeled with 15N at both 
positions of the pyrimidine ring. After incubation with the lysates and tracing of the labeled 
oligonucleotide, a small but detectable amount of [15N2]-dC was measured [Schiesser et al., 2012]. 
However, the factor(s) that catalyze this decarboxylation reaction have not been identified. 
Recently, DNMT enzymes have been shown to decarboxylate 5caC containing DNA substrates in 
vitro, but this specific activity is unlikely under reducing cellular conditions in vivo [Liutkeviciute et 
al., 2014]. 
 
Dehydroxymethylation by DNMT3 enzymes  
DNMT3A and DNMT3B enzymes were shown to directly remove the hydroxymethyl group of 
5hmC in vitro, whereas this catalytic activity was not observed for DNMT1 [Chen et al., 2012]. 
Reducing conditions favored the methyltransferase activity of DNMT3A and oxidizing conditions 
enhanced dehydroxymethylation of double-stranded DNA oligonucleotides. Whether this redox-
state dependent reaction occurs in living mammalian cells, which contain a reducing environment 
is still unknown. Furthermore, additional structural and functional data of DNMT3A/B catalyzing 
this specific dehydroxymethylation reaction were not obtained so far. 
 
Biological functions of DNA demethylation 
Global erasure of 5mC occurs at specific stages of mammalian development, including early 
preimplantation embryos and developing germ cells. Uncovering the biochemical mechanisms of 
DNA demethylation and the emergence of highly sensitive technologies for mapping cytosine 
modifications allows studying the dynamic DNA demethylation pathways in biological processes.  
 
DNA demethylation dynamics during preimplantation development 
After the sperm fertilizes the oocyte and before the two pronuclei merge, the paternal genome 
undergoes an epigenetic remodeling process, which includes global DNA demethylation [Mayer et 
al., 2000]. In contrast, the maternal genome is not affected in one-cell zygotes, but gradually loses 
5mC during subsequent cell divisions as DNMT1 is actively excluded from the nucleus (Figure 9) 
[Cardoso and Leonhardt, 1999]. Loss of genome-wide paternal DNA methylation concurs with a 
rapid increase in 5hmC, 5fC and 5caC, suggesting that TET-mediated 5mC oxidation contributes 
to demethylation [Inoue et al., 2011; Inoue and Zhang, 2011; Iqbal et al., 2011].  
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Deletion of TET3, the only TET member present at this stage, abolishes the loss of 5mC in the 
male pronucleus [Gu et al., 2011; Wossidlo et al., 2011]. After the paternal and the maternal 
pronuclei fuse, bulk 5hmC, 5fC and 5caC in sperm-derived chromosomes and 5mC in oocyte-
derived chromosomes are lost by passive demethylation [Inoue et al., 2011; Inoue and Zhang, 
2011]. However, several maternally derived methylated CpG-rich regions, including maternal 
imprinting control regions (ICRs) remain fully or partially methylated [Smallwood et al., 2011; 
Smith et al., 2012]. Recent evidence shows that persistence of 5mC at ICRs is mediated by 
recruitment of DNMT1 and DNMT3A to these regions by zinc finger transcription factor ZFP57 
[Li et al., 2008]. 
 
Figure 9 DNA methylation and 
demethylation dynamics in pre-
implantation embryos	  
Immediately after fertilization, paternal 
5mC is rapidly oxidized by TET3. 
Oxidized 5mC levels in the paternal 
genome and 5mC in the maternal 
genome are diluted through passive 
demethylation.  Blastocysts and ESCs 
show lowest mC levels. After 
implantation, DNA methylation is 
rapidly re-established. Modified from 
[Wu and Zhang, 2014] 
 
 
TET proteins in pluripotency and reprogramming 
ESCs, which are obtained from the inner cell mass of the blastocyst, are characterized by their 
pluripotency and ability for self-renewal. Under defined conditions, they can be expanded 
indefinitely in culture and maintain their full developmental potential. 
Current data indicate that, despite the presence of relatively high expression levels of TET1 and 
TET2 proteins in ESCs, both enzymes are largely dispensable for ESC maintenance but may play 
a role in guiding ESCs to properly differentiate into defined lineages [Koh et al., 2011]. Indeed, 
while Tet1−/− and Tet2−/− single-mutant mice are viable, roughly half of Tet1/Tet2 double- knockout 
mice die perinatally with severe developmental defects, indicating a key function of TET1/2 
proteins in regulating embryonic development. Interestingly, some double-mutant embryos 
survived to normal and fertile adult mice, which could be explained by partial compensation 
through TET3 [Dawlaty et al., 2013; Dawlaty et al., 2011; Li et al., 2011]. In line, Tet3−/− single 
mutant mice die perinatally [Gu et al., 2011].  
Although the exact functions of TET proteins in ESC self-renewal needs to be further studied, 
several recent publications indicate that they are involved in reprogramming of somatic cells to 
generate induced pluripotent stem cells (iPSCs). The transfection of differentiated cells with 
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specific combinations of transcription factors can reprogram them into iPSCs that show 
phenotypically similar features as pluripotent ESCs. The classic set of transcription factors (TFs) 
used in initial experiments was SOX2, OCT4, KLF4 and MYC, but other combinations have also 
been applied successfully [Takahashi and Yamanaka, 2006]. Initial studies showed that TET2 is 
recruited to the Nanog and Esrrb loci, which both are pluripotency-related TFs, to enhance their 
transcription in the early stage of reprogramming [Doege et al., 2012]. Furthermore, TET1 and 
TET2 are proposed to directly interact with NANOG and promote iPSC generation based on the 
enzymatic activity of TET [Costa et al., 2013]. Interestingly, TET1 overexpression not only 
promotes transcriptional reactivation of Oct4, but also can replace OCT4 as a reprogramming 
factor [Gao et al., 2013]. Recent reprogramming experiments also highlight the role of ascorbic 
acid (vitamin C) in modulating TET functions during iPSC generation and improvement of iPSC 
quality [Chen et al., 2013a; Stadtfeld et al., 2012]. In summary, the ability of TET proteins to 
generate oxidized methylcytosines and demethylate selected regions may help to establish the 
pluripotent state and also support the reprogramming of somatic cells to iPSCs. 
 
TET proteins and cancer  
Aberrant DNA methylation is one of the hallmarks associated with cancer cells [Baylin and Jones, 
2011]. Initially, human TET1 was identified as a rare fusion partner of MLL in patients with acute 
myeloid leukemia (AML) [Ono et al., 2002]. Subsequent studies clearly pointed out a connection 
between mutations in the TET2 gene and various myelodysplastic disorders [Ko et al., 2010; 
Konstandin et al., 2011; Langemeijer et al., 2009]. Loss of TET2 in mice causes a dysregulation and 
enhanced self-renewal of hematopoietic stem cells, indicating a potential role as a tumor suppressor for 
leukemia [Ko et al., 2011; Li et al., 2011; Moran-Crusio et al., 2011]. Interestingly, most TET2 
mutations are mutually exclusive with neomorphic mutations in IDH1/2 (isocitrate deydrogenase 1/2) 
in AML. Wild-type IDH1/2 converts isocitrate to 2-OG during the citric acid cycle, whereas mutant 
IDH produce 2-hydroxyglutarate (2-HG), an oncometabolite that competitively inhibits 2-OG-
dependent dioxygenases, including TET proteins [Dang et al., 2010; Figueroa et al., 2010; Ward et al., 
2010; Xu et al., 2011a]. Thus, mutations in citric acid cycle enzymes could result in inactivation of TET 
proteins and alteration of methylation patterns in cancer cells. In line with that, transcriptional 
downregulation of TET proteins and IDH1/2 mutations can be identified in many solid cancers and 
global loss of oxidized cytosine derivatives could be used as a diagnostic biomarker for human 
melanoma, breast, liver, and lung cancer [Lian et al., 2012; Yang et al., 2013]. Multiple mechanisms may 
affect TET-mediated 5mC oxidation, but most molecular targets of TET proteins that are causally 
linked to cancer development and progression still remain elusive.  
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1.8 Aims of this work 
In mammals, DNA methylation plays a central role in the epigenetic regulation of gene expression 
and it is crucial for maintaining genomic stability. DNA methylation was initially thought to be a 
relatively stable mark, however, the idea evolved that this modification is subject to dynamic 
changes in response to different stimuli. In 2009, the TET family of proteins was discovered, 
which catalyze the oxidation of 5mC to 5hmC, 5fC and 5caC, potential intermediates of DNA 
demethylation. 
The first objective of this thesis was to screen for reader proteins of 5mC and its oxidized 
derivatives in ESCs, NPCs and adult brain tissue. For this aim, quantitative mass spectrometry 
based proteomics was applied and the functions of specific readers were further characterized with 
structural and biochemical methods.  
After the discovery of the TET proteins, several BER-based active DNA demethylation 
mechanisms have been proposed. One controversially discussed pathway also involves the 
conversion of 5hmC to 5hmU by specific deaminases. To elucidate whether 5hmU is really 
present in genomic DNA, high sensitive mass-spectrometry was performed. Furthermore, 
isotope-tracing experiments were used to address the question, which enzyme is responsible for 
the generation of 5hmU. 
Although TET enzymes have been intensively investigated over the last five years only little is 
known how they are post-translationally modified. To investigate the phosphorylation and O-
GlcNAcylation status, mass-spectrometry was applied to obtain the modification status of all three 
TET proteins at amino acid resolution. 
Moreover, the function of the oxidized cytosine derivatives with regard to gene expression was 
analyzed. For this, an in vitro oxidation of a reporter gene was combined with the high-throughput 
expression analysis in vivo. Finally, a new glycosylase family was identified to be capable of serving 
as a backup for TDG, which was the main glycosylase involved in excision of the oxidized 
cytosines. 
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2.1 Dynamic readers for 5-(Hydroxy)Methylcytosine and its oxidized 
derivatives
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SUMMARY
Tet proteins oxidize 5-methylcytosine (mC) to
generate 5-hydroxymethyl (hmC), 5-formyl (fC), and
5-carboxylcytosine (caC). The exact function of
these oxidative cytosine bases remains elusive. We
applied quantitative mass-spectrometry-based pro-
teomics to identify readers for mC and hmC inmouse
embryonic stem cells (mESC), neuronal progenitor
cells (NPC), and adult mouse brain tissue. Readers
for thesemodifications are only partially overlapping,
and some readers, such as Rfx proteins, display
strong specificity. Interactions are dynamic during
differentiation, as for example evidenced by the
mESC-specific binding of Klf4 to mC and the
NPC-specific binding of Uhrf2 to hmC, suggesting
specific biological roles for mC and hmC. Oxidized
derivatives of mC recruit distinct transcription regu-
lators as well as a large number of DNA repair
proteins in mouse ES cells, implicating the DNA
damage response as a major player in active DNA
demethylation.
INTRODUCTION
Methylation of cytosine residues at carbon atom 5 of the base
(mC) represents a major mechanism via which cells can silence
genes. Cytosine methylation mostly occurs in a CpG dinucleo-
tide context. However, CpG islands (CGIs), which are character-
ized by a very high CpG density and are often found in promoter
regions of genes, are typically hypomethylated. Methylation of
these CGIs results in transcriptional silencing. The molecular
mechanisms underlying the association between DNA methyla-
tion and repression of transcription have proven difficult to
decipher. The classic view is that methylation of DNA results in
the recruitment of methyl-CpG-binding proteins (MBPs) that
possess transcriptionally repressive enzymatic activities (Defos-
sez and Stancheva, 2011). However, in vivo validation for this
model on a genome-wide level is still lacking. In contrast,
recent in vivo data have revealed that CXXC-domain-containing
proteins specifically bind to nonmethylated cytosines. In this
case, hypomethylated CGIs serve as a recruitment signal for
CXXC-domain-containing activators that establish a transcrip-
tionally active chromatin state (Thomson et al., 2010).
It was discovered 4 years ago that Tet enzymes convert mC
to 5-hydroxymethylcytosine (hmC) (Kriaucionis and Heintz,
2009; Tahiliani et al., 2009). This modification is particularly
abundant in the brain and in embryonic stem cells but is detect-
able in all tissues tested (Globisch et al., 2010; Szwagierczak
et al., 2010). Tet enzymes can catalyze further oxidation of
hmC to 5-formylcytosine (fC) and 5-carboxylcytosine (caC) (He
et al., 2011; Ito et al., 2011; Pfaffeneder et al., 2011). fC and
caC can subsequently serve as substrates for thymine-DNA
glycosylase (Tdg), which eventually results in the generation of
a nonmethylated cytosine (He et al., 2011; Maiti and Drohat,
2011). Therefore, this Tet-Tdg pathway represents an active
DNA demethylation pathway. It is not clear whether hmC, fC,
and caC have additional DNA-demethylation-independent
1146 Cell 152, 1146–1159, February 28, 2013 ª2013 Elsevier Inc.
functions, as very few specific binders, or ‘‘readers,’’ for these
oxidized versions of mC have been described thus far.
We applied quantitative mass spectrometry (MS)-based pro-
teomics to identify a large number of readers for mC and its
oxidized derivatives in mouse embryonic stem cells (mESCs).
Furthermore, we also identified readers for mC and hmC in
neuronal progenitor cells (NPCs) and in adult mouse brain. Our
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Figure 1. Identification of mC- and hmC-
Specific Readers in Mouse Embryonic Stem
Cells
(A) Schematic overview of the workflow.
(B) Scatterplot of a SILAC-basedmCDNA pull-down
in mESC nuclear extracts.
(C) Validation of the mC-specific binding of Klf4
and nonmethyl-C-specific binding of Cxxc5
and Kdm2b. DNA pull-downs were performed with
recombinant GST-fusion proteins followed by
western blotting. For MBD3_25, an empty lane was
cut out.
(D) Scatterplot of a SILAC-based hmC DNA pull-
down in mESC nuclear extract.
(E) Venn diagram showing overlap of readers for C,
mC, and hmC.
(F–L) Representative mass spectra obtained in
the triple-SILAC DNA pull-down in mESCs. Each
spectrum shows the relative affinity of the indicated
peptides and proteins for nonmethylated (yellow),
methylated (blue), and hydroxymethylated (red)
DNA.
See also Figure S1 and Table S1.
data reveal that each cytosine modifica-
tion recruits a distinct and dynamic set of
proteins. The known biology of these inter-
acting proteins suggests a role for hmC,
fC, and caC in active DNA demethylation
pathways via base excision repair (BER),
as well as an epigenetic recruitment func-
tion in certain cell types.
RESULTS
Identification of mC and hmC
Readers in mESCs
To identify readers for methylcytosine and
its oxidized derivatives, we made use of
a DNA pull-down approach combined
with quantitative MS. In brief, nuclear
extracts from mESCs grown in ‘‘light’’ or
‘‘heavy’’ SILAC medium were incubated
with a nonmodified or modified double-
stranded DNA sequence (50-AAG.ATG.
ATG.AXG.AXG.AXG.AXG.ATG.ATG-30,
with X representing C, mC, or hmC;
‘‘forward’’ pull-down; Figure 1A). As a
control, a label-swap, or ‘‘reverse,’’ exper-
iment was performed. Following incuba-
tion and washes, beads were combined
and bound proteins were in-gel digested
with trypsin and analyzed by liquid chromatography-tandem
mass spectrometry (LC-MS/MS). Raw MS data were analyzed
using MaxQuant (Cox and Mann, 2008). Specific interactors are
distinguishable from background proteins by their H/L ratio.
Proteins binding selectively to the modified DNA have a high
ratio in the forward pull-down and a low ratio in the reverse pull-
down, whereas readers for the nonmodified DNA show opposite
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binding (low forward ratio, high reverse ratio). Background
proteins will have a 1:1 ratio in both pull-downs (Figure 1A).
As shown in Figure 1B and Table S1 available online, we iden-
tified 19 proteins enriched for mC compared to C in mESC
nuclear extracts (p < 0.05 and ratio >2 in both pull-downs).
Among these are the methyl-CpG-binding proteins MeCP2,
Mbd1, Mbd4, and Uhrf1 (Defossez and Stancheva, 2011). Other
interactors include Rfx1 and Zfhx3, which were previously
identified as mC readers (Bartke et al., 2010; Sengupta et al.,
1999). Interestingly, three Klf proteins were identified as mC
readers: Klf2, -4, and -5. These proteins carry three Krüppel-
like zinc fingers, just like the Kaiso family of mC-binding proteins.
Klf4 is one of the four Yamanaka reprogramming factors and has
not been previously identified as amC-binding protein in HeLa or
U937 cells (Bartels et al., 2011; Bartke et al., 2010). This may
be due to the low expression of Klf4 in differentiated cells relative
to mESCs. We confirmed the direct binding of the Klf4 Krüppel-
like zinc fingers to mC using recombinant protein and two
different DNA sequences (Figure 1C and S1A). A motif bearing
similarities to a recently published consensus binding site for
Klf4, as determined by ChIP-seq (GGGXGTG) (Chen et al.,
2008), revealed that Klf4 binds this motif with the highest affinity
when ‘‘X’’ is mC (Figure S1A). These results establish Klf4 as
a sequence-specific mC binding protein.
Mining published bisulfite sequencing data of mESCs and
NPCs (Stadler et al., 2012) and overlapping this data with the
Klf4 ChIP-seq profile in mESCs (Chen et al., 2008) revealed
a substantial number of methylated Klf4-binding sites in this
cell type (Figure S1B), which are mainly intronic and intergenic
(Figure S1C). Out of the 7,321 Klf4-binding sites in mESCs that
were covered in the bisulfite sequencing data set, 1,356 show
high levels of DNAmethylation in mESCs (18.5%). Many of these
Klf4-binding sites contain a methylated Klf4-binding motif, such
as GGCGTG (Figures S1D and S1E). Interestingly, many Klf4-
binding sites that are nonmethylated in ES cells become hyper-
methylated in NPC cells (Stadler et al., 2012) (Figures S1B and
S1D). This finding may be highly relevant in the context of Klf4-
mediated cellular reprogramming. During reprogramming, Klf4
may be able to bind these methylated loci in differentiated cells
to initiate stem-cell-specific gene expression patterns. Enrich-
ment analyses for functional domains among the mC interactors
revealed DNA-binding zinc fingers to be significantly enriched
(Benj.Hoch.FDR = 102.45; Figure S3A). These zinc fingers
may also interact with the methylated DNA in a sequence-
specific manner.
In addition to the cluster of mC-binding proteins, a large
number of proteins displayed preferential binding to nonmethy-
lated DNA (Figure 1B, upper-left quadrant). Consistent with
previous observations, this cluster of proteins contains a number
of CXXC-domain-containing proteins that are known to prefer-
entially bind to nonmethylated CpGs (Blackledge et al., 2010;
Thomson et al., 2010). Examples include Cxxc5, Kdm2b, and
Mll1 (see Figure 1C). We also identified other subunits of the
Mll1 and PRC1.1 (Bcor) complexes, which most likely bind to
the nonmethylated DNA indirectly via Mll1 and Kdm2b, respec-
tively. Other interactors include the Ino80 chromatin-remodeling
complex and zinc-finger-containing transcription factors such
as Zbtb2, as well as basic leucine zipper-containing proteins
(enriched Benj.Hoch.FDR = 105.57; Figure S3A) such as JunD,
Creb1, and Atf7, for which sequence-specific DNA binding is
most likely abolished by DNA methylation.
Readers for hmC showed partial overlap with proteins
observed to interact with mC (Figure 1D, lower-right quadrant,
and Figure 1E), as only three proteins interacted with both modi-
fied baits: MeCP2, Uhrf1, and Thy28. Uhrf1 and MeCP2 are
known to bind both mC and hmC, although MeCP2 clearly
binds with a higher affinity to mC compared to hmC (Frauer
et al., 2011; Hashimoto et al., 2012; Mellén et al., 2012). Thy28
is an uncharacterized protein that is associated with apoptosis
(Toyota et al., 2012) and contains an EVE domain, which is
possibly involved in (ds)RNA binding (Bertonati et al., 2009).
Interestingly, two DNA glycosylases (Mpg and Neil3) and a heli-
case (Recql) were identified as hmC readers in mESCs. These
proteins might be involved in active DNA demethylation path-
ways to convert hmC back to cytosine via base excision repair
mechanisms, as has been suggested previously (Hajkova
et al., 2010; Wossidlo et al., 2010). In addition, a number of previ-
ously uncharacterized proteins, Wdr76 and C3orf37, preferen-
tially bound to hmC compared to C. We purified WDR76 as
a GFP fusion protein from HeLa cells and found interactions
with OCR, HELLS, and GAN (Figure S1F). The mouse protein
Hells, or Lsh, is a DNA helicase that has previously been impli-
cated in regulating DNA methylation levels in cells (Dennis
et al., 2001). Interestingly, OCR, or Spindlin-1, is a protein that
is known to bind trimethylated H3 lysine 4 (H3K4me3) (Bartke
et al., 2010). A large number of proteins preferentially bound to
the nonmodified DNA, as was observed for the mC pull-down
(Figure S1G). We validated some of these findings using western
blotting for endogenous proteins (Figure S1H).
To further investigate the relative affinity of proteins for C
versus mC versus hmC in a single experiment, we made use of
a triple pull-down approach (Vermeulen et al., 2010), in which
mESCs are grown in three different SILAC media. ‘‘Light,’’
‘‘medium,’’ and ‘‘heavy’’ nuclear extracts derived from these
cells are incubated with C-, mC-, and hmC-containing DNA,
respectively (Table S1). Quantitative MS is used to visualize the
relative abundance of a protein in each of the three different
pull-downs. This experiment confirmedmost of the observations
made in Figures 1B and 1D, although for some proteins, the
ratios in the triple pull-down are lower. As shown in Figures 1F
and 1G, Klf4 and Zbtb44 preferentially bind to the methylated
DNA. Other proteins bind to both modified baits, such as Uhrf1
(Figure 1H). Kdm2b preferentially binds to the nonmodified
DNA (Figure 1K). Contrary to a previous report (Yildirim et al.,
2011), we did not observe a specific interaction between
MBD3 and hmC (forward ratio, 0.448; reverse ratio, 1.823). We
validated these observations using recombinant protein (Fig-
ure 1C). At higher concentrations of recombinant MBD3 protein,
we observed a specific interaction with mC (Figure 1C), which is
in agreement with a recent study that revealed that MBD3 has
the highest affinity for mC compared to hmC and C (Hashimoto
et al., 2012).
Taken together, these experiments reveal that mC and hmC
both recruit distinct proteins in mESCs with little overlap.
Furthermore, a large number of proteins preferentially bind to
nonmodified DNA. The number of observed interactions with
1148 Cell 152, 1146–1159, February 28, 2013 ª2013 Elsevier Inc.
hmC is moderate, and some of these suggest that hmC acts as
an intermediate in active DNA demethylation pathways in
mESCs.
fC and caC Recruit a Large Number of Proteins inMouse
Embryonic Stem Cells, Including DNA Glycosylases and
Transcription Regulators
We also applied our SILAC-based DNA pull-down approach to
identify readers for fC and caC in mESCs. Colloidal blue analysis
revealed that the total amount of protein binding to each bait is
similar (Figure S2A). Ratios of the forward and reverse pull-
downs with hmC, fC, or caC were individually averaged, and
these average ratios were then plotted against each other in
two-dimensional graphs (Figures 2A–2C and Table S1). From
these plots, it is clear that both fC (blue, purple, and green) and
caC (yellow and green) recruit many more proteins than hmC
does (red and purple). Strikingly, there is only limited overlap
between fC and caC binders (green) (Figure 2D). One of the
proteins that binds to fC and caC, but not to hmC, is Tdg, which
is consistent with its reported substrate specificity (Maiti and
Drohat, 2011).We validated this binding behavior using recombi-
nant protein in electromobility shift assays (EMSA) (Figures 2E
and 2F). We also purified GFP-Tdg from ES cells to identify
Tdg interaction partners (Figure S2B and Table S1). None of
the Tdg interactors were identified as specific readers in the fC
and caC pull-down, indicating that these fC and caC interactions
are Tdg independent. Another fC-specific reader is the p53
protein, which plays an important role in DNA damage response
(Kastan et al., 1991). Interestingly, Dnmt1 specifically interacted
with caC. This interaction was confirmed by EMSA as well as
western blotting using an antibody against endogenous protein
(Figures 2F and S2C). We also identified subunits of the Swi/
Snf chromatin-remodeling complex, such as BAF170, as readers
for caC. Three proteins bind to all oxidized derivatives of mC:
Thy28, C3orf37, and Neil1. GO term enrichment for biological
processes shows that fC significantly enriches for proteins that
are related toDNA repair (Benj.Hoch.FDR = 10"2.71) (Figure S3A),
whereas caC interactors are not enriched for any biological
process. RNA-binding proteins, mitochondrial proteins, and
other proteins that are less likely to be associated with regulation
of gene expression or DNA repair binding were identified as
binders for fC and caC (Table S3). Some of these may have
a basic affinity for the formyl and carboxyl groups on the DNA
strands, which are more reactive than methyl or hydroxymethyl.
To exclude the possibility that many fC and caC interactors are
binding to damaged or abasic DNA, we validated the homoge-
neity of the DNA strands using HPLC (Figure S2D). Furthermore,
we analyzed the DNA before (blue) and after incubation (red) with
mESC nuclear extract by MALDI-TOF-MS (Figure S2E). Quanti-
fication of the modified residues by LC-MS/MS shows that
there is no significant loss of the modified bases after incubation
with nuclear extract (Figure S2F). Figures 2A–2C also show that
the group of proteins that bind preferentially to nonmodified
cytosine (black, lower-left quadrant) shows a large overlap
between the three pull-downs and contains the PRC1.1, Mll1,
and Ino80 complexes. To compare the relative affinity of proteins
for these three modifications in a single experiment, we per-
formed a triple pull-down. Analyses of the triple pull-down ratios
for the identified fC and caC readers show similar trends,
although some of the observed ratios are less prominent. As
shown in Figures 2G–2L (and Table S1), the representative
spectra of the indicated peptides of Tdg, Neil3, Mpg, Dnmt1,
MeCP2, and Uhrf1 show relative ratios that are in agreement
with ratios obtained in the independent experiments shown in
Figures 2A–2C.
In summary, our data suggest that oxidized cytosine bases
may induce a DNA damage response and trigger base excision
repair pathways, which may finally result in DNA demethylation.
In addition, each of these modifications recruits transcription
regulators and other proteins that are not likely to be related to
active DNA demethylation.
NPCs Contain a Distinct Set of mC and hmC Readers,
Including Uhrf2, which Has the Highest Affinity for hmC
To investigate whether interactions with mC and hmC are
dynamic during differentiation, we differentiated mESCs to
NPCs. Nuclear extracts were generated from these cells
followed by DNA pull-downs. Because no SILAC-compatible
neurobasal medium is available, these experiments were per-
formed using label-free quantification (LFQ) (Eberl et al., 2013;
Hubner andMann, 2011). Each DNApull-down is analyzed sepa-
rately and in triplicate. For all of the identified proteins (Table S1),
we used ANOVA statistics (p = 0.025 and S0 = 2) to compare the
relative enrichment of proteins for each of the three baits. All
significant outliers (192) were hierarchically clustered based on
correlation after normalization by row mean subtraction (Fig-
ure 3A). Protein enrichment is indicated in red, whereas lack of
enrichment is shown in blue. A large number of proteins bind
to C or mC, whereas fewer proteins are specifically enriched in
the pull-downs with hmC. Three smaller groups of proteins
bind specifically to two of the baits (C/hmC, C/mC, or mC/
hmC). As was observed in the DNA pull-downs from mESC
nuclear extracts, CXXC-domain-containing proteins (Kdm2b
and Mll, indicated in black) and their associated factors Bcor/
Ring1a/b (blue) and Rbbp5/Ash2l (black) are enriched in the
DNA pull-downs with nonmodified DNA relative to mC- and
hmC-containing DNA. We identified Mbd2 and associated
Mi-2/NuRD complex subunits as mC readers (indicated in
yellow). Other identified MBD proteins include Mbd4, MeCP2,
and Mbd1. Furthermore, a number of winged-helix (WH)-
domain-containing proteins bound specifically to mC, including
Rfx5 and its associated factors Rfxap and Rfxank (orange),
which have previously been identified as methyl CpG interactors
(Bartke et al., 2010).
Strikingly, these proteins bind more strongly to C compared to
hmC. We further substantiated these observations by using re-
combinant protein (Figure 3B). This result indicates that, for
some readers, oxidation of mC not only weakens the interaction,
but also repels the mC interactor. The homeobox domain is
significantly enriched in the cluster of mC-specific readers
(Benj.Hoch.FDR = 10"1.8, Figure S3A), which is consistent with
a previous study (Bartke et al., 2010). In addition, several known
mC readers, such as Kaiso, Uhrf1, andMbd4, bind bothmodified
forms of cytosine. A number of DNA glycosylases bind specifi-
cally to hmC (Neil1, Neil3), as well as some helicases (Hells,
Harp, Recql, and its homolog Bloom), which again suggests a
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Figure 2. fC and caC Recruit a Large Number of Nonoverlapping Proteins in Mouse Embryonic Stem Cells
(A–C) Scatterplots of SILAC-based hmC, fC, and caC DNA pull-downs in mESC nuclear extract. The average ratio of all the identified and quantified proteins in
the forward and reverse experiment for each of the threemodifications is plotted on the X, Y, and Z axes of a three-dimensional cube. Shown in (A–C) are different
side views of the cube. Colors indicate in which of the three pull-downs a protein was significantly enriched.
(D) Venn diagram showing the number of significantly enriched proteins for each of the baits.
(E) EMSA with GFP-Tdg at increasing protein concentrations (6.25–200 nM) incubated with dsDNA (250 nM of differentially labeled xC- and C-containing
oligonucleotide, each).
(F) Electrophoretic mobility shift assays as shown in (E) performed with GFP-Tdg and GFP-Dnmt1 for all six residue variants (C, mC, hmC, fC, caC, and abasic
site [AB]) in direct comparison to unmodified DNA. The binding preference was determined as the ratio of fluorescence signals of the different DNA substrates in
the shifted bands. Shown are the means of three experiments; error bars represent SD.
(legend continued on next page)
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DNA-repair-involved DNA demethylation pathway (GO DNA
repair; Benj.Hoch.FDR = 10"3.91; Figure S3A). Although
homeobox proteins are known to bind specifically to mC, a
number of homeobox proteins show preferential binding to
hmC in NPC extracts (examples include Zhx1 and -2). Finally,
Uhrf2 was identified as a specific hmC-binding protein in
NPCs, which we confirmed using recombinant protein (Fig-
ure 3B). Uhrf2 is not expressed in mESCs, and its levels increase
upon differentiation (Pichler et al., 2011). This explains why
Uhrf2 was not identified as an hmC-specific reader in mESC
DNA pull-downs.
Taken together, theseexperiments reveal that interactionswith
mC and hmC are highly dynamic during differentiation. Further-
more, the observations made in NPCs strengthen our hypothesis
that oxidation of mC serves as a trigger for active DNA demethy-
lation. Nevertheless, some hmC-specific readers in NPCs do not
appear to be linked to DNA repair mechanisms, indicating that, in
these cells, hmCmay also serve a role as a ‘‘classical’’ epigenetic
mark that recruits transcriptional regulators.
NMR-Based Analysis of the Rfx5 WH Domain Bound
to mC DNA
The specific interaction between the Rfx5 WH domain and mC
DNA was studied in detail using solution nuclear magnetic reso-
nance (NMR) spectroscopy in order to derive binding affinity and
identify the mC-binding site. Addition of a singly methylated
18bp DNA fragment to the Rfx5-WH domain results in large
changes in the 1H-15N HSQC ‘‘fingerprint’’ spectrum (Figure 3C).
After addition of a slightmolar excess of DNA, the spectrumdoes
not show any further changes, indicating that Rfx5-WH strongly
binds mC DNA and preferentially at only one of the two mC
sites (Figure 3C). The affinity of Rfx5 for mC DNA was derived
from the observed peak displacement for residues in the fast
exchange regime, such as T104 and E102, assuming that the
two mC are independent and equivalent, which resulted in an
apparent dissociation constant KD,app of!3 mM (with 95% prob-
ability limits 10 nM<KD<16 mM) (Figure 3D and Supplemental
Information). Based on DNA pull-downs done with recombinant
protein, which revealed a quantitative depletion of the WH
domain from the lysate, we anticipate the KD to be in the nM
range (Figure 3B) To identify the residues that are responsible
for specific mC binding, we used the DNA-bound Rfx1 WH
domain crystal structure (PDB ID 1DP7; sequence identity
35%; Avvakumov et al., 2008; Gajiwala et al., 2000) to construct
a homology model structure of Rfx5-WH and validated it
against the experimental chemical shifts (data not shown). The
homology model contains a hydrophobic pocket that includes
residues with the largest chemical shift changes and is well
aligned with an extended basic surface that is responsible for
DNA binding in Rfx1. This binding pocket, formed by the side
chains of K110, V113, Y114, T132, F135, L139, and Y169, is
appropriately shaped to capture the mC base via a flip-out
mechanism, as seen in the case of UHRF1 (Figure 3E). Steric
clashes introduced by the presence of an additional hydroxyl
group could cause the observed specificity for mC. Given the
apparent high affinity and DNA-sequence-independent binding
to mC, we propose that the WH domain that is present in Rfx
proteins is a bona fide mCpG-binding domain.
Brain-Specific Readers for mC and hmC Include Dlx
Proteins
The adult brain is the organ with the highest levels of hmC
(Globisch et al., 2010). Tet enzymes and hmC have been shown
to play a role in active DNA demethylation of certain genes in this
organ (Guo et al., 2011). To identify readers for C, mC, and hmC
in the adult brain, nuclear extracts were prepared from this
tissue, and these extracts were used for DNA pull-downs. LFQ
was used to determine differential binders (Table S1). In brain
extracts, we identified fewer specific readers compared to
NPCs (108, p = 0.025 and S0 = 0; Figure 4), most likely due to
the presence of highly abundant structural proteins derived
from connective tissue and extracellular matrix in these nuclear
extracts. Interestingly, more proteins specifically bind to hmC
compared to mC in brain extracts. This is in contrast to NPCs
and mESCs, in which more interactions with mC relative to
hmC are observed, which may imply a specific role for hmC in
brain tissue.
The nonmodifiedDNApull-down enriched for the same factors
as those observed in mESCs and NPCs, including Cxxc5,
Kdm2b, and Bcor (CXXC-domains indicated in black, PRC1
complex in blue, and Ino80 in red). In this case, mC DNA was
bound by the Mbd2/NuRD complex, which contains the brain-
specific ATPase Chd5 (Eberl et al., 2013; Potts et al., 2011) (indi-
cated in yellow). Interestingly, we identified three distal-less
homeobox proteins (Dlx1, -5, and -6) as specific mC interactors.
Dlx proteins play a role in the development of the brain and are
also expressed in specific regions of the adult brain (Jones
et al., 2011; Wang et al., 2011). Wdr76 and Thy28 are hmC
specific, as was also observed in NPCs. Thap11 (or Ronin) is
identified as a brain-specific hmC reader. Interestingly, this
protein is highly expressed in certain regions of the brain,
including Purkinje cells (Dejosez et al., 2008). Finally, we identi-
fied all four subunits of replication factor C (Rfc2-5) and the asso-
ciated factor Rfc1 as hmC-specific readers (indicated in green).
Altogether, these experiments further emphasize the dynamic
nature of the mC and hmC interactomes during development.
Global Absolute Quantification of Protein Levels in
mESCs, NPCs, and Adult Mouse Brain Extracts Reveals
Expression-Level-Dependent and -Independent
Interaction Dynamics
Our screening for mC- and hmC-specific readers in mESCs,
NPCs, and adult mouse brain revealed a large number of
cell-type- or organ-specific interactors (Figure S3B). The most
(G–L) Representative spectra of the indicated peptides obtained in the triple-labeled DNA pull-down in mESCs. Each spectrum shows the relative affinity of
the indicated peptides and proteins for hmC-containing (red), fC-containing (blue), and caC-containing (yellow) DNA. Spectra are shown for Tdg (G), Neil3 (H),
Mpg (I), Dnmt1 (J), MeCP2 (K), and Uhrf1 (L).
See also Figure S2 and Table S1.
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Figure 3. Hierarchical Clustering of NPC-Specific C, mC, and hmC Readers
(A) Correlation-based clustering of the LFQ intensities after log2 transformation and normalization by rowmean subtraction. Included in the clustering are proteins
that are significantly binding to at least one of the baits as determined by an ANOVA test. Blue indicates lack of enrichment, whereas enrichment is indicated in
red. Domain and Complex columns indicate the DNA-binding domain(s) that may be responsible for direct binding to the bait and the complexes that readers are
part of, respectively.
(B) Biochemical validation experiments using DNA pull-downs with recombinant DNA-binding domains.
(C) Overlay of Rfx5-WH HSQC spectra with increasing amounts of mC DNA added and color-coded on the indicated scale listing the WH domain:DNA ratio.
Some residues, such as F135 and R118, cannot be unambiguously tracked to their bound states because their chemical shift changes are very large. Peaks
corresponding to their bound state, such as ‘‘X,’’ appear only after addition of a full molar equivalent of DNA.
(D)Selectedbinding curves andfits for resonances that are in the fast exchange regime throughout the titration. Error bars (SD) for thepeakpositions are set to1.2Hz.
(E) Close-up of the putative mC-binding pocket in the RFX5 WH domain. The methylated cytosine is indicated in green.
See also Table S1.
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obvious explanation for these observed differential interactions
is regulation of reader abundance at the protein level. Alterna-
tively, the interaction between a reader and (modified) DNA
may be affected by posttranslational modifications (PTMs). To
investigate global absolute protein levels in the different nuclear
extracts that were used for the pull-downs, we made use of
a method called intensity-based absolute quantification (iBAQ)
(Schwanhäusser et al., 2011). Approximately 8,000 proteins
were quantified in at least one of the extracts (Table S2).
All proteins with at least a 10-fold change in concentration
were clustered based on their expression pattern (Figure S4B).
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Figure 4. Hierarchical Clustering of Brain-
Specific C, mC, and hmC Readers
Correlation-based clustering of the row-mean-
subtracted LFQ intensities of proteins in C, mC,
and hmC DNA pull-downs in adult mouse brain
nuclear extracts.
See also Table S1.
The cluster of mESC-specific proteins
is enriched for anchoring junction
(Benj.Hoch.FDR = 10"2.96) and cell
adhesion (Benj.Hoch.FDR = 10"2.14),
whereas proteins in brain enriched GO
terms such as synaptic transmission
(Benj.Hoch.FDR = 10"3.77) and cognition
(Benj.Hoch.FDR = 10"2.75), as expected
(Figure S4C). The molar concentrations
of proteins that are significantly enriched
in one of the DNA pull-downs are spread
over several orders of magnitude, indi-
cating that our screening is not biased
toward high-abundant proteins (Fig-
ure 5A). Of the 259 proteins that showed
dynamic interactions through develop-
ment (Table S3), 20 proteins were not
quantified in the iBAQ measurements.
The 74 proteins (!31%) that do show
a correlation between interaction pattern
and protein abundance in the different
extracts can be divided into six clusters
(Figure 5B). A correlation was defined as
gaining or losing an interaction accompa-
nied by at least a 2-fold change in protein
abundance. An example of a protein that
was identified as a specific (mC) reader
only in mESCs was Klf4. As shown in Fig-
ure 5B, this protein is highly expressed in
mESCs but is less abundant in NPCs or in
the adult mouse brain. Another example
is represented by the Dlx5 and Dlx6
proteins, which are highly abundant in
brain nuclear extract and exclusively
bind to mC in pull-downs from these
extracts. For about 185 proteins, no
correlation is observed between expres-
sion levels (at least 2-fold change) and
binding behavior. For these proteins, the
cause of differential binding may be explained through PTMs
that affect the interaction between a reader and DNA or a differ-
entially expressed cofactor. A good example of the latter is the
Mi-2/NuRD complex. Althoughmost of its subunits display equal
expression levels in mESCs, NPCs, and brain, mC-specific inter-
actions are not observed in mESCs. This can be explained by
the fact that Mbd2, which is the direct reader of mC within the
NuRD complex, is low in abundance in mESCs and is upregu-
lated during differentiation (Figure 5B). Thereby, it controls the
mC-specific binding of the entire complex. In mESCs, the
majority of the Mi-2/NuRD complex contains Mbd3, which is
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the MBD-containing protein that has lost its high-affinity mC
binding ability. Furthermore, technical reasons for not identifying
an interactor could be the presence of highly abundant structural
proteins in the brain lysate or binding competition among
different readers in the extracts. Altogether, the absolute quanti-
fication of protein abundance in the different nuclear extracts
revealed large differences in protein levels between mESC,
NPCs, and adult mouse brain. This data set serves as a rich
resource on its own but also enables us to explain many of the
differential interactions that we identified using quantitative
MS-based interactomics.
Uhrf2 Stimulates the Sequential Activity of the Tet1
Enzyme
The first protein that was identified as an hmC binder was Uhrf1
(Frauer et al., 2011), a protein that is involved in maintenance of
DNA methylation (Bostick et al., 2007). Our data revealed that
Uhrf1 binds with a similar affinity to mC and hmC, which is
consistent with previously published data (Frauer et al., 2011).
This is in contrast to Uhrf2, which we identified as a high-affinity
hmC-binding protein in NPC cells that shows a lower affinity for
mC. The function of Uhrf2 is not well understood. It is clear,
however, that Uhrf2 cannot rescue the phenotype of Uhrf1
knockout cells, which lose DNA methylation (Pichler et al.,
2011; Zhang et al., 2011). Uhrf1 is highly expressed in mESCs,
whereas Uhrf2 levels increase during differentiation (Table S3
and Pichler et al., 2011). Altogether, this prompted us to investi-
gate whether Uhrf2 expression affects the levels of mC and its
oxidized derivatives. The Tet1-catalytic domain was transfected
into HEK293T cells with andwithout coexpression of Uhrf2. Total
genomic DNA modification levels were determined using
LC-MS/MS (Figure 6 and Supplementary Information). As shown
in Figure 6D, Uhrf2 overexpression increases the level of hmC.
More striking is the increase of fC and caC levels upon Uhrf2 co-
expression together with the Tet1 catalytic domain. Because fC
and caC serve as substrates for Tdg and BER, the detected
increase in the levels of fC and caC following Uhrf2 expression
may be an underestimation of the actual production of these
bases. It therefore seems that Uhrf2 promotes repetitive oxida-
tion of mC by the Tet proteins. We hypothesize that flipping
the modified cytosine base out of the DNA double helix, as has
been described for Uhrf1 binding to methylated and hydroxyme-
thylated DNA (Arita et al., 2008; Frauer et al., 2011), may enhance
accessibility of the hydroxymethylated base to the Tet enzymes,
thereby promoting further oxidation.
DISCUSSION
In this study, we have used quantitative MS-based proteomics
to identify readers for mC and its oxidized derivatives in mESCs,
as well as readers for mC and hmC in NPCs and adult mouse
brain. Readers for individual modifications were found to be
highly dynamic throughout the three cell types and tissues that
we investigated (Figure 7). This is in contrast to interactions
with histone modifications, such as trimethylated lysines on
histone H3. For these modifications, the majority of interactors
are constant between different cell types or developmental
stages (Eberl et al., 2013 and M.V., unpublished data). Readers
for distinct cytosine modifications show limited overlap. This
indicates that, at least from a biochemical perspective, mC,
hmC, fC, and caC behave quite differently. Although little overlap
was observed with regard to proteins that interact with each of
the epigenetic marks, they all repelled a common set of proteins,
such as several CXXC-domain-containing proteins and their
interactors. It remains to be determined which of the conse-
quences of DNA (hydroxy)methylation is functionally most
relevant: recruitment of transcriptionally repressive complexes
or preventing the binding of certain (activating) proteins to
unmodified DNA. A detailed biochemical characterization of
the interactions and their dissociation constants will be impor-
tant to answer this question.
Our experiments revealed a number of DNA glycosylases and
DNA repair proteins that bind to hmC, fC, and caC, whereas
we identified few such proteins binding to mC. The enriched
binding of DNA-repair-associated proteins was most pro-
nounced for fC. From this observation, one can conclude that
the conversion of hmC to fC is a signal that is likely to result in
repair-associated removal of the modified base by proteins
that are rather ubiquitously expressed. It is therefore surprising
that, in different cell types and tissues, rather constant levels of
hmC, fC, and caC are found. The maintenance of such constant
levels of these bases in mESCs may indicate a high turnover of
DNA methylation, probably involving a constant ‘‘correction’’
by de novo methylation. Regardless, it will be important to
investigate which mechanisms control Tet enzyme conversion
of mC to hmC and further oxidation to fC and caC. Our data
reveal that coexpression of Uhrf2 with the catalytic domain of
Tet1 results in a (transient) upregulation of hmC, fC, and caC,
indicating that Uhrf2 promotes the sequential oxidation of
mC by Tet1. One of the other factors influencing the catalytic
activity of the Tet enzymes is the concentration of cellular
metabolites. It has been shown that oncometabolites such as
2-hydroxyglutarate can competitively inhibit the activity of
2-oxo-glutarate-dependent enzymes, such as the Tet proteins
(Chowdhury et al., 2011; Xu et al., 2011). Furthermore, mutations
in IDH1 and -2, which generate 2-oxo-glutarate, are
phenocopied by mutations in the TET enzymes and result in
cancer (Figueroa et al., 2010). Mutations in the IDH2 and TET2
genes were also linked to lower genomic hmC levels and
altered gene expression patterns in myeloid cancers (Ko et al.,
Figure 5. Global Absolute Protein Quantification in mESCs, NPCs, and Adult Mouse Brain
(A) Graphs indicating the concentration of all proteins identified in the nuclear extract (all) and the identified readers (significant) in each of the cell types. The gray
area indicates the concentration at which protein quantification is inaccurate.
(B) Readers for which protein expression levels correlate with DNA binding patterns were clustered into six groups based on their expression in the three
different nuclear extracts. The color indicates protein levels (white, low; red, high), whereas binding preference is indicated by C, mC, hmC, or combinations
thereof.
See also Figure S4 and Table S2 and Table S3.
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2010; Konstandin et al., 2011). In support of these observations,
which clearly link hmC to cancer, we noticed that many hmC,
fC, and caC readers are implicated in cancer, including
UHRF2, CARF, p53, and HELLS (Lee et al., 2000). Interestingly,
mutations in the Hells helicase, which we identified as an hmC
reader in NPCs, result in a decrease of DNA methylation levels
in cells (Myant et al., 2011). It seems clear that regulating
the levels of mC and its oxidized derivatives is essential for
normal cell homeostasis and that deregulation of the readers,
writers, and erasers of these marks results in a disturbance of
the balance between cell proliferation and differentiation during
development.
EXPERIMENTAL PROCEDURES
Cell Culture
IB10mESCswere cultured in light (R0K0) or heavy (R10K8) SILACmedium in the
presence of 2i compounds. For triple labeling, a third type of mediumwas used
containing medium-labeled L-lysine (K4) and L-arginine (R6). mESCs were
differentiated to NPCs in N2B27 medium and cultured in NSA medium, con-
sisting of NSA MEM, 1% glutamine, 13 N2 supplement, 10 ng/ml bFGF,
and 10 ng/ml EGF.
DNA Pull-Downs
Nuclear extracts were generated as described previously (Eberl et al., 2013;
Vermeulen et al., 2010). DNA (see Table S4) immobilized on Dynabeads My-
One C1 was incubated with nuclear extract in 50 mM Tris-HCl (pH 8),
150 mM NaCl, 1 mM DTT, 0.25% NP40, and complete protease inhibitors
(Roche, EDTA-free) in the presence of poly-dAdT. After extensive washes
(using incubation buffer without poly-dAdT), bound proteins were in-gel di-
gested using trypsin. After sample preparation, peptides were desalted on
Stage-tips (Rappsilber et al., 2003).
Mass Spectrometry
Peptides were separated using an EASY-nLC (Proxeon) connected online to
an LTQ-Orbitrap Velos mass spectrometer (Thermo) as described (Smits
et al., 2013). Raw data were analyzed using MaxQuant version 1.2.2.5 and
searched against protein database ipi.MOUSE.v3.68.fasta. Using Perseus,
data were filtered and scatter plots were made using R. The raw mass spec-
trometry data have been deposited to the ProteomeXchange Consortium
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Figure 6. Stable Isotope-Dilution-Based LC-ESI-MS/MS Quantification of Cytosine Derivatives in HEK293T Cells
(A) Nonquantitative LC-MS/MS chromatogram of digested genomic DNA from HEK293T cells cotransfected with Tet1-catalytic domain-GFP (GFP-Tet1cd)
and an unrelated expression construct (control). Depicted are the overlaid ion chromatograms of the MS/MS transitions for dC and the cytosine derivatives
(black curves). dC, mC, and hmC were measured by a factor of !102–103 less sensitive in comparison to caC and fC.
(B) Same as (A) except that Uhrf2-GFP was coexpressed together with GFP-Tet1cd. The MS signal intensities were normalized to the dC content of (A).
(C) Superposition of (A) and (B).
(D) Levels of cytosine derivatives relative to the total cytosine content (dG) as determined by quantitative LC-MS/MS mass spectrometry.
Shown are the means of technical triplicates; error bars reflect SD.
1156 Cell 152, 1146–1159, February 28, 2013 ª2013 Elsevier Inc.
(http://proteomecentral.proteomexchange.org) via the PRIDE partner reposi-
tory (Vizcaı́no et al., 2013) with the dataset identifier PXD000143.
Recombinant Protein Expression and DNA Pull-Downs
DNA-binding domains were cloned into the GST-containing PRP256NB
vector. The Uhrf2(aa416–626) GST-fusion construct was kindly provided by
Dr. Jiemin Wong. Protein expression was performed in E. coli BL21 codon+
cells. Bacterial lysate was cleared by ultracentrifugation. DNA pull-downs
were performed as described above with the addition of 10 mM ZnCl2 to the
incubation buffer.
iBAQ
iBAQ was performed essentially as described in Schwanhäusser et al. (2011).
A more detailed description can be found in the Extended Experimental
Procedures.
LC-MS/MS Analysis of Genomic DNA
Cotransfections were performed in HEK293T cells, and genomic DNA was
purified according to Münzel et al. (2010). Quantification of DNA nucleosides
from genomic DNA is based on a further development of our isotope dilution
method (Pfaffeneder et al., 2011 and data not shown). LC-MS/MS analysis
was performed on an Agilent 6490 triple quadrupole mass spectrometer
coupled to an Agilent 1290 UHPLC system. For general source- and
compound-dependent parameters, see the Extended Experimental Proce-
dures and Tables S5 and S6. The transitions of the nucleosides were analyzed
in the positive-ion-selected reaction monitoring mode (SRM) operating MS1
and MS2 under unit mass resolution conditions.
SUPPLEMENTAL INFORMATION
Supplemental Information includes Extended Experimental Procedures, four
figures, and six tables and can be found with this article online at http://dx.
doi.org/10.1016/j.cell.2013.02.004.
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Bostick, M., Kim, J.K., Estève, P.O., Clark, A., Pradhan, S., and Jacobsen, S.E.
(2007). UHRF1 plays a role inmaintaining DNAmethylation inmammalian cells.
Science 317, 1760–1764.
Chen, X., Xu, H., Yuan, P., Fang, F., Huss,M., Vega, V.B.,Wong, E., Orlov, Y.L.,
Zhang, W.W., Jiang, J.M., et al. (2008). Integration of external signaling path-
ways with the core transcriptional network in embryonic stem cells. Cell 133,
1106–1117.
Chowdhury, R., Yeoh, K.K., Tian, Y.M., Hillringhaus, L., Bagg, E.A., Rose, N.R.,
Leung, I.K.H., Li, X.S., Woon, E.C.Y., Yang, M., et al. (2011). The oncometabo-
lite 2-hydroxyglutarate inhibits histone lysine demethylases. EMBO Rep. 12,
463–469.
Cox, J., and Mann, M. (2008). MaxQuant enables high peptide identification
rates, individualized p.p.b.-range mass accuracies and proteome-wide
protein quantification. Nat. Biotechnol. 26, 1367–1372.
Defossez, P.A., and Stancheva, I. (2011). Biological functions of methyl-CpG-
binding proteins. Prog. Mol. Biol. Transl. Sci. 101, 377–398.
Dejosez, M., Krumenacker, J.S., Zitur, L.J., Passeri, M., Chu, L.F., Zhou, S.Y.,
Thomson, J.A., and Zwaka, T.P. (2008). Ronin is essential for embryogenesis
and the pluripotency of mouse embryonic stem cells. Cell 133, 1162–1174.
Dennis, K., Fan, T., Geiman, T., Yan, Q.S., and Muegge, K. (2001). Lsh,
a member of the SNF2 family, is required for genome-wide methylation. Genes
Dev. 15, 2940–2944.
Eberl, H.C., Spruijt, C.G., Kelstrup, C.D., Vermeulen, M., and Mann, M. (2013).
A map of general and specialized chromatin readers in mouse tissues gener-
ated by label-free interaction proteomics. Mol. Cell 49, 368–378, Published
onlne November 29, 2012. http://dx.doi.org/10.1016/j.molcel.2012.10.026.
Figueroa, M.E., Abdel-Wahab, O., Lu, C., Ward, P.S., Patel, J., Shih, A., Li, Y.,
Bhagwat, N., Vasanthakumar, A., Fernandez, H.F., et al. (2010). Leukemic
IDH1 and IDH2 mutations result in a hypermethylation phenotype, disrupt
TET2 function, and impair hematopoietic differentiation. Cancer Cell 18,
553–567.
Frauer, C., Hoffmann, T., Bultmann, S., Casa, V., Cardoso, M.C., Antes, I., and
Leonhardt, H. (2011). Recognition of 5-hydroxymethylcytosine by the Uhrf1
SRA domain. PLoS ONE 6, e21306.
Gajiwala, K.S., Chen, H., Cornille, F., Roques, B.P., Reith, W., Mach, B., and
Burley, S.K. (2000). Structure of the winged-helix protein hRFX1 reveals
a new mode of DNA binding. Nature 403, 916–921.
Globisch, D., Münzel, M., Müller, M., Michalakis, S., Wagner, M., Koch, S.,
Brückl, T., Biel, M., and Carell, T. (2010). Tissue distribution of 5-hydroxyme-
thylcytosine and search for active demethylation intermediates. PLoS ONE
5, e15367.
Guo, J.U., Su, Y.J., Zhong, C., Ming, G.L., and Song, H.J. (2011). Hydroxyl-
ation of 5-methylcytosine by TET1 promotes active DNA demethylation in
the adult brain. Cell 145, 423–434.
Hajkova, P., Jeffries, S.J., Lee, C., Miller, N., Jackson, S.P., and Surani, M.A.
(2010). Genome-wide reprogramming in the mouse germ line entails the
base excision repair pathway. Science 329, 78–82.
Hashimoto, H., Liu, Y.W., Upadhyay, A.K., Chang, Y.Q., Howerton, S.B., Ver-
tino, P.M., Zhang, X., and Cheng, X.D. (2012). Recognition and potential mech-
anisms for replication and erasure of cytosine hydroxymethylation. Nucleic
Acids Res. 40, 4841–4849.
He, Y.F., Li, B.Z., Li, Z., Liu, P., Wang, Y., Tang, Q.Y., Ding, J.P., Jia, Y.Y.,
Chen, Z.C., Li, L., et al. (2011). Tet-mediated formation of 5-carboxylcytosine
and its excision by TDG in mammalian DNA. Science 333, 1303–1307.
Hubner, N.C., and Mann, M. (2011). Extracting gene function from protein-
protein interactions using Quantitative BAC InteraCtomics (QUBIC). Methods
53, 453–459.
Ito, S., Shen, L., Dai, Q., Wu, S.C., Collins, L.B., Swenberg, J.A., He, C., and
Zhang, Y. (2011). Tet proteins can convert 5-methylcytosine to 5-formylcyto-
sine and 5-carboxylcytosine. Science 333, 1300–1303.
Jones, D.L., Howard, M.A., Stanco, A., Rubenstein, J.L.R., and Baraban, S.C.
(2011). Deletion of Dlx1 results in reduced glutamatergic input to hippocampal
interneurons. J. Neurophysiol. 105, 1984–1991.
Kastan, M.B., Onyekwere, O., Sidransky, D., Vogelstein, B., and Craig, R.W.
(1991). Participation of p53 protein in the cellular response to DNA damage.
Cancer Res. 51, 6304–6311.
Ko, M., Huang, Y., Jankowska, A.M., Pape, U.J., Tahiliani, M., Bandukwala,
H.S., An, J., Lamperti, E.D., Koh, K.P., Ganetzky, R., et al. (2010). Impaired
hydroxylation of 5-methylcytosine in myeloid cancers with mutant TET2.
Nature 468, 839–843.
Konstandin, N., Bultmann, S., Szwagierczak, A., Dufour, A., Ksienzyk, B.,
Schneider, F., Herold, T., Mulaw, M., Kakadia, P.M., Schneider, S., et al.
(2011). Genomic 5-hydroxymethylcytosine levels correlate with TET2 muta-
tions and a distinct global gene expression pattern in secondary acute myeloid
leukemia. Leukemia 25, 1649–1652.
Kriaucionis, S., and Heintz, N. (2009). The nuclear DNA base 5-hydroxymethyl-
cytosine is present in Purkinje neurons and the brain. Science 324, 929–930.
Lee, D.W., Zhang, K.J., Ning, Z.Q., Raabe, E.H., Tintner, S., Wieland, R., Wil-
kins, B.J., Kim, J.M., Blough, R.I., and Arceci, R.J. (2000). Proliferation-asso-
ciated SNF2-like gene (PASG): a SNF2 family member altered in leukemia.
Cancer Res. 60, 3612–3622.
Maiti, A., and Drohat, A.C. (2011). Thymine DNA glycosylase can rapidly excise
5-formylcytosine and 5-carboxylcytosine: potential implications for active
demethylation of CpG sites. J. Biol. Chem. 286, 35334–35338.
Mellén, M., Ayata, P., Dewell, S., Kriaucionis, S., and Heintz, N. (2012). MeCP2
Binds to 5hmC Enriched within Active Genes and Accessible Chromatin in the
Nervous System. Cell 151, 1417–1430.
Münzel, M., Globisch, D., Brückl, T., Wagner, M.,Welzmiller, V., Michalakis, S.,
Müller, M., Biel, M., and Carell, T. (2010). Quantification of the sixth DNA base
hydroxymethylcytosine in the brain. Angew. Chem. Int. Ed. Engl. 49, 5375–
5377.
Myant, K., Termanis, A., Sundaram, A.Y.M., Boe, T., Li, C., Merusi, C., Burrage,
J., de Las Heras, J.I., and Stancheva, I. (2011). LSH and G9a/GLP complex are
required for developmentally programmedDNAmethylation. GenomeRes. 21,
83–94.
Pfaffeneder, T., Hackner, B., Truss, M., Münzel, M., Müller, M., Deiml, C.A.,
Hagemeier, C., and Carell, T. (2011). The discovery of 5-formylcytosine in
embryonic stem cell DNA. Angew. Chem. Int. Ed. Engl. 50, 7008–7012.
Pichler, G., Wolf, P., Schmidt, C.S., Meilinger, D., Schneider, K., Frauer, C.,
Fellinger, K., Rottach, A., and Leonhardt, H. (2011). Cooperative DNA and
histone binding by Uhrf2 links the two major repressive epigenetic pathways.
J. Cell. Biochem. 112, 2585–2593.
Potts, R.C., Zhang, P.S., Wurster, A.L., Precht, P., Mughal, M.R., Wood, W.H.,
3rd, Zhang, Y.Q., Becker, K.G., Mattson, M.P., and Pazin, M.J. (2011). CHD5,
a brain-specific paralog of Mi2 chromatin remodeling enzymes, regulates
expression of neuronal genes. PLoS ONE 6, e24515.
Rappsilber, J., Ishihama, Y., and Mann, M. (2003). Stop and go extraction tips
for matrix-assisted laser desorption/ionization, nanoelectrospray, and LC/MS
sample pretreatment in proteomics. Anal. Chem. 75, 663–670.
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Supplemental Information
EXTENDED EXPERIMENTAL PROCEDURES
SILAC Labeling of ES Cells
IB10 murine Embryonic stem cells were cultured feeder-free on gelatin coated dishes in medium consisting of 500 ml SILAC
Dulbecco’s Modified Eagle Medium without arginine, lysine and glutamine (PAA, E15-086), supplemented with 15% MESC serum
substitute (Thermo Scientific), Glutamine, Penicillin/Streptomycin, 1x Non-essential amino acids, sodium pyruvate, 73 mg/ml
L-Lysine (light/K0 (Sigma, A6969), medium/K4 (Sigma, 616192 or Silantes, 211103912) or heavy/K8 (Sigma, 608041 or Silantes,
211603902)) and 29.4 mg/ml arginine (light/R0 (Sigma, A6969), medium/R6 (Sigma, 643440 or Silantes, 201203902) or heavy/R10
(Sigma, 608033 or Silantes, 201603902)), LIF (1000 U/ml), b-mercaptoethanol and 2i compounds (CHIR99021 and PD0325901,
3 and 1 mM respectively). Cells were cultured in SILAC medium until labeling efficiency exceeded 95% after which cells were
expanded and harvested to generate nuclear extracts.
NPC Culturing
Neuronal progenitor cells were kindly provided by Dr. N. S. Outchkourov. They were cultured in medium consisting of NSA MEM
(Euromed EVM0883LD), 1% glutamine, 1x N2 supplement, 10 ng/mL bFGF (RD systems 233-F3) and 10 ng/mL EGF (235-E9) on
gelatin-coated dishes. Cells were detached from culture plates using accutase. Nuclear extracts were made as described below.
Mice Brain Nuclear Extracts
Nuclei from adult mouse brain were purified by centrifugation through a sucrose cushion following homogenization, modified from
(Lavery and Schibler, 1993). Then nuclei were lysed as described below.
Nuclear Extract Preparation
This protocol is based essentially on Dignam et al. (Dignam et al., 1983). Briefly, cells were trypsinized and washed two times with
PBS. Using a hypotonic buffer, the cells were swollen, after which the cells were lysed by dounce homogenizing in the presence of
0.15% NP40 and complete protease inhibitors. After centrifugation, the pellet consisting of nuclei was lysed by 90 min incubation in
2 volumes of nuclear lysis buffer (420 mM NaCl, 20 mM HEPES pH 7.9, 20% v/v glycerol, 2 mM MgCl2, 0.2 mM EDTA, 0.1% NP40,
complete protease inhibitor w/o EDTA (Roche) and 0.5 mMDTT). After centrifugation, the supernatant containing the soluble nuclear
extract was aliquoted and snap frozen until further usage. Protein concentrations of the nuclear extracts were determined using the
Biorad Protein assay.
DNA Synthesis
The synthesis of the oligonucleotideswas performed on anABI 394DNA/RNASynthesizer (Applied Biosystems) using typical reagent
concentrations (activator: 0.25 M benzylthiotetrazole in MeCN (10 ppm H2O), detritylation: 3% dichloroacetic acid in CH2Cl2,
oxidation: 25mM I2 inMeCN/H2O/2,6-lutidine (11/5/1), capping: Ac2O/2,6-lutidine/MeCN (30 ppmH2O) (20/30/50) and 20%N-meth-
ylmidazole in MeCN (10 ppm H2O). The oligonucleotide syntheses were performed on 200 nmol low-volume polystyrene carriers
using 0.1 M DNA CE-phosphoramidites: A (Bz-dA), C (Bz-dC), G (iBu-dG), T, mC (Bz-mC) obtained from Glen Research or Link
Technologies. hmC, fC and caC phosphoramidites were synthesized according to literature (Münzel et al., 2010b) and incorporated
into DNA using the standard protocol. Benzylthiotetrazole was prepared according to literature (Welz andMuller, 2002). The coupling
times for the modified bases were increased to 3 min to ensure maximum coupling efficiency.
The mC and the unmodified strands were treated with ethanolic ammonia for cleavage of the carrier and removal of the permanent
protecting groups. hmC, fC and caC containing DNA was cleaved and deprotected using 0.4 M NaOH in MeOH/H2O 4:1 for 18 hr at
room temperature. After addition of 600 ml triethylammonium acetate (1 M) and centrifugation, the supernatant was concentrated to
30% of the original volume in a speedvac. Analysis and purification was performed on a Waters HPLC system (Waters Alliance 2695
with PDA 2996, preparative HPLC: 1525EF with 2482 UV detector) with VP 250/10 Nucleosil 100-7 C 18 columns from Macherey
Nagel using a gradient of 0.1 M triethylamine/acetic acid in water and 80% acetonitrile. The quality of the strands was determined
by MALDI-MS. The forward and reverse oligos were combined and annealed in 10mM Tris pH8; 50 mM NaCl and 1 mM EDTA.
Biotin-14-ATP was used to fill in the TT-overhang using Klenow exo-, followed by purification of the DNA on sephadex-G50 columns.
DNA Pull-Downs
For each DNA pull-down, 10 mg of DNA (see Table S4) was immobilized on 75 ml of Dynabeads MyOne C1 (Invitrogen) by incubating
for 1 hr at room temperature in a total volume of 350 ml of DNA binding buffer (1M NaCl, 10mM Tris-HCl pH8, 1mM EDTA pH 8 and
0.05% NP40. Coupling of the DNA to the beads was always verified by agarose gel electrophoresis. Beads containing immobilized
DNA were then incubated with 400 mg of nuclear extract in a total volume of 600 ml of protein binding buffer (50mM Tris-HCl pH8,
150 mM NaCl, 1mM DTT, 0.25% NP40 and complete protease inhibitors (Roche, EDTA-free)) in the presence of 10 mg poly-dAdT
for 2 hr at 4!C. Baits were then washed three times with 0.5 ml of protein binding buffer after which beads containing different
DNA modifications and different SILAC labels were combined and loaded on 4%–12% NuPage gradient gels (Invitrogen) (for
example, C-beads with light extract were combined with mC beads that were incubated with heavy extract; forward pull-down).
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For the label-free analysis, three separate DNA pull-downs with every bait were performed and each of these was loaded on gel
separately. For Western blot validation using endogenous antibodies, protein amounts were scaled down by a factor of four.
In-Gel Digestion
Samples were analyzed on 4%–12% precast NuPage gels (Invitrogen) and subsequently stained using colloidal blue staining
(Invitrogen). Each lanewas cut into 8-12 gel slices and each of these sliceswas subjected to in-gel trypsin digestion overnight. Tryptic
peptides were desalted on Stage-tips (Rappsilber et al., 2003).
Mass Spectrometry
Peptides were separated on an EASY-nLC (Proxeon) connected online to an LTQ-Orbitrap-Velos mass spectrometer. Spectra were
recorded in CID mode. A gradient of organic solvent (5%–30% acetonitrile) was applied (120 min) and the top 15 most abundant
peptides were fragmented for MS/MS, using an exclusion list of 500 proteins for 45 s.
Data Analysis
Raw data were analyzed using Maxquant version 1.2.2.5 and the integrated Andromeda search engine against protein database
ipi.MOUSE.v3.68. Using Perseus, data was filtered for contaminants, reverse hits, number of peptides (>1) and unique peptides
(>0). Ratios were logarithmitized (log2) and groups (consisting of forward and reverse) were defined. Proteins were filtered to have
at least 2 valid values in one of the groups and missing values were imputed based on a normal distribution (width = 0.2 and shift =
0), after which Significance B was calculated (Benj.Hoch.FDR = 0.05). Scatterplots were made using R. Proteins were defined to be
significant when both forward and reverse significance p < 0.05 and minimal ratios were > 2 in both experiments. The H/L ratios
shown in Figure 2A–C were calculated using the formula (log(forward ratio) – log(reverse ratio))/2.
Label-Free Quantification
LFQ values, based on the summed measured intensities of all tryptic peptides of a single protein, allows for comparing the relative
abundance of a protein in different pull-downs. Changes in the LFQ intensity of a protein between pull-downs with different DNA
modifications indicate preferential binding of that protein to one modification over another. Raw data were analyzed using Maxquant
version 1.2.2.5 and protein database ipi.MOUSE.v3.68.fasta. Settings that were different from SILAC analyses were: multiplicity set
at 1 and the options for ‘label-free quantification’ and ‘match between runs’ were selected Using Perseus, data were filtered for
contaminants, reverse hits, number of peptides (>1) and unique peptides (>0). LFQ intensities were logarithmitized (log2). After
defining each triplicate as a group, proteins were filtered to have at least 3 values in a single group, assuming that when a protein
binds specifically to one modification, it may only be identified in the three pull-downs with that modification. The missing values
were imputed using a normal distribution (with = 0.3, shift = 1.8). Groups were defined and the significant outliers were calculated
using ANOVA (FDR = 0.025, S0 = 2 for NPC and S0 = 0 for brain). Correlation based clustering was done in R for the ANOVA-outliers
only, using LFQ-values which had been normalized by row-mean-subtraction.
Purification of GFP-Fusion Proteins for EMSA
HEK293T cells were transfectedwith expression constructs encoding for GFP-Tdg or GFP-Dnmt1. 48 hr after transfection, cells were
lysed 30 min on ice in Lysis-Buffer (50 mM NaH2PO4, 150 mM NaCl, 10 mM Imidazole, 0.5 mM EDTA, 0.5% Tween, 1 g/l DNaseI,
2 mM MgCl2, 0.5 mM CaCl2, 1 mM PMSF, 1x Protease-Inhibitor-Mix M (SERVA Electrophoresis GmbH)). The lysate was cleared
by centrifugation (14 000 rpm, 10 min, 4!C) and incubation of the supernatant with equilibrated Ni-NTA beads (QIAGEN) in IP-buffer
(50 mM NaH2PO4, 150 mM NaCl, 10 mM Imidazole, 0.5 mM EDTA, 0.05% Tween). After centrifugation (2200 rpm, 2 min) the super-
natant was added to equilibrated GBP-Ni-NTA beads (Chromotek) in IP-buffer and rotated for 2 hr at 4!C. After washing three times
with Washing-Buffer (50 mM NaH2PO4, 300 mM NaCl, 10 mM Imidazole, 0.1% Tween), the GFP-fusion proteins were eluted with
50 mM NaH2PO4, 150 mM NaCl, 250 mM Imidazole, 0.05% Tween. The elution buffer was exchanged to 20 mM TrisHCl, pH 7.5,
150mMNaCl, 0.5mMEDTA, 1mMDTT for EMSA reactions. The glycosylase activity of the purified Tdgwas tested on T/Gmismatch
containing DNA (data not shown).
Electrophoretic Mobility Shift Assays of Fluorescent DNA Oligonucleotides with GFP-Fusion Proteins
GFP-Tdg and GFP-Dnmt1 at decreasing concentrations (200 nM, 150 nM, 100 nM, 50 nM, 25 nM 12.5 nM and 6.25 nM) were incu-
bated for 30 min on ice with a 1:1 mixture of two distinctly labeled fluorescent 42mers (see Table S4, MWG-Eurofins, 250 nM each)
containing a central CG site. The ATTO647N-labeled oligonucleotide contains only canonical bases whereas the ATTO550-labeled
DNA bears different cytosine modifications (C, mC, hmC, fC and caC) or an abasic site at the CG position on both strands. Samples
were run on a 6% non-denaturating polyacrylamide gel (pre-run 1 hr with 0.5x TBE) at 4!C. Oligonucleotide- and GFP-fluorescence
was detected by the Typhoon Scanner (GE Healthcare). Quantifications were done with ImageJ.
DNA Purification and Analysis after NE Incubation
DNA pull-downs were performed as described above, but all amounts were scaled up 3 times. As a control, all baits were also
incubated in buffer plus poly-dAdT without nuclear extract for 2 hr at 4!C. The beads were washed 3x using 1 ml of incubation buffer
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and 1x using 1M NaCl, 10mM Tris-HCl pH8, 1mM EDTA and 0.05% NP40, to reduce contamination with DNA from the nuclear
extracts. Beads were then resuspended in 200 uL incubation buffer and DNA was purified using phenol/chloroform extraction
from the beads. The DNA-strands were finally dissolved in milliQ, enzymatically hydrolyzed to nucleosides and analyzed in triplicate
(15 pmol each) by MALDI-MS or LC-MS/MS.
GFP Pull-Downs
HeLawild-type cells and a BAC-GFP transgenic cell line (WDR76) were cultured in SILACmedium for eight cell doublings, after which
cells were expanded and nuclear extracts weremade. For each pull-down 20 ml of GFP-trap slurry (50%v/v; Chromotek) waswashed
and incubated for 90 min at 4!C with 1 mg of nuclear extract of (WT L, WT H, GFP L and GFP H) in a total volume of 400 ml incubation
buffer (300 mM NaCl, 20 mM HEPES KOH pH 7.9, 20% v/v glycerol, 2 mM MgCl2, 0.2 mM EDTA, 0.1% NP40, complete protease
inhibitor w/o EDTA (Roche) and 0.5 mMDTT) in the presence of 2 ml ethidium bromide (10mg/ml, final concentration 50 mg/ml). Beads
were then washed two times with this incubation buffer, twice with PBS + 0.5% NP40 and two times with PBS only. During the last
wash, beads of light control and heavy GFP pull-down were mixed and vice versa. Bound proteins were then subjected to on-bead
trypsin digestion (Hubner and Mann, 2011) and significant proteins were determined as described for the SILAC DNA pull-downs.
For the GFP-Tdg pull-down, mESC were cultured in normal mESC medium and a transient transfection with the GFP-Tdg plasmid
(15 mg/15cm dish) using PEI (ratio DNA:PEI = 1:3) was performed. GFP-Tdg was purified in a label-free method, thus 3 pull-downs
were performed using GFP-trap beads and as a control the same extract was incubated in triplicate with control blocked agarose
beads (Chromotek). For each pull-down 20 ml of bead slurry (50% v/v) was washed and incubated for 90 min at 4!C with 1 mg of
the nuclear extract in a total volume of 400 ml incubation buffer (150 mM NaCl, 50 mM Tris-HCl pH8, 1mM DTT, 0.25% NP40 and
complete protease inhibitor w/o EDTA (Roche)) to mimic the conditions of the DNA pull-downs as close as possible in the presence
of 50 mg/ml of ethidium bromide. Beads were then washed two times with 0.5 ml of incubation buffer, twice with PBS + 0.5% NP40
and two times with PBS only, after which bound proteins were on-bead digested. The Tdg-GFP purification was analyzed using
a permutation-based t test (FDR = 0.05 & S0 = 3) to determine significant interactors.
Recombinant Protein Expression/DNA Pull-Downs
Klf4(aa396-483), KDM2B(aa606-647), Cxxc5(aa234-293), MBD3(aa1-77) and Rfx5(aa85-173) were cloned into PRP256NB vector,
containing a GST with a C-terminal multiple cloning site. Uhrf2 (aa416-626) GST fusion was kindly provided by Dr. Jiemin Wong.
hMBD2b-GST was provided by Stefanie Bartels.
Protein expression was performed in E. coli BL21-DE3 Codon+ by growing them at 37!C until OD600 of 0.5, after which expression
was induced using 1mM IPTG and culturing for 3 additional hours at 25!C. Cells were lysed in 50 mM Tris-HCl pH 8.0/ 20% sucrose/
1 mM EDTA/ 0.5 mM PMSF/ 1 mM DTT/ 1 mg/ml aprotinin using lysozyme and Triton X-100 and repeated freeze-thawing. Bacterial
debris was removed by ultracentrifugation.
DNA pull-downs were performed using 2.5 mg DNA coupled to 16.75 ml MyOne beads and 5 ml of bacterial lysate/ nuclear extract in
250 ml total volume (50mM Tris-HCl pH8, 150 mM NaCl, 1mM DTT, 0.25% NP40 and complete protease inhibitors (Roche, EDTA-
free)) in the presence of 2.5 mg polydAdT. After 3 times of washing with 0.5 ml of this buffer, beads were boiled in sample buffer.
5% of the input material and 100% of the bound material was loaded on gel for Western blot analyses.
Western Blot
Gels were blotted onto nitrocellulose membranes. Blots were blocked using 5%-skimmed milk in TBST. Used antibodies
are: MouseaMBD3 (IBL, 3A3), GoataMBD2 (Everest Biotech, EB07538), RabbitaRBBP5 (Bethyl, BL766), GoataJun-C (SantaCruz),
RabbitaDNMT1 (Abcam, ab13537), RabbitaCarf (Abcam, ab140519), RabbitaGST (Santa Cruz, SC-138), RabbitaGFP (home
made), DonkeyamouseHRP and DonkeyaRabbitHRP.
NMR-Spectroscopy-Based Interaction Study of Rfx5 and mC DNA
The winged-helix (WH) domain of human Rfx5 (residues 85-173, plus 18 additional residues at the N-terminus) was expressed as
a GST-fusion in BL21-DE3 Codon+ bacterial strains at 25!C in M9 minimal medium with 15NH4Cl and/or
13C-glucose. The protein
was purified by binding to a Glutathione agarose (GA) column (Sigma) and eluted with 50 mM reduced glutathione (Sigma). After
thrombin digestion, Rfx5-WH was purified over a Sephadex-75 (HiLoad 16/60) column in buffer A (50mM KPi pH 7, 100 mM KCl,
5 mM DTT, 0.5 mM PMSF and protease inhibitors). NMR samples used for backbone assignment contained ca. 0.3 mMWH domain
in 90/10% H2O/D2O in buffer A. NMR spectra (HNCACB, CBCACONH, HNCA, and HNCO) were recorded at 298K on a 600 or
750MHz Bruker Avance II spectrometer, processed using the NMRPipe package (Delaglio et al., 1995), and analyzed using CcpNmr
Analysis (Vranken et al., 2005). Backbone assignments were obtained for 90 out of 106 residues in the Rfx5-WH construct.
Interaction study with mC DNA was done using an 18bp DNA fragment (see Table S4; (Biolegio)) carrying a single mC on each
strand. Annealed DNA oligos were lyophilized and dissolved in buffer A to a stock concentration of 620 mM. The Rfx5-WH domain
(103 mM) was titrated with mC DNA, and after each addition (11 points in total) the 1H-15N HSQC spectrum of Rfx5-WH as recorded
(298K / 600 MHz Bruker Avance II). Since the DNA sequence used is not palindromic, the two mC may be inequivalent in their
capability to bind Rfx5. At high DNA:Rfx ratios, several peaks appear split in two in a roughly 1:1 ratio, suggesting that although
the Rfx5-WH domain senses the distinct DNA sequence context of the two mC sites, it recognizes both with similar affinities
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(data not shown). Although a few residues showed non-linear titration profiles, most peak displacements were linear. For further
analysis, the binding sites were treated as being independent, resulting an apparent dissociation constant for the Rfx5-WH – mC
interaction.
Titration data were fitted using using MatLAB scripts (MATLAB version 7.13.0, TheMathWorks Inc., 2011) using the fast-exchange
assumption for residues with observed chemical shift perturbations between 10 and 30 Hz (fast-exchange regime; 15 residues) in
a global fit. The error bars for the observed peak position was set to 1.2 Hz. The overall reduced chi-square for the fit was 2.17.
The error in the fitted KD was estimated using 1000 MonteCarlo simulations resulting in an average of 3.2 ± 0.9 mM. The range of
acceptable fits was examined using F-statistics from a grid search, resulting in 95% probability limits of 10 nM < KD < 16 mM.
A homology model of Rfx5-WH domain was constructed on the basis of the DNA-bound crystal structure of the Rfx1 winged helix
domain (PDB-id: 1DP7; 35% sequence identity) using the SwissModel server (Schwede et al., 2003). The model was validated
against the predicted backbone dihedral angles from the observed backbone chemical shifts using TALOS+ (Shen et al., 2009).
The model of mC bound to the putative binding pocket was constructed in PyMol by superimposing the mC DNA from the
UHRF1-mDNA crystal structure (PDB-id 3CLZ) onto the Rfx1-bound DNA, such that the binding pocket and mC are aligned. To
achieve a proper fit, the mC base was set to a syn-conformation. The side chains orientations of K110 and Y161 were adjusted
manually to minimize clashes.
In Silico Analysis of Klf4 ChIP-Seq Profile and Bisulfite Sequencing Data in mESCs Cells and NPCs
Klf4 binding data (ChIP-seq) was taken from (Chen et al., 2008) (GSM288354), and DNA methylation data (whole-genome bisulfite
sequencing) was taken from (Stadler et al., 2012) (GSE30202). Annotated Klf4 peak centers (mESC) were extended with 50 bp on
both sides to obtain 100-bp Klf4 binding regions. The mean CpG methylation of each 100-bp region was calculated for mESCs
and NPCs and plotted as a scatterplot (Suppl. Figure S1B). For each quadrant of this scatterplot, the genomic distribution of
the 100-bp Klf4 binding regions was calculated and plotted as a pie chart (Suppl. Figure S1C). Promoters were defined as -/+ 1
kb upstream and downstream from transcription start sites of the RefSeq mm9 annotation. The DNA sequences of the 100-bp
Klf4 binding regions were used to search for the GGCGTG motif, and the CpG methylation within these motifs was calculated.
The obtained distribution was plotted as a histogram (Suppl. Figure S1D). Analyses were done using Python, Perl and R.
iBAQ
iBAQ was performed essentially as described in (Schwanhäusser et al., 2011). 3.3 mg of UPS2 standard (Sigma) was added to 10 mg
of nuclear extract, whichwas digested using the FASP protocol (Wi!sniewski et al., 2009). In addition, 100 mg of NEwas digested using
FASP after which the peptides were separated into 8 fractions using SAX. Each of these sampleswasmeasured during a 4 hr gradient
of LC-MSMS. A linear fit was made for the known amounts of the UPS2 standard and the measured iBAQ intensities in the 10 mg
sample. Using this curve, iBAQ values of all other identified proteins in the 10 mg sample were converted to amounts. A linear fit
was againmade using these amounts and the iBAQ values in the eight SAX fractions, whichwere used to extrapolate absolute protein
amounts of all identified proteins in these samples.
Cell Culture and Transfection Experiments
The mammalian GFP-Tet1cd expression vector was generated by PCR amplification of mouse (E14) cDNA encoding the catalytic
domain of Tet1 (amino acids 1365 to 2057) andN-terminal GFP fusion. HEK293T cells were grown at 37!Cand 5%CO2 in Dulbecco’s
Modified Eagle Medium (DMEM, Invitrogen 41966-029) supplemented with 10% fetal bovine serum and 1%Penicillin-Streptomycin.
Cells were passaged at 80% confluency. All transfections were performed using the jetPRIME system (PEQLAB Biotechnologie
GmbH) according to the manufacturer’s instructions. HEK293T cells were seeded 24 hr prior to transfection at a density of 3x106
cells per 75 cm2-flask and incubated in 10 ml of medium at 37!C and 5% CO2 for 24 hr. Cotransfection of GFP-Tet1cd plasmid
(6 mg) either with mouse Uhrf2-GFP plasmid DNA (6 mg) (Pichler et al., 2011) or 6 mg of pCMV6-Cdk5Rap1-v2 (Origene
RG216600) as an unrelated control was carried out in a 75 cm2 flask containing 10 ml of fresh medium. The transfection solution
(500 ml of jetPRIME buffer, 12 mg of plasmid DNA and 24 ml of jetPRIME reagent) was added to the medium and the cells were incu-
bated at 37!C and 5% CO2 for 48 hr. After removal of the medium the cells were washed once with PBS and then lysed for DNA
extraction according to (Münzel et al., 2010). The DNA was enzymatically digested to the nucleosides and subsequently analyzed
by LC-ESI-MS/MS.
LC-MS/MS Analysis of Genomic DNA and Synthetic DNA
The following LC-MS/MS method for the quantification of DNA-nucleosides is based on a further development of our precise and
sensitive isotope dilution method ((Pfaffeneder et al., 2011) and manuscript in preparation). In the following we shortly summarize
the parameters of the method. Genomic or synthetic DNA was enzymatically digested to the nucleoside level. A specific amount
of internal standards with a stable isotope label were spiked to the digestion mixture for precise quantification. The following labeled
nucleosides were used as internal standards: [15N2]-dC, [D3]-mC, [D2,
15N2]-hmC, [
15N2]-fC, [
15N2]-caC and [D3]-dT. In case of
genomic DNA the dC- or dG-content was determined by LC-UV-Detection.
LC-MS/MS analysis was performed on an Agilent 6490 triple quadrupol mass spectrometer coupled to an Agilent 1290 UHPLC
system. The general source-dependent parameters were as follows: Gas Temp 50!C, Gas Flow 15 L/min, Nebulizer 30 psi, Sheath
S4 Cell 152, 1146–1159, February 28, 2013 ª2013 Elsevier Inc.
GasHeater 300!C, Sheath Gas Flow 11 L/min, Capillary Voltage 2500 V andNozzle Voltage 500 V. For compound-dependent param-
eters used for genomic DNA see Table S5, for compound-dependent parameters used for synthetic DNA see Table S6. The transi-
tions of the nucleosides were analyzed in the positive ion selected reaction monitoring mode (SRM) operating MS1 and MS2 under
unit mass resolution conditions.
For the analysis a C8 column from Agilent was used (1.8 mm, 2.1 mm x 150 mm). The compounds were separated by a gradient
using water and acetonitril with 0.0075% formic acid. The column temperature was maintained at 30!C. The flow rate was
400 ml min"1, and the injection volume amounted to 29 mL. The effluent up to 1.5 min (total run time of 12 min) was diverted to waste
by a Valco valve in order to protect the mass spectrometer.
Validation of Quantification Method for Genomic DNA Modifications
In accordancewith the FDA guidance for bioanalytical method validation, linearity, precision, and accuracy (i.e., recovery determined
from spiked matrix samples) of the established method were investigated. Validation for the established LC-MS/MS quantification
method was based on five different series (i.e., calibration functions and quality control samples) accomplished on different days.
Calibration standards were analyzed at least in triplicates. Quality control samples to evaluate accuracy, intra- and inter-batch
(see intra- and inter-assay) precisionwere determined using a biological samplewith internal standards. Furthermore, each validation
experiment was complemented by matrix blanks (analyzed in triplicates) to ensure selectivity and specificity of the method.
Additionally, acceptable accuracy (80%–120%) as well as precision (<20% RSD) was required. Linear regression was applied
to obtain calibration curves. Therefore, the peak area ratio (y) of the unlabeled nucleoside to the internal standard versus the con-
centration ratio of the unlabeled nucleoside to the internal standard (x) was plotted. Calibration functions were calculated without
weighting. Long-term stability of aqueous solutions of the labeled and unlabeled nucleosides at a storage temperature of "20!C
was investigated over two months including several freeze and thaw cycles by analyzing the MS/MS-responses with each batch.
Short-term stability at room temperature was studied in overnight experiments. In this process, the results of quantification by
LC-ESI-MS/MS directly after preparing the samples were compared with those obtained from samples kept overnight at room
temperature.
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Figure S1. Genome-wide Localization of Klf4 Partially Correlates with DNA Methylation, Related to Figure 1
(A) DNA pull-downs with recombinant GST-fusion proteins of DNA binding domains and Western blotting analysis.
(B) DNAmethylation of Klf4 sites in ES cells and NPCs.Whole-genome bisulfite sequencing was used to determine DNAmethylationwithin a windowof +/" 50 bp
around Klf4 peak centers. Darker coloring indicates high density of datapoints.
(C) Pie charts showing the genomic distribution of Klf4 sites as presented in the different quadrants of (B).
(D) Distribution of DNA methylation specifically within the GGCGTG sequence present underneath Klf4 sites.
(E) Example of DNAmethylation profiles and Klf4 binding (ChIP-seq), showing binding of Klf4 to both methylated and unmethylated sites. Yellow squares indicate
the presence of the GGCGTG sequence underneath Klf4 sites.
(F) SILAC-based GFP-purification from HeLa cells stably expressing WDR76-GFP. Significant interactors are indicated in black (high forward WDR76-GFP/
control ratio, low reverse control/WDR76-GFP ratio).
(G) Venn diagram showing the overlap of C-specific readers in the mC and hmC DNA pull-downs from mESC nuclear extracts.
(H) Validation of C and mC specific binders by DNA pull-downs in HeLa nuclear extract and Western blotting for the endogenous proteins.
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Figure S2. Identification of TDG Interactors, Western Blot Verification of fC and caC Interactors, and Validation of Bait DNA Quality, Related
to Figure 2
(A) The indicated immobilized DNA baits were incubated with mouse nuclear extract. Following washes, bound proteins were analyzed by colloidal blue staining.
Note that the elution profile of all these baits looks similar, indicating that specific interactors aremasked by a large number of high abundant background binders.
(B) Volcano plot of a label-free GFP-Tdg pull-down in mESC nuclear extract. Significant interactors of GFP-Tdg are identified by permutation-based t test
(FDR = 0.05 & S0 = 3). The LFQ intensity of the GFP pull-down over the control is plotted against the –Log10 (p-value). The red line indicates the permutation-
based FDR. Also see Table SI.
(C) Western blot validation of the fC-specific binding of Carf and caC-specific binding of Dnmt1 in mESC nuclear extract. A single empty lane was removed from
the blot.
(D) HPL-Chromatograms of the purified FW and RV DNA obtained from solid phase DNA synthesis showing the purity of the employed strands.
(E) The mass spectra of the DNA before (blue) and after (red) NE incubation as determined by MALDI MS showing the expected m/z before and after NE
incubation. Major alterations of the DNA like degradation or strand breaks can be excluded.
(F) Synthetic DNA-strands which were used for DNA pull-downs were compared without (w/o) and with nuclear extract (NE) treatment (2 hr, 4!C) to proof the
stability of the indicated modifications. The quantification of the nucleoside content was carried out by LC-MS/MS. For this, the DNA was digested to the
nucleoside level and spiked with a specific amount of the following internal standards for precise quantification: [15N2]-dC, [D2,
15N2]-hmC, [
15N2]-fC, [
15N2]-caC
and [D3]-dT. The absolute amount (pmol) of each nucleoside was calculated by calibration curves (not shown). Depicted are ratios of the modified nucleoside
(pmol) to deoxy-thymidine (dT; pmol), which were obtained from three independentmeasurements. The relative standard deviation was between 0.3%–6.2%. No
or only marginal loss of the modified nucleosides was observed.
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Figure S3. Modification and Cell-Type-Specific GO Term Enrichment Analysis, Related to Figures 1, 2, 3, and 4
(A) Shows GO term enrichment and enriched domains for the different baits (C, mC, hmC, fC and caC) in mESC, NPCs and adult mouse brain.
(B) Venn diagrams showing the overlap between C,mCand hmC readerswithin each cell type and the overlap between C,mCand hmC readers betweenmESCs,
NPCs and adult mouse brain.
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Figure S4. iBAQ Analyses of mESC, NPC, and Adult Mouse Brain Nuclear Extracts, Related to Figure 5
(A) Standard and linear regression curves for the iBAQ of protein abundance in the different nuclear extracts that were used for the DNA pull-downs.
(B) Correlation based clustering of proteins that show at least a 10-fold change in protein levels. Yellow is low abundance, red is high.
(C) GO term enrichment for mESC (indicated in blue in fig S4B), NPC (indicated in red in fig S4B) and adult mouse brain (indicated in green in fig S4) specific
proteins.
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Methylcytosine is an epigenetically important nucleobase associated with the control of transcriptional activity, genomic imprinting, X-chromosome inactivation and 
suppression of transposable elements1. Controlled formation and 
removal of mC at specific genomic loci is critical for correct genome 
programming or reprogramming during cellular differentiation2. 
Recently, it was discovered that Tet proteins (Tet1–3) oxidize mC 
to give the oxidized C-derived nucleobases hmC3, 5-formylcytosine 
(fC)4,5 and 5-carboxycytosine (caC)5,6, whose biological functions 
are still yet unclear (Fig. 1a)7. As fC and caC are both removed 
by thymine DNA glycosylase (Tdg)6,8, it is currently assumed that 
they serve as intermediates of an active DNA demethylation pro-
cess involving base excision repair. In addition to these oxidized 
C derivatives, cells also contain oxidized T nucleobases such as hmU 
and fU. These compounds are currently known as oxidative lesions 
that are thought to form upon the reaction of T with reactive oxygen 
species (ROS)9,10. It was recently suggested that hmU might also be 
produced by deamination of hmC, a hypothesis that remains con-
troversial11–14. Deamination of hmC, situated in a base pair with G 
(hmC:G), would give rise to hmU:G mismatches, which are known 
substrates for the DNA glycosylases Tdg, Smug1, Mbd4, Ung2 
(ref. 15), Neil1 and Nthl1 (ref. 16). Deamination of hmC:G to 
hmU:G followed by mismatch repair would therefore establish an 
alternative pathway to active demethylation (Fig. 1a).
To unravel the origin of oxidized nucleobases, and of hmU 
in particular, in DNA from mESCs, we performed isotope trac-
ing and quantitative MS studies using the chemically synthesized 
isotopologs of mC, hmC, fC, caC, hmU and fU as internal standards 
(Fig. 1b and Supplementary Results, Supplementary Fig. 1). For 
the assessment of oxidation products that are formed by the action 
of ROS, we additionally quantified 8-oxo-G because 8-oxo-G is a 
well-established ROS reaction product formed from G17,18. We show 
here that hmU is generated enzymatically from thymidine during 
stem cell differentiation by the action of the Tet enzymes. A pro-
teomic analysis provides new insight into how genomic hmU can 
influence the binding of chromatin remodeling proteins and tran-
scription factors.
RESULTS
hmU is present at elevated levels in mESCs
We first created an inventory of the named nucleosides 
(Supplementary Fig. 1) in mESCs (Fig. 1c) and adult cortex tissue 
(Fig. 1d). In mESCs, we observed that hmC is, as expected, the most 
abundant oxidized pyrimidine (10% relative to mC), followed by fC 
(~1–2% of hmC). The ROS marker 8-oxo-G was detected at simi-
lar levels (~45% of fC), showing that nonenzymatic, ROS-induced 
oxidations of nucleobases are important processes, as expected. We 
also found relatively high levels of fU (22% of fC). Clearly detect-
able were also caC and hmU. hmU, which is at the center of this 
study, was unequivocally detected, as shown by its retention time 
and its specific fragmentation pattern, which were found to be iden-
tical with that of the internal standard [D2]hmU (Fig. 1e). Notably, 
both caC and hmU were present in comparable amounts (5% 
of fC). In adult mouse cortex DNA (Fig. 1d; for other tissues see 
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Tet oxidizes thymine to 5-hydroxymethyluracil  
in mouse embryonic stem cell DNA
Toni Pfaffeneder1,8, Fabio Spada1,8, Mirko Wagner1,8, Caterina Brandmayr1, Silvia K Laube1, David Eisen1,  
Matthias Truss2, Jessica Steinbacher1, Benjamin Hackner1, Olga Kotljarova1, David Schuermann3, 
Stylianos Michalakis4, Olesea Kosmatchev1, Stefan Schiesser1, Barbara Steigenberger1,  
Nada Raddaoui1, Gengo Kashiwazaki1, Udo Müller5, Cornelia G Spruijt6, Michiel Vermeulen6,7, 
Heinrich Leonhardt5, Primo Schär3, Markus Müller1* & Thomas Carell1*
Ten eleven translocation (Tet) enzymes oxidize the epigenetically important DNA base 5-methylcytosine (mC) stepwise 
to 5-hydroxymethylcytosine (hmC), 5-formylcytosine and 5-carboxycytosine. It is currently unknown whether Tet-induced 
oxidation is limited to cytosine-derived nucleobases or whether other nucleobases are oxidized as well. We synthesized 
isotopologs of all major oxidized pyrimidine and purine bases and performed quantitative MS to show that Tet-induced 
oxidation is not limited to mC but that thymine is also a substrate that gives 5-hydroxymethyluracil (hmU) in mouse 
embryonic stem cells (mESCs). Using MS-based isotope tracing, we show that deamination of hmC does not contribute to the 
steady-state levels of hmU in mESCs. Protein pull-down experiments in combination with peptide tracing identifies hmU as a 
base that influences binding of chromatin remodeling proteins and transcription factors, suggesting that hmU has a specific 
function in stem cells besides triggering DNA repair. 
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Supplementary Fig. 2), the hmC levels are very high (13% rela-
tive to mC), as previously reported19–21. In contrast, fC was detected 
only in very small amounts (0.03% relative to hmC), and caC was 
not observed at all22. The detected amounts of 8-oxo-G and fU are 
comparable. Notably, the detected levels of hmU in the cortex were 
significantly lower compared to that in mESCs (27%; P = 2.2 × 10−4 
by Student’s t-test). Because the detected levels of 8-oxo-G were 
similar in the cortex (Fig. 1d) and in mESCs (Fig. 1c), the elevated 
hmU levels in mESCs cannot be explained by greater ROS-induced 
damage in mESCs and must have a different origin.
We next investigated this in more detail and quantified the levels 
of hmU in three different mESC lines (WT01, J1 and R1) and in 
a variety of tissues (Fig. 2a). Clearly, the hmU levels were higher 
in mESCs than in somatic tissues by factors of 2–15. The detected 
hmU levels correspond roughly to 500–1,700 hmU bases per 
genome in tissue and 2,900–7,800 in mESCs (Fig. 2a) depending on 
the cell type and growth conditions. We cannot explain these differ-
ences by elevated oxidative stress levels in mESCs (Supplementary 
Fig. 3). We next analyzed the levels of C, mC and the oxidized 
pyrimidines hmC, fC, hmU and fU as well as 8-oxo-G in somatic 
tissues (Supplementary Fig. 2) and performed a correlation and 
cluster analysis to reveal relationships of the modification levels 
(Fig. 2b). The data analysis confirmed that the low levels of hmU 
in somatic tissues correlate strongly (significant on a level <0.001) 
with the levels of fU and 8-oxo-G within a separated cluster. 
This result showed that in somatic cells, hmU and fU are ROS-
induced reaction products. If we assume that in somatic tissues 
hmU is exclusively formed by ROS, the data showed that in mESCs, 
70–80% of the detected hmU is produced by ROS-independent 
processes (Supplementary Fig. 3).
hmU formation by oxidation of T
To analyze the origin of the oxidized nucleobases in mESCs, we per-
formed isotope tracing experiments (Fig. 3a–c and Supplementary 
Fig. 4). Substitution of L-methionine with [methyl-13CD3]L- 
methionine ([13CD3]L-Met) in the growth medium is known to give 
the labeled S-adenosylmethionine cofactor, which is needed for the 
conversion of C to mC. Replacement of L-Met by [13CD3]L-Met for 5 d 
(2 passages) in the medium at a concentration of 0.2 mM furnished 
89% labeled [13CD3]mC, 88% labeled [hydroxymethyl-13CD2]hmC 
and 93% labeled [formyl-13CD]fC (Fig. 3b and Supplementary 
Fig. 4). Within the detection limit (7 and 50 molecules per 108  
nucleosides, respectively), no incorporation of the isotopes 13C and 
D into hmU and fU was observed, showing that hmC is not the pre-
cursor of hmU. We next added isotope-labeled [13C,15N2]thymidine 
([13C,15N2]T) to the growth medium and observed ~76% of label 
incorporation into T, hmU and fU (Fig. 3a, Supplementary Fig. 4  
and Supplementary Table 1). The combined data showed that 
hmU is not generated by deamination of hmC but by oxidation of 
T (T  hmU; Fig. 3c). Consequently, all of the detected hmU 
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Figure 1 | Metabolism of cytosine derivatives, their detection by LC-UV-ESI-MS/MS and levels in mESCs and mouse cortex. (a) Potential active 
demethylation pathways. (b) Overlaid LC/UV and LC/MS/MS chromatograms of a representative DNA sample from mESCs. The dotted LC/UV 
chromatogram of C, G, T and A is scaled arbitrarily; the overlaid LC/MS/MS chromatograms of hmC, mC, fC and 8-oxo-G are scaled to the left y axis; the 
LC/MS/MS chromatograms of caC, hmU and fU are scaled to the right y axis. Red chromatograms refer to the corresponding labeled internal standards 
depicted in Supplementary Figure 1. AU, arbitrary units. (c,d) DNA modification levels per nucleoside (N) in mESCs (c; WT01, n = 7) and 3-month-old 
mouse cortex tissue (d; n = 3). Depicted are mean values  s.d. (e) Representative LC/MS/MS chromatograms for identification and quantification of 
hmU. Shown are the overlaid chromatograms for the two characteristic fragment ions of hmU (top trace) and the [D2]hmU internal standard (bottom 
trace) derived from a mESC DNA sample. The insets show the MS/MS full-scan spectra of synthetic hmU and [D2]hmU matching the proposed 
fragmentation pathway.
np
g
©
 2
01
 
N
at
ur
e 
A
m
er
ic
a,
 In
c.
 A
ll 
rig
ht
s 
re
se
rv
ed
.
576  NATURE CHEMICAL BIOLOGY | VOL 10 | JULY 2014 | www.nature.com/naturechemicalbiology
ARTICLE NATURE CHEMICAL BIOLOGY DOI: 10.1038/NCHEMBIO.1532
(and also fU) resides in an A base pair context (hmU:A). In this 
base pair, hmU is repaired by Smug1 but not Tdg12. This was con-
firmed by siRNA-mediated knockdown of Smug1 in mESC cells 
and HEK-293T cells. Indeed, the hmU level increased in these cells 
(Supplementary Fig. 5).
The fact that we were unable to detect hmU derived from 
hmC deamination, which would be situated in a base pair with G 
(hmU:G), could also be explained by very fast repair. If repair of the 
hmU:G base pair is extremely efficient, for example, because deami-
nation and glycosylase-based repair occurs in a tight complex of the 
involved enzymes, we would be unable to detect this type of hmU 
because of low steady state levels. Indeed, it was proposed that hmC 
deamination and hmU excision requires a complex of the cytidine 
deaminase Aid and the glycosylase Tdg12. To assess this possibility, 
we performed isotope tracing experiments using [13CD3]L-Met in 
Tdg−/− mESCs stably complemented with either empty vector (con-
trol) or a minigene expressing a catalytically incompetent Tdg at 
near-endogenous levels. These cells are able to form the Aid–Tdg 
complex, but the Tdg is inactive, which should give elevated hmU 
levels if deamination occurs. In both cell lines, we detected high 
levels of labeled hmC. In the control cells, [hydroxymethyl-13CD2]
hmU was not detected. However, in the cell line complemented 
with inactive Tdg, some labeled [hydroxymethyl-13CD2]hmU was 
indeed observed, albeit only in small amounts (~7% of total hmU 
and ~0.06% of total hmC; Supplementary Fig. 6). Thus, the Tdg 
protein is required for deamination of hmC to hmU. In wild-type 
(WT) mESCs, the hmU:G mismatches are obviously repaired so 
quickly that they do not contribute to steady state levels of hmU. 
All of the detected hmU was derived from T oxidation and resided 
in hmU:A base pairs.
Tet enzymes form hmU in correlation with mC oxidation
We next investigated whether enzymatic oxidation or ROS-
dependent processes are responsible for the observed oxidation of 
T to hmU. To this end, we studied mESCs with genetic or func-
tional depletions of Tet or DNA methyltransferase (Dnmt) 
enzymes (Fig. 4). Although hmU levels were maintained at nor-
mal levels in the severely hypomethylated, Dnmt-depleted cell 
lines, they were substantially reduced upon knockdown of Tet1 
and Tet2. As the levels of fU and 8-oxo-G remained unaffected, 
the data establish that, though both hmU and fU are generated by 
T oxidation, their formation must occur by two independent pro-
cesses in mESCs. The data supported the idea that fU is a ROS-
created lesion similar to 8-oxo-G9,10,17,18, whereas most hmU is 
generated by Tet-induced oxidation of T.
In support of enzymatic T oxidation by Tet proteins, ectopic 
expression of the catalytic domain of Tet1 (Tet1cd) in HEK-293T 
cells led to a 65-fold increase for both hmC and hmU levels. This was 
not observed when a catalytic mutant of Tet1 (Tet1cm) was expressed 
(Supplementary Fig. 7a). To determine whether under these condi-
tions hmU is generated by deamination, as previously suggested11,12, 
we again replaced natural L-Met with [13CD3]L-Met in the medium, 
but we did not detect incorporation of heavy isotopes into hmU, 
providing evidence that the elevated hmU levels do not originate 
from hmC deamination (Supplementary Table 1). Finally, we con-
firmed enzymatic generation of hmU in vitro by incubating recom-
binant Tet1cd with a plasmid that was premethylated by bacterial 
methyltransferase M.SssI. In addition to oxidation of mC to hmC, 
fC and caC, we detected hmU at a prominent level of 9% relative to 
hmC (Supplementary Fig. 7b), showing that the catalytic center of 
the Tet enzymes clearly has the capacity to oxidize T to hmU.
To further confirm that hmU is formed in mESCs in the process 
of epigenetic reprogramming, we analyzed the dynamic changes of 
mC and all of the oxidized pyrimidines plus 8-oxo-G during dif-
ferentiation. It was recently shown that mC and hmC levels sharply 
increase when mESCs maintained in the naive state are shifted to a 
primed state in serum-containing medium23–25. To investigate global 
kinetics of all of the Tet-generated oxidation products under more 
physiologically relevant priming conditions, we used established 
protocols based on serum-free N2B27 medium for differentiation 
of naive mESCs into states resembling that of post-implantation 
epiblasts26,27. mESCs were first grown for several passages in the 
presence of MEK and GSK3 inhibitors (dual inhibition or 2i condi-
tions) and LIF to induce a hypomethylated state resembling that of 
the naive epiblast23–25. The data in Figure 5a are averaged from three 
independent differentiation experiments, each performed with two 
cell lines in the absence of growth factors. First, we observed that 
the fU and 8-oxo-G levels stayed constant (Fig. 5a), in line with the 
idea that both are ROS-derived products. In contrast, fC and caC 
levels peaked at about 8 h. Both hmU and hmC also peak between 
8 h and 16 h. Isotope tracing with [13CD3]L-Met under these condi-
tions provided no evidence for switched-on deamination of hmC to 
hmU (Supplementary Table 1). At these peak levels, we estimated 
that mESCs contain roughly 110,000 fC bases, 4,400 caC bases and 
Figure 2 | hmU is present at elevated levels in mESCs compared to tissue. 
(a) hmU levels per genome in mESCs (nWT01 = 7 replicates, nJ1 = 2, nR1 = 3) 
and mouse tissue (3-month-old individuals, n = 3). Levels per genome 
were obtained considering a mouse genome size of 2.7 × 109 base pairs. 
Depicted are mean values  s.d. The differences between mESCs and 
mouse tissues are significant (P = 2.9 × 10−5 to 3.6 × 10−2; unpaired  
two-tailed t-test) except for WT01 and hippocampus (P = 0.292) or 
heart (P = 0.069). These exceptions are due to higher hmU levels in the 
hippocampus and heart caused by higher background oxidation (higher 
8-oxo-G levels). hmU levels normalized to oxidative background (8-oxo-G) 
levels are in Supplementary Figure 3. NS, not significant. (b) Unsupervised 
clustering analysis of Pearson correlation coefficients of 24 data sets of 
selected mouse organs at a defined time point (3-month-old individuals: 
cortex, hippocampus, cerebellum, heart, liver and kidney). Discussed 
correlations are strong to very strong (Pearson coefficient >0.7) and 
significant on a level <0.001.
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14,000 hmU bases per genome, showing that, at its peak level, hmU 
is three times more abundant than caC. The dynamic peaking data 
allowed us to estimate half-life times for fC (7 h), caC (5 h) and hmU 
(4 h) during the differentiation process (Supplementary Fig. 8). 
Using the dynamic quantitative data, we performed a correlation 
and cluster analysis of the DNA modification levels (Fig. 5b). Three 
independent clusters were obtained. One cluster involves members 
of cytosine methylation (and demethylation) dynamics, including 
C, mC, fC and caC, but, to our surprise, not hmC. Instead, hmC 
groups with hmU. We therefore concluded that the formation 
of these modifications is tightly coupled by the action of the Tet 
enzymes. The ROS-induced lesions fU and 8-oxo-G form the third, 
well-separated cluster. Notably, hmU does not correlate with the 
ROS lesions.
Recently, it was shown that exposure of naive mESCs to fibro-
blast growth factor 2 (FGF-2) and activin A (ActA) for 48 h under 
similar conditions as those described above gives a homogeneous 
cell population whose transcriptome closely resembles that of the 
post-implantation epiblast26. Under these conditions, mC levels 
increased more rapidly, approaching somatic levels within a time 
frame closely reflecting that observed during embryonic develop-
ment (Supplementary Fig. 9a). Levels of hmC rose steadily 
throughout the 48-h time course. Whereas fC peaked at 36 h, hmU 
reached its maximum at 24 h (Supplementary Fig. 9b). qPCR data 
showed a robust induction of Dnmt3b that is 
most likely responsible for the increasing mC 
levels (Supplementary Fig. 9a). A transient 
peak of Tet1 expression at 24 h went in hand 
with rising hmU and fC levels, whereas Tet3 
expression started rising slowly from the same 
time point and may drive further accumulation 
of hmC and fC (Supplementary Fig. 9b). Tdg 
was progressively upregulated together with the 
onset of methylation activity, whereas Smug1 
showed little, if any, change (Supplementary 
Fig. 10). These data supported our view that 
hmU peaking is not caused by downregulation 
of the repair pathway.
Thus, the kinetic data showed a com-
plex interplay between methylation and two 
oxidation reactions during differentiation, 
which depends on the exact conditions. Most 
important is the fact that hmU showed a time-
 dependent occurrence similar to the other oxi-
dized bases hmC, fC and caC independently 
of the conditions investigated, confirming its 
formation during epigenetic reprogramming.
hmU attracts specific readers
To obtain initial insight into a potential biologi-
cal function of hmU in comparison to hmC, we 
screened for specific readers associating with 
hmU:A as well as with hmC:G and hmU:G 
using protein pulldown and relative quantifica-
tion by LC/MS/MS. In previous stable isotope 
labeling by amino acids in cell culture (SILAC)-
based proteomics studies with hmC, fC and 
caC containing oligonucleotides, we and oth-
ers observed a high number of specific protein 
readers, arguing that the new bases influence a 
variety of different processes28,29. For this hmU 
study, we further developed this approach for 
the detection of proteins that directly interact 
with the modified bases hmU (as well as hmC 
for comparison) to get a more direct insight into 
their function (Fig. 6a). For the study, we not 
only included into the biotinylated DNA duplexes (24mers) an hmU 
(hmC) base but also equipped the counter strand with a polyethylene 
glycol–based linker carrying a reactive N-hydroxysuccinimide 
(NHS) ester moiety and a reductively cleavable disulfide bond in 
the middle. This reactive linker cannot be inserted into the DNA 
strand using solid phase synthesis. In addition, the NHS ester does 
not survive hybridization conditions. We therefore attached the 
linker as its azide derivative, using Cu(I)-catalyzed click chem-
istry, to an alkyne-bearing base present in the DNA duplex30,31. 
These DNA duplexes were subsequently incubated with nuclear 
extracts from mESCs. The DNA-bound protein complexes were 
isolated using streptavidin-coated magnetic beads (Fig. 6a)32. 
DNA duplexes with the canonical base pairs A:T and C:G at the 
respective positions served as reference strands. The NHS linker has 
two functions in the experiment: First, it will covalently trap the 
reader proteins specifically at the -amino groups of lysines, which 
allows the identification of transiently binding proteins as well. 
Second, because the linker is cleavable, it will tag the trapped lysine 
residues, leaving a defined label on those proteins that bind in close 
proximity to the modified bases hmC and hmU. This allowed us to 
distinguish protein readers that bound close to hmC and hmU from 
proteins that are secondary members of the complexes. The cova-
lently trapped proteins were next tryptically digested and labeled 
with tandem mass tagging (TMT) isobaric tags to allow protein 
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identification and quantification by MS32,33. Only proteins that were 
enriched in both the forward and the reverse TMT experiment were 
considered to be specific hmU (hmC) readers (Fig. 6). All of the 
readers were subsequently divided into two groups. Proteins that 
were enriched relative to the control strands are termed specific 
readers (sRs). Of those, the proteins that were identified with a pep-
tide containing the tag are termed direct-specific readers (dsRs).
The scatter plot (Fig. 6b and Supplementary Fig. 11a) revealed 
over 250 sRs recognizing the hmU:A base pair (relative to T:A). 
Of those proteins, 99 were identified with tagged peptides. These 
proteins were therefore designated dsRs. A gene ontology analysis 
showed that 64 proteins of the 250 sRs are nucleotide bind-
ers, and 25 proteins are involved in chromatin organization 
(Supplementary Fig. 11b).
Among the dsRs we identified were the regulatory proteins Uhrf2, 
transcription factor HIVEP3 or the poly [ADP-ribose]  polymerase 14 
(Parp14), which showed that these proteins interacted directly with 
hmU. We also detected several H2A and H2B histone proteins among 
the dsRs and the sRs. Notably, in the group of the sRs, we observed 
also Dnmt3a and Dnmt3b, which are involved in gene expression 
regulation. Methyl CpG-binding protein 2 (MeCP2) was identified 
as well, but it showed only low enrichment. We also detected sev-
eral transcriptional regulators, such as bromodomain PHD finger 
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Figure 4 | Tet1 and Tet2 generate hmU in mESCs. Effect of Tet and Dnmt 
depletion on DNA modification levels in mESCs. J1 cell lines bearing 
homozygous Dnmt-null mutations and WT01 mESCs expressing Tet1 or 
Tet2 shRNAs (knockdown (KD)) were analyzed. Depicted are mean  
values per nucleoside (N)  s.d. of biological replicates as follows:  
wild type (WT01, n = 7), Tet1 KD (WT01, n = 3) and Tet2 KD (WT01, n = 3);  
WT (J1, n = 2), Dnmt1−/− (J1, n = 2) and Dnmt3a/b−/− (J1, n = 6).
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Figure 5 | hmU is produced during mESC differentiation. (a) Time course 
of DNA modification levels during early differentiation (0−40 h) of naive 
mESCs in the absence of growth factors. Box plot of relative modification 
changes for hmC, fC, caC and hmU averaged from six independent 
experiments using two different mESC lines. In the four upper plots, colored 
diamonds reflect mean values of technical triplicate measurements, open 
squares reflect mean values of biological replicates, boxes represent the 
s.e.m., and whiskers represent the the s.d. of the biological replicates;  
*P < 0.05, **P < 0.01 and ***P < 0.005 by unpaired two-tailed t-test. In 
the two lower plots, the relative modification changes of mC, hmU, fU and 
8-oxo-G are depicted as biological mean values  s.e.m. (b) Unsupervised 
clustering analysis of Pearson correlation coefficients of 22 data sets 
obtained from the differentiation experiments depicted in a. Discussed 
correlations are strong to very strong (Pearson coefficient >0.7) and 
significant on a level <0.001.
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transcription factor (Bptf), transcription factor E2F6 and mediator of 
RNA polymerase II transcription subunit 12 (Med12). Moreover, we 
identified hmU-binding E3 ubiquitin-protein ligases such as Uhrf1, 
Trim37 and Huwe1 and finally the chromodomain helicase DNA-
binding proteins 1 and 9 (Chd1 and Chd9) among the hmU readers, 
which are chromatin remodeling factors and regulate polymerase I 
and II transcription. To exclude bias by sequence-specific binding, 
we repeated the experiment with hmU in a different sequence con-
text. Indeed, 78% of the identified protein readers are also observed 
in this control experiment, and included among them were all of 
the proteins discussed above, with the notable exception of Uhrf1, 
which was not observed in this experiment (Supplementary Data 
Set 1). The data show that hmU:A recruits specific proteins that are 
involved in chromatin biochemistry in a broad sense.
As a first validation of the MS-identified readers, we focused on 
Uhrf1 and Uhrf2. Uhrf1 is a known mC and hmC binder34, whereas 
we recently identified the homolog Uhrf2 as a specific binder of 
hmC29. The MS data for hmU obtained in this study showed an 
enrichment of Uhrf1 and Uhrf2. In addition, Uhrf2 was identified 
as a direct binder. To validate the MS findings, we overexpressed 
Uhrf1 or Uhrf2 together with Tet1cd in 
HEK-293T29 and measured the levels of mC, 
hmC, fC, caC and also hmU. Indeed, we 
observed increased levels of hmU, proving a 
functional relation between hmU levels and 
Uhrf1 and Uhrf2 (Supplementary Fig. 12). 
As Uhrf2 is known to interact with Dnmt3a 
and Dnmt3b35 and these two proteins are 
also identified as sRs of hmU, our initial data 
provide a consistent picture.
Analysis of the specific hmU readers 
showed that 49 of the identified proteins were 
also enriched with an hmC-modified strand. 
Among these proteins were, for instance, 
 bromodomain PHD finger transcription factor 
(Bptf), MeCP2 and 19 other nucleotide- binding 
proteins. The obtained list of specifically bind-
ing proteins is in good agreement with our 
recently published data set29, which further 
supports the validity of the covalent trapping 
method. Finally, we compared the results 
of the hmU:A pulldown with a pulldown of 
hmU:G, which would be the product of hmC 
deamination. We found 69 of 280 sRs in both 
experiments. We identified transcription regu-
lators as sRs as well in the hmU:G pulldown. 
However, we also found several DNA repair 
proteins, such as DNA repair protein comple-
menting XP-C cells homolog (XPC), DNA 
repair protein Rad50 and five helicases, among 
others (Supplementary Data Set 1).
DISCUSSION
This work aimed to analyze the origin of hmU 
in mESCs. Although hmU as well as fU are 
both well-characterized oxidation products of 
thymidine9,10, hmU in particular was recently 
discussed as an intermediate in active demeth-
ylation by deamination of hmC11,12. We used sta-
ble isotopologs of the main oxidation products 
hmC, fC, caC, hmU, fU and 8-oxo-G in com-
bination with quantitative MS to show that the 
levels of hmU are strongly elevated in stem 
cells in comparison to somatic tissue. Notably, 
we did not observe equally elevated levels of 
fU and 8-oxo-G, both of which are formed by 
the reaction of DNA with ROS. This analysis suggests that hmU in 
stem cells is not only formed by ROS. The quantitative data allowed 
us to estimate that in WT stem cells, about 70–80% of the found 
hmU is not formed by ROS but is derived from a different process. 
Isotope tracing studies with labeled [13CD3]L-Met and [13C,15N2] 
thymidine showed that the detected hmU originates exclusively from 
T. Previous studies already proposed a connection between Tet activ-
ity and hmU levels, but these studies did not address the origin of 
hmU, which led to the hypothesis that hmU could form by deamina-
tion of hmC11,22. To investigate the involvement of deamination11–14, 
we studied Tdg−/− stem cells reconstituted with a catalytically inac-
tive Tdg. In these cells, the putative deamination–repair complex12 
of Tdg and Aid could form, and we expected to see elevated hmU 
levels. Indeed, in this experiment, we were able to detect labeled 
hmU, showing that deamination of hmC does occur, but the levels 
were low. Most notably, special conditions were required to detect 
this deamination. In WT cells, all of the detected hmU is clearly 
derived from T oxidation. As such, the detected hmU is situated in 
a base pair with A (hmU:A). In conclusion, the majority of hmU in 
mESCs is produced independently of both ROS and deamination. 
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Figure 6 | Identification of hmU:A readers. (a) Workflow of pulldown experiments with hmU:A–
containing oligonucleotides. DNA oligomers with the modified base Z containing an alkyne group 
for click reaction and biotin for the pulldown are hybridized with DNA oligomers containing hmU 
(X = hmU and Y = A). After the click reaction with the DNA-protein cross-linker (red), which has 
an NHS ester as a lysine-specific reactive group (RG), the dsDNA oligomers are incubated with 
a nuclear extract from mESCs, and specific binders are covalently linked to the DNA. After three 
washing steps, the linker is reductively cleaved, and the proteins are enzymatically digested  
and labeled with TMT2plex reagents. The same dsDNA oligomer without hmU modification  
(X = T and Y = A) was used as a control sample. Specifically enriched proteins are mixed with the 
control sample before LC/MS analysis. The same workflow was used for experiments with hmU:G 
or hmC:G and C:G as a control. (b) Magnified view of proteins enriched with hmU:A–containing 
oligomer. Specific readers in the forward and reverse experiment are marked in blue. Direct-specific 
readers are identified by the presence of the DNA-protein cross-linker and marked in red. Black 
dots are considered unspecific binders. A full-scale representation is shown in Supplementary 
Figure 11. (c) Venn diagram showing overlap of specific binders for hmU:A, hmU:G and hmC:G.
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Using a combination of functional knockdown in mESCs, ecto-
pic expression of Tet1 catalytic domain in HEK-293T cells and 
in vitro studies with recombinant Tet protein, we showed that the 
Tet enzymes, known to oxidize mC to hmC, are also responsible 
for oxidation from T to hmU. A kinetic study in which the tempo-
ral changes of all of the oxidized pyrimidines were observed under 
two different differentiation kinetics showed finally that hmU is 
formed in processes that also generate hmC and fC. Together with 
the observed peak levels of hmU of about 14,000 bases per genome, 
this suggests that hmU could have an epigenetic function similar 
to hmC. It is conceivable that the Tet enzymes introduce a small 
amount of hmU during the hmC manufacturing process to trigger 
faster demethylation by induction of DNA repair. It is known that 
hmC is not a substrate for repair8,12, whereas hmU is efficiently rec-
ognized and repaired36, for example, by the repair glycosylase Smug1 
(refs. 37,38). Sporadic introduction of hmU could therefore allow 
recruitment of repair factors, for example, for long patch repair, as 
recently suggested39. Alternatively, hmU might influence transcrip-
tion factor binding, which is known to be a hallmark of epigenetic 
reprogramming40. To study the proteins that closely interact with 
hmU, a new pulldown experiment was devised in which we inserted 
a trapping linker into the oligonucleotide. This linker is able to react 
covalently with proteins that assemble on the DNA duplex close to 
the hmU base. Because the linker is reductively cleavable, it leaves 
a tag on the respective lysine residues, which is detected in subse-
quent MS-based proteomics measurements. Using this technology, 
we observed that hmU:A recruits transcription factors and proteins 
that are involved in chromatin biochemistry, including Uhrf1 and 
Uhrf2. This result is in line with the recent observation that oxida-
tive lesions in DNA can change the binding affinity of the transcrip-
tion factor CREB when they are present in the respective cognate 
sequence41. A further analysis in HEK-293T revealed that the hmU 
readers Uhrf1 and Uhrf2 are able to modulate the levels of all of 
the oxidized mC bases and of hmU. It is interesting to note that the 
observed level increases of hmC were small, whereas they were sub-
stantial for hmU and also for the further oxidized bases fC and caC. 
As Uhrf1 and Uhrf2 are proteins known to be involved in numer-
ous epigenetic processes, our data supported the hypothesis that 
Tet-induced oxidation of T to hmU may have an epigenetic func-
tion. Even in the case that hmU is formed just as a side product 
of Tet-induced hmC formation, it is now clear that the oxidation 
chemistry performed by the Tet enzymes has to go in hand with 
effective DNA repair. 
Received 15 December 2013; accepted 17 April 2014; 
published online 18 May 2014
METHODS
Methods and any associated references are available in the online 
version of the paper.
References
1. Smith, Z.D. & Meissner, A. DNA methylation: roles in mammalian 
development. Nat. Rev. Genet. 14, 204–220 (2013).
2. Franchini, D.M., Schmitz, K.M. & Petersen-Mahrt, S.K. 5-Methylcytosine 
DNA demethylation: more than losing a methyl group. Annu. Rev. Genet. 46, 
419–441 (2012).
3. Tahiliani, M. et al. Conversion of 5-methylcytosine to 
5-hydroxymethylcytosine in mammalian DNA by MLL partner TET1. Science 
324, 930–935 (2009).
4. Pfaffeneder, T. et al. The discovery of 5-formylcytosine in embryonic stem cell 
DNA. Angew. Chem. Int. Ed. Engl. 50, 7008–7012 (2011).
5. Ito, S. et al. Tet proteins can convert 5-methylcytosine to 5-formylcytosine 
and 5-carboxylcytosine. Science 333, 1300–1303 (2011).
6. He, Y.F. et al. Tet-mediated formation of 5-carboxylcytosine and its excision 
by TDG in mammalian DNA. Science 333, 1303–1307 (2011).
7. Tan, L. & Shi, Y.G. Tet family proteins and 5-hydroxymethylcytosine in 
development and disease. Development 139, 1895–1902 (2012).
8. Maiti, A. & Drohat, A.C. Thymine DNA glycosylase can rapidly excise 
5-formylcytosine and 5-carboxylcytosine: potential implications for active 
demethylation of CpG sites. J. Biol. Chem. 286, 35334–35338 (2011).
9. Bjelland, S. et al. Oxidation of thymine to 5-formyluracil in DNA: 
mechanisms of formation, structural implications, and base excision by 
human cell free extracts. Biochemistry 34, 14758–14764 (1995).
10. Mouret, J.F., Polverelli, M., Sarrazini, F. & Cadet, J. Ionic and radical oxidations 
of DNA by hydrogen peroxide. Chem. Biol. Interact. 77, 187–201 (1991).
11. Guo, J.U., Su, Y., Zhong, C., Ming, G.L. & Song, H. Hydroxylation of 
5-methylcytosine by TET1 promotes active DNA demethylation in the adult 
brain. Cell 145, 423–434 (2011).
12. Cortellino, S. et al. Thymine DNA glycosylase is essential for active DNA 
demethylation by linked deamination-base excision repair. Cell 146, 67–79 (2011).
13. Nabel, C.S. et al. AID/APOBEC deaminases disfavor modified cytosines 
implicated in DNA demethylation. Nat. Chem. Biol. 8, 751–758 (2012).
14. Rangam, G., Schmitz, K.M., Cobb, A.J. & Petersen-Mahrt, S.K. AID 
enzymatic activity is inversely proportional to the size of cytosine C5 orbital 
cloud. PLoS ONE 7, e43279 (2012).
15. Jacobs, A.L. & Schär, P. DNA glycosylases: in DNA repair and beyond. 
Chromosoma 121, 1–20 (2012).
16. Zhang, Q.M. et al. DNA glycosylase activities for thymine residues oxidized 
in the methyl group are functions of the hNEIL1 and hNTH1 enzymes in 
human cells. DNA Repair (Amst.) 4, 71–79 (2005).
17. Burrows, C.J. Surviving an oxygen atmosphere: DNA damage and repair. ACS 
Symp. Ser. Am. Chem. Soc. 2009, 147–156 (2009).
18. Taghizadeh, K. et al. Quantification of DNA damage products resulting from 
deamination, oxidation and reaction with products of lipid peroxidation by 
liquid chromatography isotope dilution tandem mass spectrometry. Nat. 
Protoc. 3, 1287–1298 (2008).
19. Globisch, D. et al. Tissue distribution of 5-hydroxymethylcytosine and search 
for active demethylation intermediates. PLoS ONE 5, e15367 (2010).
20. Kriaucionis, S. & Heintz, N. The nuclear DNA base 5-hydroxymethylcytosine 
is present in Purkinje neurons and the brain. Science 324, 929–930 (2009).
21. Münzel, M. et al. Quantification of the sixth DNA base 
hydroxymethylcytosine in the brain. Angew. Chem. Int. Ed. Engl. 49, 
5375–5377 (2010).
22. Liu, S. et al. Quantitative assessment of Tet-induced oxidation products of 
5-methylcytosine in cellular and tissue DNA. Nucleic Acids Res. 41, 
6421–6429 (2013).
23. Ficz, G. et al. FGF signaling inhibition in ESCs drives rapid genome-wide 
demethylation to the epigenetic ground state of pluripotency. Cell Stem Cell 
13, 351–359 (2013).
24. Habibi, E. et al. Whole-genome bisulfite sequencing of two distinct 
interconvertible DNA methylomes of mouse embryonic stem cells. Cell Stem 
Cell 13, 360–369 (2013).
25. Leitch, H.G. et al. Naive pluripotency is associated with global DNA 
hypomethylation. Nat. Struct. Mol. Biol. 20, 311–316 (2013).
26. Hayashi, K., Ohta, H., Kurimoto, K., Aramaki, S. & Saitou, M. Reconstitution 
of the mouse germ cell specification pathway in culture by pluripotent stem 
cells. Cell 146, 519–532 (2011).
27. Ying, Q.L., Stavridis, M., Griffiths, D., Li, M. & Smith, A. Conversion of 
embryonic stem cells into neuroectodermal precursors in adherent 
monoculture. Nat. Biotechnol. 21, 183–186 (2003).
28. Iurlaro, M. et al. A screen for hydroxymethylcytosine and formylcytosine 
binding proteins suggests functions in transcription and chromatin 
regulation. Genome Biol. 14, R119 (2013).
29. Spruijt, C.G. et al. Dynamic readers for 5-(hydroxy)methylcytosine and its 
oxidized derivatives. Cell 152, 1146–1159 (2013).
30. Burley, G.A. et al. Directed DNA metallization. J. Am. Chem. Soc. 128, 
1398–1399 (2006).
31. Rostovtsev, V.V., Green, L.G., Fokin, V.V. & Sharpless, K.B. A stepwise huisgen 
cycloaddition process: copper(i)-catalyzed regioselective “ligation” of azides 
and terminal alkynes. Angew. Chem. Int. Ed. 41, 2596–2599 (2002).
32. Thompson, A. et al. Tandem mass tags: a novel quantification strategy for 
comparative analysis of complex protein mixtures by MS/MS. Anal. Chem. 
75, 1895–1904 (2003); erratum 75, 4942 (2003); erratum 78, 4235 (2006).
33. Gygi, S.P. et al. Quantitative analysis of complex protein mixtures using 
isotope-coded affinity tags. Nat. Biotechnol. 17, 994–999 (1999).
34. Frauer, C. et al. Recognition of 5-hydroxymethylcytosine by the Uhrf1 SRA 
domain. PLoS ONE 6, e21306 (2011).
35. Pichler, G. et al. Cooperative DNA and histone binding by Uhrf2 links the two 
major repressive epigenetic pathways. J. Cell. Biochem. 112, 2585–2593 (2011).
36. Lewis, H.L., Muhleman, D.R. & Ward, J.F. Serologic assay of DNA base 
damage. I. 5-Hydroxymethyldeoxyuridine, a radiation product of thymidine. 
Radiat. Res. 75, 305–316 (1978).
37. Boorstein, R.J. et al. Definitive identification of mammalian 
5-hydroxymethyluracil DNA N-glycosylase activity as SMUG1. J. Biol. Chem. 
276, 41991–41997 (2001).
np
g
©
 2
01
 
N
at
ur
e 
A
m
er
ic
a,
 In
c.
 A
ll 
rig
ht
s 
re
se
rv
ed
.
NATURE CHEMICAL BIOLOGY | VOL 10 | JULY 2014 | www.nature.com/naturechemicalbiology 581
ARTICLENATURE CHEMICAL BIOLOGY DOI: 10.1038/NCHEMBIO.1532
38. Kavli, B., Otterlei, M., Slupphaug, G. & Krokan, H.E. Uracil in DNA—general 
mutagen, but normal intermediate in acquired immunity. DNA Repair (Amst.) 
6, 505–516 (2007).
39. Santos, F. et al. Active demethylation in mouse zygotes involves cytosine 
deamination and base excision repair. Epigenetics Chromatin 6, 39 (2013).
40. Silva, J. & Smith, A. Capturing pluripotency. Cell 132, 532–536 (2008).
41. Moore, S.P.G., Toomire, K.J. & Strauss, P.R. DNA modifications repaired by 
base excision repair are epigenetic. DNA Repair (Amst.) 12, 1152–1158 (2013).
Author contributions
T.P. synthesized MS standards, performed the sample preparation and ultra high-
performance LC/MS/MS method development, did LC/MS analysis, interpreted data and 
performed statistical analysis. F.S. and N.R. performed mESC differentiation and isotope 
tracing experiments. M.W. and C.B. performed the HEK-293T experiments, did LC/MS 
analysis and interpreted data. C.B. performed qPCR and analyzed the data. S.K.L. and  
D.E. performed the protein pulldown studies and interpreted data. M.T. performed 
mESC knockdown and knockout experiments. J.S. and O. Kosmatchev did sample 
preparation and LC/MS analysis. B.H., S.S. and J.S. prepared MS standards. O. Kotljarova 
performed in vitro assays. B.S. synthesized oligonucleotides for protein capture.  
G.K. synthesized tandem mass tags, and S.M. provided mouse tissue samples. U.M. and 
H.L. constructed Tet expression plasmids. C.G.S. and M.V. performed Uhrf1/2 over-
expression in HEK-293T cells. P.S. and D.S. provided plasmids and cell lines. M.M. and 
T.C. conceived and supervised the project, interpreted data and wrote the manuscript.
Competing financial interests
The authors declare no competing financial interests.
Additional information
Supplementary information is available in the online version of the paper. Reprints and 
permissions information is available online at http://www.nature.com/reprints/index.
html. Correspondence and requests for materials should be addressed to M.M. and T.C.
Acknowledgments
We thank the Excellence Cluster Center for Integrated Protein Science Munich (CiPSM) 
and the collaborative research centers SFB749, SFB646 and SFB1032 as well as German 
Research Foundation (DFG) grant CA275/8-4, the Volkswagen foundation, NGFNplus 
(01GS0870) and the Netherlands Organization for Scientific Research (NWO-VIDI)  
for financial support. T.P. and S.S. thank the Fonds der Chemischen Industrie for  
predoctoral fellowships. C.B. thanks the Boehringer Ingelheim Fonds for a predoctoral 
fellowship. G.K. thanks the Japan Society for the Promotion of Science (JSPS) for a  
postdoctoral fellowship for research abroad. We thank M. Moser (Max Planck Institute  
for Biochemistry) for providing R1- and C57Bl6/129–derived mESCs, G. Höfner and 
K.T. Wanner for their initial help with MS as well as M. Wirsing, L. Belzner and  
P. Laube for providing bioinformatic tools for data processing.
np
g
©
 2
01
 
N
at
ur
e 
A
m
er
ic
a,
 In
c.
 A
ll 
rig
ht
s 
re
se
rv
ed
.
NATURE CHEMICAL BIOLOGY doi:10.1038/nchembio.1532
ONLINE METHODS
General materials and methods. Chemicals were purchased from Sigma-
Aldrich, Fluka, ABCR or Acros Organics and used without further purifica-
tion. Acetonitrile of LC/MS grade was purchased from Carl Roth GmbH + Co., 
KG. Formic acid, p.a. for MS, was purchased from Fluka, and water was puri-
fied with a Milli-Q Plus system from Merck Millipore.
The MS standards 5-methyl-2 -deoxycytidine (mC), 5-trideuteromethyl-
2 -deoxycytidine ([D3]mC), 5-hydroxymethyl-2 -deoxycytidine (hmC), 
5-dideuterohydroxymethyl-2 -deoxy-(N1,N3–15N2)-cytidine ([15N2,D2]
hmC), 5-formyl-2 -deoxycytidine (fC), 5-formyl-2 -deoxy-(N1,N3–15N2)-
cytidine ([15N2]fC), 5-carboxy-2 -deoxycytidine (caC), 5-carboxy-2 -deoxy-
(N1,N3–15N2)-cytidine ([15N2]caC), 5-hydroxymethyl-2 -deoxyuridine (hmU), 
5-(dideuterohydroxymethyl)-2 -deoxyuridine ([D2]hmU), 5-formyl-2 -
deoxyuridine (fU) and 5-formyl-2 -deoxy-(N1,N3–15N2)-uridine ([15N2]fU) were 
synthesized according to earlier published work19,21,42. All of the synthesized 
compounds were characterized and purity confirmed by 1H-NMR, 13C-NMR 
and ESI-MS, and some were additionally validated by 15N-NMR. 8-hydroxy-2 -
deoxy-(15N5)-guanosine ([15N5]8-oxo-G) (99 atom% 15N) was purchased from 
Cambridge Isotope Laboratories; 8-hydroxy-2 -deoxyguanosine (8-oxo-G) was 
from BIOLOG; 2 -deoxyguanosine (G) and 2 -deoxycytidine (C) were from 
ChemGenes. (methyl-13C,D3)-L-Met (99 atom% D and 13C) was purchased from 
Sigma-Aldrich, and 2 -deoxy-(C2–13C, N1,N3–15N2)-thymidine (99 atom% 13C 
and 15N) from Hartmann Analytic. Aqueous stock solutions of these com-
pounds were stored at −20 °C and warmed up to RT before usage.
Oligonucleotide synthesis. Oligonucleotide synthesis was performed on an 
ABI 394 DNA/RNA synthesizer (Applied Biosystems) using standard DNA 
synthesis conditions (DMT off) and acetyl-protected dC. Phosphoramidites 
(including the 5-hydroxymethyl-dU-CE phosphoramidite and the 5 -biotin 
phosphoramidite) and polystyrene carriers were obtained from Glen Research. 
5-octadinyl-dU (Z) phosphoramidite was synthesized according to litera-
ture and characterized by 1H-NMR, 13C-NMR, 31P-NMR and ESI-MS43. The 
crude oligonucleotide was cleaved from the resin and deprotected in 30% (v/v) 
ammonium hydroxide and 40% (v/v) methylamine (1:1) at 65 °C for 10 min 
and purified by preparative and analytical HPLC (Waters Breeze and Alliance, 
respectively). Separation was performed by applying a VP 250/10 Nucleosil 
100-7 C18 column (flow: 5 ml/min) from Macherey-Nagel with a gradient 
of buffer A (0.1 M NHEt3OAc in water) and buffer B (0.1 M NHEt3OAc in 
80% MeCN). DNA-containing fractions were characterized by MALDI-TOF 
(Bruker Autoflex II) and analytical HPLC, combined, and desalted by C18-
Sep-Pak cartridges (Waters). For analytical HPLC, separation was performed 
by applying a CC 250/4 Nucleosil 120-3 C18 column from Macherey-Nagel 
(flow: 0.5 ml/min) with the aforementioned buffer system.
For the protein pulldown studies, an hmU-containing oligonucleotide was 
hybridized with a DNA strand modified with a 5 -biotin and a 5-octadienyl- 
dU. The sequences of the DNA strands are summarized in Supplementary 
Table 3. To 10 nmol of the dsDNA, 0.5 l of a 200 mM solution of the cross- 
linking azide-PEG3-S-S-NHS ester (C18H29N5O8S2, Jena Bioscience, 
Jena, Germany) in DMSO was added. In a separate tube, CuBr was dis-
solved in a TBTA solution (DMSO/tBuOH 3:1, 100 mM) resulting in a 1:1 
Cu(I):TBTA ratio. This solution was immediately added to the DNA/azide 
mixture. Furthermore, 45 l of DMSO/tBuOH (3:1) were added, the mixture 
was shaken at 37 °C for 3 h, and the resulting product was purified by 
ethanol precipitation.
LC/MS analysis of DNA samples. Quantitative LC/UV-ESI-MS/MS analysis of 
digested DNA samples was performed using an Agilent 1290 UHPLC system 
equipped with a UV detector and an Agilent 6490 triple quadrupole mass 
spectrometer coupled with the stable isotope dilution technique. An improved 
method, based on earlier published work29,42,44,45, was developed, which allowed 
the concurrent analysis of all nucleosides in one single analytical run. The 
source-dependent parameters were as follows: gas temperature 50 °C, gas 
flow 15 l/min (N2), nebulizer 30 psi, sheath gas heater 275 °C, sheath gas flow 
11 l/min (N2), capillary voltage 2,500 V in the positive ion mode, capillary volt-
age −2,250 V in the negative ion mode and nozzle voltage 500 V. The fragmentor 
voltage was 380 V. Delta EMV was set to 500 (positive mode) and 800 (negative 
mode). Compound-dependent parameters are summarized in Supplementary 
Tables 4 and 5. Chromatography was performed by a Poroshell 120 SB-C8 
column (Agilent, 2.7 m, 2.1 mm × 150 mm) at 30 °C using a gradient of water 
and MeCN, each containing 0.0085% (v/v) formic acid, at a flow rate of 
0.35 ml/min: 0  5 min; 0  3.5% (v/v) MeCN; 5  6.9 min; 3.5  5% MeCN; 
6.9  7.2 min; 5  80% MeCN; 7.2  10.5 min; 80% MeCN; 10.5  11.3 min; 
80  0% MeCN; 11.3  13 min; 0% MeCN. The effluent up to 1.5 min and after 
9 min was diverted to waste by a Valco valve. The autosampler was cooled to 
10 °C. The injection volume was amounted to 29 l. Calibration curves, method 
validation and data processing are in Supplementary Note 2. A complete 
compilation of LC/MS quantifications results see Supplementary Note 3.
DNA digestion. 5–25 g of genomic DNA in 25 l H2O were digested as follows: 
An aqueous solution (7.5 l) of 480 M ZnSO4, containing 42 U nuclease S1 
(Aspergillus oryzae, Sigma-Aldrich), 5 U Antarctic phosphatase (New England 
BioLabs) and specific amounts of labeled internal standards (Supplementary 
Note 2) were added, and the mixture was incubated at 37 °C for 3 h. After 
addition of 7.5 l of a 520 M [Na]2-EDTA solution, containing 0.2 U snake 
venom phosphodiesterase I (Crotalus adamanteus, USB corporation), the sam-
ple was incubated for another 3 h at 37 °C and then stored at −20 °C. Prior to 
LC/MS/MS analysis, samples with up to 15 g DNA, for which the quantifica-
tion of low amounts of caC was aspired, were filtered by using an AcroPrep 
Advance 96 filter plate 0.2 m Supor (Pall Life Sciences). In contrast, samples 
with 15–25 g DNA (isotope-tracing experiments) were filtered by using an 
AcroPrep Advance 96 filter plate 10K Omega (Pall Life Sciences).
Genomic DNA isolation. Tissues of female WT mice (C57-BL6/N) were 
dissected at postnatal day 90 and prepared as earlier described19,21. Genomic 
DNA was extracted using the Qiagen Blood and Cell Culture DNA Midi Kit 
except for mESC samples differentiated in the presence of growth factors 
(see below). Extraction was performed following the manufacturer’s instruc-
tions for genomic DNA isolation from cell culture samples or tissue samples, 
respectively. All buffers until loading of the sample on Genomic-tip 100/G 
were additionally supplemented with antioxidants 3,5-di-tert-butyl-4- 
hydroxytoluene. (BHT, 200 M) and deferoxamine mesylate salt (desferal, 
200 M) as well as the deaminase inhibitor tetrahydrouridine (THU, 200 M), 
according to published methods, to reduce background oxidation or deamina-
tion18. Elution buffer QF was supplemented with 200 M BHT. Following elu-
tion, all steps were performed on ice. DNA was then precipitated with NaOAc 
(0.3 M final) and 0.7 volumes iPrOH. DNA pellets from cultured cells were 
washed twice with ice-cold 70% EtOH and resuspended in H2O containing 
20 M BHT using a Qiagen TissueLyser (30 Hz, 2 min). DNA pellets from 
mouse tissues were resuspended in PBS buffer and additionally extracted with 
phenol/CHCl3, precipitated, washed and resuspended as described above.
R1 mESC samples differentiated in the presence of growth factors or trans-
fected with Smug1 esiRNAs were lysed directly in the plates with RLT buffer 
(Qiagen) supplemented with BHT and desferal as described above. DNA was 
isolated using the Zymo Quick gDNA Midi Kit according to the manufacturer’s 
instruction, except that elution was repeated four times with 100 l of elu-
tion buffer supplemented with BHT (200 M). Eluted DNA was precipitated 
with 2 M ammonium acetate and two volumes of absolute ethanol and finally 
resuspended in H2O containing 20 M BHT. The flow-through from the spin 
columns was used to isolate RNA (see real-time PCR analysis).
mESC cell culture. Feeder independent WT01 mESCs (C57BL/6 strain)46 were 
cultured in the presence of serum and LIF as previously described4. Tdg+/− and 
Tdg−/− mESCs were described previously47. Tdg−/− mESCs were complemented 
by random integration of either empty vector (hereafter referred to as Tdg−/− 
mESCs) or a minigene expressing catalytically inactive Tdg (N151A)47. Clonal 
mESC lines with targeted Tdg alleles, R1 cells (strain 129/Sv)48, J1 cell lines 
(strain 129S4/SvJae)49 and a mESC line derived from C57Bl/6/129 mixed 
background50 were routinely maintained on gelatinized plates in DMEM 
(PAA or Sigma) supplemented with 10% FBS, 1× MEM-nonessential amino 
acids (NEAA), 0.2 mM L-alanyl-L-glutamine, 100 U/ml penicillin, 100 g/ml 
strepto mycin (all from PAA), 0.1 mM -mercaptoethanol, 20 ng/ml 
( 1 ×103 U/ml) mouse recombinant LIF (ORF Genetics), 1 M PD 0325901 and 
3 M CHIR 99021 (2i; both from Axon Medchem). In these conditions, the glo-
bal levels of genomic mC were very low (and, as a consequence, the levels of its 
oxidized derivatives were even lower; data not shown). Before DNA isolation, 
2i cultures were passaged twice (over 5 d) in DMEM supplemented with FBS 
and LIF as above but lacking 2i. With this strategy, primed mESC cultures were 
obtained with no sign of overt differentiation and modified genomic cytosines 
reached reproducibly higher and stable levels. For isotope tracing with heavy 
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thymidine in serum-primed mESCs 2i cultures of R1, cells were passaged 
twice (5 d) in the same serum-containing medium lacking 2i and simultane-
ously supplemented with 100 M [13C,15N2]T. For isotope tracing with heavy 
methionine in serum-primed mESCs, 2i cultures of R1 cells and mESC lines 
with targeted Tdg alleles were passaged twice (over 5 d) without 2i in L-Met-
free DMEM (Life Technology) supplemented as above and with 0.2 mM of 
either [methyl-13C,D3]L-Met or natural L-Met. For mESC differentiation with-
out growth factors, R1 cells and the C57Bl/6/129 mixed background cell line 
were first plated at 1 × 105 cells/cm2 on gelatin-coated plates in N2B27 medium 
containing 1,000 U/ml LIF to favor attachment and initial survival51. After 12 h, 
the medium was replaced without addition of LIF (defined as time point 0 h). 
The medium was replaced once more at 24 h. For isotope tracing with [methyl-
13C,D3]L-Met during mESC differentiation, R1 cells were cultured for two pas-
sages in L-Met-free N2B27 medium supplemented with LIF, 2i and 0.2 mM 
of either [methyl-13C,D3]L-Met or natural L-Met. Differentiation of R1 cells 
in the presence of FGF-2 and ActA was as described26, with minor modifi-
cations. Briefly, mESCs were cultured in N2B27 medium containing 2i and 
1,000 U/ml LIF for several passages and then seeded at 2.2 × 105 cells/cm2 in N2B27 
medium containing 1% KnockOut Serum Replacement (Life Technologies), 
12 ng/ml FGF-2 (PeproTech) and 20 ng/ml ActA (ORF Genetics) on 
plates coated with a thin layer of Geltrex extracellular matrix preparation 
(Life Technologies). The medium was exchanged after 24 h.
Knockdown experiments in mESCs. shRNA expression vectors targeting 
Tet1 and Tet2 were generated by cloning synthetic oligonucleotides in pLKO.1 
(ref. 52). Recombinant lentiviruses were produced by cotransfecting pLKO.1 
shRNA expression vectors and packaging plasmids in HEK-293 cells. 48 h after 
transduction in the presence of 8 g/ml polybrene, shRNA-expressing mESCs 
were selected with 4 g/ml puromycin. Cell pools were continuously cultured 
in the presence of puromycin. shRNA target sequences were as follows: SCR 
(control), 5 -CCT AAG GTT AAG TCG CCC TCG-3  (ref. 52); Tet1, 5 -TGT 
AGA CCA TCA CTG TTC GAC-3  (see ref. 52), Tet2: 5 -TTC GGA GGA 
GAA GGG TCA TAA-3 . esiRNAs for Smug1 knockdown were generated as 
described53. The cDNA template for in vitro transcription was generated by 
PCR using following primers: forward, 5 - CGT AAT ACG ACT CAC TAT 
AGG GAG CCC GTG GGT G-3 , and reverse, 5 -CGT AAT ACG ACT CAC 
TAT AGG GGT TTC GTC CAC TGG G-3 . R1 mESCs were weaned from 
2i for two passages in FBS- and LIF-containing medium as described above. 
Upon plating the second passage, the cells were transfected in a p60 plate with 
6 g of Smug1 esiRNAs (34.5 nM) and 20 l of Lipofectamine RNAi MAX 
(Life Technologies) according to the manufacturer’s instructions and were 
lysed 72 h after transfection.
Culture and transfection procedures for HEK-293T cells. All transfections 
were performed using jetPRIME transfection reagent (PEQLAB Biotechnologie 
GmbH) according to the manufacturer’s instructions. HEK-293T cells were 
seeded 24 h before transfection at a density of 2.5 × 106 cells per 75 cm2 flask and 
incubated in 10 ml of medium. The transfection solution (500 l of jetPRIME 
buffer, a specific amount of plasmid DNA (Supplementary Note 4) and 20 l 
of jetPRIME reagent) was added to the medium, and the cells were incub-
ated for 48 h, with an additional medium exchange 24 h after transfection. 
When cotransfection of esiRNA was performed, a second transfection step 
(500 l of jetPRIME buffer, 5 g of esiRNA and 20 l of jetPRIME reagent) was 
carried out 4 h after transfection of plasmid DNA. esiRNAs were purchased 
from Sigma (human TDG esiRNA EHU038971; human SMUG1 esiRNA 
EHU098861; human CDK5RAP1 esiRNAEHU079221). Supplementary 
Note 4 summarizes the overexpression and knockdown procedures.
Isotope tracing with [13C,15N2]thymidine or [13C,D3]L-Met in HEK-293T cells 
transfected with Tet1cd. 24 h before transfection, 2.5 × 106 cells were seeded 
in a 75-cm2 flask containing 10 ml either of (for [13C,15N2]thymidine) DMEM 
medium supplemented with 50 M [13C,15N2]T or (for [13C,D3]L-Met) DMEM 
medium lacking L-Met, L-cystine and pyruvate, which was supplemented with 
10% dialyzed FBS, 2 mM [13C,D3]L-Met and 0.2 mM L-cystine. Transfection 
was performed as described above using labeled medium.
Real-time PCR analysis of mRNA expression. For analysis of Tet1 and Tet2 
knockdown in mESC total RNA was prepared with Trizol (Invitrogen), cDNA 
synthesis was performed with Quantitect reverse transcription kit from 
Qiagen, and real-time PCR was performed with the Power Sybr Green PCR 
master mix from Applied Biosystems on an Applied Biosystems 7500 Fast 
system. Knockdown efficiencies relative to control samples transfected with 
SCR esiRNAs were 79% and 70% for Tet1 and Tet2, respectively. The primers 
used to estimate them are listed in Supplementary Note 4. For analysis of Smug1 
knockdown in mESCs and EpiLC differentiation samples, total RNA was pre-
pared with RNeasy spin columns (Qiagen), followed by DNase treatment using 
TURBO DNA-free (Ambion, Life Technologies); cDNA synthesis was carried 
out using iScript cDNA Synthesis kit (Bio-Rad); real-time PCR was performed 
with SsoFast EvaGreen Supermix (Bio-Rad). Smug1 knockdown efficiency rel-
ative to control samples transfected with esiRNAs targeting GFP was estimated 
to be 60%. Quantification of Tet, Dnmt, Tdg and Smug1 transcripts during 
EpiLC differentiation and Smug1 knockdown samples was performed using 
the primers listed in Supplementary Note 4. Expression levels were quanti-
fied with respect to the housekeeping gene Gapdh and normalized to time 
point 0 h.
Tet in vitro assay. A plasmid was prepared from dam−/dcm− competent E. coli 
strain (New England BioLabs) and methylated with M.SssI (New England 
BioLabs). 1.5 g of plasmid DNA were then treated with recombinant Tet1 
from the 5hmC TAB-Seq Kit (Wisegene) corresponding to ref. 54. After 3 h 
incubation at 37 °C and proteinase K treatment, the oxidized plasmids were 
purified with GeneJET PCR Purification Kit from Thermo Scientific and 
eluted in 25 l water. Samples were then subjected to LC/MS/MS analysis as 
described42. The results are compiled in Supplementary Note 3.
Correlation and cluster analyses. Statistical data analysis was performed using 
IBM SPSS Statistics 19. Results of bivariate correlation analyses are summarized 
in Supplementary Note 5. Unsupervised clustering of species with respect to 
its correlation coefficients was applied by average linkage hierarchical cluster-
ing using a squared Euclidean distance measure.
Pulldown assay. For the pulldown assay, 250 g (50 l) of the crude nuclear 
protein extracts were filled up to 500 l with 50 mM TEAB and 1 mM MgCl2. 
The binding conditions were 45 mM TEAB, 1.1 mM MgCl2, 2 mM HEPES, 
42 mM NaCl and 20 M EDTA. Complete Protease Inhibitor Cocktail Tablets 
were used from Roche Diagnostics (Indianapolis, IN, USA). The DNA oligo-
mers with DNA-protein cross-linker were dissolved in neat DMSO, and 1 nmol 
was added to the protein lysate and incubated for 20 min at room temperature. 
Streptavidin-coated magnetic particles (Roche Diagnostics, Indianapolis, IN, 
USA) were washed three times with binding buffer (100 mM NaCl, 10 mM 
Tris, 1 mM EDTA, pH 7.4) before 200 l of the bead slurry (equal to 2 mg 
beads) were added to the sample. Following 2 h incubation at room tempera-
ture under constant rotating, the beads were washed three times with 50 mM 
TEAB and 1 mM MgCl2. The beads were reconstituted in 50 mM TEAB and 
1 mM MgCl2. Disulfide bonds of the cross linker were cleaved and alkylated in 
the process of enzymatic digestion, and the magnetic particles were removed 
before adding trypsin (described below).
Protein sample preparation. Cell lysis of mouse embryonic stem cells was per-
formed as described in ref. 29. For each lysis, approximately 7.5 × 107 cells were 
used. Protein concentration was determined by Bradford assay. For each exper-
iment 250 g (50 l) of the crude nuclear protein extract were used. Protein 
samples for MS analysis were reduced by adding 100 mM TCEP and by incu-
bating on a shaker at 650 r.p.m. for 1 h at 60 °C and subsequently alkylated with 
200 mM iodoacetamide in the dark for 30 min at 25 °C. Protein samples were 
digested with 0.5 g trypsin (Promega, Madison, MA, USA) for 16 h at 37 °C. 
The reaction was stopped using 1 mM phenylmethylsulphonylfluoride. After 
tryptic digestion, peptide labeling with the TMT2plex reagents (Thermo Fisher 
Scientific, Waltham, MA, USA) was performed according to the manufacturer’s 
instructions. TMT2plex reagents 126 and 127 were used to label the samples. 
When the sample (proteins enriched with hmU- or hmC-containing DNA 
strands) was labeled with TMT126, the control sample (proteins enriched with 
no modified DNA-bases) was labeled with the TMT127 reagent and vice versa. 
Subsequent to the labeling, both sample and control, were combined. This way, 
each experiment was performed twice as a so-called label swap experiment. 
Organic solvent was removed by vacuum centrifugation, and the sample was 
finally reconstituted in 1% (v/v) formic acid for MS analysis.
LC/MS analysis of protein samples. The samples were analyzed using an 
UltiMate 3000 nano liquid chromatography system (Dionex, Fisher Scientific, 
Waltham, MA, USA) coupled to an LTQ-Orbitrap XL (Thermo Fisher 
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proteins, the only proteins considered as ‘specific readers’ were enriched in 
both the forward and the reverse experiment.
Scientific, Waltham, MA, USA). Of each eluate, 15 l were injected for the 
analysis. The samples were desalted and concentrated on a -precolumn 
cartridge (PepMap100, C18, 5 M, 100 Å, size 300 m i.d. x 5 mm) and fur-
ther processed on a custom-made analytical column (ReproSil-Pur, C18, 3 M, 
120 Å, packed into a 75 m i.d. x 150 mm and 8 m picotip emitter). A 57-min 
multistep analytical separation was performed at a flow rate of 300 nl/min. 
In the first 50 min, a linear gradient was ramped up from 5% (v/v) solvent B 
(acetonitrile containing 0.1% formic acid and 5% DMSO) and 95% solvent A 
(water containing 0.1% formic acid and 5% DMSO) to 95% solvent B. This level 
was held for 5 min and then ramped down again to 5% solvent B within 2 min. 
Mass spectrometric analyses were performed starting with a full mass scan in 
the mass range between m/z 300 and m/z 1,650. This survey scan was followed 
by three MS/MS scans using the FTMS mass analyzer and high normalized 
collision energy of 70 in the HCD cell and three additional scans using the ion 
trap mass analyzer and a normalized collision energy of 35.
Protein identification and relative quantification method. The Thermo 
Proteome Discoverer 1.1 software (Thermo Fisher Scientific, Waltham, MA, 
USA) was used for protein identification and for relative quantification. The 
Sequest (Thermo Fisher Scientific, Waltham, MA, USA) search engine was 
used in combination with a Uniprot database (Mus musculus; date of download, 
04/2013). As a limit of detection, a ratio of threefold signal over the noise filter 
was applied. A maximum of two missed cleavage sites was allowed. The mass 
tolerances were 10 p.p.m. for the precursor mass and 0.5 Da for the fragment 
ion mass. Carbamidocysteine was set as static modification. Dynamic modi-
fications were: cation, Na (D, E); the residue of the DNA-protein crosslinker 
(+146.028 Da; K, Y); Oxidation (M) as well as TMT2plex (N-term. and K). 
Identified, nonredundant peptides, which were labeled with the TMT2 reagent, 
were used for relative quantification. The integration window tolerance was 
20 p.p.m., and the integration method was set to ‘most confident centroid’. The 
signals of the TMT2 reporter ions 126 and 127 were used to calculate ratios and 
monitor either preferred or nonpreferred binding of the identified proteins to the 
modified DNA bases in comparison to the control strand. From the identified 
42. Schiesser, S. et al. Deamination, oxidation, and C–C bond cleavage reactivity 
of 5-hydroxymethylcytosine, 5-formylcytosine, and 5-carboxycytosine. J. Am. 
Chem. Soc. 135, 14593–14599 (2013).
43. Gierlich, J. et al. Click chemistry as a reliable method for the high-density 
postsynthetic functionalization of alkyne-modified DNA. Org. Lett. 8, 
3639–3642 (2006).
44. Cao, H. & Wang, Y. Collisionally activated dissociation of protonated 
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J. Am. Soc. Mass Spectrom. 17, 1335–1341 (2006).
45. Wang, J. et al. Quantification of oxidative DNA lesions in tissues of 
Long-Evans Cinnamon rats by capillary high-performance liquid 
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dilution method. Anal. Chem. 83, 2201–2209 (2011).
46. Chen, T., Ueda, Y., Dodge, J.E., Wang, Z. & Li, E. Establishment and 
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48. Nagy, A., Rossant, J., Nagy, R., Abramow-Newerly, W. & Roder, J.C. 
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52. Williams, K. et al. TET1 and hydroxymethylcytosine in transcription and 
DNA methylation fidelity. Nature 473, 343–348 (2011).
53. Kittler, R., Heninger, A.K., Franke, K., Habermann, B. & Buchholz, F. 
Production of endoribonuclease-prepared short interfering RNAs for gene 
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Supplementary Results 
 
 
Supplementary Figure 1. Isotopically labeled nucleosides used as internal standards for quantitative LC-MS/MS 
analysis (dR = -2´-deoxyribose). 
 
 
Supplementary Figure 2. DNA modification levels per nucleoside (N) of different murine tissues from 3 month 
old individuals (n = 3). Depicted are biological mean values ±SD. 

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Supplementary Figure 3. hmU-levels normalized to the oxidative background marker 8-oxo-G in mESCs (nWT01 
= 7; nJ1 = 2, nR1 = 2) and murine tissues (n = 3, 3 month old individuals) in order to dissect ROS dependent and 
ROS independent processes. Normalization was necessary to take deviating background oxidation of DNA sample 
preparation into account. The light grey area reflect the hmU-level fractions, which are generated by ROS 
dependent processes. The green area reflect the hmU-level fractions, which are generated by ROS independent 
processes. The assignment is based on the assumption, that hmU-levels in somatic tissue are exclusively ROS 
created lesions (derived from the cluster analysis in Fig. 2b). The dark grey area reflect the mean value ±SD of 
hmU/8-oxo-G ratios of the tissue data. The difference between the height of the hmU/8-oxo-G ratios of mESCs 
and the mean of the tissue data give the hmU-fraction which is formed by ROS-independent processes. In WT01, 
J1 and R1 cells about 67%, 83% and 74%, respectively, of the global hmU-levels are estimated to be created by 
ROS independent processes. Bars reflect biological mean values ±SD. The differences between mESCs (WT01, 
J1) and murine tissues are significant (P = 9.3x10-5–5.0x10-3; unpaired two-tailed t-test) except for mESCs (WT01, 
J1) and liver (P = 0.081, 0.15). 
 
Supplementary Figure 4.Schematic representation of isotope tracing experiments with [13C,15N2]-T (left; blue) 
and [13C,D3]-methionine (right; red) and exchange rates of derived genomic isotopologues. Small negligible 
deviations in the exchange rates are due to differential noise sources. LOD = limit of detection. wt = wild type 
mESCs; Tdg cm = Tdg /  mESCs complemented with catalytic inactive Tdg (see Supplementary Fig. 6). 
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Supplementary Figure 5. (a) Effect of Smug1 depletion on modification levels in mESCs (R1). Effect of SMUG1 
(b) and TDG (c) depletion on modification levels in HEK-293T cells overexpressing Tet1cd. Shown is the percent 
change in modification content per nucleoside in cells co-transfected with esiRNAs targeting TDG or SMUG1 
relative to co-transfection with control esiRNA. Depicted are technical mean values ± SD. 
 
Supplementary Figure 6. Isotope tracing experiments with Tdg+/-, Tdg-/- mESCs as well as Tdg-/- mESCs 
complemented with a catalytic mutant of Tdg (Tdg cm) grown in the presence of [13C,D3]-methionine (200 µM). 
The catalytic mutant of Tdg is not completely inactive (fC levels are between Tdg +/- and Tdg -/- cells, left). Only 
in case of Tdg-/- cells complemented with a catalytic inactive Tdg (Tdg cm) labeled hmU was detected, which 
originated from the deamination of labeled hmC. ~7% [13C,D2]-hmU over total hmU was observed. This 
corresponds to ~0.06% deamination of hmC to hmU under these conditions (2.5x10-4 total hmC / N; 2.2x10-6 total 
hmU / N). Labeled fU was not observed. Depicted fC-levels represent technical mean values ±SD. 
 
Supplementary Figure 7. Tet1 and Tet2 generate hmU in HEK-293T and in vitro (a) Effect of Tet1 
overexpression on modified pyrimidines in HEK-293T cells. Modification levels in cells overexpressing wt and 
catalytic mutant versions of Tet1 catalytic domain (Tet1cd, blue bars and Tet1cm, gray bars, respectively), or a 
control construct (white bars). Depicted are mean values ±SD of technical triplicates on a logarithmic scale. (b) 
Pyrimidine modification levels in methylated plasmid DNA after treatment in vitro with Tet1cd. Depicted are 
mean values ±SD of technical duplicates. Note the logarithmic scale. 
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Supplementary Figure 8. Exponential models for fitting the decay curve of fC, caC and hmU in combined data 
sets from differentiation of R1 and C57Bl6/129-derived mESCs (6 biological independent experiments). In a 
simplified approach a single exponential decay model (y = y0 + A*exp(-x/t0)) was plotted using ORIGIN®. The 
parameters y0 (offset), t0 (time constant) and A (amplitude) of each decay function were iteratively optimized until 
the minimum of the Chi2 value of the fitting was reached. Half-life times (t1/2= t0*ln2) for fC, caC and hmU were 
7.2±1.2, 5.1±1.1 and 4.1 h, respectively. 
 
Supplementary Figure 9. Normalized transcript levels of Dnmts (c), Tet1–3 (d) and normalized modification 
levels of mC (c), hmC, fC and hmU (d) during differentiation of naïve mESCs in the presence of FGF-2 and ActA.  
 
 
Supplementary Figure 10. Expression level analysis of Tdg and Smug1 during differentiation of mESCs in the 
presence of FGF-2 and ActA. Expression levels were quantified with respect to the housekeeping gene Gapdh and 
normalized to time point 0 h. Depicted are technical mean values ± SD. 
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Supplementary Figure 11. (a) Scatterplot of proteins enriched with the hmU:A containing oligomer. Ratios of a 
forward and a reverse experiment are plotted. Specific readers in the forward and reverse experiment are marked 
in blue. Direct-specific readers are identified by the presence of the DNA-protein cross linker and marked in red. 
Gray dots are considered unspecific binders. See Fig. 6 for detailed view. (b) Gene Ontology Analysis performed 
with DAVID Bioinformatics Resources 6.74 
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Supplementary Figure 12. Effect on modified pyrimidines in HEK-293T cells upon Tet1cd and Uhrf1 (light gray 
bars) or Uhrf2 (gray bars) co-overexpression. Depicted are mean values ±SD of technical triplicates on a 
logarithmic scale. 
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Supplementary Table 1. Isotope tracing experiments by supplementing the growth medium of mES cells (LIF), 
differentiating mESCs (R1, without growth factors) and HEK-293T cells with either [13C,15N2]-T (50 or 100 µM) 
or [13C,D3]-methionine (0.2 mM). Small deviations in the exchange yields are due to differential noise sources and 
are negligible. LOD = Limit of detection. In case of [13C,D1]-fU no difference was observed compared to the 
natural control. 
cell type growth medium [
13C,15N2]-T /
T [%] 
[13C,15N2]-hmU /
hmU [%] 
[13C,15N2]-fU / 
fU [%]  
mESC (2i) 100 µM natural T 0.1 < LOD < LOD  
mESC (2i) 100 µM [13C,15N2]-T 76.0 78.2 74.6  
HEK + Tet1cd (72h) 50 µM [13C,15N2]-T 73.8 74.2 71.0  
      
cell type growth medium [
13C,D3]-mC /
mC [%] 
[13C,D2]-hmC / 
hmC [%] 
[13C,D2]-hmU / 
hmU [%] 
[13C,D1]-fU /
fU [%] 
mESC (LIF) natural methionine 0.1 < LOD < LOD 3.3 
mESC (LIF; 0 h) [13C,D3]-methionine 88.9 87.6 < LOD 3.0 
diff. mESC (12 h) [13C,D3]-methionine 89.3 88.4 < LOD 3.1 
diff. mESC (24 h) [13C,D3]-methionine 90.1 89.3 < LOD 3.2 
diff. mESC (48 h) [13C,D3]-methionine 90.4 90.5 < LOD 3.5 
mESC Tdg+/- [13C,D3]-methionine 88.0 87.6 < LOD 3.7 
mESC Tdg-/- [13C,D3]-methionine 87.4 87.2 < LOD < LOD 
mESC Tdg-/- + Tdg cm [13C,D3]-methionine 86.9 86.7 7.4 2.2 
HEK + Tet1cd (72h) [13C,D3]-methionine 87.4 83.4 < LOD < LOD 
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Supplementary Table 2. Assessment of ROS dependent hmU and fU product ratio of T-oxidation in HEK-293T 
wild type cells where TET activity is lowest (related to Fig. 3c). Modified nucleosides / N are given as mean values 
plus SD of three independent technical replicates. When T is oxidized by ROS about 9.8% hmU and 90.2% fU is 
generated. 
n 
mC / N hmC / N fC / N caC / N  
techn. 
mean SD 
techn. 
mean SD 
techn. 
mean SD 
techn. 
mean  
1 6.14E-03 1.97E-04 2.92E-05 9.90E-08 2.56E-07 2.59E-09 n.d.  
2 6.21E-03 1.32E-05 2.95E-05 2.21E-09 3.10E-07 2.06E-08 n.d.  
3 5.76E-03 4.36E-05 3.32E-05 6.55E-07 2.86E-07 2.95E-09 n.d.  
4 9.01E-03 2.87E-04 5.23E-05 5.01E-07 3.50E-07 5.00E-09 n.d.  
5 8.80E-03 9.62E-05 3.39E-05 5.44E-07 2.43E-07 2.41E-09 n.d.  
6 8.55E-03 7.69E-05 3.70E-05 2.17E-07 2.14E-07 1.30E-08 n.d.  
biol. mean 7.41E-03  3.59E-05  2.76E-07    
biol. SD 1.52E-03  8.56E-06  4.90E-08    
         
n 
hmU / N fU / N hmU/ (hmU+fU) 
fU/ 
(hmU+fU) 8-oxo-G / N 
techn. 
mean SD 
techn. 
mean SD [%] [%] 
techn. 
mean SD 
1 2.66E-07 5.54E-08 5.15E-06 1.59E-07 4.9 95.1 8.49E-06 1.30E-07 
2 1.21E-06 1.62E-07 8.02E-06 6.66E-07 13.1 86.9 1.00E-05 1.98E-07 
3 3.65E-08 7.35E-09 9.76E-07 8.75E-09 3.6 96.4 3.02E-06 7.02E-08 
4 6.31E-07 9.10E-10 3.51E-06 3.28E-08 15.3 84.7 7.43E-06 1.34E-07 
5 7.21E-07 5.93E-08 4.89E-06 1.59E-07 12.8 87.2 1.06E-05 1.14E-07 
6 3.58E-07 4.95E-08 3.56E-06 9.64E-09 9.1 90.9 7.22E-06 1.15E-08 
biol. mean 5.37E-07  4.35E-06  9.8 90.2 7.80E-06  
biol. SD 4.13E-07  2.33E-06  4.8 4.8 2.70E-06  
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Supplementary Note 1: oligonucleotide sequences for protein pull-down 
assays 
Supplementary Table 3. DNA oligonucleotides used in protein pull-down studies. 
ODN Sequence (5´o 3´) Modifications 
1 Biotin-GCA-TCC-GGT-CAY-CGT-TCC-TTC-GGA Y = 5-octadienyl-U 
2 Biotin-GCA-TCC-GGT-CAY-CAT-TCC-TTC-GGA Y = 5-octadienyl-U 
3 
TCC-GAA-GGA-AXG-ATG-ACC-GGA-TGC 
X= T 
4 X= hmU 
5 X= C 
6 X= hmC 
7 Biotin-GCT-CAC-GCT-AGY-CGA-CTC-CGT-GCA Y = 5-octadienyl-U 
8 TGC-ACG-GAG-TXG-ACT-AGC-GTG-AGC X = T 
9 Y = hmU 
 
Hybridization scheme: 
Pull-down 1: hmU:A vs. T:A : ODN4/2 vs. ODN3/2 
Pull-down 2: hmU:G vs. C:G = ODN4/1 vs. ODN5/1 
Pull-down 3: hmC:G vs. C:G = ODN6/1 vs. ODN5/1 
Pull-down 4 (scrambled sequence): hmU:A vs. T:A = ODN9/7 vs. ODN8/7 
 
Supplementary Note 2: LC-UV-ESI-MS/MS analysis of DNA 
Supplementary Table 4. Compound-dependent LC-MS/MS-parameters used for the analysis of genomic DNA. 
CE: collision energy; CAV: collision cell accelerator voltage; EMV: electron multiplier voltage. The nucleosides 
were analyzed in the positive ([M+H]+ species) as well as in the negative ([M-H]- species) ion selected reaction 
monitoring mode (SRM). 
compound Precursor Ion (m/z) 
MS1 
Resolution 
Product 
Ion (m/z) 
MS2 
Resolution 
Dwell 
time 
[ms] 
CE 
(V) 
CAV 
(V) Polarity 
time segment 1.5–4.0 min 
[15N2]-caC 274.08 Wide 158.03 Wide 170 5 5 Positive 
caC 272.09 Wide 156.04 Wide 170 5 5 Positive 
[15N2,D2]-hmC 262.12 enhanced 146.07 enhanced 40 27 1 Positive 
hmC 258.11 enhanced 142.06 enhanced 40 27 1 Positive 
[D3]-mC 245.13 enhanced 129.09 enhanced 30 60 1 Positive 
mC 242.11 enhanced 126.07 enhanced 30 60 1 Positive 
C 228.1 enhanced 112.05 enhanced 1 1 0 Positive 
time segment 4.0–6.0 min 
[D2]-hmU 259.09 Wide 216.08 Wide 48 7 5 Negative 
[D2]-hmU 259.09 Wide 126.05 Wide 48 7 5 Negative 
hmU 257.08 Wide 214.07 Wide 48 7 5 Negative 
hmU 257.08 Wide 124.04 Wide 48 7 5 Negative 
[15N2]-fU 257.06 Wide 213.05 Wide 48 6 5 Negative 
fU 255.06 Wide 212.06 Wide 48 6 5 Negative 
time segment 6.0–9.0 min 
[15N5]-8-oxo-G 289.08 Wide 173.04 Wide 120 9 7 Positive 
8-oxo-G 284.1 Wide 168.05 Wide 120 9 7 Positive 
[15N2]-fC 258.09 Wide 142.04 Wide 120 5 5 Positive 
fC 256.09 Wide 140.05 Wide 120 5 5 Positive 
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Supplementary Table 5. Compound-dependent LC-MS/MS-parameters used for the analysis of genomic DNA 
obtained from cells which were grown in medium supplemented with labeled thymidine ([13C,15N2]-T). CE: 
collision energy; CAV: collision cell accelerator voltage; EMV: electron multiplier voltage. The nucleosides were 
analyzed in the positive ([M+H]+ species) as well as in the negative ([M-H]- species) ion selected reaction 
monitoring mode (SRM). 
compound Precursor Ion (m/z) 
MS1 
Resolution 
Product 
Ion (m/z) MS2 Resolution 
Dwell 
time 
[ms] 
CE 
(V) 
CAV 
(V) Polarity 
time segment 1.5–4.0 min 
[13C,15N2]-caC 275.09 wide 159.04 wide 65 5 5 Positive 
caC 272.09 wide 156.04 wide 65 5 5 Positive 
[13C,15N2]-hmC 261.11 enhanced 145.06 enhanced 40 27 1 Positive 
hmC 258.11 enhanced 142.06 enhanced 40 27 1 Positive 
[13C,15N2]-mC 245.13 enhanced 129.09 enhanced 30 60 1 Positive 
mC 242.11 enhanced 126.07 enhanced 30 60 1 Positive 
[13C,15N2]-C 231.1 enhanced 115.05 enhanced 40 1 3 Positive 
C 228.1 enhanced 112.1 enhanced 40 1 3 Positive 
time segment 4.0–6.0 min 
[13C,15N2]-hmU 260.08 wide 215.07 wide 50 7 5 Negative 
hmU 257.08 wide 214.07 wide 50 7 5 Negative 
[13C,15N2]-fU 258.06 wide 213.05 wide 50 6 5 Negative 
fU 255.06 wide 212.06 wide 50 6 5 Negative 
time segment 6.0–9.0 min 
[15N5]-8-oxo-G 289.08 wide 173.04 wide 80 9 7 Positive 
8-oxo-G 284.1 wide 168.05 wide 80 9 7 Positive 
[13C,15N2]-fC 259.09 wide 143.04 wide 80 5 5 Positive 
fC 256.09 wide 140.05 wide 80 5 5 Positive 
[13C,15N2]-T 246.1 enhanced 130.05 enhanced 30 40 3 Positive 
T 243.1 enhanced 127.05 enhanced 30 40 3 Positive 
 
Supplementary Table 6. Compound-dependent LC-MS/MS-parameters used for the analysis of genomic DNA 
obtained from cells which were grown in medium supplemented with labeled (methyl-13C,D3)-methionine.CE: 
collision energy; CAV: collision cell accelerator voltage; EMV: electron multiplier voltage. The nucleosides were 
analyzed in the positive ([M+H]+ species) as well as in the negative ([M-H]- species) ion selected reaction 
monitoring mode (SRM). 
compound Precursor Ion (m/z) 
MS1 
Resolution 
Product 
Ion (m/z) MS2 Resolution 
Dwell 
time 
[ms] 
CE 
(V) 
CAV 
(V) Polarity 
time segment 1.5–4.0 min 
[13C]-caC 273.09 wide 157.04 wide 65 5 5 Positive 
caC 272.09 wide 156.04 wide 65 5 5 Positive 
[13C,D2]-hmC 261.12 enhanced 145.08 enhanced 40 27 1 Positive 
hmC 258.11 enhanced 142.06 enhanced 40 27 1 Positive 
[13C,D3]-mC 246.14 enhanced 130.09 enhanced 30 60 1 Positive 
mC 242.11 enhanced 126.07 enhanced 30 60 1 Positive 
C-dN 228.1 enhanced 112.1 enhanced 40 1 3 Positive 
time segment 4.0–6.0 min 
[13C,D2]-hmU 260.09 wide 217.09 wide 60 7 5 Negative 
hmU 257.08 wide 214.07 wide 60 7 5 Negative 
[13C,D]-fU 257.07 wide 214.07 wide 60 6 5 Negative 
fU 255.06 wide 212.06 wide 60 6 5 Negative 
time segment 6.0–9.0 min 
[15N5]-8-oxo-G 289.08 wide 173.04 wide 80 9 7 Positive 
8-oxo-G 284.1 wide 168.05 wide 80 9 7 Positive 
[13C,D]-fC 258.1 wide 142.06 wide 80 5 5 Positive 
fC 256.09 wide 140.05 wide 80 5 5 Positive 
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Spiking amounts of labeled internal standards for quantitative LC-MS/MS analysis 
The quantification of nucleosides of genomic DNA isolated from mESC or mouse tissue was carried 
out with the following amounts of internal standards: 51.03 pmol [D3]-mC, 7.655 pmol [15N2,D2]-hmC, 
45.6 fmol [15N2]-fC, 43.0 fmol [15N2]-caC, 108.9 fmol [15N5]-8-oxo-G; 160.1 fmol [D2]-hmU and 
180.0 fmol [15N2]-fU. The quantification of nucleosides of genomic DNA isolated from HEK293 cells 
overexpressing Tet was carried out with the following amounts of internal standards: 34.02 pmol [D3]-
mC, 5.103 pmol [15N2,D2]-hmC, 303.8 fmol [15N2]-fC, 215.1 fmol [15N2]-caC, 108.9 fmol [15N5]-8-oxo-
G; 160.1 fmol [D2]-hmU and 180.0 fmol [15N2]-fU. Genomic DNA samples isolated from cells grown 
in media supplemented with either [13C,15N2]-T or [13C,D3]-methionine were not spiked with internal 
standards except [15N5]-8-oxo-G. 
Validation of the LC-UV-MS/MS quantification method: 
Method validation, in particular linearity, precision, and accuracy (i.e. determined from matrix samples 
spiked with isotopically labeled internal standards) of the established method were investigated. 
Validation for the established LC-UV-ESI-MS/MS quantification method was based on three different 
series (i.e., calibration functions and quality control samples) accomplished on different days. Each 
calibration standard (5-8 standard concentrations) was analyzed five times. Each validation experiment 
was complemented by matrix blanks (analyzed in triplicates) to ensure selectivity and specificity of the 
method. Linear regression was applied by Origin® 6.0 (Microcal™) to obtain calibration curves. 
Therefore, the ratio of the area under the curve (A/A*) of the unlabeled nucleoside to the internal 
standard (*) was plotted against the ratio of the amount of substance (n/n*) of the unlabeled nucleoside 
to the internal standard (*) (see Supplementary Fig. 13). Calibration functions were calculated without 
weighting. Additionally, acceptable accuracy (80–120%) as well as precision (<20% RSD) was 
required. Accuracy was proven by computing the amount of substance n from the obtained A/A* ratios 
of the calibration standards using the respective calibration function. Here, accuracy was defined as the 
ratio of the used amount of substance to the calculated amount of substance in percent and had to be 
between 80–120% for each standard concentration. Precision was defined as follows: technical 
replicates of A/A* ratios for each calibration standard had to have relative standard deviations (RSD) 
smaller than 20%. The lower limit of quantification (LLOQ) was defined as the lowest concentration 
fulfilling the requirements of accuracy and precision and achieving a response of at least three times the 
response compared with the blank response. A compilation of absolute and relative LLOQs is shown in 
Supplementary Table 7. 
Quality control samples to evaluate intra-batch precision (see below) were investigated using a 
biological sample spiked with internal standards. Long-term stability of aqueous solutions of the labeled 
and unlabeled nucleosides at a storage temperature of í20 °C was investigated over two months 
including several freeze and thaw cycles by analyzing the MS/MS-responses with each batch. 
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Supplementary Table 7. Compilation of absolute lower limits of quantification [fmol] (LLOQ; see 
Supplementary Fig. 13) and relative LLOQs [per N] depending on the amount of DNA, which is digested. The 
relative LLOQs were computed by generating ratios of the absolute LLOQ [pmol] to the total amount of 
nucleosides (N; [pmol]) in the respective amount of DNA [µg]. The total amount of nucleosides was obtained by 
using the average molar mass of 308.91 g mol-1 for the monomeric DNA entity by taking the GC-content (21% C 
or G) in mouse into account. 
 
absolute
LLOQ  
[fmol] 
relative
LLOQ  
[per N] 
relative
LLOQ  
[per N] 
relative
LLOQ  
[per N] 
DNA amount  5 µg 10 µg 25 µg 
mC 104.5 6.5E-06 3.2E-06 1.3E-06 
hmC 100.8 6.2E-06 3.1E-06 1.2E-06 
fC 2.1 1.3E-07 6.5E-08 2.6E-08 
caC 2.0 1.2E-07 6.2E-08 2.5E-08 
8-oxo-G 2.0 1.2E-07 6.2E-08 2.5E-08 
dU 14.1 8.7E-07 4.4E-07 1.7E-07 
hmU 6.4 4.0E-07 2.0E-07 7.9E-08 
fU 5.7 3.5E-07 1.8E-07 7.0E-08 
 
 
Intra-batch assay and quantification data processing: 
In order to evaluate intra-batch precision (see below) quality samples were investigated using a 
biological sample spiked with internal standards. The intra-batch-assay was performed for the LC-ESI-
MS/MS analysis of the nucleosides G, C, mC, hmC, fC, caC, hmU, fU and 8-oxo-G. For this, a 
representative mESC DNA sample was analyzed. Technical replicates (n=5; each 4 µg DNA) were 
independently prepared using the below described digestion protocol. For data processing MassHunter 
Quantitative Analysis from Agilent was used. The area under the curve (A) was determined by LC-
MS/MS for mC, hmC, fC, caC, hmU, fU, 8-oxo-G and for the corresponding labeled internal standards 
(A*); the area under the curve (AUV) for G and C was determined by LC-UV. The amount of substance 
(n; pmol) of each nucleoside was computed by using the calibration curves (see Supplementary Fig. 
13). The total sample volume was 40 µL, the injection volume after sample filtration was 29 µL. 
Therefore, the obtained values of G and C by LC-UV quantification were corrected by the factor given 
by the ratio of 40 µL/29 µL. Careful monitoring of the exact pipetting and injection volumes was 
therefore necessary. The obtained absolute amounts (pmol) of the DNA modifications (X= C, mC, fC, 
caC, hmU, fU, 8-oxo-G) were then related to the amount of G (pmol) giving ratios of X / G in %. The 
sum of X / G was defined as 100%. These values were then transferred in X / N values, considering that 
the G content is 21% in mouse.  
The determined A/A* ratios of the DNA nucleosides to the labeled internal standards (see 
Supplementary Table 8) showed a high precision (RSD = 3.9-18%) for each nucleoside. The necessity 
in using labeled internal standards for quantification is shown by comparing these results with the 
relative standard deviation (RSD = 7.6-49.5%) of the uncorrected mass signal (A) of the respective DNA 
modification. Moreover, in order to gain precision between sample batches measured on different days 
(data not shown), it is even more important to use internal standards. No memory effect was observed 
during blank experiments performed after several measurements of a sample. The blank analyses were 
not contaminated by carry-over. 

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Supplementary Figure 13. UV and LC-MS/MS calibration curves and representative chromatograms of C (UV), 
G (UV), mC/[D3]-mC, hmC/[15N2,D2]-hmC, fC/[15N2]-fC, caC/[15N2]-caC, 8-oxo-G/[15N5]8-oxo-G, U/[15N2]-U, 
hmU/[D2]-hmU, fU/[15N2]-fU. These were obtained by applying the compound-dependent parameters summarized 
in Supplementary Table 4. For hmU the MS/MS transition 257ĺ214 was used. Depicted are the means of five 
technical replicates of one sample batch. Error bars reflect SD. Linearity was given across the following compound 
amounts in 29 µL injection volume: 10.63–7751 pmol C; 19.11–4892 pmol G; 104.5 fmol–228.6 pmol mC; 
100.8 fmol–73.45 pmol hmC; 2.1–515.0 fmol fC; 2.0–496.6 fmol caC; 2.0–475.7 fmol 8-oxo-G; 6.4–519.3 fmol 
hmU; 5.7–459.6 fmol fU. The amounts of the labeled internal standards in 29 µL injection volume were as follows: 
51.03 pmol [D3]-mC; 7.655 pmol [15N2,D2]-hmC; 45.6 fmol [15N2]-fC; 43.0 fmol [15N2]-caC; 108.9 fmol [15N5]-8-
oxo-G;96.1 fmol [D2]-hmU; 135.0 fmol [15N2]-fU. 
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Supplementary Table 8. Intra-batch-assay and quantification data processing. 
 AUV(G) n(G) [pmol] AUV(C) n(C) [pmol] C / G [%] C / N 
techn. replicate 1 956 2431 485 2341 96.3 2.02E-01 
techn. replicate 2 980 2493 495 2391 95.9 2.01E-01 
techn. replicate 3 1043 2654 531 2566 96.7 2.03E-01 
techn. replicate 4 979 2492 498 2406 96.5 2.03E-01 
techn. replicate 5 982 2498 498 2406 96.3 2.02E-01 
techn. mean value 988 2513 501 2422 96.4 2.02E-01 
SD 33 83 18 85 0.3 6.29E-04 
RSD [%] 3.3 3.3 3.5 3.5 0.3 0.3 
       
 A(mC) A([D3]-mC) A(mC)/ A([D3]-mC n(mC) [pmol] mC / G [%] mC / N 
techn. replicate 1 636358 510501 1.247 91.9 3.78 7.94E-03 
techn. replicate 2 678284 512180 1.324 97.7 3.92 8.23E-03 
techn. replicate 3 565889 447103 1.266 93.4 3.52 7.39E-03 
techn. replicate 4 664238 546597 1.215 89.6 3.60 7.56E-03 
techn. replicate 5 719777 570445 1.262 93.1 3.73 7.82E-03 
techn. mean value 652909 517365 1.263 93.1 3.71 7.79E-03 
SD 57206 46591 0.040 2.9 0.16 3.30E-04 
RSD [%] 8.8 9.0 3.1 3.1 4.2 4.2 
       
 A(hmC) A([D2,15N2]-hmC) 
A(hmC)/ 
A([D2,15N2]-
hmC) 
n(hmC) [pmol] hmC / G [%] hmC / N 
techn. replicate 1 80754 84338 0.958 8.51 0.350 7.35E-04 
techn. replicate 2 115869 108774 1.065 9.46 0.380 7.97E-04 
techn. replicate 3 264594 269496 0.982 8.72 0.329 6.90E-04 
techn. replicate 4 139093 133830 1.039 9.23 0.371 7.78E-04 
techn. replicate 5 116163 106074 1.095 9.73 0.389 8.18E-04 
techn. mean value 143295 140502 1.028 9.13 0.364 7.64E-04 
SD 70941 74213 0.057 0.51 0.024 5.12E-05 
RSD [%] 49.5 52.8 5.6 5.6 6.7 6.7 
       
 A(fC) A([15N2]-fC) A(fC)/ A([15N2]-fC) n(fC) [pmol] fC / G [%] fC / N 
techn. replicate 1 163427 31747 5.148 0.199 8.18E-03 1.72E-05 
techn. replicate 2 178366 32585 5.474 0.211 8.48E-03 1.78E-05 
techn. replicate 3 196827 35504 5.544 0.214 8.07E-03 1.69E-05 
techn. replicate 4 193392 33755 5.729 0.221 8.88E-03 1.86E-05 
techn. replicate 5 193493 35959 5.381 0.208 8.32E-03 1.75E-05 
techn. mean value 185101 33910 5.455 0.211 8.38E-03 1.76E-05 
SD 14070 1816 0.214 0.008 3.17E-04 6.66E-07 
RSD [%] 7.6 5.4 3.9 3.9 3.8 3.8 
 A(caC) A([15N2]-caC) A(caC)/ A([15N2]-caC) n(caC) [pmol] caC / G [%] caC / N 
techn. replicate 1 1444 6666 0.217 0.0104 4.28E-04 8.99E-07 
techn. replicate 2 1735 8205 0.211 0.0102 4.08E-04 8.57E-07 
techn. replicate 3 2111 9709 0.217 0.0104 3.93E-04 8.26E-07 
techn. replicate 4 1985 8301 0.239 0.0114 4.59E-04 9.63E-07 
techn. replicate 5 1927 8581 0.225 0.0108 4.31E-04 9.05E-07 
techn. mean value 1840 8292 0.222 0.0106 4.24E-04 8.90E-07 
SD 260 1089 0.011 0.0005 2.48E-05 5.20E-08 
RSD [%] 14.1 13.1 4.8 4.6 5.8 5.8 
       
 A(hmU) A([D2]-hmU) A(hmU)/ A([D2]-hmU) n(hmU) [pmol] hmU / G [%] hmU / N 
techn. replicate 1 894 5799 0.154 0.0090 3.69E-04 7.74E-07 
techn. replicate 2 1278 6368 0.201 0.0130 5.23E-04 1.10E-06 
techn. replicate 3 1561 7679 0.203 0.0133 5.00E-04 1.05E-06 
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techn. replicate 4 1695 8148 0.208 0.0137 5.49E-04 1.15E-06 
techn. replicate 5 1236 9010 0.137 0.0075 3.00E-04 6.29E-07 
techn. mean value 1333 7401 0.181 0.0113 4.48E-04 9.41E-07 
SD 312 1309 0.033 0.0029 1.08E-04 2.27E-07 
RSD [%] 23.4 17.7 18.1 25.3 24.2 24.2 
       
 A(fU) A([15N2]-fU) A(fU)/ A([15N2]-fU) n(fU) [pmol] fU / G [%] fU / N 
techn. replicate 1 7527 19661 0.383 0.0553 2.27E-03 4.78E-06 
techn. replicate 2 8672 22769 0.381 0.0550 2.21E-03 4.63E-06 
techn. replicate 3 11884 23930 0.497 0.0711 2.68E-03 5.63E-06 
techn. replicate 4 10143 27784 0.365 0.0528 2.12E-03 4.45E-06 
techn. replicate 5 14349 30152 0.476 0.0682 2.73E-03 5.73E-06 
techn. mean value 10515 24859 0.420 0.0605 2.40E-03 5.04E-06 
SD 2695 4148 0.061 0.0085 2.82E-04 5.93E-07 
RSD [%] 25.6 16.7 14.5 14.0 11.7 11.7 
       
 A(8oxo-G) A([15N5]-8oxo-G) 
A(8oxo-G)/
A([15N5]-
8oxo-G) 
n(8oxo-G) [pmol] 8oxo-G / G [%] 8oxoG / N
techn. replicate 1 237655 245919 0.966 0.113 4.63E-03 9.73E-06 
techn. replicate 2 256991 266182 0.965 0.113 4.51E-03 9.48E-06 
techn. replicate 3 310924 294412 1.056 0.123 4.64E-03 9.74E-06 
techn. replicate 4 282245 299479 0.942 0.110 4.41E-03 9.26E-06 
techn. replicate 5 327930 305105 1.075 0.125 5.01E-03 1.05E-05 
techn. mean value 283149 282219 1.001 0.117 4.64E-03 9.75E-06 
SD 37187 25225 0.060 0.007 2.28E-04 4.79E-07 
RSD [%] 13.1 8.9 6.0 6.0 4.9 4.9 
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Supplementary Note 3: LC-MS/MS quantification results of genomic DNA 
Supplementary Table 9. LC-MS/MS quantification results of mESC (WT01, J1 and R1) wild type, knock down 
(KD) and knock out cells (related to Fig. 1c,, 2a and 4a). The results of independent biological replicates are shown, 
the biological mean values / N and the biological standard deviation (SD). n.d. = not detected. 
biol. replicate C / N mC / N hmC / N fC / N caC / N hmU / N fU / N 8-oxo-G / N 
mESC (WT01) 1 2.01E-01 8.08E-03 6.53E-04 9.35E-06 6.01E-07 6.94E-07 3.51E-06 6.75E-06 
mESC (WT01) 2 2.02E-01 7.71E-03 6.41E-04 9.81E-06 5.90E-07 7.04E-07 2.52E-06 5.95E-06 
mESC (WT01) 3 2.02E-01 7.78E-03 6.82E-04 9.26E-06 5.24E-07 4.81E-07 1.60E-06 4.02E-06 
mESC (WT01) 4 2.01E-01 8.17E-03 6.92E-04 1.03E-05 6.44E-07 4.73E-07 2.17E-06 4.90E-06 
mESC (WT01) 5 2.02E-01 6.72E-03 8.63E-04 1.36E-05 7.25E-07 3.83E-07 4.34E-06 5.76E-06 
mESC (WT01) 6 2.03E-01 6.43E-03 7.70E-04 1.32E-05 3.81E-07 5.14E-07 1.30E-06 3.17E-06 
mESC (WT01) 7 2.03E-01 6.10E-03 8.18E-04 1.08E-05 6.77E-07 4.78E-07 1.03E-06 3.47E-06 
biol. mean value 2.02E-01 7.28E-03 7.31E-04 1.09E-05 5.92E-07 5.32E-07 2.35E-06 4.86E-06 
SD 7.75E-04 8.48E-04 8.63E-05 1.81E-06 1.13E-07 1.21E-07 1.21E-06 1.36E-06 

biol. replicate C / N mC / N hmC / N fC / N caC / N hmU / N fU / N 8-oxo-G / N 
Tet1 KD  (WT01) 1 2.01E-01 8.99E-03 2.76E-04 3.31E-06 2.21E-07 1.42E-07 7.98E-07 3.21E-06 
Tet1 KD  (WT01) 2 2.02E-01 7.77E-03 1.39E-04 2.53E-06 2.20E-07 6.44E-08 2.00E-06 3.73E-06 
Tet1 KD  (WT01) 3 2.03E-01 6.37E-03 2.36E-04 6.51E-06 2.07E-07 3.07E-07 4.13E-06 7.08E-06 
biol. mean value 2.02E-01 7.71E-03 2.17E-04 4.11E-06 2.16E-07 1.71E-07 2.31E-06 4.67E-06 
SD 1.33E-03 1.31E-03 7.03E-05 2.11E-06 7.87E-09 1.24E-07 1.69E-06 2.10E-06 

biol. replicate C / N mC / N hmC / N fC / N caC / N hmU / N fU / N 8-oxo-G / N 
Tet2 KD (WT01) 1 2.00E-01 9.41E-03 4.45E-04 6.12E-06 2.38E-07 9.51E-08 5.18E-07 2.82E-06 
Tet2 KD (WT01) 2 2.02E-01 7.25E-03 3.38E-04 4.52E-06 9.02E-08 3.23E-07 6.01E-07 1.78E-06 
Tet2 KD (WT01) 3 2.02E-01 7.36E-03 3.98E-04 6.25E-06 3.36E-07 1.21E-07 2.50E-06 5.21E-06 
Tet2 KD (WT01) 4 2.02E-01 7.69E-03 3.90E-04 6.78E-06 3.37E-07 n.d. 1.16E-06 6.52E-06 
biol. mean value 2.02E-01 7.93E-03 3.93E-04 5.92E-06 2.50E-07 1.80E-07 1.20E-06 4.08E-06 
SD 1.04E-03 1.01E-03 4.36E-05 9.73E-07 1.16E-07 1.25E-07 9.16E-07 2.17E-06 

biol. replicate C / N mC / N hmC / N fC / N caC / N hmU / N fU / N 8-oxo-G / N 
mESC (J1) 1 2.04E-01 5.53E-03 3.61E-04 2.18E-06 7.95E-07 1.48E-06 3.98E-06 6.68E-06 
mESC (J1) 2 2.04E-01 5.63E-03 3.32E-04 2.17E-06 9.30E-07 1.41E-06 4.19E-06 6.64E-06 
biol. mean value 2.04E-01 5.58E-03 3.47E-04 2.17E-06 8.62E-07 1.44E-06 4.08E-06 6.66E-06 
SD 4.96E-05 6.97E-05 2.06E-05 8.94E-09 9.55E-08 4.91E-08 1.51E-07 2.93E-08 

biol. replicate C / N mC / N hmC / N fC / N caC / N hmU / N fU / N 8-oxo-G / N 
DNMT1 -/- (J1) 1 2.07E-01 2.72E-03 1.80E-04 1.36E-06 3.10E-07 1.68E-06 4.56E-06 7.22E-06 
DNMT1 -/- (J1) 2 2.07E-01 2.71E-03 1.77E-04 1.55E-06 2.94E-07 1.56E-06 3.90E-06 6.73E-06 
biol. mean value 2.07E-01 2.72E-03 1.79E-04 1.46E-06 3.02E-07 1.62E-06 4.23E-06 6.97E-06 
SD 5.80E-06 3.35E-06 2.28E-06 1.31E-07 1.11E-08 8.47E-08 4.73E-07 3.45E-07 

biol. replicate C / N mC / N hmC / N fC / N caC / N hmU / N fU / N 8-oxo-G / N 
DNMT3ab -/- (J1) 1 2.10E-01 4.12E-04 3.01E-05 2.46E-07 n.d. 8.02E-07 6.25E-07 2.68E-06 
DNMT3ab -/- (J1) 2 2.10E-01 3.76E-04 3.54E-05 5.67E-07 n.d. 2.60E-06 7.86E-07 5.73E-06 
DNMT3ab -/- (J1) 3 2.10E-01 3.81E-04 3.03E-05 3.71E-07 n.d. 2.27E-06 3.94E-07 2.32E-06 
DNMT3ab -/- (J1) 4 2.10E-01 2.67E-04 2.67E-05 4.52E-07 n.d. 1.71E-06 4.50E-07 1.79E-06 
DNMT3ab -/- (J1) 5 2.10E-01 2.50E-04 1.07E-05 3.78E-07 n.d. 7.41E-07 4.51E-06 7.68E-06 
DNMT3ab -/- (J1) 6 2.10E-01 2.32E-04 1.60E-05 2.64E-07 n.d. 5.28E-07 2.87E-06 5.50E-06 
biol. mean value 2.10E-01 3.20E-04 2.48E-05 3.80E-07  1.44E-06 1.61E-06 4.28E-06 
SD 9.60E-05 7.83E-05 9.51E-06 1.19E-07  8.76E-07 1.70E-06 2.35E-06 

biol. replicate C / N mC / N hmC / N fC / N caC / N hmU / N fU / N 8-oxo-G / N 
mESC (R1) 1 2.01E-01 8.37E-03 2.00E-04 1.04E-06 n.d. 1.52E-06 2.56E-06 1.21E-05 
mESC (R1) 2 2.03E-01 6.76E-03 3.30E-04 2.00E-06 3.03E-07 9.23E-07 1.20E-06 n.d. 
mESC (R1) 3 2.01E-01 8.68E-03 2.70E-04 2.12E-06 n.d. 1.77E-06 4.67E-06 1.05E-05 
biol. mean value 2.02E-01 7.94E-03 2.67E-04 1.72E-06 3.03E-07 1.40E-06 2.81E-06 8.42E-06 
SD 9.92E-04 1.03E-03 6.52E-05 5.91E-07  4.35E-07 1.75E-06 5.00E-06 
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Supplementary Table 10. LC-MS/MS quantification results of different murine organs of 3 months old wild type 
individuals (n) (related to Fig. 1d, 2 and Supplementary Fig. 2). Compiled are mean values / N obtained from three 
independent technical replicates and the standard deviation (SD).  
n organ DNA isolation C / N mC / N hmC / N fC / N 
      techn. mean SD 
techn. 
mean SD 
techn. 
mean SD 
techn. 
mean SD 
1 cerebellum   2.01E-01 2.30E-04 8.06E-03 2.40E-04 6.59E-04 1.08E-05 3.45E-07 3.14E-08 
1 cerebellum BHT, + Desf., 2.01E-01 2.67E-04 8.27E-03 2.59E-04 7.37E-04 1.76E-05 2.86E-07 1.30E-08 
1 cerebellum BHT, + Desf., +THU 2.01E-01 3.66E-04 8.52E-03 3.45E-04 7.29E-04 2.14E-05 2.97E-07 2.03E-08 
2 cerebellum BHT, + Desf., +THU 2.00E-01 3.92E-04 9.81E-03 2.80E-04 6.37E-04 4.00E-05 2.73E-07 1.16E-08 
3 cerebellum BHT, + Desf., +THU 2.00E-01 3.95E-04 8.95E-03 3.45E-04 6.90E-04 2.91E-05 2.61E-07 1.57E-08 
4 cerebellum BHT, + Desf., +THU 2.00E-01 4.55E-04 9.46E-03 3.60E-04 6.69E-04 2.45E-05 2.59E-07 3.89E-09 
                      
1 kidney   2.01E-01 1.72E-04 8.13E-03 1.59E-04 4.37E-04 2.79E-05 2.27E-07 1.10E-08 
1 kidney BHT, + Desf. 2.02E-01 3.38E-04 7.79E-03 3.29E-04 4.33E-04 8.84E-06 2.25E-07 2.75E-08 
1 kidney BHT, + Desf., +THU 2.02E-01 1.70E-04 7.71E-03 1.76E-04 4.27E-04 2.15E-05 2.11E-07 1.19E-08 
2 kidney BHT, + Desf., +THU 2.01E-01 4.44E-04 8.59E-03 3.75E-04 3.78E-04 1.35E-05 1.86E-07 1.43E-08 
3 kidney BHT, + Desf., +THU 2.01E-01 1.46E-04 8.20E-03 1.02E-04 3.73E-04 1.67E-05 1.88E-07 8.82E-09 
4 kidney BHT, + Desf., +THU 2.01E-01 3.17E-04 8.30E-03 2.45E-04 3.79E-04 2.06E-05 1.94E-07 2.45E-08 
                      
1 cortex BHT, + Desf., +THU 2.00E-01 4.48E-04 9.06E-03 3.37E-04 1.12E-03 7.21E-05 4.09E-07 4.17E-08 
2 cortex BHT, + Desf., +THU 1.99E-01 2.05E-04 9.29E-03 1.48E-04 1.37E-03 2.05E-05 4.34E-07 1.14E-08 
3 cortex BHT, + Desf., +THU 2.00E-01 4.65E-04 9.23E-03 3.73E-04 1.14E-03 7.48E-06 4.24E-07 1.92E-08 
                      
1 hippocampus BHT, + Desf., +THU 1.98E-01 1.88E-04 1.08E-02 2.11E-04 1.56E-03 6.83E-05 4.49E-07 2.82E-08 
2 hippocampus BHT, + Desf., +THU 1.98E-01 2.13E-04 1.08E-02 1.73E-04 1.55E-03 3.08E-05 7.08E-07 4.67E-08 
3 hippocampus BHT, + Desf., +THU 1.97E-01 1.78E-04 1.09E-02 1.44E-04 1.71E-03 2.66E-05 3.89E-07 2.66E-08 
                      
1 heart BHT, + Desf., +THU 2.02E-01 3.25E-04 7.96E-03 2.87E-04 4.08E-04 3.32E-05 1.85E-07 1.66E-08 
2 heart BHT, + Desf., +THU 2.02E-01 1.68E-04 7.87E-03 1.31E-04 3.84E-04 2.30E-05 1.48E-07 2.64E-09 
3 heart BHT, + Desf., +THU 2.01E-01 4.25E-04 8.07E-03 3.42E-04 4.56E-04 4.39E-05 1.41E-07 1.35E-08 
                      
1 liver BHT, + Desf., +THU 2.01E-01 2.32E-04 8.35E-03 1.92E-04 2.44E-04 3.24E-06 1.66E-07 2.23E-08 
2 liver BHT, + Desf., +THU 2.02E-01 3.16E-04 8.10E-03 2.61E-04 2.73E-04 8.57E-06 1.78E-07 2.26E-08 
3 liver BHT, + Desf., +THU 2.01E-01 3.04E-04 8.42E-03 2.39E-04 2.82E-04 3.44E-05 1.81E-07 2.91E-08 
           
n organ DNA isolation hmU / N fU / N 8-oxo-G / N  
      
techn. 
mean SD 
techn. 
mean SD 
techn. 
mean SD   
1 cerebellum   7.27E-08   2.03E-06 2.29E-07 5.09E-06 1.92E-07   
1 cerebellum BHT, + Desf., n.d.   6.89E-07 2.65E-08 2.96E-06 6.04E-08   
1 cerebellum BHT, + Desf., +THU n.d.   8.05E-07 7.34E-08 3.30E-06 3.79E-08   
2 cerebellum BHT, + Desf., +THU 1.30E-07 7.94E-08 1.02E-06 4.83E-08 3.86E-06 2.70E-07   
3 cerebellum BHT, + Desf., +THU 6.01E-08 3.67E-08 9.33E-07 9.52E-08 3.66E-06 2.26E-07   
4 cerebellum BHT, + Desf., +THU 1.07E-07 7.00E-08 1.03E-06 8.63E-08 4.67E-06 5.69E-07   
                    
1 kidney   n.d.   7.58E-07 7.38E-08 3.66E-06 2.63E-07   
1 kidney BHT, + Desf. n.d.   7.00E-07 5.30E-08 3.24E-06 3.73E-07   
1 kidney BHT, + Desf., +THU n.d.   7.16E-07 1.73E-08 3.48E-06 2.63E-07   
2 kidney BHT, + Desf., +THU 1.08E-07 7.89E-08 1.08E-06 1.45E-07 3.73E-06 1.42E-07   
3 kidney BHT, + Desf., +THU 1.29E-07 9.06E-08 1.17E-06 1.67E-07 3.91E-06 5.99E-08   
4 kidney BHT, + Desf., +THU n.d.   9.34E-07 6.36E-08 3.65E-06 1.57E-07   
                    
1 cortex BHT, + Desf., +THU 1.46E-07 6.19E-09 1.28E-06 1.22E-07 2.51E-06 3.74E-08   
2 cortex BHT, + Desf., +THU 8.24E-08 2.81E-08 1.30E-06 7.35E-08 3.13E-06 1.16E-07   
3 cortex BHT, + Desf., +THU 2.05E-07 5.83E-08 1.43E-06 3.72E-08 3.58E-06 2.83E-07   
                    
1 hippocampus BHT, + Desf., +THU 2.74E-07 6.06E-08 2.18E-06 1.29E-07 6.30E-06 2.17E-07   
2 hippocampus BHT, + Desf., +THU 6.00E-07 5.50E-08 3.20E-06 3.46E-07 1.31E-05 7.69E-07   
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3 hippocampus BHT, + Desf., +THU 4.68E-08 1.85E-08 9.85E-07 2.26E-07 5.03E-06 8.96E-08   
                    
1 heart BHT, + Desf., +THU 4.14E-07 7.28E-08 1.97E-06 3.46E-07 7.85E-06 1.69E-06   
2 heart BHT, + Desf., +THU 9.81E-08 4.23E-09 1.15E-06 7.63E-08 2.48E-06 1.18E-07   
3 heart BHT, + Desf., +THU 1.04E-07 3.36E-08 1.55E-06 7.55E-08 3.14E-06 2.27E-07   
                    
1 liver BHT, + Desf., +THU n.d.   1.13E-06 9.97E-08 2.69E-06 3.93E-07   
2 liver BHT, + Desf., +THU 1.48E-07 8.67E-08 1.09E-06 1.96E-07 2.43E-06 9.41E-08   
3 liver BHT, + Desf., +THU 2.34E-08   1.05E-06 1.18E-07 2.39E-06 4.69E-08   
 
Supplementary Table 11. LC-MS/MS quantification results of n = 6 independent mESC differentiation 
experiments without growth factors (related to Fig. 5a,b). Compiled are mean values / N obtained from three 
independent technical measurements and their standard deviation (SD). K = C57Bl6/129 derived mES cell line. 
n Sample C / N mC / N hmC / N fC / N caC / N 
 mESC diff. time 
techn. 
mean SD 
techn. 
mean SD 
techn. 
mean SD 
techn. 
mean SD 
techn. 
mean SD 
1 K, t= 0h 2.06E-01 1.47E-04 3.79E-03 1.52E-04 4.25E-04 8.84E-06 1.68E-05 9.20E-07 1.21E-06 5.80E-08 
1 K, t= 8h 2.06E-01 9.23E-05 3.43E-03 9.96E-05 5.33E-04 1.27E-05 1.71E-05 7.46E-07 1.09E-06 2.97E-08 
1 K, t= 16h 2.06E-01 1.07E-04 3.88E-03 1.15E-04 4.93E-04 9.98E-06 6.69E-06 2.33E-07 3.92E-07 4.81E-08 
                       
2 R1, t= 0h 2.08E-01 1.38E-04 1.87E-03 1.05E-04 3.89E-04 3.33E-05 2.17E-05 5.00E-07 1.52E-06 6.10E-08 
2 R1, t= 8h 2.08E-01 2.55E-05 1.60E-03 1.73E-05 5.50E-04 1.14E-05 2.91E-05 1.12E-06 1.91E-06 3.30E-08 
2 R1, t= 16h 2.08E-01 7.54E-05 1.74E-03 7.53E-05 5.87E-04 1.28E-05 1.89E-05 4.48E-07 1.04E-06 2.38E-08 
                       
3 K, t= 0h 2.05E-01 6.83E-05 4.24E-03 6.36E-05 3.84E-04 6.03E-06 9.95E-06 1.46E-07 1.74E-07 1.70E-08 
3 K, t= 8h 2.05E-01 7.08E-05 4.08E-03 7.14E-05 4.85E-04 5.17E-06 1.47E-05 7.35E-07 2.60E-07 1.84E-08 
3 K, t= 24h 2.05E-01 5.00E-05 4.65E-03 5.74E-05 4.48E-04 7.86E-06 4.00E-06 1.67E-07 8.74E-08 2.02E-08 
                       
4 R1, t= 0h 2.07E-01 6.37E-05 2.49E-03 5.86E-05 4.61E-04 1.43E-05 1.71E-05 4.28E-07 3.25E-07 4.80E-08 
4 R1, t= 8h 2.07E-01 5.45E-05 2.27E-03 4.25E-05 5.53E-04 1.69E-05 2.63E-05 8.05E-07 5.71E-07 2.45E-08 
4 R1, t= 24h 2.06E-01 5.12E-05 3.00E-03 5.28E-05 5.93E-04 7.13E-06 8.39E-06 2.73E-07 1.74E-07 2.04E-08 
                       
5 K, t=0 h 2.04E-01 1.02E-04 5.38E-03 1.04E-04 3.89E-04 4.27E-06 7.66E-06 2.13E-07 2.29E-07 1.73E-08 
5 K, t=8 h 2.04E-01 1.74E-04 5.10E-03 1.72E-04 4.65E-04 4.64E-06 1.01E-05 5.36E-07 2.37E-07 8.38E-10 
5 K, t=16 h 2.04E-01 2.04E-04 5.88E-03 2.09E-04 5.22E-04 9.13E-06 4.40E-06 2.13E-07 1.92E-07 1.34E-08 
5 K, t=24 h 2.04E-01 1.84E-04 5.40E-03 1.79E-04 4.01E-04 6.47E-06 2.06E-06 1.87E-07 1.00E-07 1.16E-08 
5 K, t=40 h 2.04E-01 1.71E-04 5.72E-03 1.71E-04 3.00E-04 1.20E-06 1.20E-06 5.32E-08 7.93E-08   
                       
6 R1, t=0 h 2.06E-01 2.16E-05 3.56E-03 3.01E-05 5.85E-04 1.80E-05 2.08E-05 4.72E-07 5.49E-07 5.15E-08 
6 R1, t=8 h 2.05E-01 9.98E-05 3.83E-03 8.48E-05 7.63E-04 1.51E-05 2.05E-05 5.32E-07 8.74E-07 9.94E-09 
6 R1, t=16 h 2.06E-01 4.53E-05 3.44E-03 3.95E-05 6.89E-04 7.42E-06 1.20E-05 5.65E-07 3.03E-07 8.59E-09 
6 R1, t=24 h 2.06E-01 1.19E-04 3.57E-03 8.65E-05 6.16E-04 3.52E-05 7.18E-06 2.03E-07 1.55E-07 2.87E-08 
6 R1, t=40 h 2.05E-01 6.38E-06 4.95E-03 1.56E-05 4.42E-04 1.11E-05 1.97E-06 4.48E-08 9.46E-08 1.84E-08 
            
n Sample hmU / N fU / N 8-oxo-G / N    
 mESC diff. time 
techn. 
mean SD 
techn. 
mean SD 
techn. 
mean SD     
1 K, t= 0h 3.75E-07 1.67E-09 3.89E-06 2.73E-07 6.66E-06 2.74E-07     
1 K, t= 8h 1.08E-06 1.57E-07 4.83E-06 3.45E-07 7.79E-06 3.05E-07     
1 K, t= 16h 1.01E-06 1.76E-07 5.11E-06 5.69E-07 8.07E-06 5.57E-07     
                   
2 R1, t= 0h 1.14E-06 3.65E-07 3.82E-06 4.10E-07 6.70E-06 1.72E-07     
2 R1, t= 8h 2.97E-06 4.13E-07 5.23E-06 9.97E-08 9.08E-06 5.89E-07     
2 R1, t= 16h 3.75E-06 6.55E-07 5.15E-06 5.72E-07 8.81E-06 5.37E-07     
                   
3 K, t= 0h 8.76E-07 2.02E-08 8.86E-06 9.44E-07 1.35E-05 9.84E-07     
3 K, t= 8h 1.29E-06 1.76E-07 6.90E-06 9.81E-07 1.00E-05 6.53E-07     
3 K, t= 24h 6.55E-07 5.89E-08 6.72E-06 7.12E-07 9.73E-06 5.55E-07     
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4 R1, t= 0h 1.22E-06 1.58E-07 8.62E-06 7.83E-07 1.26E-05 8.90E-08     
4 R1, t= 8h 1.91E-06 2.69E-07 6.02E-06 4.56E-07 8.05E-06 2.35E-07     
4 R1, t= 24h 1.82E-06 3.67E-07 6.60E-06 6.25E-07 1.06E-05 6.27E-07     
                   
5 K, t=0 h 9.98E-07 2.95E-07 7.04E-06 1.35E-06 9.98E-06 9.08E-07     
5 K, t=8 h 2.97E-06 2.62E-07 6.89E-06 5.67E-07 9.64E-06 5.85E-07     
5 K, t=16 h 1.43E-06 3.46E-07 2.71E-06 1.92E-07 3.82E-06 3.04E-07     
5 K, t=24 h 8.01E-07 2.16E-07 6.60E-06 5.93E-07 9.72E-06 1.33E-07     
5 K, t=40 h 8.30E-07 3.44E-08 7.78E-06 1.31E-07 1.13E-05 3.07E-07     
                   
6 R1, t=0 h 1.85E-06 3.00E-07 8.62E-06 1.94E-07 1.12E-05 7.13E-07     
6 R1, t=8 h 3.77E-06 6.22E-07 4.01E-06 7.44E-07 6.02E-06 1.41E-06     
6 R1, t=16 h 3.94E-06 8.01E-08 5.93E-06 3.24E-07 7.61E-06 2.01E-07     
6 R1, t=24 h 3.84E-06 3.90E-07 8.92E-06 1.03E-06 1.23E-05 2.83E-07     
6 R1, t=40 h 1.84E-06 9.73E-08 8.44E-06 2.94E-07 1.26E-05 1.02E-06     
 
Supplementary Table 12. Relative modification levels of combined data sets from differentiation (0–40 h) of R1 
and C57Bl6/129-derived mESCs without growth factors (related to Fig. 5a and Supplementary Fig. 8). In order to 
obtain these, the absolute modification levels of t = 0 h time points compiled in Supplementary Table 11 were set 
as 1 and the modification levels of later time points respectively related to these. Summarized are the biological 
mean values at each differentiation time point and the standard deviation (SD). 
  relative C / N relative mC / N relative hmC / N 
time biol. mean SD biol. mean SD biol. mean SD 
t = 0 h 1.00000E+00  1.000E+00  1.000E+00  
t = 8 h 1.00024E+00 1.2480E-03 9.435E-01 7.579E-02 1.270E+00 8.082E-02 
t = 16 h 9.98952E-01 1.4308E-03 1.004E+00 7.157E-02 1.296E+00 1.629E-01 
t = 24 h 9.98556E-01 1.4742E-03 1.077E+00 9.513E-02 1.133E+00 1.176E-01 
t = 40 h 9.96347E-01 3.4067E-03 1.228E+00 2.314E-01 7.634E-01 1.034E-02 
       
  relative fC / N relative caC / N  
time biol. mean SD biol. mean SD   
t = 0 h 1.000E+00  1.000E+00    
t = 8 h 1.280E+00 2.318E-01 1.339E+00 3.329E-01   
t = 16 h 6.051E-01 1.980E-01 5.991E-01 2.175E-01   
t = 24 h 3.769E-01 9.373E-02 4.393E-01 1.122E-01   
t = 40 h 1.255E-01 4.352E-02 2.589E-01 1.225E-01   
       
  relative hmU / N relative fU / N relative 8-oxo-G / N 
time biol. mean SD biol. mean SD biol. mean SD 
t = 0 h 1.000E+00  1.000E+00  1.000E+00  
t = 8 h 2.258E+00 6.597E-01 9.221E-01 3.417E-01 9.024E-01 3.178E-01 
t = 16 h 2.390E+00 8.012E-01 9.337E-01 4.755E-01 8.978E-01 4.410E-01 
t = 24 h 1.278E+00 6.283E-01 8.742E-01 1.357E-01 9.086E-01 1.623E-01 
t = 40 h 9.129E-01 1.155E-01 1.043E+00 8.856E-02 1.129E+00 3.665E-04 
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Supplementary Table 13. LC-MS/MS quantification results of mESC differentiation with the growth factors 
FGF-2 and ActA (related to Supplementary Fig. 9). Modified nucleosides / N are given as mean values plus SD 
of three independent technical replicates. 
Sample C / N mC / N hmC / N fC / N 
EpiLC diff. time techn. mean SD 
techn. 
mean SD 
techn. 
mean SD 
techn. 
mean SD 
t= 0h 2.096E-01 1.40E-05 3.92E-04 1.35E-05 4.57E-05 6.48E-07 2.88E-07 4.52E-09 
t= 12h 2.093E-01 1.01E-05 5.80E-04 4.94E-06 6.85E-05 5.47E-06 1.65E-06 1.34E-07 
t= 24h 2.074E-01 1.17E-04 2.29E-03 1.02E-04 2.60E-04 1.41E-05 4.45E-06 6.30E-09 
t= 36h 2.044E-01 9.71E-05 4.96E-03 7.38E-05 5.81E-04 2.30E-05 6.16E-06 5.27E-08 
t= 48h 2.020E-01 8.85E-05 7.23E-03 8.83E-05 7.53E-04 8.90E-07 4.92E-06 1.31E-07 
 
Sample hmU / N fU / N 8-oxo-G / N 
EpiLC diff. time techn. mean SD 
techn. 
mean 
techn. 
mean SD 
techn. 
mean 
t= 0h 4.76E-07 7.05E-08 1.87E-06 9.10E-08 4.00E-06 1.10E-07 
t= 12h 2.01E-06 1.90E-07 3.91E-06 7.84E-07 9.80E-06 3.07E-07 
t= 24h 2.78E-06 7.20E-07 2.42E-06 3.65E-07 5.19E-06 1.45E-07 
t= 36h 2.10E-06 5.82E-07 2.20E-06 1.51E-07 5.42E-06 4.12E-07 
t= 48h 1.90E-06 1.03E-07 3.74E-06 3.74E-07 6.69E-06 3.08E-07 
 
Supplementary Table 14. HEK-293T wild type vs. HEK + Tet1cm vs. HEK + Tet1cd (related to Supplementary 
Fig. 7a). Modified nucleosides / N are given as mean values of three independent technical replicates. 
  HEK-293T wild type  HEK + Tet1cm  HEK + Tet1cd  
Nucleosides techn. mean SD techn. mean SD techn. mean SD 
C / N 2.01E-01 9.67E-05 2.02E-01 1.09E-04 2.03E-01 3.91E-04 
mC / N 8.80E-03 9.62E-05 8.04E-03 1.09E-04 4.18E-03 3.93E-05 
hmC / N 3.39E-05 5.44E-07 4.95E-05 1.04E-06 2.21E-03 9.42E-05 
fC / N 2.43E-07 2.41E-09 2.18E-07 1.17E-08 2.48E-04 5.96E-06 
caC / N n.d.  n.d.  1.29E-04 3.35E-06 
hmU / N 7.21E-07 5.93E-08 1.51E-07 9.07E-09 4.24E-05 2.51E-06 
fU / N 4.89E-06 1.59E-07 1.42E-06 6.66E-08 8.79E-06 1.07E-07 
8-oxo-G / N 1.06E-05 1.14E-07 6.83E-06 1.47E-07 8.31E-06 9.03E-07 
 
Supplementary Table 15. DNA modification levels of Tet1 in vitro assay (related to Supplementary Fig. 7b). 
Plasmid DNA with full CpG methylation was treated with commercially available Tet1. 
 plasmid mC / N hmC / N fC / N caC / N hmU / N fU / N 8-oxo-G / N 
untreated 4.8E-02 n.d. n.d. n.d. n.d. 4.4E-06 8.6E-06 
untreated 4.6E-02 n.d. n.d. n.d. n.d. 4.0E-06 9.4E-06 
+Tet1 7.6E-04 4.8E-03 5.0E-03 9.0E-03 3.8E-04 1.5E-04 4.0E-05 
+Tet1 6.5E-04 4.7E-03 4.8E-03 9.3E-03 4.4E-04 1.6E-04 3.7E-05 
-Tet1 4.8E-02 n.d. 3.5E-05 n.d. 1.6E-05 2.5E-04 4.0E-05 
-Tet1 4.7E-02 n.d. 3.5E-05 n.d. 1.2E-05 2.3E-04 4.5E-05 
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Supplementary Table 16. Effect of Smug1 depletion on modification levels in mESCs (R1) and effect of TDG 
and SMUG1 depletion on modification levels in HEK-293T cells overexpressing Tet1cd (related to Supplementary 
Fig. 5). Percent change values for modified nucleosides of cells treated with esiRNA (targeting Smug1/SMUG1 
or TDG) with respect to unrelated control esiRNA. The absolute modification content of HEK-293T cells was 
normalized based on Tet1cd expression levels (determined by TECAN reading). The percent change is given as a 
mean value of three independent technical replicates. 
  mESC  Smug1 KD HEK-293T + Tet1cd / TDG KD HEK-293T + Tet1cd / SMUG1 KD 
Nucleosides Percent change SD Percent change SD Percent change SD 
hmC -0.15 4.07 -2.22 2.61 -3.43 2.24 
fC -1.26 3.29 38.15 1.25 0.77 2.05 
caC 14.04 29.24 33.51 2.72 6.59 3.24 
hmU 37.14 9.47 -10.41 4.74 46.46 5.65 
fU 71.00 15.73 -4.36 2.34 22.66 1.91 
8-oxo-G 17.27 14.26 -5.36 2.04 -6.97 1.77 
 
Supplementary Table 17. HEK-293T wild type, HEK with Tet1cd-overexpression, Tet1cd/Uhrf1 co-
overexpression or Tet1cd/Uhrf2 co-overexpression (related to Supplementary Fig. 12). Modified nucleosides / N 
are given as mean values of three independent technical replicates. 
 HEK-293T wt  
HEK 
+ Tet1cd  
HEK 
+ Tet1cd 
+ Uhrf1
 
HEK 
+ Tet1cd 
+ Uhrf2 
 
Nucleosides techn. mean SD 
techn. 
mean SD 
techn. 
mean SD 
techn. 
mean SD 
C / N 2.04E-01 2.97E-05 2.04E-01 1.24E-04 2.05E-01 8.32E-05 2.04E-01 1.15E-04 
mC / N 6.01E-03 2.74E-05 5.29E-03 1.22E-04 4.63E-03 8.93E-05 5.11E-03 1.15E-04 
hmC / N 2.86E-05 1.57E-06 4.29E-04 1.85E-05 3.31E-04 1.93E-05 5.13E-04 9.85E-06 
fC / N 4.51E-07 5.21E-08 5.97E-05 3.43E-06 7.21E-05 4.24E-06 1.39E-04 5.61E-06 
caC / N 1.77E-07 2.67E-09 2.32E-05 8.50E-07 2.23E-04 1.84E-05 1.66E-04 1.21E-06 
hmU / N 8.18E-07 8.89E-08 2.55E-06 6.26E-08 1.27E-05 4.30E-07 6.74E-06 1.59E-06 
fU / N 7.60E-06 3.39E-07 5.40E-06 5.26E-07 5.64E-06 8.42E-07 1.22E-05 2.10E-06 
8-oxo-G / N 1.27E-05 7.08E-07 9.23E-06 3.22E-07 6.93E-06 1.09E-06 1.62E-05 8.43E-07 
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Supplementary Note 4: materials in cell culture 

Supplementary Table 18. Overexpression plasmids and esiRNAs used in HEK-293T cell experiments. 
Figure Experiment Sample Plasmid DNA esiRNA 
S7a HEK-293T +/- Tet1xx 
HEK + Tet1cd GFP-Tet1cd (7.5 µg) x 
HEK + Tet1cm mCh-Tet1cm (7.5 µg) x 
Wild type pCMV6-Cdk5Rap1-v2 (7.5 µg) x 
S5b,S5c Tet1cd with TDG or SMUG1 KD 
HEK + Tet1cd GFP-Tet1cd (10 µg) 
CDK5RAP1 esiRNA 
(5 µg) 
HEK + Tet1cd 
with TDG KD 
GFP-Tet1cd 
(10 µg) 
TDG esiRNA 
(5 µg) 
HEK + Tet1cd 
with SMUG1 KD 
GFP-Tet1cd 
(10 µg) 
SMUG1 esiRNA 
(5 µg) 
 HEK-293T Tet1cd GFP-Tet1cd (6 µg) x 
S12 HEK-293T Tet1cd + Uhrf1 GFP-Tet1cd, GFP-Uhrf1
1 
(each 6 µg) x 
 HEK-293T Tet1cd + Uhrf2 GFP-Tet1cd, GFP-Uhrf2
1 
(each 6 µg) x 
 
Supplementary Table 19. Knockdown (KD) efficiencies by Tet relative to SCR shRNAs. 
  FWD REV Reference 
Tet1 GAGCCTGTTCCTCGATGTGG  CAAACCCACCTGAGGCTGTT Ito et. al.2 
Tet2 TGTTGTTGTCAGGGTGAGAATC  TCTTGCTTCTGGCAAACTTACA Ito et. al.2 
actin AAGGCCAACCGTGAAAAGAT GTGGTACGACCAGAGGCATAC This work 
 
 
Supplementary Table 20. Primers for qPCR analysis of Tet, Dnmt, Tdg and Smug1 of EpiLC differentiation and 
Smug1 knockdown samples. 
  FWD REV Reference 
Gapdh CATGGCCTTCCGTGTTCCTA CTTCACCACCTTCTTGATGTCATC Szwagierzcak et al.3 
Tet1 CCAGGAAGAGGCGACTACGTT TTAGTGTTGTGTGAACCTGATTTATTGT Szwagierzcak et al.3 
Tet2 ACTTCTCTGCTCATTCCCACAGA TTAGCTCCGACTTCTCGATTGTC Szwagierzcak et al.3 
Tet3 GAGCACGCCAGAGAAGATCAA CAGGCTTTGCTGGGACAATC Szwagierzcak et al.3 
Dnmt1 CCTAGTTCCGTGGCTACGAGGAG TCTCTCTCCTCTGCAGCCGACTC This work 
Dnmt3a GCTTTCTTCTCAGCCTCCCT CCATGCCAAGACTCACCTTC This work 
Dnmt3b CTGGCACCCTCTTCTTCATT ATCCATAGTGCCTTGGGACC This work 
Tdg GTCTGTTCATGTCGGGGCTGAGTGAG CTGCAGTTTCTGCACCAGGATGCGC This work 
Smug1 CACTGGGGCCTACCCATGA CTCCCAAGCATAATCCACCG This work 
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Supplementary Note 5: correlation analysis results of modification levels 

Supplementary Table 21. Correlation analysis of DNA modification levels comparing murine tissues from three 
months old individuals (cortex, hippocampus, cerebellum, heart, liver and kidney). Pearson coefficients (p) and 
significance values (s) are summarized. n=24 independent DNA samples (see Supplementary Table 10). 
Highlighted in gray are strong to very strong correlations (ŇpŇ> 0.7) with significance levels (s) lower than 0.001 
(marked with *). Additionally, moderate correlations (0.7 > ŇpŇ> 0.6) with significance level lower than 0.001 
are highlighted in light gray.  
 C mC hmC fC 8-oxo-G hmU fU 
C 
p 1.000 -0.986* -0.935* -0.832* -0.534 -0.466 -0.479 
s  0.000 0.000 0.000 0.007 0.022 0.018 
mC p 
-0.986* 1.000 0.863* 0.769* 0.534 0.464 0.460 
s 0.000  0.000 0.000 0.007 0.022 0.024 
hmC p 
-0.935* 0.863* 1.000 0.887* 0.481 0.420 0.472 
s 0.000 0.000  0.000 0.017 0.041 0.020 
fC p 
-0.832* 0.769* 0.887* 1.000 0.663* 0.586 0.649* 
s 0.000 0.000 0.000  0.000 0.003 0.001 
8-oxo-G p 
-0.534 0.534 0.481 0.663* 1.000 0.837* 0.835* 
s 0.007 0.007 0.017 0.000  0.000 0.000 
hmU p 
-0.466 0.464 0.420 0.586 0.837* 1.000 0.871* 
s 0.022 0.022 0.041 0.003 0.000  0.000 
fU 
p -0.479 0.460 0.472 0.649* 0.835* 0.871* 1.000 
s 0.018 0.024 0.020 0.001 0.000 0.000  

Supplementary Table 22. Correlation analysis of DNA modification levels during early mESC differentiation (0-
40 h). Pearson coefficients (p) and significance values (s) are summarized. n=22 independent DNA samples (see 
Supplementary Table 11). Highlighted in gray are strong to very strong correlations (ŇpŇ> 0.7) with significance 
levels (s) lower than 0.001 (marked with *). Additionally, weak correlations of hmC/hmU with mC/C are 
highlighted in pale pink.  
 C mC hmC fC caC 8-oxo-G hmU fU 
C p 
1 -0.997* 0.324 0.806* 0.699* -0.032 0.299 -0.145 
s  0.000 0.141 0.000 0.000 0.889 0.176 0.518 
mC p 
-0.997* 1 -0.399 -0.815* -0.693* 0.057 -0.356 0.160 
s 0.000  0.066 0.000 0.000 0.801 0.104 0.476 
hmC p 
0.324 -0.399 1 0.404 0.182 -0.312 0.783* -0.227 
s 0.141 0.066  0.062 0.417 0.157 0.000 0.309 
fC p 
0.806* -0.815* 0.404 1 0.797* -0.266 0.303 -0.299 
s 0.000 0.000 0.062  0.000 0.232 0.170 0.177 
caC p 
0.699* -0.693* 0.182 0.797* 1 -0.435 0.165 -0.567 
s 0.000 0.000 0.417 0.000  0.043 0.463 0.006 
8-oxo-G p 
-0.032 0.057 -0.312 -0.266 -0.435 1 -0.080 0.959* 
s 0.889 0.801 0.157 0.232 0.043  0.723 0.000 
hmU p 
0.299 -0.356 0.783* 0.303 0.165 -0.080 1 -0.022 
s 0.176 0.104 0.000 0.170 0.463 0.723  0.921 
fU 
p -0.145 0.160 -0.227 -0.299 -0.567 0.959* -0.022 1 
s 0.518 0.476 0.309 0.177 0.006 0.000 0.921  
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CAPSULE 
Background: TET proteins oxidize 5-methyl-
cytosine and contribute to active DNA 
demethylation. 
Results: OGT modifies TET proteins with N-
acetylglucosamine and thereby counteracts TET 
phosphorylation. 
Conclusion: An interplay of post-translational 
modifications (PTMs) regulates TET proteins at 
low complexity regions. 
Significance: This first map of phosphorylation 
and O-GlcNAcylation sites of TET proteins at 
amino acid resolution is the basis for 
understanding TET regulation. 
 
ABSTRACT  
TET proteins oxidize 5-methylcytosine (mC) to 5-
hydroxymethylcytosine (hmC), 5-formylcytosine 
(fC) and 5-carboxylcytosine (caC) and thus 
provide a possible means for active DNA 
demethylation in mammals. Although their 
catalytic mechanism is well characterized and the 
catalytic dioxygenase domain is highly conserved, 
the function of the regulatory regions — the N-
terminus and the low complexity insert between 
the two parts of the dioxygenase domains — is 
only poorly understood. Here, we demonstrate that 
TET proteins are subject to a variety of PTMs that 
mostly occur at these regulatory regions. We 
mapped TET modification sites at amino acid 
resolution and show for the first time that TET1, 
TET2, and TET3 are highly phosphorylated. The 
glycosyltransferase OGT, which we identified as a 
strong interactor of all three TET proteins, 
catalyzes the addition of an N-acetylglucosamine 
(GlcNAc) group to serine and threonine residues 
of TET proteins and thereby decreases both the 
number of phosphorylation sites as well as the site 
occupancy. Interestingly, the different TET 
proteins display unique PTM patterns and some 
modifications occur in distinct combinations. In 
summary, our results provide a novel potential 
mechanism for TET protein regulation based on a 
dynamic interplay of phosphorylation and O-
GlcNAcylation at the N-terminus and the low 
complexity insert region. Our data suggest strong 
crosstalk between the modification sites that could 
allow rapid adaption of TET protein localization, 
activity, or targeting due to changing environ-
mental conditions as well as in response to 
external stimuli.  
 
INTRODUCTION  
A major epigenetic mechanism of gene regulation 
in higher eukaryotes is methylation of DNA at the 
carbon 5 atom of cytosines (1,2). Recently, the 
family of TET (ten-eleven-translocation)
5
 proteins 
has been shown to successively oxidize mC to 
hmC, fC and caC (3-6), providing novel insights 
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into the dynamics of DNA modifications. TET 
proteins are also active on genomic thymine 
residues, leading to the generation of 5-
hydroxyuracil (hmU) (7). In gnathostomata, there 
are three TET proteins: TET1, TET2, and TET3 
(8), that show distinct expression patterns and 
functions in different tissues or during 
development (9-13). TET1 and TET2 are highly 
expressed in mouse embryonic stem cells 
(mESCs) and are associated with oxidation of 
transcription start sites or gene bodies, 
respectively (14). TET3 is upregulated in the 
oocyte and oxidizes the silenced paternal 
pronuclear DNA (10,15). High levels of TET 
proteins and genomic hmC are described for 
neuronal tissues (11,16-18). In several patients 
with myeloid malignancies, mutations of TET2 
correlate with decreased hmC levels and altered 
gene expression patterns (19-22). 
The activity of TET proteins directly depends on 
two co-factors: Fe(II) and 2-oxoglutarate (2-OG) 
(3,8). Interestingly, gain-of-function mutations of 
the enzymes responsible for 2-OG synthesis, IDH1 
and IDH2, have been associated with 
tumorigenesis, in particular glioblastomata and 
acute myeloid leukemia (AML) (20,23,24). These 
mutations lead to the synthesis of 2-
hydroxyglutarate (2-HG), a potent inhibitor of 2-
OG dependent dioxygenases such as TET proteins 
(24,25). Since IDH1 and IDH2 are enzymes of the 
Krebs cycle, these findings represent a direct link 
of TET protein activity to metabolism, especially 
since low hmC levels are not only found in AML 
patients with TET2 loss-of-function mutations, but 
also with IDH2 gain-of-function mutations (20). 
Besides 2-HG, ascorbate has also been shown to 
influence cytosine oxidation by TET proteins (26-
28). In summary, TET protein activity appears to 
be modulated by several small molecules, either 
inhibitory such as 2-HG or stimulating like 
ascorbate. 
TET proteins are not only influenced by certain 
metabolites, but also by interacting proteins. TET1 
forms complexes with heterochromatin-associated 
proteins like HDAC1, HDAC2, SIN3A or EZH2 
(29). All three TET proteins interact with a variety 
of factors of the base-excision repair pathway, 
including PARP1, LIG3, or XRCC1, and also with 
several DNA glycosylases such as TDG, NEIL1, 
or MDB4 (30). Another known interactor of TET 
proteins is the glycosyltransferase OGT (31-36) 
that represents an additional interesting connection 
with metabolism. OGT catalyzes the addition of a 
GlcNAc group to serine or threonine residues of 
target proteins (37). Its activity is dependent on the 
availability of a variety of metabolic molecules 
like glucose, ATP, glutamine and acetyl-CoA (38). 
The association of OGT with TET proteins has 
been reported to influence histone modifications 
and gene expression (31,36), TET1 protein 
stability (33) and activity (34) and, for TET3, also 
on subcellular localization (35).  
 
Taken together, TET protein activity is widely 
studied in the context of development, 
tumorigenesis and metabolic conditions. However, 
only very little is known about the structure and 
function of the non-catalytic domains of TET 
proteins. In this study, we show that TET proteins 
are subject to a large number of PTMs, 
predominantly occurring at the two low 
complexity regions, which display only little 
sequence conservation: the N-terminus and the 
insert region that separates the two parts of the 
catalytic dioxygenase domain and is predicted to 
be unstructured (8). We describe that TET proteins 
are phosphorylated and that this phosphorylation 
can be suppressed via O-GlcNAcylation by the 
glycosyltransferase OGT. Detailed mapping of 
modification sites to the protein sequence shows 
that mostly N-terminus and insert region of TET 
proteins are subjected to PTMs and that their 
regulation depends on a dynamic interplay of 
different PTMs. 
 
EXPERIMENTAL PROCEDURES 
Antibody generation 
A His-tagged protein fragment from the insert 
region of each TET protein (Supplemental data S1, 
S2) was expressed in E. coli BL21 (DE3) cells 
(Novagen, Darmstadt, Germany) and purified with 
the TALONTM Superflow Metal Affinity Resin 
system (Clontech, Saint Germain, France) under 
native conditions as described previously (39). 
Approximately 100 µg of each antigen were 
injected both intraperitoneally (i.p.) and 
subcutaneously (s.c.) into Lou/C rats using 
CPG2006 (TIB MOLBIOL, Berlin, Germany) as 
adjuvant. After eight weeks, immune response was 
boosted i.p. and s.c. three days before fusion. 
Fusion of the myeloma cell line P3X63-Ag8.653 
with the rat immune spleen cells was performed 
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using polyethylene glycol 1500 (PEG 1500, 
Roche, Mannheim, Germany). After fusion, the 
cells were cultured in 96 well plates using 
RPMI1640 with 20 % fetal calf serum, 
Penicillin/streptomycin, pyruvate, nonessential 
amino acids (PAA, Linz, Austria) supplemented 
by aminopterin (Sigma, St. Louis, MO). 
Hybridoma supernatants were tested in a solid-
phase immunoassay. Microtiter plates were coated 
over night with His-tagged TET antigens at a 
concentration of 3-5 µg/ml in 0.1 M sodium 
carbonate buffer, pH = 9.6. After blocking with 
non-fat milk (Frema, Neuform, Zarrentin, 
Germany), hybridoma supernatants were added. 
Bound rat mAbs were detected with a cocktail of 
biotinylated mouse mAbs against the rat IgG 
heavy chains, avoiding IgM mAbs (α-IgG1, α-
IgG2a, α-IgG2b (ATCC, Manassas, VA), α-IgG2c 
(Ascenion, Munich, Germany)). The biotinylated 
mAbs were visualized with peroxidase-labelled 
avidin (Alexis, San Diego, CA) and o-
phenylenediamine as chromogen in the peroxidase 
reaction. Anti-TET1 5D6 (rat IgG2a), anti-TET1 
5D8 (rat IgG2a), anti-TET1 2H9 (rat IgG2a), anti-
TET1 4H7 (rat IgG2a), anti-TET2 9F7 (rat 
IgG2a), anti-TET3 11B6 (rat IgG2a) and anti-
TET3 23B9 (rat IgG2a) were stably subcloned and 
further characterized (Supplemental data S1). 
 
ESC culture, co-IP and MS/MS analysis 
mESCs (J1) were cultured as described previously 
(9). Endogenous TET1 and TET2 proteins were 
pulled out via monoclonal antibodies (5D6, 5D8, 
and 9F7) coupled to protein G sepharose beads as 
described in (39). After co-immunoprecipitation 
(co-IP), protein samples were digested on beads 
with trypsin according to standard protocols. 
Peptide mixtures were analyzed using electrospray 
tandem mass spectrometry. Experiments were 
performed with an LTQ Orbitrap mass 
spectrometer (Thermo Scientific, Waltham, MA). 
Spectra were analyzed with the Mascot™ 
Software (Matrix Science, Boston, MA). 
 
Expression constructs 
Expression constructs for GFP-TET1, GFP-TET2, 
GFP-TET3, GFP and mCherry (mCh) were 
described previously (40-42). To generate the 
mCh-OGT construct, the coding sequence was 
amplified using cDNA from mouse E14 ESCs as 
template and subcloned into the pCAG-Cherry-IB 
vector. Expression constructs for mCh-OGTH508A 
(subsequently referred to as OGTmut) were 
generated by overlap extension PCR. All 
constructs were verified by DNA sequencing 
(Eurofins, Ebersberg, Germany). 
 
HEK293T culture, co-IP and Western blot 
analysis 
Co-IP followed by Western blot with GFP- and 
mCh-tagged proteins expressed in HEK293T cells 
was performed as described previously (30). O-
GlcNAc was detected with a mouse monoclonal 
antibody (RL2, abcam, Cambridge, UK) and an 
Alexa647N-conjugated secondary antibody 
(Sigma, St. Louis, MO).  
 
Sample preparation for mass spectrometric 
analysis  
All experiments were performed in triplicates. 
GFP-tagged TET proteins and/or mCh-tagged 
OGT or OGTmut were expressed in HEK293T 
cells. Cell lysis with RIPA buffer and IP with the 
GFP-Trap® (Chromotek, Martinsried, Germany) 
was performed as described previously (30). After 
IP, samples on beads were rinsed two times with 
wash buffer (20 mM TrisHCl, pH = 7.5, 300 mM 
NaCl, 0.5 mM EDTA) and two times with IP 
buffer (20 mM TrisHCl, pH = 7.5, 150 mM NaCl, 
0.5 mM EDTA). 
100 µl of denaturation buffer (6 M GdnHCl, 10 
mM Tris(2-carboxyethyl)phosphine and 40 mM 
chloroacetamide in 100 M Tris pH = 8.5) was 
added to the beads and heated at 70 °C for 5 min. 
The samples were then subjected to sonication in 
Diagenode bioruptor plus (UCD-300-TO) at 
maximum power settings, for 10 cycles consisting 
of 30 s pulse and 30 s pause. Following sonication, 
the samples were diluted 1:10 with digestion 
buffer (25 mM Tris pH = 8.5 containing 10 % 
acetonitrile) and mixed by vortexing prior to 
enzyme digestion. Each sample was digested with 
1 µg of endoproteinase lysC (Wako Chemicals, 
Neuss, Germany) for 4 h with subsequent 
digestion using 1 µg of trypsin (Promega, 
Madison, WI) under gentle rotation at 37 °C. After 
digestion, the samples were placed in a speed-vac 
for 10 minutes to remove acetonitrile from the 
sample before StageTip purification using SDB-
XC material (43). Peptides were then eluted from 
the StageTip, placed in speed-vac to reduce the 
sample volume to approximately 6 µl and 5 µl of 
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the sample was injected on the column for MS/MS 
analysis.  
 
Liquid chromatography tandem mass 
spectrometry and data analysis  
Samples were loaded on a column (15 cm length 
and 75 µm inner diameter (New Objective, 
Woburn, MA)) packed with 3 µm Reprosil C18 
beads (Dr Maisch GmbH, Ammerbuch-Entringen, 
Germany) using the auto sampler of Thermo Easy 
n-LC (Thermo Scientific, Waltham, MA) coupled 
via a nano-electrospray source to a LTQ Orbitrap 
XL mass spectrometer. Each sample was analyzed 
using a 2 h reversed phase gradient and using a top 
5 method for data dependent acquisition. Full 
scans were acquired in the Orbitrap after 
accumulating up to 1x106 charges and the MS/MS 
of the five most abundant precursors were 
performed using low energy ion trap CID. MS/MS 
spectra were recorded using the ion trap by radial 
ejection.  
All raw files were analyzed using the MaxQuant 
(44) computational proteomics platform (version 
1.4.1.6). Peak lists were searched with an initial 
mass deviation of 7 ppm and fragment ion 
deviation of 0.5 Th. Carbamidomethylation was 
used as fixed modification and oxidation of 
methionine, phosphorylation of serine, threonine 
and tyrosine, O-linked GlcNAc of serine and 
threonine, ubiquitination (diglycine motif) of 
lysine and acetylation of the protein N-terminus 
were used as variable modification. All 
unmodified and oxidized methionine and N-
acetylation containing peptides were used for 
protein quantification. 
MaxQuant output data were further analyzed with 
the Perseus software 1.4.1.3 (44). Modifications 
that were detected in only one out of three 
biological replicates were excluded from analysis. 
Hierarchical clustering (Figure 3) is based on 
euclidean distances.  
 
Results  
TET proteins interact with OGT 
The three TET proteins share a common domain 
architecture: the C-terminal catalytic dioxygenase 
domain is split into two parts separated by a low 
complexity insert region and is preceded by an 
extension enriched in cysteines (8). All three TET 
proteins have a large N-terminal part that is mostly 
uncharacterized so far, except for a CXXC-type 
zinc finger at the N-terminus of TET1 and TET3 
(8,40,45). Murine TET3 exists in two isoforms: 
one with the zinc finger and one without (41). The 
cysteine-rich region and the split-dioxygenase 
domain are conserved among the three murine 
TET proteins whereas N-terminus and insert 
region display only little sequence similarity 
(Figure 1a). The three-dimensional structure of 
mammalian TET proteins remains unresolved with 
the exception of the cysteine-rich and dioxygenase 
domains of TET2 (46), leaving structure and 
function of the N-terminus and the low complexity 
insert unknown. 
As a first step towards understanding the 
regulation of TET proteins, we screened for 
interaction partners in mESCs. Since TET1 and 
TET2 are highly expressed in mESCs, we 
generated antibodies against murine TET1 and 
TET2 using protein fragments derived from the 
insert region of the catalytic domains as antigens. 
A detailed description of the obtained antibodies 
can be found in Supplemental data S1. Clones 
5D6-anti-TET1, 5D8-anti-TET1 and 9F7-anti-
TET2 proved to be suited for immunoprecipitation 
of the specific TET protein, respectively, and were 
used to pull down endogenous TET1 and TET2 
from mESCs. Subsequent LC-MS/MS analysis 
revealed that both TET1 and TET2 interact with 
the glycosyltransferase OGT (Figure 1b). In 
accordance with this result, co-IP analysis of GFP-
TET1 and GFP-TET2 followed by Western blot 
analysis shows co-precipitation of mCh-OGT. We 
also analyzed whether TET3 can interact with 
OGT and could indeed detect a strong mCh-OGT 
signal in the bound fraction of the co-IP of GFP-
TET3. Taken together, our data indicate that all 
three TET proteins interact with OGT (Figure 1c).  
 
OGT catalyzes O-GlcNAcylation of TET 
proteins 
Having observed the interaction between TET 
proteins and OGT, we examined whether TET 
proteins are modified by OGT and screened for O-
GlcNAcylation, the modification that is transferred 
to the OH-group of serine or threonine residues of 
target proteins by OGT (38,47). To this end, we 
specifically enriched GFP-tagged TET proteins 
co-expressed with either OGT or its catalytically 
inactive point mutant OGTmut with the GFP-Trap® 
and probed the subsequent Western blot with an 
anti-GlcNAc antibody. All three TET proteins 
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were found to be increasingly O-GlcNAcylated 
dependent on the coexpression of catalytically 
active OGT (Figure 2).  
 
O-GlcNAcylation suppresses 
phosphorylation of TET proteins  
To identify OGT-dependent O-GlcNAcylation 
sites on TET proteins, we performed mass 
spectrometric analysis of semi-purified proteins. 
We therefore expressed GFP-tagged TET1, TET2, 
and TET3 in HEK293T cells, either with OGT, 
OGTmut, or without interactor. After pull-down 
with the GFP-Trap® and stringent washing steps, 
the samples were analyzed by LC-MS/MS. An 
overall sequence coverage of about 50 % was 
achieved for TET1, about 60 % for TET2 and 
about 65 % for TET3 (Supplemental data S3, 
Supplemental table S4). For data analysis, only 
sites were considered that were detected in at least 
two out of three biological replicates. Without co-
expression of interactor, only few residues on TET 
proteins are found to be O-GlcNAcylated at low 
site occupancy. Coexpression of OGT leads to a 
strong increase in both number of O-
GlcNAcylation sites and site occupancy for TET2 
and TET3. The difference in number of O-GlcNAc 
sites is either due to de novo modification by OGT 
or because the site occupancy without OGT co-
expression is below detection limit. For TET1, 
however, the O-GlcNAc pattern is relatively 
heterogeneous and only few O-GlcNAc sites can 
be detected. This heterogeneity is also illustrated 
by the fact that residues 1327 and 327, which are 
O-GlcNAcylated in the TET1 samples, are only 
detected to be modified in one out of three 
replicates in the TET1/OGT samples and therefore 
do not occur in the heat map. Although mCh-
OGTmut is supposed to be catalytically inactive, 
co-expression leads to a small increase in O-
GlcNAcylation and represents a distinct state from 
basal levels (Figure 3a). 
Since O-GlcNAcylation occurs at serine or 
threonine residues of the target protein, we also 
screened for another post-translational 
modification that can occur at these amino acids, 
namely phosphorylation. Interestingly, high 
phosphorylation of TET1 and TET2 and, to a 
lesser extent, of TET3, was observed. 
Phosphorylation of all TET proteins decreased 
dramatically upon co-expression of active OGT, 
regarding both site occupancy and number of 
detected phosphorylation sites (Figure 3b).  
 
PTMs occur mostly at the N-terminus 
and the low complexity insert of TETs 
To date, the domains of TET proteins are largely 
uncharacterized except for the conserved catalytic 
dioxygenase domain and the CXXC-type zinc 
finger at the N-terminus of TET1 (8,40,46). 
Mapping of the detected O-GlcNAc and 
phosphorylation sites to the TET protein sequence 
reveals that mostly the N-terminus and the low 
complexity insert, which separates the two parts of 
the dioxygenase domain, are subjected to PTMs 
(Figure 4). Remarkably, O-GlcNAcylation and 
phosphorylation rarely occur at the exact same 
residue, although O-GlcNAcylation suppresses 
phosphorylation. Furthermore, the three TET 
proteins carry different modification patterns: 
Whereas TET1 is mostly modified at the N-
terminus and the very C-terminal part and is 
hardly glycosylated, TET2 and TET3 show strong 
O-GlcNAcylation at the low complexity insert 
region. The first 350 amino acids of TET3 remain 
free of PTMs. The observed pattern is not due to 
differences in sequence coverage as the detected 
peptides are homogenously distributed over the 
whole protein sequence (Supplemental data S3). 
Interestingly, some of the modifications are 
detected on the same peptides, indicating that they 
occur together at the same molecule. For example, 
TET2-S23 phosphorylation can be found with S15 
phosphorylation and phosphorylation of S376 only 
occurs when S374 is O-GlcNAcylated, but not 
when it is phosphorylated (Table 2). For TET3, a 
variety of PTM combinations can be observed for 
residues 360-368 and 1071-1077. Phosphorylation 
at S362, for example, exists either alone or in 
combination with S360 O-GlcNAcylation and 
S368 phosphorylation. Phospho-S362 also co-
occurs with O-GlcNAc-S361. If S362 is O-
GlcNAcylated, however, no further modifications 
on this peptide was observed (Table 3, Figure 4). 
Apparently, some residues such as TET3-S362 
serve as O-GlcNAc/phosphorylation switches that 
can either promote or suppress neighboring PTMs. 
These data indicate a strong crosstalk between O-
GlcNAcylation and phosphorylation at different 
residues. Modifications on TET1, on the other 
hand, appear more isolated and no peptide bearing 
more than one modification was detected (Table 
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1). In summary, we detect many interdependent 
modification sites on TET proteins suggesting that 
TET1, TET2, and TET3 are dynamically regulated 
by PTMs. 
 
DISCUSSION 
Since oxidation of mC to hmC, fC and caC by 
TET proteins represents a potential mechanism for 
active DNA demethylation in higher vertebrates 
(3-5), these proteins are currently intensively 
investigated. Here, we provide evidence that all 
three TET proteins are subject to O-
GlcNAcylation through OGT. This finding is in 
accordance with previous studies, showing that 
TET1 and TET2 interact with OGT in ESCs and 
are O-GlcNAcylated (33,34). TET3 has also been 
described to associate with OGT (32,35) and to 
alter its subcellular localization dependent on 
glucose metabolism and O-GlcNAcylation (35). 
OGT not only directly modifies TET proteins, but 
the interaction also promotes histone 
modifications such as H3K4me3 or 
H2BS112GlcNAc (31,36). TET1 has been shown 
to associate with the repressive SIN3A complex 
(48) and TET2 and TET3 with the 
SET1/COMPASS complex (31). 
We show that per default, TET proteins are 
phosphorylated. Basal O-GlcNAc levels are low, 
but enhance upon OGT expression. 
Simultaneously, the phosphorylation levels 
decrease. This finding indicates regulation of the 
phosphorylation signal as a novel function for 
TET O-GlcNAcylation. Interestingly, the under-
lying mechanism of this observation seems not to 
be direct competition for the serine or threonine 
residue that is to be modified, but rather proximal 
site competition as neighboring residues are 
interdependent (49). O-GlcNAcylation and 
phosphorylation occur at distinct amino acids and 
often, several modifications of the same type 
appear in close proximity in "modification 
islands", e.g. O-GlcNAcylation at S1252/S1256/ 
S1263 of TET3, or phosphorylation at 
S15/S23/S39 of TET2. Furthermore, phos-
phorylation is not reduced because the residues are 
masked by the co-expressed OGT as demonstrated 
by expression of the catalytically inactive OGTmut, 
where the reduction is far less pronounced. 
Nevertheless, O-GlcNAcylation of TET proteins is 
slightly increased by OGTmut, either due to 
residual activity of the mutant (50) or, more likely, 
due to recruitment of endogenous active OGT via 
trimerization of the TPR domain (51).  
This observed effect of O-GlcNAcylation on 
phosphorylation is of particular interest since  
protein O-GlcNAc levels are influenced by a 
variety of factors, such as different subcellular 
localization of OGT and nutrient availability, and 
seem to be tightly regulated (38). For example, O-
GlcNAcylation of TET3 can be enhanced when 
cells are cultured in high glucose medium, leading 
to nuclear export of TET3 (35). Therefore, OGT-
dependent dephosphorylation represents a novel 
mechanism on how TET proteins can be regulated 
in response to changing environmental conditions. 
 
Interestingly, some residues remain stably 
phosphorylated even at high OGT levels. For 
TET2 and TET3, they appear in close proximity to 
each other and just N-terminal of the cysteine-rich 
region. This persistence of phosphorylation 
suggests an important OGT-independent 
regulatory role of these residues that is of interest 
for future studies. Nevertheless, the majority of 
phosphorylation sites are reduced in occupancy 
upon O-GlcNAcylation. We thus observe two 
different types of phosphorylation, dependent and 
independent of O-GlcNAcylation. 
The hypothesis of interdependence of PTMs on 
TET proteins is further strengthened by the fact 
that some modifications are detected on the same 
peptides in stable combinations whereas others 
occur as stand-alone modifications. Certain 
residues appear to be O-GlcNAc/phosphorylation 
switches that influence the PTM pattern on the 
neighboring amino acids. The observed crosstalk 
of modifications enables a variety of potential 
regulatory mechanisms that could fine-tune TET 
activity dependent on different environmental 
conditions such as nutrient availability. 
 
To date, the domain architecture and three-
dimensional structure of TET proteins is only 
poorly understood. The catalytic domain is highly 
conserved and homologous to other types of 
Fe(II)- and 2-OG-dependent dioxygenases that act 
on nucleic acids (8,52). Recently, the crystal 
structure of the catalytic part of TET2 has 
provided insights into the reaction mechanism 
(46). However, the large N-terminus and the low 
complexity insert, that is characteristic for TET 
proteins, remain poorly understood — both in 
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terms of structure and of function. So far, no 
homologous domains have been described except 
for the CXXC-type zinc finger at the N-terminus, 
and the insert region is predicted to be largely 
unstructured (8). In this study, we show that these 
two regions are subject to many dynamic PTMs. 
For TET1 and TET3, few modification sites are 
also found at the very C-terminus of the proteins, 
but N-terminus and insert region are the major 
target of O-GlcNAcylation and phosphorylation. 
In general, the lower the conservation of one 
region, the more modification sites are detected. 
This provides an interesting possible mechanism 
for regulation of TET protein activity, stability, or 
targeting. In line, TET1, TET2, and TET3 have 
been described to colocalize with OGT at 
transcription start sites and influence gene 
expression (31,34). The different modifications 
that we describe in this study might alter binding 
of TET interaction partners and thus provide a 
possible explanation of the observed dual role in 
both transcriptional activation and repression (53).  
 
In summary, we provide the first systematic 
mapping of O-GlcNAcylation and phosphorylation 
sites on TET proteins at amino acid resolution. 
The distribution of these PTMs and the described 
crosstalk open new perspectives on the regulatory 
role of the so far poorly characterized non-
catalytic domains, the N-terminus and the low 
complexity insert region. The observed O-
GlcNAcylation and phosphorylation are linked to 
metabolic conditions and thus provide a possible 
mechanism of TET protein regulation in response 
to external stimuli. 
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FIGURE LEGENDS 
Figure 1: All three TET proteins interact with OGT 
a) Schematic representation of the domain architecture of the three murine TET proteins: The catalytic 
dioxygenase domain (D) is split in two parts, separated by a presumably unstructured low complexity 
insert (8), and is N-terminally preceded by a cysteine-rich region (Cys). The Fe(II)-binding residues are 
marked by green asterisks. The N-terminus (NT) of TET1 contains a CXXC-type zinc finger (ZF); TET3 
exists in two isoforms, one with zinc finger and one without (41). The mean percent identity of the single 
domains of TET1, TET2, and TET3 is represented by different shades of grey and was calculated with 
Clustal2.1 (54).  
b) The table depicts the number of detected unique peptides of TET1, TET2, and OGT in IP experiments 
from mESCs followed by LC-MS/MS.  
c) Co-IP of GFP-TET1, GFP-TET2, and GFP-TET3, each coexpressed with mCh-OGT, precipitated with 
the GFP-Trap® and analyzed by Western blot, shows that all three TET proteins interact with OGT (full 
arrowheads). GFP as a negative control does not coprecipitate mCh-OGT (empty arrowhead) (I: Input, 
FT: Flowthrough, B: Bound). 
 
Figure 2: TET proteins are O-GlcNAcylated by OGT 
Western blot analysis of TET1, TET2, and TET3 specifically enriched with the GFP-Trap®. Upon co-
expression of active OGT, the O-GlcNAcylation signal increases for all three TET proteins (black 
arrowheads) compared to coexpression of catalytically inactive OGTmut. Interaction between TET proteins 
and OGT is independent of OGT activity. 
 
Figure 3: TET phosphorylation is suppressed by O-GlcNAcylation 
a) Mass spectrometry analysis of TET proteins reveals that the number of O-GlcNAcylated residues and 
their modification occupancy strongly increases for TET2 and TET3 when OGT is co-expressed. In 
contrast, TET1 only harbors few O-GlcNAc sites. Heat maps display O-GlcNAc occupancy of single 
residues (mean of three biological replicates). Residue numbering refers to the murine protein sequences 
specified in the Supplemental data S3. 
b) TET proteins are highly phosphorylated when expressed alone, but the number of phosphorylated 
residues and the fraction of phosphorylated protein decreases upon coexpression of OGT. Heat maps 
display phosphorylation occupancy of single residues (mean of three biological replicates). Residue 
numbering refers to the murine protein sequences specified in the Supplemental data S3. 
 
Figure 4: N-termini and insert regions of TET proteins are densely modified 
Schematic and scaled mapping of all TET phosphorylation and O-GlcNAcylation sites to the protein 
sequence. Modifications are mostly found in the N-terminus and the insert region and rarely occur at the 
same residue. Residue numbering refers to the murine protein sequences specified in the Supplemental 
data S3. Green asterisks mark catalytic Fe(II)-binding residues. Basal O-GlcNAc sites occur without any 
coexpression of OGT or OGTmut; persistent phosphorylation sites show high occupancy despite increase 
of O-GlcNAcylation. An example of the PTM crosstalk on TET proteins is shown for TET3-
S360/361/362/368. empty arrowhead: 2 cooccurring modifications; full arrowheads: 3 cooccurring 
modifications; blunt arrows: mutual exclusivity. 
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TABLES 
 
# aa LP Modified sequence 
160 100% HSENDSVPSQHATVS(ph)PGTENGEQNR 
177 100% CLVEGES(ph)QEITQSCPVFEER 
253 85% NT(o-)SNQLADLSSQVESIK 
270 84% LS(o-)DPSPNPTGSDHNGFPDSSFR 
320 100% FILAGS(ph)QPDVFDTKPQEK 
327 100% FILAGSQPDVFDT(o-)KPQEK 
556 81% ATAM(ox)SMPVTQASTSS(ph)PPCNSTPPMVER 
561 89% ATAMSMPVTQASTSSPPCNS(ph)TPPM(ox)VER 
734 98% QQTNPS(ph)PTFAQTIR 
736 96% QQTNPSPT(ph)FAQTIR 
794 77% DAM(ox)SVTTS(o-)GGECDHLK 
854 100% DGS(ph)PVQPSLLSLMK 
892 70% LTLEQVVAIEALTQLSEAPSESSS(ph)PSKPEK 
950 100% S(ph)PDSFATNQALIK 
969 74% SQGYPSS(ph)PTAEK 
1327 66% REAQT(o-)SSNGPLGPTTDSAQSEFK 
1964 89% ELHATTSLRS(ph)PK 
2016 100% PADRECPDVS(ph)PEANLSHQIPSR 
2016 56% PADRECPDVS(o-)PEANLSHQIPSR 
2042 99% DNVVTVS(ph)PYSLTHVAGPYNR 
 
Table 1: Detected modified peptides of TET1 
# aa: residue number of modified amino acid; LP: Localization probability; (ph): phosphorylated; (o-): O-
GlcNAcylated; (ox): oxidized; LP was calculated with the MaxQuant software (44). Residue numbering 
refers to the murine protein sequences specified in the Supplemental data S3. Only peptides that were 
detected in a minimum of two out of three samples are shown. 
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# aa LP Modified sequence 
15 100% TTHAEGTRLS(ph)PFLIAPPSPISHTEPLAVK 
23 100% TTHAEGTRLS(ph)PFLIAPPS(ph)PISHTEPLAVK 
39 98% LQNGS(ph)PLAERPHPEVNGDTK 
95 98% RT(o-)VS(o-)EPSLSGLHPNK 
97 100% TVS(ph)EPSLSGLHPNK 
97 97% RT(o-)VS(o-)EPSLSGLHPNK 
165 100% SSRQPNVSGLSDNGEPVTSTTQESSGADAFPT(o-)R 
317 98% SALDIGPS(o-)RAENK 
374 82% DS(ph)ISPTTVTPPSQSLLAPR 
374 99% DS(o-)IS(ph)PTTVTPPSQSLLAPR 
376 99% DS(o-)IS(ph)PTTVTPPSQSLLAPR 
464 100% TSSSQSLNPSVHTPNPPLMLPEQHQNDCGS(ph)PS(ph)PEK 
466 100% TSSSQSLNPSVHTPNPPLMLPEQHQNDCGS(ph)PS(ph)PEK 
514 89% QT(o-)QGSVQAAPGWIELK 
545 94% DIS(o-)LHSVLHSQTGPVNQM(ox)SSK 
552 87% DIS(o-)LHSVLHS(o-)QTGPVNQMSSK 
561 95% DISLHSVLHSQTGPVNQMS(o-)S(o-)K 
562 97% DISLHSVLHSQTGPVNQMS(o-)S(o-)K 
565 98% QS(o-)TGNVNM(ox)PGGFQR 
603 100% AQMYQVQVNQGPS(ph)PGMGDQHLQFQK 
625 96% ALYQECIPRT(o-)DPSSEAHPQAPSVPQYHFQQR 
746 98% VEESFCVGNQYS(o-)K 
778 92% ILT(o-)PNSSNLQILPSNDTHPACER 
807 100% EQALHPVGS(o-)K 
889 100% ALPVPEQGGSQTQT(ph)PPQK 
944 100% YPLS(ph)PPQENMSSR 
951 97% PSSYRYPLSPPQENMS(ph)SR 
1437 63% QM(ox)T(o-)AQPQLSGPVIRQPPTLQR 
1443 98% QMTAQPQLS(o-)GPVIR 
1613 87% DLHRYPNQDHLTNQNLPPIHT(o-)LHQQTFGDSPSK 
1622 74% YPNQDHLTNQNLPPIHTLHQQTFGDS(ph)PSK 
1640 76% DAFT(o-)TNSTLKPNVHHLATFSPYPTPK 
1672 100% M(ox)DSHFM(ox)GAAS(o-)R 
1749 100% TASAQELLYSLTGSS(ph)QEK 
 
Table 2: Detected modified peptides of TET2 
# aa: residue number of modified amino acid; LP: Localization probability; (ph): phosphorylated; (o-): O-
GlcNAcylated; (ox): oxidized; grey: multiple modifications occuring on one peptide; LP was calculated 
with the MaxQuant software (44). Residue numbering refers to the murine protein sequences specified in 
the Supplemental data S3. Only peptides that were detected in a minimum of two out of three samples are 
shown. 
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# aa LP Modified sequence 
360 93% VEAPS(o-)SS(ph)PAPVPS(ph)PISQR 
361 79% VEAPSS(o-)S(ph)PAPVPSPISQR 
362 100% VEAPSSS(ph)PAPVPSPISQR 
362 67% VEAPSSS(o-)PAPVPSPISQR 
368 100% VEAPS(o-)SS(ph)PAPVPS(ph)PISQR 
478 100% S(ph)RDM(ox)QPLFLPVR 
557 83% S(ph)PSPM(ox)VALQSGSTGGPLPPADDKLEELIR 
557 76% S(o-)PSPM(ox)VALQSGSTGGPLPPADDKLEELIR 
634 79% IES(o-)SGAVTVLSTTCFHSEEGGQEATPTK 
665 100% AENPLT(ph)PTLSGFLES(ph)PLK 
667 96% AENPLTPT(ph)LSGFLESPLK 
674 100% AENPLT(ph)PTLSGFLES(ph)PLK 
674 99% AENPLT(ph)PTLSGFLES(o-)PLK 
1008 83% VS(o-)SGAIQVLTAFPR 
1071 97% QEALELAGVT(o-)T(o-)DPGLSLK 
1072 89% QEALELAGVT(o-)T(o-)DPGLSLK 
1077 99% QEALELAGVTT(o-)DPGLS(o-)LK 
1105 89% YS(o-)GNAVVESYSVLGSCRPSDPYSMSSVYSYHSR 
1252 94% VPQLHPAS(o-)RDPSPFAQSSSCYNR 
1256 62% VPQLHPASRDPS(o-)PFAQSSSCYNR 
1263 84% VPQLHPASRDPSPFAQSSS(o-)CYNR 
1282 88% QEPIDPLTQAES(o-)IPR 
1293 100% T(o-)PLPEASQNGGPSHLWGQYSGGPSMSPK 
1318 100% TPLPEASQNGGPSHLWGQYSGGPSM(ox)S(ph)PK 
1351 61% LNSFGAS(ph)CLTPSHFPESQWGLFTGEGQQSAPHAGAR 
1404 76% FGNGTSALTGPSLT(o-)EK 
1412 100% PWGM(ox)GT(o-)GDFNPALK 
1442 100% VEEGRIPT(ph)PGANPLDK 
1651 72% QALAMPTDSAVT(o-)VSSYAYTK 
1653 71% QALAM(ox)PTDSAVTVS(o-)SYAYTK 
1654 77% QALAMPTDSAVTVS(o-)S(o-)YAYTK 
1658 99% GAIPTRQALAMPTDSAVTVSSYAYT(o-)K 
 
Table 3: Detected modified peptides of TET3 
# aa: residue number of modified amino acid; LP: Localization probability; (ph): phosphorylated; (o-): O-
GlcNAcylated; (ox): oxidized; grey: multiple modifications occuring on one peptide; LP was calculated 
with the MaxQuant software (44). Residue numbering refers to the murine protein sequences specified in 
the Supplemental data S3. Only peptides that were detected in a minimum of two out of three samples are 
shown. 
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Phosphorylation of TET proteins is regulated via O-GlcNAcylation by the 
glycosyltransferase OGT $ # 
 
Christina Bauer1, Klaus Göbel1, Nagarjuna Nagaraj2, Christian Colantuoni1, Mengxi Wang1, Udo Müller1, 
Elisabeth Kremmer3, Andrea Rottach1*, Heinrich Leonhardt1,4*  
LEGENDS 
Supplemental data S1: Characterization of TET antibodies 
a) TET antigens selected for immunization. The Figure shows a schematic outline of the TET proteins. 
The low complexity insert region of the TET proteins was chosen as antigen, and is highlighted in yellow. 
Amino acid numbers, sequence and tag of the respective antigens are shown in S2. 
b) Generation of monoclonal TET antibodies using the hybridoma technology. Depicted is a typical 
workflow starting from the immunization of a Lou/C rat with the TET antigen to the final testing of the 
hybridoma supernatants in different applications. WB: western blot; IP: immunoprecipitation; IF: 
immunofluorescence; IH: immunohistology. 
c) Stably subcloned anti-TET hybridoma clones and their application spectra.  
d) Immunofluorescence staining of CGR8 embryonic stem cells using the TET1 5D6 antibody. In 
addition, cells were stained with an anti-mC antibody (mouse; Eurogentec, Köln, Germany) and a 5-hmC 
antibody (rabbit; Active Motif, Carlsbad, CA). DAPI was used as DNA counterstain. Merge images are 
shown in the lower panel. Scale bar represents 5 µm.  
 
Supplemental data S2: Fragments of TET1, TET2, and TET3 used for immunization 
Protein fragment sequences comprise a major part of the TET insert region. Amino acid numbers flanking 
the fragment are indicated. Purification of the antigen was performed via His-Tag (depicted in red). 
 
Supplemental data S3: TET protein sequences 
Annotated amino acid sequence of the TET constructs used for PTM mapping experiments. 
Uniprot entries: Q3URK3 (TET1), Q4JK59 (TET2), Q8BG87 (TET3) 
green: catalytic residues (FeII binding) 
orange: Phosphorylation 
pink: GlcNAcylation 
blue: alternative splicing (variation compared to Uniprot sequence) 
grey: sequences not covered by MS (no information about PTMs available) 
 
Supplemental table S4 (Excel file) 
MaxQuant output tables of all detected TET peptides. Numbering of modified residues (column 
"positions within proteins") refers toUniprot TET protein sequence and might differ from the positions 
used in the rest of the paper which refer to the used splicing variants cloned from murine tissues as 
specified in the experimental procedures.  
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S2: Fragments of TET1, TET2, and TET3 used for immunization  
 
TET1_1682-1914 (254 aa) 
MGHHHHHHHHHHSSGHIEGRHMQLHVLPLYRLADTDEFGSVEGMKAKIKSGAIQVNGPTRKRRLRFTE
PVPRCGKRAKMKQNHNKSGSHNTKSFSSASSTSHLVKDESTDFCPLQASSAETSTCTYSKTASGGFAE
TSSILHCTMPSGAHSGANAAAGECTGTVQPAEVAAHPHQSLPTADSPVHAEPLTSPSEQLTSNQSNQQ
LPLLSNSQKLASCQVEDERHPEADEPQHPEDDNLPQLDEFWSDSEEIYAD 
 
TET2_1332-1779 (500 aa) 
MGSSHHHHHHSSGLVPRGSHMASMTGGQQMGRGSEFELRRPPEDEQFHVLPMYIIAPEDEFGSTEGQE
KKIRMGSIEVLQSFRRRRVIRIGELPKSCKKKAEPKKAKTKKAARKHSSLENCSSRTEKGKSSSHTKL
MENASHMKQMTAQPQLSGPVIRQPPTLQRHLQQGQRPQQPQPPQPQPQTTPQPQPQPQHIMPGNSQSV
GSHCSGSTSVYTRQPTPHSPYPSSAHTSDIYGDTNHVNFYPTSSHASGSYLNPSNYMNPYLGLLNQNN
QYAPFPYNGSVPVDNGSPFLGSYSPQAQSRDLHRYPNQDHLTNQNLPPIHTLHQQTFGDSPSKYLSYG
NQNMQRDAFTTNSTLKPNVHHLATFSPYPTPKMDSHFMGAASRSPYSHPHTDYKTSEHHLPSHTIYSY
TAAASGSSSSHAFHNKENDNIANGLSRVLPGFNHDRTASAQELLYSLTGSSQEKQPEVSGQDAAAVQE
IEYWSDSEHNFQDAAALEHHHHHH 
 
TET3_976-1521 (584 aa) 
MGHHHHHHHHHHSSGHIEGRHMQIPEDEQLHVLPLYKMASTDEFGSEENQNAKVSSGAIQVLTAFPRE
VRRLPEPAKSCRQRQLEARKAAAEKKKLQKEKLSTPEKIKQEALELAGVTTDPGLSLKGGLSQQSLKP
SLKVEPQNHFSSFKYSGNAVVESYSVLGSCRPSDPYSMSSVYSYHSRYAQPGLASVNGFHSKYTLPSF
GYYGFPSSNPVFPSQFLGPSAWGHGGSGGSFEKKPDLHALHNSLNPAYGGAEFAELPGQAVATDNHHP
IPHHQQPAYPGPKEYLLPKVPQLHPASRDPSPFAQSSSCYNRSIKQEPIDPLTQAESIPRDSAKMSRT
PLPEASQNGGPSHLWGQYSGGPSMSPKRTNSVGGNWGVFPPGESPTIVPDKLNSFGASCLTPSHFPES
QWGLFTGEGQQSAPHAGARLRGKPWSPCKFGNGTSALTGPSLTEKPWGMGTGDFNPALKGGPGFQDKL
WNPVKVEEGRIPTPGANPLDKAWQAFGMPLSSNEKLFGALKSEEKLWDPFSLEEGTAEEPPSKGVVKE
EKSGPTVEEDEEELWSDSEHNFLD 
S1: Characterization of TET antibodies 
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S3: TET protein sequences  TET1 
MSRSRPAKPSKSVKTKLQKKKDIQMKTKTSKQAVRHGASAKAVNPGKPKQ 50      
LIKRRDGKKETEDKTPTPAPSFLTRAGAARMNRDRNQVLFQNPDSLTCNG 100     
FTMALRRTSLSWRLSQRPVVTPKPKKVPPSKKQCTHNIQDEPGVKHSEND 150     
SVPSQHATVSPGTENGEQNRCLVEGESQEITQSCPVFEERIEDTQSCISA 200     
SGNLEAEISWPLEGTHCEELLSHQTSDNECTSPQECAPLPQRSTSEVTSQ 250     
KNTSNQLADLSSQVESIKLSDPSPNPTGSDHNGFPDSSFRIVPELDLKTC 300     
MPLDESVYPTALIRFILAGSQPDVFDTKPQEKTLITTPEQVGSHPNQVLD 350     
ATSVLGQAFSTLPLQWGFSGANLVQVEALGKGSDSPEDLGAITMLNQQET 400     
VAMDMDRNATPDLPIFLPKPPNTVATYSSPLLGPEPHSSTSCGLEVQGAT 450     
PILTLDSGHTPQLPPNPESSSVPLVIAANGTRAEKQFGTSLFPAVPQGFT 500     
VAAENEVQHAPLDLTQGSQAAPSKLEGEISRVSITGSADVKATAMSMPVT 550     
QASTSSPPCNSTPPMVERRKRKACGVCEPCQQKANCGECTYCKNRKNSHQ 600     
ICKKRKCEVLKKKPEATSQAQVTKENKRPQREKKPKVLKTDFNNKPVNGP 650     
KSESMDCSRRGHGEEEQRLDLITHPLENVRKNAGGMTGIEVEKWAPNKKS 700     
HLAEGQVKGSCDANLTGVENPQPSEDDKQQTNPSPTFAQTIRNGMKNVHC 750     
LPTDTHLPLNKLNHEEFSKALGNNSSKLLTDPSNCKDAMSVTTSGGECDH 800     
LKGPRNTLLFQKPGLNCRSGAEPTIFNNHPNTHSAGSRPHPPEKVPNKEP 850     
KDGSPVQPSLLSLMKDRRLTLEQVVAIEALTQLSEAPSESSSPSKPEKDE 900     
EAHQKTASLLNSCKAILHSVRKDLQDPNVQGKGLHHDTVVFNGQNRTFKS 950     
PDSFATNQALIKSQGYPSSPTAEKKGAAGGRAPFDGFENSHPLPIESHNL 1000    
ENCSQVLSCDQNLSSHDPSCQDAPYSQIEEDVAAQLTQLASTINHINAEV 1050    
RNAESTPESLVAKNTKQKHSQEKRMVHQKPPSSTQTKPSVPSAKPKKAQK 1100    
KARATPHANKRKKKPPARSSQENDQKKQEQLAIEYSKMHDIWMSSKFQRF 1150    
GQSSPRSFPVLLRNIPVFNQILKPVTQSKTPSQHNELFPPINQIKFTRNP 1200    
ELAKEKVKVEPSDSLPTCQFKTESGGQTFAEPADNSQGQPMVSVNQEAHP 1250    
LPQSPPSNQCANIMAGAAQTQFHLGAQENLVHQIPPPTLPGTSPDTLLPD 1300    
PASILRKGKVLHFDGITVVTEKREAQTSSNGPLGPTTDSAQSEFKESIMD 1350    
LLSKPAKNLIAGLKEQEAAPCDCDGGTQKEKGPYYTHLGAGPSVAAVREL 1400    
METRFGQKGKAIRIEKIVFTGKEGKSSQGCPVAKWVIRRSGPEEKLICLV 1450    
RERVDHHCSTAVIVVLILLWEGIPRLMADRLYKELTENLRSYSGHPTDRR 1500    
CTLNKKRTCTCQGIDPKTCGASFSFGCSWSMYFNGCKFGRSENPRKFRLA 1550    
PNYPLHNYYKRITGMSSEGSDVKTGWIIPDRKTLISREEKQLEKNLQELA 1600    
TVLAPLYKQMAPVAYQNQVEYEEVAGDCRLGNEEGRPFSGVTCCMDFCAH 1650    
SHKDIHNMHNGSTVVCTLIRADGRDTNCPEDEQLHVLPLYRLADTDEFGS 1700    
VEGMKAKIKSGAIQVNGPTRKRRLRFTEPVPRCGKRAKMKQNHNKSGTAG 1750    
LRRKRISASPKGAPGSHNTKSFSSASSTSHLVKDESTDFCPLQASSAETS 1800    
TCTYSKTASGGFAETSSILHCTMPSGAHSGANAAAGECTGTVQPAEVAAH 1850    
PHQSLPTADSPVHAEPLTSPSEQLTSNQSNQQLPLLSNSQKLASCQVEDE 1900    
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RHPEADEPQHPEDDNLPQLDEFWSDSEEIYADPSFGGVAIAPIHGSVLIE 1950    
CARKELHATTSLRSPKRGVPFRVSLVFYQHKSLNKPNHGFDINKIKCKCK 2000    
KVTKKKPADRECPDVSPEANLSHQIPSRVASTLTRDNVVTVSPYSLTHVA 2050    
GPYNRWV* 2058     TET2 
MEQDRTTHAEGTRLSPFLIAPPSPISHTEPLAVKLQNGSPLAERPHPEVN  50 
GDTKWQSSQSCYGISHMKGSQSSHESPHEDRGYSRCLQNGGIKRTVSEPS  100 
LSGLHPNKILKLDQKAKGESNIFEESQERNHGKSSRQPNVSGLSDNGEPV  150 
TSTTQESSGADAFPTRNYNGVEIQVLNEQEGEKGRSVTLLKNKIVLMPNG  200 
ATVSAHSEENTRGELLEKTQCYPDCVSIAVQSTASHVNTPSSQAAIELSH  250 
EIPQPSLTSAQINFSQTSSLQLPPEPAAMVTKACDADNASKPAIVPGTCP  300 
FQKAEHQQKSALDIGPSRAENKTIQGSMELFAEEYYPSSDRNLQASHGSS  350 
EQYSKQKETNGAYFRQSSKFPKDSISPTTVTPPSQSLLAPRLVLQPPLEG  400 
KGALNDVALEEHHDYPNRSNRTLLREGKIDHQPKTSSSQSLNPSVHTPNP  450 
PLMLPEQHQNDCGSPSPEKSRKMSEYLMYYLPNHGHSGGLQEHSQYLMGH  500 
REQEIPKDANGKQTQGSVQAAPGWIELKAPNLHEALHQTKRKDISLHSVL  550 
HSQTGPVNQMSSKQSTGNVNMPGGFQRLPYLQKTAQPEQKAQMYQVQVNQ  600 
GPSPGMGDQHLQFQKALYQECIPRTDPSSEAHPQAPSVPQYHFQQRVNPS  650 
SDKHLSQQATETQRLSGFLQHTPQTQASQTPASQNSNFPQICQQQQQQQQ  700 
QLQRKNKEQMPQTFSHLQGSNDKQREGSCFGQIKVEESFCVGNQYSKSSN  750 
FQTHNNTQGGLEQVQNINKNFPYSKILTPNSSNLQILPSNDTHPACEREQ  800 
ALHPVGSKTSNLQNMQYFPNNVTPNQDVHRCFQEQAQKPQQASSLQGLKD  850 
RSQGESPAPPAEAAQQRYLVHNEAKALPVPEQGGSQTQTPPQKDTQKHAA  900 
LRWLLLQKQEQQQTQQSQPGHNQMLRPIKTEPVSKPSSYRYPLSPPQENM  950 
SSRIKQEISSPSRDNGQPKSIIETMEQHLKQFQLKSLCDYKALTLKSQKH  1000 
VKVPTDIQAAESENHARAAEPQATKSTDCSVLDDVSESDTPGEQSQNGKC  1050 
EGCNPDKDEAPYYTHLGAGPDVAAIRTLMEERYGEKGKAIRIEKVIYTGK  1100 
EGKSSQGCPIAKWVYRRSSEEEKLLCLVRVRPNHTCETAVMVIAIMLWDG  1150 
IPKLLASELYSELTDILGKCGICTNRRCSQNETKKKQSPPRNCCCQGENP  1200 
ETCGASFSFGCSWSMYYNGCKFARSKKPRKFRLHGAEPKEEERLGSHLQN  1250 
LATVIAPIYKKLAPDAYNNQVEFEHQAPDCCLGLKEGRPFSGVTACLDFS  1300 
AHSHRDQQNMPNGSTVVVTLNREDNREVGAKPEDEQFHVLPMYIIAPEDE  1350 
FGSTEGQEKKIRMGSIEVLQSFRRRRVIRIGELPKSCKKKAEPKKAKTKK  1400 
AARKHSSLENCSSRTEKGKSSSHTKLMENASHMKQMTAQPQLSGPVIRQP  1450 
PTLQRHLQQGQRPQQPQPPQPQPQTTPQPQPQPQHIMPGNSQSVGSHCSG  1500 
STSVYTRQPTPHSPYPSSAHTSDIYGDTNHVNFYPTSSHASGSYLNPSNY  1550 
MNPYLGLLNQNNQYAPFPYNGSVPVDNGSPFLGSYSPQAQSRDLHRYPNQ  1600 
DHLTNQNLPPIHTLHQQTFGDSPSKYLSYGNQNMQRDAFTTNSTLKPNVH  1650 
HLATFSPYPTPKMDSHFMGAASRSPYSHPHTDYKTSEHHLPSHTIYSYTA  1700 
AASGSSSSHAFHNKENDNIANGLSRVLPGFNHDRTASAQELLYSLTGSSQ  1750 
EKQPEVSGQDAAAVQEIEYWSDSEHNFQDPCIGGVAIAPTHGSILIECAK  1800 
CEVHATTKVNDPDRNHPTRISLVLYRHKNLFLPKHCLALWEAKMAEKARK  1850 
EEECGKNGSDHVSQKNHGKQEKREPTGPQEPSYLRFIQSLAENTGSVTTD  1900 
STVTTSPYAFTQVTGPYNTFV*   
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TET3 
MDSGPVYHGDSRQLSTSGAPVNGAREPAGPGLLGAAGPWRVDQKPDWEAA 50      
SGPTHAARLEDAHDLVAFSAVAEAVSSYGALSTRLYETFNREMSREAGSN 100     
GRGPRPESCSEGSEDLDTLQTALALARHGMKPPNCTCDGPECPDFLEWLE 150     
GKIKSMAMEGGQGRPRLPGALPPSEAGLPAPSTRPPLLSSEVPQVPPLEG 200     
LPLSQSALSIAKEKNISLQTAIAIEALTQLSSALPQPSHSTSQASCPLPE 250     
ALSPSAPFRSPQSYLRAPSWPVVPPEEHPSFAPDSPAFPPATPRPEFSEA 300     
WGTDTPPATPRNSWPVPRPSPDPMAELEQLLGSASDYIQSVFKRPEALPT 350     
KPKVKVEAPSSSPAPVPSPISQREAPLLSSEPDTHQKAQTALQQHLHHKR 400     
NLFLEQAQDASFPTSTEPQAPGWWAPPGSPAPRPPDKPPKEKKKKPPTPA 450     
GGPVGAEKTTPGIKTSVRKPIQIKKSRSRDMQPLFLPVRQIVLEGLKPQA 500     
SEGQAPLPAQLSVPPPASQGAASQSCATPLTPEPSLALFAPSPSGDSLLP 550     
PTQEMRSPSPMVALQSGSTGGPLPPADDKLEELIRQFEAEFGDSFGLPGP 600     
PSVPIQEPENQSTCLPAPESPFATRSPKKIKIESSGAVTVLSTTCFHSEE 650     
GGQEATPTKAENPLTPTLSGFLESPLKYLDTPTKSLLDTPAKKAQSEFPT 700     
CDCVEQIVEKDEGPYYTHLGSGPTVASIRELMEDRYGEKGKAIRIEKVIY 750     
TGKEGKSSRGCPIAKWVIRRHTLEEKLLCLVRHRAGHHCQNAVIVILILA 800     
WEGIPRSLGDTLYQELTDTLRKYGNPTSRRCGLNDDRTCACQGKDPNTCG 850     
ASFSFGCSWSMYFNGCKYARSKTPRKFRLTGDNPKEEEVLRNSFQDLATE 900     
VAPLYKRLAPQAYQNQVTNEDVAIDCRLGLKEGRPFSGVTACMDFCAHAH 950     
KDQHNLYNGCTVVCTLTKEDNRCVGQIPEDEQLHVLPLYKMASTDEFGSE 1000    
ENQNAKVSSGAIQVLTAFPREVRRLPEPAKSCRQRQLEARKAAAEKKKLQ 1050    
KEKLSTPEKIKQEALELAGVTTDPGLSLKGGLSQQSLKPSLKVEPQNHFS 1100    
SFKYSGNAVVESYSVLGSCRPSDPYSMSSVYSYHSRYAQPGLASVNGFHS 1150    
KYTLPSFGYYGFPSSNPVFPSQFLGPSAWGHGGSGGSFEKKPDLHALHNS 1200    
LNPAYGGAEFAELPGQAVATDNHHPIPHHQQPAYPGPKEYLLPKVPQLHP 1250    
ASRDPSPFAQSSSCYNRSIKQEPIDPLTQAESIPRDSAKMSRTPLPEASQ 1300    
NGGPSHLWGQYSGGPSMSPKRTNSVGGNWGVFPPGESPTIVPDKLNSFGA 1350    
SCLTPSHFPESQWGLFTGEGQQSAPHAGARLRGKPWSPCKFGNGTSALTG 1400    
PSLTEKPWGMGTGDFNPALKGGPGFQDKLWNPVKVEEGRIPTPGANPLDK 1450    
AWQAFGMPLSSNEKLFGALKSEEKLWDPFSLEEGTAEEPPSKGVVKEEKS 1500    
GPTVEEDEEELWSDSEHNFLDENIGGVAVAPAHCSILIECARRELHATTP 1550    
LKKPNRCHPTRISLVFYQHKNLNQPNHGLALWEAKMKQLAERARQRQEEA 1600    
ARLGLGQQEAKLYGKKRKWGGAMVAEPQHKEKKGAIPTRQALAMPTDSAV 1650    
TVSSYAYTKVTGPYSRWI* 1669    
Phosphorylation and O-GlcNAcylation of TET proteins Supplemental data
5
  RESULTS 
 
 117 
 
 
 
 
 
 
 
 
 
 
 
 
2.4 TET-mediated oxidation of methylcytosine causes TDG or NEIL 
glycosylase dependent gene reactivation 
8592–8604 Nucleic Acids Research, 2014, Vol. 42, No. 13 Published online 19 June 2014
doi: 10.1093/nar/gku552
TET-mediated oxidation of methylcytosine causes
TDG or NEIL glycosylase dependent gene reactivation
Udo Müller, Christina Bauer, Michael Siegl, Andrea Rottach and Heinrich Leonhardt*
Department of Biology II, Ludwig-Maximilians University Munich and Center for Integrated Protein Science Munich
(CIPSM), 82152 Planegg-Martinsried, Germany
Received March 28, 2014; Revised June 05, 2014; Accepted June 10, 2014
ABSTRACT
The discovery of hydroxymethyl-, formyl- and
carboxylcytosine, generated through oxidation of
methylcytosine by TET dioxygenases, raised the
question how these modifications contribute to epi-
genetic regulation. As they are subjected to complex
regulation in vivo, we dissected links to gene ex-
pression with in vitro modified reporter constructs.
We used an Oct4 promoter-driven reporter gene and
demonstrated that in vitro methylation causes gene
silencing while subsequent oxidation with purified
catalytic domain of TET1 leads to gene reactiva-
tion. To identify proteins involved in this pathway
we screened for TET interacting factors and identi-
fied TDG, PARP1, XRCC1 and LIG3 that are involved
in base-excision repair. Knockout and rescue ex-
periments demonstrated that gene reactivation de-
pended on the glycosylase TDG, but not MBD4, while
NEIL1, 2 and 3 could partially rescue the loss of TDG.
These results clearly show that oxidation of methyl-
cytosine by TET dioxygenases and subsequent re-
moval by TDG or NEIL glycosylases and the BER
pathway results in reactivation of epigenetically si-
lenced genes.
INTRODUCTION
DNA methylation at the C5-position of cytosine plays an
essential role in a variety of fundamental processes, such
as early embryonic development, X-chromosome inactiva-
tion, genome stability and imprinting (1,2). In vertebrates,
this epigenetic modification is set by the three DNA methyl-
transferases DNMT1, DNMT3A and DNMT3B and the
regulatory subunit DNMT3L (3–5).
Recently, it was discovered that the TET family of Fe(II)-
and 2-oxoglutarate-dependent dioxygenases can succes-
sively convert 5-methylcytosine to 5-hydroxymethylcytosine
(hmC), 5-formylcytosine (fC) and 5-carboxylcytosine (caC)
in vitro and in vivo (6–8). Three different TET proteins
(TET1, TET2 and TET3), each showing tissue-specific dif-
ferential expression (9), have been identified in mouse and
human (10). Functional studies indicate that they are in-
volved in a variety of cellular processes including epigenetic
reprogramming, differentiation, myelopoiesis and imprint-
ing (11–13). Mutations of TET2 correlating with lower hmC
levels and altered gene expression patterns have been linked
to various hematopoietic malignancies (14,15).
The discovery of TET proteins and their catalytic prod-
ucts hmC, fC and caC has raised the question about the
functions of these oxidized cytosine variants. They might
serve as independent epigenetic signals and have been
shown to recruit a distinct and dynamic set of ‘reader’ pro-
teins in embryonic stem cells (ESCs) and differentiated cells
(16). It also has been described that cytosine oxidation af-
fects the efficiency of transcription by RNA polymerase II
(17). However, the low abundance of fC and caC suggests
that these cytosine variants are quickly processed in vivo
and have been proposed to be intermediates in active DNA
demethylation (18,19).
Whereas the mechanism of setting the methylation mark
is well understood, the process of its removal has long been
elusive. DNA demethylation may either occur by a passive
process via the inhibition of DNMT1 maintenance methy-
lation after replication (20–22) or by an active enzymatic
reaction. In principle, there are three possibilities: first, the
direct removal of the methyl group, second, the excision of
either the methylated cytosine or third, of the entire nu-
cleotide. It is currently proposed that the additional oxi-
dized cytosine derivatives hmC, fC and caC are intermedi-
ates in active DNA demethylation, thereby contributing to
epigenetic plasticity and transcriptional regulation (23,24).
Several biochemical studies revealed that thymine DNA
glycosylase (TDG) can specifically bind to and excise fC
and caC, resulting in abasic sites, which might be subse-
quently processed by the base-excision repair (BER) ma-
chinery (18,25). In general, the BER pathway repairs dam-
aged DNA sites through recognition and excision of base le-
sions by substrate-specific glycosylases. The generated aba-
sic site is subsequently cleaved by the AP endonuclease 1
(APEX1), leading to a single-strand break, which is recog-
nized by PARP1 through its N-terminal zinc fingers. PARP1
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then recruits XRCC1, LIG3 and DNA polymerase beta
to complete the BER reactions (26–28). TDG depletion in
mice causes embryonic lethality, and TDG deficient ESCs
display prominent alterations of CpG modifications at a
large number of gene regulatory regions (29,30).
Another discussed alternative for DNA demethylation is
based on the initial deamination of hmC to hydroxymethy-
luracil (hmU) by members of the AID/APOBEC cytidine
deaminase family (23). In the following step, hmU might
be excised either by TDG, methyl-CpG-binding domain
protein 4 (MBD4) or the single-strand-specific monofunc-
tional uracil-DNA glycosylase 1 (SMUG1) (31–33). How-
ever, there is evidence that AID/APOBEC members are
less active on modified cytosines in vitro or in vivo, chal-
lenging the prominence of the proposed deamination-linked
demethylation pathway in living cells (34). Furthermore, a
direct decarboxylation of caC to unmodified cytosine has
been detected in ESC lysates, but no specific decarboxylase
has been identified so far (35).
In addition to TDG, two members of the NEIL family of
glycosylases (NEIL1 and NEIL3) have recently been iden-
tified as potential binders for oxidized cytosine derivatives
(16). However, their function in TET-dependent demethy-
lation has not been investigated to date.
To unravel the effects of TET-mediated cytosine oxida-
tion on gene expression, we generated in vitro modified
pOct4-reporter plasmids and monitored their in vivo expres-
sion in ESCs. Whereas methylation of the reporter DNA
leads to silencing of gene expression, subsequent oxidation
results in gene reactivation. We show that TET proteins in-
teract with BER factors in vivo and propose that the ob-
served oxidation-dependent gene reactivation requires the
BER machinery. We demonstrate that initiation of this
pathway is mainly dependent on TDG activity, but not
on MBD4. Our results also indicate that the glycosylases
NEIL1, NEIL2 and NEIL3 can contribute to an alterna-
tive BER pathway for DNA demethylation and cause gene
reactivation.
MATERIALS AND METHODS
Cell culture and transfection
Human embryonic kidney 293T (HEK293T) and baby
hamster kidney (BHK) cells containing a stably integrated
lac operator array (36) were cultured in Dulbecco’s modi-
fied Eagle’s medium (Sigma) supplemented with 10% Fetal
Calf Serum (FCS) (Biochrom) and 50 !g/!l gentamycine
(PAA). HEK293T and BHK cells were transiently trans-
fected using polyethylenimine pH 7.0 (Sigma) according to
the manufacturer’s instructions.
Mouse wild-type (wt) E14 as well as Tdg-/- and Mbd4-/-
ESCs (29,37) were cultured on gelatin coated flasks or op-
tical 96-well plates (Greiner) using 1000 U/ml LIF, 1!M
PD032591 and 3 !M CHIR99021 (Axon Medchem, (38)).
ESCs were transfected with Lipofectamine 2000 (Invitro-
gen) according to the manufacturer’s instructions.
In vitro methylation and oxidation of plasmid DNA
In vitro methylation of pOct4-GFP plasmid DNA was per-
formed using M.SssI methyltransferase (New England Bi-
olabs) according to the manufacturer’s instructions. The
methylation status of the plasmid was tested by HpaII and
MspI (Fermentas) digestion.
For the in vitro oxidation, GFP-TET1CD or GFP-
TET1CDmut (H1652Y, D1654A) was purified from mam-
malian cells. In detail, HEK293T cells were transfected with
an expression construct for GFP-TET1CD/TET1CDmut
and immunoprecipitation was carried out using GBP-Ni-
NTA beads. Proteins were eluted using imidazole. The
in vitro methylated plasmid was diluted in TET reaction
buffer (50 mM HEPES pH 8.0, 75 !M Fe(II), 2 mM
Sodium-Ascorbate, 1 mM Di-Sodium-Ketoglutarate (39))
and added to the purified GFP-TET1CD.
Digestion of hydroxymethylated plasmid with PvuRts1I
A total of 200 ng oxidized plasmid DNA and 100 ng of
reference DNA fragments containing exclusively unmodi-
fied C, mC or hmC were digested with PvuRts1I (150 mM
NaCl, 20 mM Tris pH 8.0, 5 mM MgCl2, 1 mM DTT) at
22◦C for 20 min (40). The reaction was inactivated at 65◦C
for 10 min and digestion of the samples was analyzed by
agarose-gelelectrophoresis.
Co-immunoprecipitation (Co-IP) using the GFP-Trap
Note that 36 h after transfection, whole cell lysates of
HEK293T cells were prepared using RIPA-lysis buffer (50
mM Tris pH 7.0, 150 mM NaCl, 0.1% sodium dodecyl sul-
phate (SDS), 0,5% sodium deoxycholate, 5 mM ethylene-
diaminetetraacetic acid (EDTA), 2.5 mM MgCl2, 0.5 mM
CaCl2, 2 mM PMSF, 1x Mammalian Protease Inhibitor
Cocktail and 1 !g/!l DNaseI). After centrifugation, 10%
of the supernatant was collected as input fraction and the
remaining supernatant was diluted in IP-buffer (10 mM
Tris/Cl pH 7.5, 150 mM NaCl and 0.5 mM EDTA) to 800
!l. Green Fluorescent Protein (GFP)-Trap beads (Chro-
motek, (41)) pre-equlibrated with IP-buffer were added to
the supernatant dilution and rotated for 1.5 h at 4◦C. The
GFP-beads were centrifuged and 10% of the supernatant
was collected as flowthrough fraction. For western blot-
ting, input, flowthrough and bead fractions were boiled
with Laemmli buffer at 95◦C for 10 min, loaded on an SDS-
polyacrylamide gel electrophoresis (SDS-PAGE) and trans-
ferred to a nitrocellulose membrane (Biorad). Immunode-
tection was performed using mouse monoclonal anti-GFP
(Roche, 11814460001) or rat monoclonal anti-RFP anti-
bodies (42) and Alexa488/Alexa594 coupled secondary an-
tibodies (Jackson ImmunoResearch).
For mass spectrometry analysis, protein samples were de-
natured with GdnHCl, precipitated with acetone and di-
gested with trypsin. Peptide mixtures were analyzed us-
ing electrospray tandem mass spectrometry in collaboration
with the Core Facility of the Max-Planck-Institute for Bio-
chemistry, Martinsried. Experiments were performed with
an LTQ Orbitrap mass spectrometer (Thermo Scientific).
Spectra were analyzed with MaxQuant (43).
Fluorescent-three-hybrid assay (F3H)
Transgenic BHK cells containing stably integrated lac-
operator repeats (36) were grown to 60–70% confluence
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on coverslips. The cells were transiently cotransfected
with expression constructs encoding for LacI-GBP, murine
RFP/mCherry- and GFP-fusion proteins (44). As controls
the catalytically inactive mutants GFP-TET1H1652Y&D1654A,
GFP-TET2H1304Y&D1306A and GFP-TET3H950Y&D952A were
used. Note that 24 h after transfection cells were fixed with
4% formaldehyde in phosphate buffered saline (PBS), per-
meabilized with 0.5% Triton X-100/PBST, counterstained
with 4’,6-diamidino-2-phenylindole (DAPI) and mounted
in Vectashield (Vector Laboratories). Imaging was per-
formed using a Leica TCS SP5 confocal laser scanning mi-
croscope with a 63x/1.4 NA Plan-Apochromat oil immer-
sion objective.
The Operetta automated imaging system (PerkinElmer)
was used for F3H quantification (Harmony 3.6 software).
After imaging, nuclei were detected based on DAPI signal.
The lacO-spot was defined in the GFP channel and screened
for enrichment at the RFP channel (intensity spot >1.2x
mean intensity nucleus; see also Supplementary Figure S4).
High-throughput pOct4-reporter gene expression analysis
Wild type, Tdg-/- and Mbd4-/- ESCs were transiently trans-
fected with unmodified, M.SssI methylated or in vitro oxi-
dized pOct4-GFP plasmid DNA on coated optical 96-well
plates (PerkinElmer). Note that 24 h after transfection, the
cells were fixed with 4% formaldehyde/PBS, permeabilized
with 0.5% Triton X-100/PBST and counterstained with
DAPI.
Images were acquired using the Operetta automated
imaging system with an 40x high NA objective and
expression was quantified using Harmony 3.6 software
(PerkinElmer). A total of 16 fields per well were imaged,
cells were counted and segmented into nuclei and cytoplasm
on the basis of DAPI and reporter mCherry/GFP signal.
Prism software (GraphPad) was used for statistical analy-
sis.
Generation of stable transgenic cell lines
Tdg-/- ESCs stably expressing GFP-fusions of wt TDG,
TDGN151A, TDGN168D and TDGM280H were generated by
transfecting the respective plasmids in the presence of the
selection marker blasticidine followed by repeated sort-
ing for GFP expression with the fluorescence-activated cell
sorting (FACS) AriaII (Becton-Dickinson) system. Single
cell sorting was used to generate clonal transgenic cell lines.
GFP-expression of the single cell clones was analyzed using
the Operetta system or western blotting.
Activity of GFP-TDG in vitro
GFP-TDG and the different mutants were expressed
in HEK293T cells and immunoprecipitated as described
above. Equal amounts of GFP-tagged protein immobilized
on GFP-Trap beads were incubated with 0.4 !M of DNA
substrate in TDG reaction buffer (20 mM TrisHCl, pH
8.0 or pH 6.5, 100 mM NaCl, 1 mM MgCl2, 0.2 mM
EDTA, 1 mM DTT, 0.01 mM ZnCl2). In detail, these
DNA substrates were fluorescently (ATTO550) labeled 42
bp oligonucleotides (GGA TGA TGA CTC TTC TGG
TCC GGA TGG TAG TTA AGT GTT GAG) (Eurofins
MWG Operon) with a central modified CpG site: either
hmCpG, fCpG or caCpG or harboring a G◦T mismatch at
this site. Incubation was performed in the presence of pu-
rified GFP-APEX1 for 2 h at room temperature. Follow-
ing heat-inactivation of TDG (2 min, 95◦C), fresh GFP-
APEX1 was added and further incubated for 4 h at room
temperature. An oligonucleotide containing a deoxyabasic
site (‘dSpacer’, Eurofins MWG Operon) served as a pos-
itive control for APEX1 activity. DNA was analyzed on
a denaturing 17% polyacrylamide gel with the Typhoon
TRIO (GE Healthcare Life Sciences). Quantification was
performed with ImageJ.
Genomic DNA extraction and slot blot analysis
Genomic DNA from ESCs was extracted using the Blood &
Cell Culture Midi Kit (Qiagen) according to the manufac-
turer’s instruction. Anti-oxidant BHT (200 !M, Sigma) and
deaminase inhibitor THU (200 !M, Sigma) were added to
the lysis buffer and elution buffer. The Bio-Rad slot blot sys-
tem was used according to the manufacturer’s instruction.
Nitrocellulose membranes (Amersham) were crosslinked,
blocked with 5% milk and immunostaining was performed
using a mouse monoclonal antibody against mC (Eurogen-
tec, 33D3) or rabbit polyclonal antibodies against hmC, fC
and caC (Active motif: 39791, 61233, 61224). Alexa488-
coupled secondary antibodies were used for detection and
the membranes were scanned with the Typhoon TRIO (GE
Healthcare Life Sciences). Quantification was performed
with ImageJ.
Re-isolation of transfected plasmids
Note that 36 h after transfection, nuclei were extracted from
the ESCs using the Blood & Cell Culture Midi Kit (Qia-
gen) according to the manufacturer’s instructions. Plasmid
DNA was re-isolated using the Qiaprep Plasmid Midi Kit
(Qiagen). A total of 200 ng of re-isolated plasmid DNA was
digested with 0.5 !l HpaII (Fermentas).
RESULTS
In vitro oxidation of Oct4 reporter plasmid DNA causes gene
activation
Since the discovery of hmC, fC and caC, two major roles
for these cytosine modifications have been proposed: first,
as intermediates in active DNA demethylation, and second,
as independent epigenetic marks. The latter has been inves-
tigated by identifying reader proteins for hmC, fC and caC
in different murine tissues. These new DNA modifications
recruit a dynamic set of readers including DNA repair fac-
tors and chromatin remodelers (16). TET-dependent cyto-
sine oxidation has been shown to occur at a large number
of gene regulatory elements and repetitive loci (30).
Here, we focus on the effects of hmC, fC and caC on
gene expression. We transfected ESCs with Oct4 promoter-
driven GFP and mCherry reporter plasmids (pOct4-GFP
or pOct4-mCherry) in different modification states and an-
alyzed expression of the reporter by quantitative imag-
ing. To generate the different cytosine modifications in
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vitro, the unmodified pOct4-reporter construct (CpG) was
initially treated with the DNA-methyltransferase M.SssI,
thereby creating fully methylated CpG sites (mCpG), and
subsequently incubated with the purified catalytic domain
of TET1 (TET1CD) to create oxidized cytosine residues
(oxCpG; Figure 1a). Specific restriction enzymes were used
to monitor the methylation and oxidation state of the plas-
mid DNA. The in vitro methylation of the reporter con-
struct was confirmed by the mC-sensitive restriction en-
donuclease HpaII and the mC-insensitive enzyme MspI.
Both MspI and HpaII fully cleave the unmethylated pOct4-
reporter plasmid at CCGG sites, whereas the restriction pat-
tern of the M.SssI-methylated reporter only appeared with
MspI digestion (Figure 1b).
To follow the oxidation of mC to hmC by TET1CD, the
reporter DNA was treated with the hmC-specific endonu-
clease PvuRts1I (40) (Supplementary Figure S1a). Treat-
ment with TET1CD resulted in a gradual increase of hmC
levels after 15, 45 and 90 min of incubation, visible as pro-
gressing fragmentation (Figure 1b). While using a catalyti-
cally inactive TET1CD mutant (TET1CDmut) as a control,
no hmC levels were detected (ox*CpG), indicating specific
enzymatic mC oxidation by TET1CD (Supplementary Fig-
ure S1b).
Consistent with the restriction digest results, methylation
and oxidation of the reporter plasmid could also be shown
by slot blot analysis (Figure 1c). Incubation of methy-
lated plasmid DNA with TET1CD resulted in an increase
of not only hmC but also of fC and caC, demonstrating
that purified TET1CD did carry out the three oxidation
steps in vitro (Figure 1c and d). The mC signal decreased
over time as hmC, fC and caC appeared in the presence
of active TET1CD, while remaining constantly high with
TET1CDmut (Supplementary Figure S1d).
Transfection of ESCs with the TET1CD-treated plasmid
DNA allows to directly monitor the effect of the oxidized
cytosines on gene expression, independent from in vivo TET
activity. Reporter gene expression from either unmodified,
in vitro methylated or oxidized pOct4-mCherry was visual-
ized using confocal imaging or automated image acquisi-
tion for quantification. Transfection of ESCs with unmod-
ified pOct4-mCherry resulted in a strong nuclear and cy-
toplasmic expression of the reporter, whereas expression
drastically decreased when using the methylated construct.
Interestingly, prominent reporter expression could be ob-
served upon transfection of the oxidized plasmid DNA, but
not with the ox*CpG reporter DNA (Figure 1e). This sug-
gests that reactivation of gene expression requires oxidation
of methylcytosine by TET proteins.
TET proteins interact with the BER machinery
Currently, three pathways for TET-mediated active DNA
demethylation are discussed: TDG-dependent BER,
deamination-dependent BER and direct decarboxylation
of caC (18,23,35). Since the proteins responsible for gene
reactivation in our assay might be physical interaction
partners of the TET proteins, we performed an initial
unbiased screen for interactors. We expressed GFP-TET1
in HEK293T cells, performed immunoprecipitation and
analyzed the co-precipitated proteins by mass spectrome-
try. Prominently, we found PARP1, XRCC1 and LIG3, a
subset of proteins involved in the BER pathway (Supple-
mentary Figure S2a). These results point toward the two
BER-dependent demethylation mechanisms.
To further investigate the interplay between TET pro-
teins and BER, we systematically performed Co-IP and a
recently established F3H assay of all three TET proteins
with the following BER factors: TDG, MBD4, SMUG1,
NEIL1, NEIL2, NEIL3, PARP1, LIG3 and XRCC1.
F3H allows to directly visualize protein–protein interac-
tions in living cells (44). We therefore co-expressed full-
length GFP-TET fusion proteins together with potential
mCherry/RFP-tagged interactors (Supplementary Figure
S3a) and LacI-GBP in BHK cells containing a stably inte-
grated lac-operator array (45). The GFP-tagged bait is en-
riched at the lac-operator array via LacI-GBP and is visible
as a single spot inside the nucleus. If the mCherry/RFP-
tagged prey protein interacts with the bait, it colocalizes at
the same spot (Figure 2a).
Consistent with the mass spectrometry results, inter-
actions of TET1, TET2 and TET3 were observed with
PARP1, LIG3 and XRCC1 both in Co-IP and F3H. Inter-
estingly, several glycosylases also showed a clear interaction
in both assays, among them TDG, MBD4, NEIL1, NEIL2
and NEIL3, but not SMUG1 (Figure 2b and c; Supplemen-
tary Figures S2b and S3b, c). Automated high-throughput
image analysis was used to quantify the F3H results (Sup-
plementary Figure S4). The interaction of all three TET
proteins with TDG was the most robust and detectable in
more than 80% of all analyzed cells. For the other factors,
numbers vary between 40% and 75% (Figure 2d).
To exclude that the recruitment to the lacO-spot is de-
pendent on the locally enriched cytosine oxidation products
generated by TET proteins, we repeated the F3H quantifi-
cation with catalytically inactive TET mutants (Figure 2e).
The percentage of cells showing an interaction did hardly
differ compared to the assay with active TET proteins. The
only exception is XRCC1 where only half as many cells dis-
played a colocalization at the spot, suggesting a potential
cooperative effect.
Taken together, these results suggest that TET proteins
physically interact with the BER machinery and are there-
fore able to recruit these factors to the site of cytosine oxi-
dation for immediate removal of the modified base in vivo.
TDG but not MBD4 mediates oxidation-dependent gene re-
activation in ESCs
Since DNA glycosylases catalyze the first step of the BER
pathway and are therefore the initiators of TET-dependent
cytosine demethylation, we investigated their role in gene
reactivation with the reporter gene assay. Besides TDG,
also MBD4 has been implicated in DNA demethylation via
excision of hmU, the deamination product of hmC (46).
To investigate the role of these two glycosylases, we trans-
fected Tdg-/- and Mbd4-/- ESCs (29,37) with either un-
modified, in vitro methylated or oxidized pOct4-mCherry
plasmid DNA. In contrast to wt E14 ESCs, Tdg-/- ESCs
showed no reporter gene expression from the oxidized plas-
mid. However, Mbd4 knockouts were able to fully reacti-
vate gene expression from the oxidized reporter construct.
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Figure 1. In vitro oxidation of mC causes gene reactivation in ESCs. (a) Schematic representation of in vitro reporter DNA modification: Unmethylated
pOct4-reporter DNA was methylated using the CpG methyltransferase M.SssI. Incubation with purified TET1CD results in oxidation of mC sites to hmC,
fC and caC. (b) M.SssI treatment of pOct4-mCherry results in full methylation as shown after restriction with the methylation sensitive enzyme HpaII.
MspI cuts irrespective of the methylation state. The hmC-specific restriction endonuclease PvuRts1I detects increasing hmC levels during incubation of
methylated pOct4-mCherry with TET1CD. (c) Cytosine modification states of untreated, methylated and TET1CD oxidized pOct4-mCherry plasmid
DNA were detected by slot blot. A 2-fold serial dilution of the plasmid DNA was loaded and detected using antibodies against mC, hmC, fC and caC.
A gradual increase of hmC, fC and caC signals was obtained with longer incubation time with TET1CD while the mC signal decreases accordingly. (d)
Quantification of the slot blot signals of pOct4-mCherry after treatment with TET1CD shows increasing oxidation of mC to hmC, fC and caC. The sum
of all CpG modification signals was set to 100%. Error bars indicate standard deviation (n = 3). (e) ESCs were transfected with pOct4-mCherry plasmids
containing either unmodified (CpG), methylated (mCpG), TET1CD-oxidized (oxCpG) or TET1CDmut-treated (ox*CpG) cytosines. Confocal imaging and
quantification show reporter gene silencing upon methylation and reactivation upon oxidation. Cells were fixed with formaldehyde and counterstained
with DAPI. Scale bar: 5 !m. (Right: n = 200 000; error bars indicate standard deviation).
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Figure 2. All three TET proteins interact with a variety of BER factors. (a) Scheme depicting the F3H assay for in vivo visualization of protein interactions:
BHK cells containing a stably integrated lac-operator array were transfected with plasmids expressing a lac-repressor-GBP fusion protein, GFP-BAIT
and mCherry/RFP-PREY. The Lac-repressor binds to the lac-operator array and recruits the GFP-BAIT through GBP. Proteins interacting with the
BAIT are consequently enriched at the lac-operator array. (b) Co-IP with subsequent SDS-PAGE and western blotting shows interaction of the three TET
proteins with TDG, PARP1, MBD4 but not SMUG1. GFP-tagged TET proteins and the respective mCherry-fusions were expressed in HEK293T cells
and immunoprecipitated with the GFP-Trap (I: Input; F: Flowthrough; B: Bound). (c) F3H was used to confirm TET1 interactions with different factors
involved in BER. GFP-TET1 is enriched at the lac-operator array and mCherry-tagged interacting factors are recruited to the same spot (solid triangle).
SMUG1 shows no co-localization at the lacO-spot (empty triangle). Scale bar: 5 !m. (d) Quantification of the F3H assay of all three TET proteins with
the indicated BER factors. Bars represent percentage of cells that show colocalization at the lacO-spot (n>200). (e) As in (d) but with catalytically inactive
TET mutants.
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The rescue experiment with wt GFP-TDG re-established
the ability of Tdg-/- to express mCherry from the oxCpG
plasmid, whereas the transient rescue of Mbd4-/- cells with
GFP-MBD4 led to no significant differences with regard to
reporter gene expression (Figure 3a).
High-throughput image analysis of 200 000 cells revealed
that the signal from the oxidized plasmid in wt E14 ESCs is
about 80% of the signal from unmodified reporter DNA. In
Tdg-/- cells, the oxCpG signal drops almost to the level of
the fully methylated reporter. Thus, the oxCpG construct re-
mains silent in Tdg-/- ESCs. The stable rescue with wt GFP-
TDG led to a recovery of mCherry expression to about 70%
of the signal from the unmodified reporter. Knockout of
Mbd4 and also the corresponding rescue did not alter ex-
pression levels compared to wt E14 ESCs (Figure 3b), indi-
cating that oxidation-dependent gene reactivation requires
TDG but not MBD4 expression.
To gain insight into the mechanism by which TDG medi-
ates gene activation, we recovered the transfected reporter
plasmid DNA from wt E14 ESCs, Tdg-/- and Mbd4-/-
ESCs. We analyzed the modification status by digestion
with HpaII, which specifically cuts unmodified cytosines in
a CCGG context (Supplementary Figure S1c). We observed
a reappearance of the HpaII restriction pattern on the
oxCpG plasmids isolated from wt E14 and Mbd4-/- ESCs
indicating that TET-dependent demethylation occurred in
vivo. HpaII only displayed minor activity on oxCpG re-
porter DNA re-isolated from Tdg-/- cells (Figure 3c). This
provides strong evidence that the substitution of oxidized
cytosine by unmodified cytosine is the major mechanism for
the observed gene reactivation and that this substitution de-
pends on TDG.
TDG activity is required for reporter gene reactivation
To investigate whether the glycosylase activity of TDG is re-
sponsible for the observed gene reactivation, we generated
Tdg-/- rescue cell lines, which stably express GFP-fusions
of either wt, catalytically inactive (N151A), DNA binding
deficient (M280H) or caC-specific (N168D) TDG (31,47) at
equal levels (Supplementary Figure S5a). The murine caC-
specific mutant corresponds to a published human TDG
mutant (48). Expression of the oxidized mCherry-reporter
plasmid in the stable rescue with wt GFP-TDG increased
almost to the levels of wt E14 ESCs in line with the results
from the transient rescues. In contrast, the catalytically in-
active mutant (N151A) or DNA binding deficient (M280H)
TDG was not able to recover reporter expression. Cells sta-
bly expressing the caC-specific TDG (N168D) were only ca-
pable of partially restoring reporter expression (Figure 4a
and b; Supplementary Figure S5b). This demonstrates that
base excision by active TDG is essential for gene reactiva-
tion.
To further characterize the activity of wt TDG as well
as the TDG mutants, we established an in vitro assay based
on a defined DNA substrate with a single modification site.
Base excision by TDG generates an abasic site, which can
specifically be converted into a single-strand break by puri-
fied APEX1 and can be detected on a denaturing gel. Thus,
this assay mimics the first two steps of the BER reactions
and is also applicable on fluorescently labeled DNA sub-
strates, in contrast to the previously described ‘nicking as-
say’, in which alkaline treatment and subsequent boiling is
used to create single-strand breaks (49,50).
TDG has long been known to repair G◦T mismatches
(51) and was recently found to excise fC and caC (18,25).
We could show that wt TDG is more active on fC and
caC than on G◦T mismatches, its eponymous substrate. No
activity was detected on hmC-containing DNA. Although
the caC-specific TDG mutant (N168D) was able to par-
tially reactivate reporter gene expression in vivo, we could
only detect basal activity on the caC substrate in vitro (Fig-
ure 4c, Supplementary Figure S5d). Since the activity of
TDG in vitro is pH-dependent (48), we repeated the as-
say at pH = 6.5. Under these conditions, the preference of
the caC-specific TDG mutant (N168D) toward caC could
be confirmed (Supplementary Figure S5d). Taken together,
these data suggest that the excision of fC and caC by TDG
is essential for TET-mediated demethylation and causes re-
activation of gene expression.
NEIL1, NEIL2 and NEIL3 glycosylases can partially com-
pensate for loss of TDG
Besides TDG, we identified the family of NEIL glycosylases
as interactors of TET proteins (Figure 2c). Interestingly,
NEIL1 and NEIL3 have also been described as binders of
hmC, fC or caC cytosines in ESCs in a proteome wide screen
(16). However, their function in this context has not been in-
vestigated so far.
To elucidate whether the NEIL glycosylase family con-
tributes to gene reactivation, we measured the expression
of the modified reporter plasmids in Tdg-/- cells transiently
overexpressing NEIL1, NEIL2 or NEIL3 at similar lev-
els (Figure 5a). Interestingly, we observed a significant in-
crease of pOct4-GFP expression in Tdg-/- ESCs rescued
with mCherry-NEIL1, NEIL2 or NEIL3 in comparison to
Tdg-/- ESCs. However, lower expression levels as in rescues
with wt TDG were detected. RFP-MBD4 was not able to
rescue the Tdg-/- phenotype (Figure 5b).
Additionally, we isolated genomic DNA from wt E14 and
Tdg-/- ESCs as well as from the transient rescues with wt
TDG and NEIL1, 2 and 3. Slot blot analyses were carried
out for relative hmC, fC and caC quantifications. Genomic
hmC was present at comparable levels in all tested cell lines
and was not affected by Tdg knockout or NEIL overexpres-
sion. Since TDG is able to recognize and excise fC and caC,
accumulation of these oxidized bases was observed in Tdg-
/- ESCs, consistent with previous reports (30,52). Rescues
of Tdg-/- cells with transiently expressed wt TDG, NEIL1,
NEIL2 or NEIL3 resulted in decreased genomic fC, and
for wt TDG and NEIL1, also in decreased caC levels (Fig-
ure 5c). These findings support the role of the glycosylases
TDG, NEIL1, NEIL2 and NEIL3 in active DNA demethy-
lation and subsequent reactivation of gene expression via
excision of fC and caC followed by BER (Figure 6).
DISCUSSION
In this study, we investigated the effects of the oxidized
cytosine variants hmC, fC and caC on gene expression.
By carrying out the enzymatic oxidation of a methylated
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Figure 3. Oxidation of mCpG plasmid DNA leads to TDG-dependent gene reactivation. (a) Tdg-/- ESCs were transfected with pOct4-mCherry plas-
mids containing either unmodified, methylated or oxidized CpGs. Confocal images show a defect of oxCpG gene reactivation in Tdg-/- ESCs but not in
Mbd4-/- ESCs. Transient rescue of Tdg-/- ESCs with GFP-TDG re-establishes oxCpG reporter gene expression. Cells were fixed with formaldehyde and
counterstained with DAPI. Scale bar: 5 !m. (b) High-throughput image acquisition and quantification of pOct4-mCherry expression shows that oxidation
of mCpG sites in the pOct4-reporter results in reactivation of mCherry-expression in wt E14 ESCs and Mbd4-/- ESCs, but not in Tdg-/- ESCs. Expression
of GFP-TDG rescues the phenotype (student’s t-test, **P < 0.025, n = 200 000; error bars indicate standard deviation). (c) Analytical digest with HpaII
of differentially modified reporter plasmid DNA before and after transfection confirms substitution of oxCpG with CpG in wt E14 and Mbd4-/- ESCs.
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Figure 4. TDG activity is essential for gene reactivation. (a) Confocal images depicting expression levels of oxidized pOct4-mCherry expression in Tdg-/-
ESCs stably rescued with GFP-TDGN151A, GFP-TDGM280H and GFP-TDGN168D in comparison to wt E14 ESCs. Scale bar: 5 !m. (b) High-throughput
image acquisition and quantification of pOct4-mCherry expression in wt E14, Tdg-/- and Tdg-/- ESCs stably expressing wt, catalytically inactive, DNA
binding deficient and caC-specific TDG mutants. Methylation of the pOct4-mCherry reporter leads to a 5-fold lower expression compared to unmodified
plasmid. Oxidation of mCpG sites in the pOct4-reporter results in reactivation of mCherry-expression in wt ESCs but not in Tdg-/- ESCs. This re-increase
was also obtained in Tdg-/- ESCs rescued with wt or caC-specific TDG, while the latter was not as efficient (student’s t-test, **P < 0.025, n = 200 000;
error bars indicate standard deviation). (c) TDG activity was monitored using an in vitro assay based on the ability of APEX1 to create a single strand
break out of an abasic site, detectable as distinct band on the gel (empty triangle). Full length DNA is indicated by a solid triangle. The DNA substrates
contain one defined modification site as indicated in the figure. Wt TDG is highly active on fC or caC and to a much lesser extent on a G◦T mismatch.
pOct4-reporter construct in vitro, we separated the gener-
ation of modified cytosines from their further processing
in vivo. This allowed us to directly investigate the cellu-
lar factors responsible for gene reactivation independent of
endogenous TET activity and regulation. In wt ESCs, we
observed strong reporter expression from oxidized but not
from methylated plasmids, suggesting oxidation-dependent
gene reactivation.
To investigate which pathway is responsible for the ob-
served gene reactivation, we searched for potential TET in-
teraction partners. So far, it has been shown that MBD3
colocalizes with TET1 regulating hmC-marked gene ex-
pression (53) and that TET1, TET2 and TET3 interact
with OGT controlling protein stability, localization and his-
tone modification (54–57). Also, several chromatin-binding
factors, such as HDAC1, EZH2 and MeCP2, have been
described to associate with TET1 (58). However, none
of these factors is likely to be involved in the process
of DNA demethylation. Therefore, we performed a mass
spectrometry-based pull-down approach in which several
BER factors co-precipitated with TET1. To confirm these
results, we used Co-IP and a recently described F3H as-
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Figure 5. The NEIL glycosylase family can partially compensate for TDG. (a) Quantification of mCherry intensities with high-throughput imaging shows
that transient Tdg-/- rescue ESCs express mCherry-tagged TDG, NEIL1/2/3 and MBD4 glycosylases at comparable levels (n = 100 000; error bars
indicate standard deviation). (b) The ability of the NEIL family of glycosylases to substitute TDG in vivo was monitored by expression of differentially
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genomic fC amounts but does not reach wt E14 levels. Expression of wt TDG or NEIL1 also reduces caC accumulation.
say to test interaction of all three TETs with different BER
factors in vitro and in vivo. We were able to detect inter-
actions of TET proteins with the DNA glycosylases TDG,
MBD4 as well as NEIL1, NEIL2 and NEIL3, which excise
damaged or oxidized DNA bases (18,25,32,59,60). Further-
more, interactions of all three TET proteins were observed
with PARP1, which detects single-strand breaks and mod-
ifies repair factors by PolyADP-ribosylation (61). Finally,
we showed TET interactions with LIG3 and XRCC1, which
are recruited by PARP1 to the site of DNA damage and lig-
ate the DNA strand after the insertion of cytosine (62–64).
The observed interactions were largely independent of TET
activity, indicating direct protein–protein interactions.
Our findings suggest that both TET-dependent oxidation
of mC and subsequent excision of oxidized cytosines by the
BER machinery take place in one large protein complex in
a spatially and temporally coordinated manner. This close
association enables highly efficient replacement of oxidized
cytosines. In accordance with these results, fC and caC, in
contrast to hmC, are detected at very low genomic levels and
are proposed to be immediately removed after generation
(18,19).
Initial hypotheses proposed that hmC might be deami-
nated to hmU by AID/APOBEC deaminases prior to base
excision by DNA glycosylases. Suggested candidates were
TDG and MBD4, which both have been shown to recog-
nize G◦T and G◦hmU mismatches (23,65) and have been
identified as TET protein interactors in this study. TDG has
also been described to be active on fC and caC (18,25). In
contrast to wt ESCs, no gene reactivation on the oxidized
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Figure 6. Two alternative pathways for TET-mediated active demethyla-
tion. TDG is the major glycosylase that removes fC or caC, generated by
TET proteins. Alternatively, the NEIL glycosylases can excise oxidized cy-
tosines, but less efficiently. Both pathways are completed by the BER ma-
chinery.
reporter plasmid was observed in Tdg-/- cells. Knockout of
Mbd4, however, had no effect on reporter gene expression,
although MBD4 interacts with TET1, TET2 and TET3.
Apparently, this association does not contribute to gene ac-
tivation and may be involved in a different regulatory mech-
anism.
Our data suggest that conversion of hmC to hmU and
subsequent excision by MBD4 does not play a major role
in ESCs and are in line with previous studies showing that
AID is unable to operate on double-stranded DNA and
no detectable deamination of hmC by AID/APOBEC in
vitro or in vivo could be observed (34,66). However, we can-
not rule out that AID/APOBEC is involved in the TDG-
dependent demethylation pathway or that this pathway con-
tributes to TET3-dependent active demethylation in zy-
gotes (67). Restriction enzyme-based analysis of the oxi-
dized plasmid DNA recovered from wt E14 ESCs provided
evidence that conversion of oxidized cytosine to unmodi-
fied cytosine led to gene activation. Again, this effect was
dependent on TDG but not on MBD4.
Additional in vivo experiments with different TDG mu-
tants showed that TDG activity and not the recruitment of
unknown factors through TDG is essential for the recov-
ery of gene expression. The specificity of TDG toward fC
and caC, but not hmC, was confirmed using a newly estab-
lished assay based on the ability of APEX1 to recognize
glycosylase-generated abasic sites and convert them into
single-strand breaks. The results also revealed that TDG ac-
tivity is much higher on fC or caC than on a G◦T mismatch,
arguing that oxidized cytosines are the major substrate for
TDG and that deamination is not necessary for gene reac-
tivation.
Besides TDG and MBD4, we also investigated the role of
the NEIL glycosylase family in TET-mediated demethyla-
tion. NEIL1, NEIL2 and NEIL3 have been shown to excise
several lesions resulting from DNA oxidations, such as 5-
hydroxyuracil or thymine glycol (59,68). NEIL glycosylases
are bifunctional, i.e. are also able to convert abasic sites into
single-strand breaks (69). Neil3-/- mice have been reported
to be viable as well as fertile, and the expression of NEIL3
is elevated in hematopoietic tissues, suggesting a function in
the immune system or hematopoiesis (70).
Since the NEIL glycosylases have been described as po-
tential binders of oxidized cytosines (16), we tried to com-
pensate for the loss of TDG in Tdg-/- cells with each of
the three NEIL proteins. Indeed, we could detect a signifi-
cant reactivation of reporter gene expression, although not
reaching the levels of the rescue with wt TDG. We conclude
that the NEIL glycosylases can also initiate BER after TET-
mediated cytosine oxidation. This hypothesis was further
confirmed by the fact that the accumulation of genomic
fC and caC in Tdg-/- ESCs was far less prominent when
NEIL1, 2 or 3 was overexpressed. These data clearly show
that the NEIL proteins are not only capable of reactivating
the oxidized reporter gene, but also of excising formylated
and carboxylated cytosine in its chromatin context. Thus,
the NEIL glycosylases may constitute an alternative path-
way for active demethylation and reactivation of epigeneti-
cally silenced genes (Figure 6).
In summary, we show that the TET proteins interact with
a set of factors involved in catalyzing the multiple steps of
BER. Furthermore, we demonstrate that TDG is the main
glycosylase in TET-mediated reactivation of the epigeneti-
cally silenced Oct4 promoter via the BER pathway. It would
be of interest whether the activity of the TET–BER machin-
ery differs on other promoter types, such as CpG island con-
taining promoters. Our results also indicate that the NEIL
family of glycosylases can functionally replace TDG. It re-
mains to be elucidated to which extent the NEIL glycosy-
lases contribute to TET-mediated demethylation and gene
reactivation and how the usage of different glycosylases is
regulated in vivo.
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Supplementary Figure S1 
 
 
Supplementary Figure S1: 
a) PvuRts1I specifically cuts hmC-containing DNA. PCR fragments were generated using dATP, 
dTTP and dGTP with either dCTP, dmCTP or dhmCTP. 
b) Incubation of methylated pOct4-GFP with TET1CDmut does not result in any PvuRts1I digestion 
showing that no DNA oxidation takes place. 
c) HpaII specifically cuts unmodified cytosine in a CCGG context. Substrate: 42 bp oligo, containing 
one defined modification site. 
d) Cytosine modifications of untreated, M.SssI-methylated and TET1CDmut-incubated pOct4-
mCherry plasmid DNA are detected by slot blot. A 2fold serial dilution of the plasmid DNA was loaded 
and detected using antibodies against mC, hmC, fC and caC. The mC levels remain high for all 
samples, except for untreated DNA. Almost no detectable increase in hmC, fC and caC can be 
observed. 
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Supplementary Figure S2: 
a) PARP1, XRCC1 and LIG3 have been identified as interactors of TET1 by mass spectrometry. 
Numbers represent the average of three biological replicates. PEP: Posterior error probability. 
b) Co-immunoprecipitation with subsequent SDS-PAGE and Western Blotting shows interaction of 
all three TET proteins with the NEIL1, NEIL2 and NEIL3 glycosylases as well as XRCC1 and LIG3. 
GFP-tagged TET proteins and the respective mCherry-fusions were expressed in HEK293T cells and 
immunoprecipitated using the GFP-Trap (I: Input, F: Flowthrough, B: Bound). 
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Supplementary Figure S3: 
a) Schematic representation of the GFP-BAIT and mCherry-PREY constructs used to analyze TET-
BER interactions in F3H and Co-IP. 
b, c) F3H assay shows in vivo interactions of TET2 and TET3 with various glycosylases and BER 
factors. Positive and negative interactions are marked with a solid or empty triangle, respectively. 
Scale bar: 5 µm  
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Supplementary Figure S4: 
Schematic depiction of the workflow used for automated image acquisition and quantification of the 
F3H assay.  
 
  
DAPI
Nucleus 
detection
GFP
GFP-Bait
detection
lacO-spot
detection
GFP
RFP-BAIT
detection
DAPII
GFP
GFP
RFP-Spot
detection
RFP RFP
RFP
no interaction interaction
RFP
compare RFP intensity on spot
to mean nuclear RFP intensity
d)
! 6 
Supplementary Figure S5 
 
 
 
Supplementary Figure S5: 
a) Stable Tdg-/- rescue ESCs express GFP-TDG and mutants at comparable levels as shown by 
Western blot analysis (upper left), high-throughput imaging (lower left) and confocal microscopy (right) 
(n=100,000; error bars indicate standard deviation). Scale bar: 5 µm 
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b) Rescue of Tdg-/- ESCs with wt GFP-TDG re-establishes the capability to express the reporter 
gene from the oxCpG plasmid. Scale bar: 5 µm 
c) Schematic representation of the APEX1-based TDG activity assay: if TDG is active the formed 
abasic site is converted into a single strand break by APEX1, resulting in two DNA fragments on a 
denaturing gel. 
d) Quantification of the in vitro base-excision activity of purified TDG on defined DNA substrates 
(left). Equal amounts of GFP-TDG and the mutants were incubated with a 42 bp DNA oligonucleotide 
harboring a central modified CpG site. At pH=6.5, the caC-specific TDG mutant (N168D) displays a 
preference for caC and, to a lesser extent, towards fC (right). To confirm equivalent protein levels, 
protein signal was immunodetected by Western blot using a mouse-anti-GFP antibody (Roche) 
(bottom). 
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3 DISCUSSION 
3.1 Dynamic readers of cytosine derivatives 
Catching specific binders of DNA modifications with quantitative proteomics  
Tandem mass spectrometry (MS/MS) is a powerful tool to identify protein-protein interactions, 
however, the increasing sensitivities of modern mass spectrometers make this approach prone to 
false positive identifications of interaction partners. SILAC (stable isotope labeling by amino acids 
in cell culture) based quantitative proteomics can be applied to circumvent these problems. SILAC 
uses the metabolic incorporation of a given “light” or “heavy” form of stable isotope labeled 
amino acids into cellular proteins [Ong et al., 2002]. When protein abundance is quantified, the 
ration of heavy to light enables to distinguish enriched proteins from the background. As this 
approach also allows purifications to be performed in one step at low stringency, low-affinity but 
functionally relevant interactions can be retained that would otherwise be lost [Vermeulen et al., 
2008]. 
In the context of epigenetics, interaction mapping followed by classical MS was initially applied 
with peptide baits that only differ by a single functional group, such as particular histone 
modifications, to detect “readers” of this mark [Chan et al., 2009; Stucki et al., 2005]. Without a 
quantitative setting, however, these peptide pull-downs are very challenging as it is difficult to 
define specific interactors in the presence of a large number of nonspecific binders [Vermeulen et 
al., 2010]. In addition, using immobilized oligonucleotides, binders of DNA containing 5mC or 
interactors of single-nucleotide polymorphisms could be identified [Mittler et al., 2009]. Given the 
increasing importance of long non-coding RNAs in epigenetic regulation, the application of 
quantitative RNA pull-downs is also of great interest [Butter et al., 2009; Scheibe et al., 2012]. 
We used SILAC-based quantitative MS to identify readers of unmodified cytosine, 5mC and its 
oxidized derivatives 5hmC, 5fC and 5caC as well as 5hmU in ESCs. Furthermore, 5mC and 5hmC 
binders were analyzed during differentiation from murine ESCs to neuronal progenitor cells 
(NPCs) and adult brain tissue. Different biochemical and structural methods were further applied 
to characterize selected readers of these DNA modifications [Spruijt et al., 2013]. 
 
 
C, 5mC and 5hmC recruit a distinct set of readers with little overlap in ESCs 
We found a large number of factors participating in the epigenetic regulation of gene expression 
that preferentially bind to unmodified DNA substrates. Among these proteins was INO80, the 
helicase of the INO80/SWR chromatin-remodeling complex along with its NFRKB (Nuclear 
factor related to kappa-B-binding protein) subunit, which is responsible for DNA binding [Yao et 
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al., 2008]. The INO80 complex participates in transcription, replication, cell division, and DNA 
repair by replacing H2A.Z/H2B histone dimers with the canonical H2A/H2B [Bonisch and Hake, 
2012; Papamichos-Chronakis et al., 2011; Shen et al., 2000]. Consequently, higher order processes 
such as genome stability, pluripotency and differentiation involve INO80 remodeling [Billon and 
Cote, 2013; Li et al., 2012; Wang et al., 2014]. 
As another cluster of unmodified DNA-binders we detected CXXC-domain containing proteins, 
including the transcription factors CXXC5 and ZBTB2 (Zinc finger and BTB domain-containing 
protein 2). CXXC5 participates in modulating WNT-signaling and serves as a transcriptional 
activator of FLK1, a receptor for vascular endothelial growth factors [Andersson et al., 2009; Kim 
et al., 2014]. ZBTB2 was initially described to be located to unmethylated CG-rich sequences, 
where it acts as a repressor of the ARF-HDM2-P53-p21 pathway, which is crucial for cell cycle 
regulation [Jeon et al., 2009]. Recently, ZBTB2 was also found to be attracted by 5mC but repelled 
by 5hmC in vitro [Lafaye et al., 2014]. In addition, we identified the CXXC-domain containing 
lysine demethylase KDM2B (Histone-H3-lysine-36 demethylase 2B), which recruits PRC1 
(Polycomb Repressive complex 1) to CpG islands and is important for self-renewal of ESCs as a 
reader of unmodified DNA [He et al., 2013; Wu et al., 2013].  
In line, we found several subunits of the PRC1 itself, such as PCGF1 (Polycomb group RING 
finger protein 1), the ubiquitin-ligases RING1A/RING1B and BCOR (BCL6-corepressor) in the 
pull-downs with unmethylated DNA substrates. PRC1 sets the H2AK119ub1 mark and regulates 
silencing of target genes by interfering with the SWI/SNF chromatin remodeling machinery, 
blocking transcriptional initiation or recruiting additional silencing factors [Dellino et al., 2004; 
Lavigne et al., 2004; Shao et al., 1999]. However, the exact function and DNA-binding modes for 
several readers of unmodified cytosines are still not fully understood yet. Further biochemical and 
structural studies are needed to elucidate their role in the chromatin context. 
 
Next, we identified 16 proteins enriched for 5mC containing DNA substrates in ESC [Spruijt et 
al., 2013]. Among these readers were the methyl-CpG-binding group proteins MBD1 and MBD4. 
Notably, MBD2 was not detected in the pull-downs, which could be explained by the fact that it is 
not expressed in ESCs [Hendrich and Bird, 1998].  
Other 5mC interactors include the transcription factor RFX1 (Regulatory factor X1), which 
regulates expression of FGF (Fibroblast growth factor) and MHC (Major histocompatability 
complex) class II genes [Herrero Sanchez et al., 1992; Hsu et al., 2012]. RFX1 is an unusual 
member of helix-turn-helix DNA-binding proteins because it uses a beta-hairpin (or wing) to 
recognize DNA instead of the typical recognition helix (Figure 10A) [Gajiwala et al., 2000]. The 
preference for methylated DNA substrates is surprising, as it was shown that RFX proteins can 
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prevent methylation of F-box sequences inside promoters of MHC class II genes, the 
physiological binding sites of RFX proteins [Seguin-Estevez et al., 2009]. 
Interestingly, we detected the Krüppel-like zinc finger containing transcription factors KLF2, 
KLF4 and KLF5 among the 5mC binders. KLF4 is one of the four classic Yamanaka 
reprogramming factors and essential for self-renewal of ESCs as it prevents their differentiation 
[Takahashi et al., 2007; Zhang et al., 2010b]. Crystal structures of KLF4 bound to a 5mC substrate 
revealed that methylation had modest, though significant, effects on binding (Figure 10B). 
Mutating the DNA sequence outside the CpG site, however, abolishes KLF4 binding, regardless 
of the modification status [Chen et al., 2008]. These data indicate that the interaction between 
KLF4 and DNA depends largely on the specific sequence context and less profoundly on the 
cytosine modification state. Recent KLF4 ChIP-seq and genome wide methylation data indicate 
that CpG sites in the core KLF4 binding motif GGCG are highly methylated in mouse and 
human ESCs [Liu et al., 2014; Stadler et al., 2011]. 
 
 
 
Figure 10: Crystal structures of the 5mC binders RFX1 and KLF4 
(A) Binding mode of the human RFX1 transcription factor to a 16-bp DNA oligonucleotide, which resembles the X-box sequence, the 
physiological RFX1 binding site (PDB 1DP7). The RFX1 DNA-binding domain uses a special mechanism for DNA recognition, which 
differs from all other known HTH-proteins. Two beta-strands (yellow) and their connecting loop or wing (red), make extensive contacts with 
the major groove of one half-site DNA (blue). A single side chain from an alpha-helix (light-brown) interacts with the minor groove of the 
other half-site (not shown).  
(B) Murine KLF4 in complex with a methylated CpG containing DNA substrate (PBD 4M9E). KLF4 contains three tandem CXXC-zinc 
fingers (ZnF; green, zinc ions brown) at its C-terminus, which bind in the major groove of the DNA (blue). The second ZnF (ZnF2) interacts 
with the central methylated cytosine (red). A spatially conserved Asp-Glu pair is mainly involved in stabilizing the binding to 5mC (right). 
 
 
Furthermore, five proteins specifically binding to 5hmC containing DNA substrates. Among these 
factors were the BER glycosylase MPG (N-methylpurine glycosylase) and the helicase RECQ1 
(DNA-dependent ATPase Q1).  
MPG catalyzes the excision of several mutagenic base substrates, including methylpurines, 
deaminated adenine and oxidized guanine [Elder et al., 1998; Wyatt et al., 1999]. Crystal structures 
indicated that MPG intercalates with the minor groove of the DNA, causing base flipping into the 
active site of the enzyme [Lau et al., 1998]. Interestingly, MBD1 has been identified to interact 
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ZnF1
ZnF2
ZnF3
5mC
Glu446
Arg443
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with MPG, leading to a synergistic effect on gene silencing. MBD1 and MPG normally bind to 
methylated promoters. As exogenous and endogenous DNA damage causes the generation of 7-
methyl-guanine, the MBD1-MPG complex dissociates from the damaged methylated CpG sites. 
MPG then spreads along the promoter to remove damaged bases and inhibit transcription at these 
sites. After completion of repair, MBD1 returns to the repaired methyl-CpG sites together with 
MPG to reconstruct the repressive chromatin [Hameed et al., 2014; Watanabe et al., 2003]. As will 
be discussed in section 3.4, MPG binding or activity towards 5hmC has not been described yet 
and could potentially serve as a pathway for TET-mediated DNA demethylation. 
RECQ1 rapidly accumulates at oxidatively damaged DNA sites and at double-strand breaks, thus 
contributing to the non-homologous end-joining repair pathway [Parvathaneni et al., 2013; 
Sharma et al., 2012]. Additionally, RECQ1 also plays an essential role in maintenance of telomeres 
and restoring active replication forks that have regressed as a result of topoisomerase 1 inhibition 
[Berti et al., 2013; Popuri et al., 2014]. Binding of RECQ1 to 5hmC indicates that this factor might 
be involved in active DNA demethylation via different repair pathways, however also regulatory 
functions are conceivable. 
We did not detect binding of MBD3 to 5hmC using quantitative MS analysis, which is in line with 
previous results [Hashimoto et al., 2012b; Iurlaro et al., 2013]. Nevertheless, MBD3 localization to 
5hmC has been proposed to be involved in active DNA demethylation and activation of gene 
expression [Shimbo et al., 2013; Yildirim et al., 2011]. Very recently, binding properties were 
characterized by the solution structure of the MBD3-MBD in complex with unmethylated, 5mC 
and 5hmC containing DNA [Cramer et al., 2014]. The overall fold of this domain is highly similar 
to other MBDs, yet, a key loop involved in DNA targeting is more disordered. It could also be 
shown that MBD3 preferentially recognizes methylated and to a lesser degree unmethylated CpGs, 
however, it does not distinguish between hydroxymethylated and unmethylated sites. The 
homologous MBD2 protein shows much stronger binding to methylated than to unmethylated 
CpGs. These findings correlate with the observations that both MBD2 and MBD3 are found at 
unmethylated CGIs, whereas MBD2 binds with much greater affinity to methylated CGIs. 
 
We observed that MECP2 and UHRF1 bind to 5mC as well as 5hmC [Spruijt et al., 2013]. 
MECP2 is an essential transcriptional repressor that mediates gene silencing through binding to 
methylated DNA. The additional interaction with 5hmC supports the role of MECP2 as the main 
5hmC-binding factor in the brain. In line, MECP2 was shown to bind hemimodified 5hmC- and 
5mC-containing DNA with similar affinities [Hashimoto et al., 2012b; Mellen et al., 2012]. Binding 
specificity has been thought to depend on interactions between 5mC and a hydrophobic patch 
within the MBD. X-ray analysis of a methylated DNA-MBD crystal revealed, however, that the 
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methyl group makes contact with a predominantly hydrophilic surface that includes tightly bound 
water molecules [Ho et al., 2008]. This suggests that MECP2 recognizes hydration of the major 
groove of methylated DNA rather than cytosine methylation per se. Interestingly, the Rett-
syndrome causing mutation R133C inhibits 5hmC binding [Mellen et al., 2012]. This indicates that 
5hmC and MECP2 contribute to a cell-specific epigenetic mechanism for regulation of chromatin 
structure and gene expression. In contrast, in vitro studies showed a clear preference for methylated 
CpGs compared to hydroxymethylated by MECP2 [Frauer et al., 2011a; Valinluck et al., 2004]. 
The conflicting binding features are also reflected by the findings as MECP2 was shown to serve 
as a global activator of gene expression in neurons by binding to 5hmC [Li et al., 2013], which 
contrasts with the notion of MECP2 acting as a transcriptional repressor [Ebert et al., 2013; Jones 
et al., 1998]. 
Different opinions prevail regarding the specificity of UHRF1 towards 5hmC. In line with our 
proteome-wide MS screen, the SRA domain of UHRF1 was shown to bind 
hemihydroxymethylated DNA with a comparable affinity as hemimethylated substrates. Molecular 
dynamics simulations indicated that the flipped out 5hmC base fits into the binding pocket of the 
UHRF1-SRA domain and is additionally stabilized by hydrogen bond formation involving the 
hydroxyl group [Frauer et al., 2011a]. Notably, UHRF1 and its homologue UHRF2 are the only 
proteins known so far using a base-flipping mechanism and not showing any catalytic activity on 
the target base. In contrast, it was proposed that the binding pocket of UHRF1 is too narrow to 
accommodate 5hmC and the affinity of the SRA domain bound to hemimethylated DNA was 
significantly higher as for 5mC [Otani et al., 2013]. The difference in the sequences and the lengths 
of the DNA substrates used in the different approaches may partly be the reason for this 
discrepancy. Nevertheless, the specific binding of UHRF1 to 5hmC containing DNA is very 
surprising as UHRF1 was shown to be crucial for the maintenance of DNA methylation by 
directing DNMT1 to hemimethylated CpG sites [Sharif et al., 2007], which raises the question 
about the exact function UHRF1 in this context.  
 
 
5fC and 5caC recruit a large number of binders, including repair proteins and 
transcription factors 
We applied the SILAC-based DNA pull-down approach to also identify readers for 5fC and 5caC 
in ESCs. Both modifications recruit more proteins than 5hmC and again we only observed limited 
overlap between their binders [Spruijt et al., 2013]. A number of factors involved in DNA damage 
response were significantly enriched for 5fC-containing substrates. Among these proteins was the 
BER glycosylase UNG (see chapter 3.4) as well as DDB2 (DNA damage binding protein 2). 
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DDB2 recognizes UV-induced DNA damage and recruits proteins of the NER pathway to initiate 
DNA repair [Li et al., 2006]. Interestingly, the tumor suppressor P53, which was shown to induce 
upregulation of DDB2 resulting in increased DNA repair, was also able to bind to 5fC 
[Barckhausen et al., 2014].  
Interestingly, among the proteins specifically interacting with 5caC was DNMT1, which was also 
confirmed using EMSAs as well as western blotting. DNMT1 was shown to decarboxylate 5caC 
under specific conditions in vitro resulting in unmodified cytosine [Liutkeviciute et al., 2014]. 
Although this enzymatic activity seems unlikely under a reducing cellular environment in vivo, these 
data indicate that DNMT1 binding to 5caC can occur in ESC lysates. 
One of the proteins that binds to 5fC and 5caC, but not to 5hmC, is the glycosylase TDG, which 
is consistent with its reported substrate specificity and its ability to excise 5fC and 5caC [He et al., 
2011; Maiti and Drohat, 2011]. Crystal structures of the catalytic domain of human TDG showed 
that the double-stranded DNA backbone is bend by ~45° and 5caC is flipped out into the active 
site (Figure 11). Inside the active site pocket 5caC is stabilized via hydrogen bonds and 
hydrophobic interactions from surrounding residues [Zhang et al., 2012]. These binding properties 
suggest that TDG is one of the glycosylases involved in the removal of 5fC and 5caC bases via the 
BER pathway as will be discussed in more detail in chapter 3.4.  
 
Figure 11: Crystal structure of human 
TDG bound to a caC- containing 
substrate. 
TDG interacts with the backbone of the 5caC-
containing DNA strand via electrostatic 
interactions and bends the backbone (blue) by 
~45° towards the active site. The 5caC base 
(red) is pushed out of the DNA groove and 
flipped inside the active site. In addition to 
several interactions from Asn191 and His151, 
the carboxyl-group is accommodated in the 
active site with a binding pocket defined by 
Ala145, and hydrogen bonds from Asn157 and 
the backbone amide of Tyr152 (PBD 3UO7). 
 
 
 
We identified three proteins being pulled-down with all oxidized derivatives of 5mC: First the 
uncharacterized factor THY27 (Thymocyte protein 28). Second, C3ORF37, which is a eukaryotic 
member of the prokaryotic SRAP (SOS response associated peptidase) protein family and is 
proposed to serve as an autoproteolytic switch that recruits repair enzyme upon DNA damage 
[Aravind et al., 2013]. Third, NEIL1, a glycosylase with a broad substrate range, which is involved 
in BER. Thus, C3ORF37 and especially NEIL1 may have a role in removal of the oxidized 
methylcytosine bases as part of the DNA demethylation pathway. 
 
caC
Asn191
His151
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Asn157
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Readers are highly dynamic during development 
To investigate whether interactions with C, 5mC and 5hmC change during development, ESCs 
were differentiated to NPCs and label-free quantitative MS analysis was applied. In summary, we 
found a large number of proteins in NPCs, which bound to unmodified cytosine or 5mC, whereas 
fewer factors were specific for 5hmC. Three smaller groups of proteins were enriched for two 
different modification states [Spruijt et al., 2013]. 
As we already observed in ESCs, several CXXC-domain-containing proteins such as the lysine 
demethylase KDM2B and the histone methyltransferase MLL1 (Myeloid/lymphoid or mixed-
lineage leukemia protein 1), together with their associated factors BCOR, RING1A/B and RBBP5 
were enriched for unmodified DNA substrates. KDM2B plays an essential role in repressing the 
Ink4/Arf locus and thus suppressing cellular senescence [He et al., 2008; Tzatsos et al., 2009]. 
Recently, KDM2B was also found to facilitate reprogramming into iPSCs and recruit PRC1/2 to 
CGIs [Guo et al., 2011b; He et al., 2013]. Interestingly, the reprogramming efficiency of KDM2B 
increased using Vitamin-C as was also previously reported for TET proteins [Chen et al., 2013a; 
Wang et al., 2011b]. Both enzymes belong to the family of Fe(II)-2-oxoglutarate dependent 
dioxygenases and share a similar reaction mechanism. MLL1 is a member of the mixed-lineage 
leukemia family of histone methyltransferases in mammals [Milne et al., 2002; Nakamura et al., 
2002]. It catalyzes mono- di-, and trimethylation of histone H3 on K4 through its conserved SET 
domain. Both MLL1 and H3K4 methylation were shown to localize across gene promoters, 
transcription start sites, and 5′ transcribed regions of target genes and facilitate transcription 
initiation especially controlling the expression of homeobox (Hox) genes during differentiation 
[Guenther et al., 2005; Lauberth et al., 2013].  
The MBD proteins MBD1 and MECP2 were specifically enriched for 5mC containing DNA in 
NPCs. In contrast to ESCs, MBD2 and the associated Mi-2/NuRD complex subunits could be 
detected as 5mC readers as well. MBD2 was shown to mediate gene repression through 
recruitment of the Mi-2/NuRD complex to methylated promoters [Barr et al., 2007; Zhang et al., 
1999]. It has not only been reported that MBD2 selectively binds methylated DNA in vitro [Le 
Guezennec et al., 2006] but the quantitative MS-based approach supports the very recent findings 
that this binding also happens in vivo [Baubec et al., 2013]. Genome wide mapping of MBD2 
binding further showed that binding predominantly occurs at highly methylated, CpG dense 
regions [Menafra et al., 2014].  
Interestingly, several known 5mC readers, such as Kaiso, UHRF1, and MBD4, were also able to 
bind to 5hmC containing substrates in NPCs, suggesting a potential dual role for these factors 
previously associated only with transcriptional repression and maintenance of DNA methylation. 
Again, DNA glycosylases such as NEIL1, NEIL3 and OGG1 (8-oxoguanine DNA glycosylase 1) 
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as well as several helicases bound specifically to 5hmC, which again suggests DNA repair 
contributing to DNA demethylation.  
Finally, we found that UHRF2 was specific for 5hmC in NPCs. UHRF2 is not expressed in ESCs 
and is upregulated upon differentiation [Pichler et al., 2011], explaining why UHRF2 was not 
detected in ESCs. Recently, a crystal structure of the SRA domain of UHRF2 in complex with 
5hmC containing DNA [Zhou et al., 2014] revealed that its binding mode is similar to that of the 
UHRF1-SRA with 5mC DNA [Arita et al., 2008; Avvakumov et al., 2008; Hashimoto et al., 2008]. 
The UHRF2-SRA folds into a saddle-shaped structure, which contains seven β-strands and four 
α-helices. A positively charged surface area surrounding the loop connecting α1 and β2, generally 
mediates the DNA binding properties. The 5hmC is flipped out of the DNA duplex and is bound 
inside a narrow pocket adjacent to this positively charged area. Different hydrophobic contacts 
and hydrogen bonds stabilize the 5hmC base itself. Additionally, UHRF2 has a binding preference 
for 5hmC over 5mC due to an extra intermolecular hydrogen bond, with greatest affinity for fully 
hydroxymethylated sites.  
 
Figure 11: Crystal Structure of UHRF2-
SRA bound to hemi-hydroxymethylated 
DNA. 
The UHRF2-SRA domain folds into a saddle-
shaped structure consisting of seven β-strands (light 
blue) and four α-helices (green). UHRF2-SRA 
contacts the DNA substrate mostly by its phosphate 
backbone. The SRA-domains bound to a blunt-
ended hemi-hydroxymethylated DNA (blue) uses a 
mechanism, in which both 5hmC (red) and 
unmethylated cytosine (orange) on the opposite 
strand are flipped out. The 5hmC base is bound 
inside a narrow pocket adjacent to a positively 
charged area. 5hmC is stabilized with hydrophobic 
contacts by aromatic residues and an additional 
hydrogen bond (PBD 4PW6). 
 
 
The binding of UHRF2 to 5hmC could also explain the enhanced activity of TET1, which we 
observed by co-expression of both factors [Spruijt et al., 2013]. UHRF2 could either target TET 
proteins to the site of action or more likely by flipping out the base, increase the accessibility of 
5hmC for subsequent oxidation. Both cases would lead to elevated 5fC and 5caC levels as we 
measured in additional experiments [Spruijt et al., 2013]. 
Readers for the different modified cytosines were also identified in the adult brain, the tissue with 
highest 5hmC levels. In contrast to NPCs and ESCs, most proteins specifically bound to 5hmC, 
which may imply a specific role for this cytosine modification in the brain. The analyses with 
unmodified DNA were enriched for the same proteins as those observed in ESCs and NPCs, 
including different CXXC containing factors and chromatin remodelers. With exception of 
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MBD3, all other MBD family members were enriched for 5mC. Notably, the four subunits of 
replication factor C (RFC2-5) and the associated factor RFC1 were specific 5hmC readers. 
Replication factor C loads PCNA on the DNA, which organizes various proteins involved in 
DNA replication, DNA repair, DNA modification, and chromatin modeling [Indiani and 
O'Donnell, 2006]. Nevertheless, the function of RFC binding to 5hmC remains unclear and has to 
be further investigated.  
Altogether, these results underline the highly dynamic behavior of factors binding to unmodified 
cytosine, 5mC or 5hmC during differentiation. This study concentrated on the development from 
ESCs to neuronal cells. It remains to be elucidated, how readers of different DNA modifications 
act and function in other developmental processes. 
 
 
3.2 TET proteins oxidize thymine to 5hmU 
5hmU is present in ESCs and is bound by specific readers 
Naturally occurring DNA damage is responsible for the generation of a variety of base lesions 
including oxidations, deaminations and base adducts. The presence of 5hmC, 5fC and 5caC in the 
genome raises the question whether additional base variants can be detected in cells, which are 
enzymatically generated. 
As these oxidized derivatives are present at very low levels compared to 5mC, they can only be 
quantified using high sensitive MS approaches. These precise quantifications are based on 
chemically synthesized isotopologues of the different cytosine bases, which are used as internal 
standards during MS analysis [Pfaffeneder et al., 2011].  
With this technique we could detect and quantify for the first time 5hmU at similar levels as 5caC 
in genomic DNA from ESCs [Pfaffeneder et al., 2014]. Depending on the cell line and growth 
conditions around 3000-8000 5hmU bases are present in ESCs. Comparable levels of 5hmU were 
also detected in sperm DNA by a subsequent study [Guz et al., 2014]. In somatic tissues, genomic 
5hmU levels were much lower (500-1700 hmU bases) and at the same levels as 5-formlyuracil 
(5fU) and 8oxoG, which are both formed by reactive-oxygen-species (ROS). Notably, the presence 
of 5fU in the DNA does not affect replication, however DNA polymerases such as the Klenow-
fragment of DNA polymerase I, DNA polymerase alpha and gamma are able to incorporate any 
of the four bases opposite 5fU allowing transition and transversions.  [Bjelland et al., 2001]. 5fU 
has been described to be repaired by either BER or NER pathways [Belousova et al., 2013; Kino 
et al., 2004]. 
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The high levels of 5hmU compared to 5fU and 8oxoG in ESCs suggests that 5hmU may be 
formed by a ROS independent mechanism. Recent studies proposed that deamination of 5hmC by 
the AID/APOBEC enzymes could lead to the generation of 5hmU [Cortellino et al., 2011]. The 
AID/APOBEC family of enzymes are mainly involved in converting cytosine to uracil. This 
reaction plays a key role in adaptive immunity as it seeds the process of antibody diversification 
and maturation via somatic hypermutation and class-switch recombination [Muramatsu et al., 
2000; Pavri and Nussenzweig, 2011]. In innate immunity, deaminases from the APOBEC3 
subfamily have been shown to mutate foreign viral genomic intermediates to promote their 
degradation and prevent viral integration [Marin et al., 2003; Sheehy et al., 2002]. 
To test whether AID/APOBEC enzymes can also deaminate 5hmC in vivo, we performed isotope-
tracing experiments by substitution of L-methionine with (methyl-13CD3)-L-methionine, which is 
needed as the methyl-group donor for DNMTs [Pfaffeneder et al., 2014]. We detected the 
incorporation of the isotope-labeled L-methionine into 5mC, 5hmC and 5fC but not into 5hmU, 
which indicates that this base is not a product of enzymatic deamination of 5hmC. Using isotope-
labeled [13C,15N2]thymidine we observed its incorporation into T and also 5hmU, which clearly 
demonstrates that genomic 5hmU is generated via oxidation of T. 
 
The presence of 5hmU implies that it may serve as an additional epigenetic mark that is 
recognized and bound by specific readers as shown for the individual cytosine derivatives. Thus, 
we also applied SILAC-based quantitative mass spectrometry to identify proteins binding directly 
or indirectly to 5hmU in ESCs.  
Amongst the readers we found the methyltransferases DNMT3A/3B as well as their interacting 
partners UHRF1 and UHRF2 [Meilinger et al., 2009; Zhang et al., 2011]. It has been shown that 
DNMT3A interacts with TDG, which mutually affects the enzymatic activity of both proteins: 
DNMT3A enhances the glycosylase activity, while TDG inhibits the methylation activity in vitro 
[Li et al., 2007]. These data suggest a functional link between DNA repair and DNA methylation 
at specific sites. Moreover, DNMT3A had no effect on the activity of SMUG1, while it stimulated 
the excision activity of TDG towards GŊU mismatches. TDG has been shown to be active on 
5hmU [Hashimoto et al., 2012a], which could be a potential targeting mechanism. These findings, 
however, were based on the generation of uracil by 5mC deamination and no hmUŊA substrate 
was tested, the result of TET-mediated thymine oxidation. It remains elusive and needs to be 
validated whether TDG displays in vivo activity at hmUŊA mismatches. 
Furthermore, we found UHRF2 to directly bind to 5hmU and additional biochemical studies 
revealed that co-expression of UHRF1 or UHRF2 with the catalytic domain of TET1 led to 
increased 5hmU levels [Pfaffeneder et al., 2014]. Binding to 5hmU could increase epigenetic 
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crosstalk, as UHRF proteins were shown to link DNA modifications with histone modifications 
[Pichler et al., 2011], however, their exact mode of action has to be further studied. 
In line, other chromatin modifying enzymes were identified to interact directly or indirectly with 
5hmU, such as JARID2 (Jumonji/ARID domain-containing protein 2), which contains an AT-rich 
binding domain and a CXXC zinc finger with a preference for GC rich sequences [Son et al., 
2013]. JARID2 mediates localization of PRC2 to the chromatin, inhibiting methylation of H3K27 
in ESCs, a mark associated with repressed transcription [Peng et al., 2009; Shen et al., 2009]. 
JARID2 has also been shown to be involved in gene repression by inhibition of cyclin D1, OCT4 
and genes involved in X-inactivation [da Rocha et al., 2014; Li et al., 2010; Shirato et al., 2009]. 
Thus, 5hmU recognition by JARID2 could provide further possibilities to fine-tune epigenetic 
regulation. 
5hmU also recruits other chromatin-associated proteins such as the CXXC containing histone 
H3K36me3 demethylase KDM2B and its counterpart SETD2 (SET domain-containing protein 2), 
which generates the methylation mark leading to transcriptional activation [Edmunds et al., 2008]. 
Recently, it was shown that H3K36me3 is also required to recruit mismatch repair proteins in vivo 
[Walters et al., 2014]. Further DNA repair proteins were identified as 5hmU binders such as the 
NEIL3 glycosylase and several helicases indicating a role for these factors in removal of this base. 
These hmU binders enable a dynamic interplay between DNA modifications, histone marks and 
DNA repair. 
 
 
TET proteins convert thymine to 5hmU 
As we could show that genomic 5hmU is not generated via enzymatic deamination of 5hmC but 
by oxidation of thymine [Pfaffeneder et al., 2014] we addressed the question, which enzyme could 
be responsible for catalyzing this reaction. Given their function as oxidases, we analyzed TET 
proteins in more detail. Indeed Tet1/Tet2 knockdowns resulted in decreased 5hmU levels whereas 
expression of the catalytic domain of TET1 led to a significant increase. Together with the isotope 
tracing experiments showing no incorporation of (methyl-13CD3)-L-methionine into 5hmU and 
thus no deamination of 5hmC, these data clearly indicate that TET enzymes can directly oxidize 
thymine to 5hmU. This enzymatic oxidation leads to hmUŊA basepairs, which can be recognized 
by the SMUG1 glycosylase. In line, knockdown of SMUG1 led to increased 5hmU levels whereas 
knockdown of TDG had no significant effect on these bases. Recently, the activity of SMUG1 has 
been additionally confirmed in vivo using expression constructs containing multiple 5hmU sites 
[Luhnsdorf et al., 2014]. As will be discussed in chapter 3.4, the glycosylases UNG1, UNG2, 
MBD4 and TDG have been shown to be active on uracil-derivatives in vitro in addition to SMUG1 
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and could also constitute alternative pathways for removal of 5hmU in vivo [Hashimoto et al., 
2012a; Hendrich et al., 1999; Kavli et al., 2002; Krokan et al., 2002].  
How can mammalian TET enzymes additionally oxidize thymine and not only cytosines? 
Trypanosomatids, including the human pathogen Trypanosoma brucei, possess a unique DNA 
modification within the trypanosoma genome known as β-d-glucopyranosyloxymethyluracil (base 
J) [Gommers-Ampt et al., 1993]. Base J is a hypermodified thymine residue that accounts for 
about 1% of thymines in their genome and is enriched in repetitive sequences, including telomeric 
repeats [van Leeuwen et al., 1998a; van Leeuwen et al., 1998b]. Base J is generated by a two-step 
enzymatic process: JBP1 and JBP2 (J-binding proteins 1/2) first oxidize thymine in the DNA to 
5hmU [Cliffe et al., 2012]. Second, JGT (J-associated glycosyltransferase) completes the synthesis 
of base J by adding a glucose group to 5hmU (Figure 13) [Bullard et al., 2014].  
 
Figure 12: Base J synthesis in 
trypanosomatids 
 
(Top) Base J synthesis is a two-step reaction in 
which thymines are first hydroxylated by JBP1 and 
JBP2 to form 5hmU. The intermediate hmU is 
subsequently glycosylated by JGT.  
(Bottom) Like TET proteins, JBP1 and JBP2 are 
members of the Fe(II)-2-OG dioxygenase family 
and both contain a DNA binding motif.  
 
 
 
Together with the TET proteins, JBP1/2 are members of the Fe(II)-2OG dependent dioxygenase 
family [Loenarz and Schofield, 2009; Yu et al., 2007]. Moreover, TET and JBP proteins share 
some unique features, which are not found in any other dioxygenase. Both families have an 
extended α-helix just N-terminal to the first core strand inside the DSBH. This long α-helix is 
kinked due to a conserved proline in the middle of the helix [Hashimoto et al., 2014; Iyer et al., 
2009]. Furthermore, JBP and TET proteins show either fusions to DNA-binding or chromatin-
associated protein domains, or gene-neighborhood associations with known DNA-binding 
domains. JBP2 contains a SWI2/SNF2 ATPase module, which is consistent with the role for 
ATP-dependent chromatin reorganization in synthesis of the J base [DiPaolo et al., 2005]. In 
contrast, JBP1 binds DNA by a helix-turn-helix domain [Heidebrecht et al., 2011]. TET1 and 
TET3 proteins either have an intrinsic CXXC DNA-binding domain or in the case of TET2 the 
neighboring Idax gene encodes for a CXXC zinc-finger [Iyer et al., 2009; Ko et al., 2013; Liu et al., 
2013b]. 
A recent evolutionary computational screen identified further JBP/TET members in phages, fungi 
and algae. Phages encoding TET/JBP genes do not possess any DNA methyltransferases, which 
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serves as an essential pre-requisite for 5hmC generation [Iyer et al., 2013]. These observations 
suggest that the nucleotide substrate oxidized by TET/JBP enzymes of phages is very likely a 
thymine, which is also in line with the TET activity we observed in ESCs. In cyanophages, the 
TET/JBP gene is further linked to a uracil-5-methyltransferase. In this case, the TET/JBP protein 
generates 5hmU after synthesis of 5mU (5-methyl-uracil) from thymine. However, in other 
bacterial species, the TET/JBP gene is fused to a DNA methyltransferase; hence, these versions 
might oxidize 5mC to generate its oxidized derivatives [Iyer et al., 2013]. This suggests that 
mammalian TET proteins retained both catalytic activities: oxidation of 5mC and generation of 
the oxidized cytosine derivatives as well as oxidation of thymine to 5hmU. It remains elusive how 
the different catalytic activities are regulated in different species and whether they are sequence-
context or gene specific. 
 
 
3.3 Regulation of TET proteins by posttranslational modifications 
TET proteins are subject to glycosylation and phosphorylation 
So far only little is known how TET proteins are regulated and whether they are subject to 
posttranslational modifications. We found that all three TET proteins can interact with OGT (O-
linked GlcNAc-transferase), which is in line with previous studies [Deplus et al., 2013; Shi et al., 
2013; Vella et al., 2013]. OGT transfers O-GlcNAc from UDP-GlcNAc to the hydroxyl group of 
serine or threonine residues of nuclear and cytoplasmic proteins [Kreppel et al., 1997]. Using a 
highly sensitive MS approach we could further map individual glycosylation and phosphorylation 
sites. Increasing OGT expression led to higher O-GlcNAc levels whereas phosphorylation 
decreases simultaneously [Bauer et al., 2014].  
Interestingly, we did not detect a direct competition for the same serine or threonine residues that 
are modified, but rather proximal site occupancy. Previous O-GlcNAc and O-phosphate site-
mapping studies proposed that there are at least three different types of dynamic interplay 
between both modifications. First, there is competitive occupancy at the same site, which has been 
shown for the transcription factor c-MYC and estrogen receptor-beta [Cheng and Hart, 2001; 
Kamemura et al., 2002]. Second, the competitive and alternative occupancy occur at proximal 
residues, as observed in the tumour suppressor P53, synapsin I and in our case in TET proteins 
[Cole and Hart, 1999; Yang et al., 2006]. Third, there is a complex interplay whereby some 
phosphorylation sites are identical to O-GlcNAc sites, whereas others are adjacent to, or even 
distant from, each other, such as at the C-terminal domain of RNA polymerase II [Comer and 
Hart, 2001]. The direct interplay between O-GlcNAc and phosphorylation is also underscored by 
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the recent finding that OGT forms transient complexes containing the catalytic subunit of protein 
phosphatase 1 [Wells et al., 2004]. Additional in vitro assays depicted that phosphopeptides could 
be concurrently dephosphorylated and remodified by OGT in this functional unit.  
The biological importance of OGT and O-GlcNAcylation is manifested by its essential roles in 
ESC viability and mouse embryonic development [Shafi et al., 2000]. Although OGT has been 
shown to interact with all three TET proteins and catalyze O-GlcNAcylation of TET1 and TET2, 
OGT was not found to significantly affect their activities. In contrast, TET proteins were 
described to mediate targeting of OGT to chromatin and enhancing its enzymatic activity [Chen et 
al., 2013b; Deplus et al., 2013; Ito et al., 2014; Vella et al., 2013]. However, a recent study depicted 
that OGT drives TET3 out of the nucleus in a glucose-dependent manner and, thus, is able to 
inhibit TET3 activity by altering its subcellular localization [Zhang et al., 2014].  
Further evidence for an epigenetic function of OGT has evolved with the discovery that it can 
glycosylate histone H2B on serine 112, causing its ubiquitinylation and the subsequent 
trimethylation of histone H3 at lysine 4 (H3K4me3). This modification is associated with active 
genes and mainly recognized by the SET1/COMPASS complex [Fujiki et al., 2011]. These data 
propose a model of gene activation, in which TETs associate with OGT on CpG rich promoters 
and enhance its glycosyltransferase activity. 
Protein kinases control a variety of cellular processes, including signal transduction, cell cycle 
progression, protein localization and activity. Protein phosphorylation also plays a crucial role in 
intercellular communication during development, in physiological responses and in homeostasis. 
Mutations or dysregulation of kinases play causal roles in human disease, affording the possibility 
of developing agonists and antagonists of these enzymes for use in therapy [Blume-Jensen and 
Hunter, 2001]. Given the large number of more that 500 protein kinases, of which the majority are 
serine/threonine kinases [Manning et al., 2002] the identification for the TET specific one will be 
challenging but of great interest.  
 
 
3.4 DNA demethylation leads to gene expression 
The proteins involved in setting the different cytosine modifications, namely DNMTs and TETs, 
have been intensively studied. We could also show that 5mC and its oxidized derivatives attract 
specific readers, which are highly dynamic during development. However, it is not fully 
understood, which mechanisms or pathways can contribute to the removal of the methylation 
mark, how they are regulated and what effect they have on gene expression. 
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DNA glycosylases involved in TET mediated gene re-activation 
Almost all suggested active DNA demethylation pathways start with the initial recognition and 
removal of the oxidized bases by specific DNA glycosylases. Eleven DNA glycosylases have been 
identified in mammals, which show different structural features and are active on a variety of 
damaged bases. These glycosylases can be divided into two main classes: monofunctional 
glycosylases, which only display glycosylase activity and bifunctional glycosylases, which also 
possess AP-lyase activity [Jacobs and Schar, 2012]. This additional activity allows to cleave the 
phospho-diester bond of the DNA, creating a single-strand break without the need for the AP-
Endonuclease (APEX1). It is still not fully understood how DNA glycosylases locate damaged 
nucleobases among millions of undamaged base pairs. The main challenge is that many damaged 
bases targeted by glycosylases only slightly differ from their normal counterparts. As glycosylases 
do not use biochemical energy during the search for DNA damage, they are only thermally driven 
to translocate and move along the genome. One mechanism for the detection of oxidatively 
damaged bases suggests the insertion of specific residues into the DNA helix. Thereby, 
glycosylases diffusely scan the DNA and simultaneously test the strength and flexibility of base 
pairs and the sugar backbone [Banerjee et al., 2006; Dunn et al., 2011; Nelson et al., 2014]. 
Whether all glycosylases use the same scanning mechanism or differ depending on their substrates 
remains elusive. 
 
Applying Co-IP and Fluorescent Three Hybrid (3FH) assays, we demonstrated interactions of all 
three TET proteins with the monofunctional glycosylases TDG, MBD4 and the bifunctional 
NEIL1, NEIL2, NEIL3 [Muller et al., 2014]. The recruitment of glycosylases to the site of 
oxidation could imply that the oxidized products are immediately removed. We also observed 
interactions of TET proteins with downstream factors of the BER, such as PARP1, LIG3, 
XRCC1. Thus, not only the removal, but also its replacement with unmodified cytosine takes 
place in one large complex and enables efficient site-specific DNA demethylation. 
 
In this study we developed a reporter gene assay to further investigate the underlying effects of 
5mC and its oxidized derivatives with regard to TDG, MBD4 and the NEIL glycosylase family on 
gene expression. The enzymatic oxidation of a methylated pOct4-reporter was carried out in vitro, 
thus, the generation of modified cytosines was separated from their further processing in vivo. This 
approach enables a more direct investigation of the biological pathways responsible for gene 
expression independent of endogenous TET activity and regulation. We applied high-throughput 
imaging, followed by automated image acquisition and quantification for measurement of 
reporter-gene expression [Muller et al., 2014]. Using GFP or mCherry expression as readout 
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allows parallel analysis of a large number of single cells. In contrast to other methods such as the 
luciferase assay, this approach does not require the addition of the luciferase substrate and thus 
removes a possible source of error or bias. Furthermore, it is also suited for following expression 
in living cells, as no cell lysis has to be performed. 
In wt and Mbd4-/- ESCs, we observed strong reporter expression from unmethylated or oxidized 
but not from methylated plasmids, suggesting oxidation-dependent gene re-activation. In contrast, 
Tdg-/- ESCs showed no reporter gene expression from the oxidized plasmid. Re-isolating the 
transfected plasmids clearly showed that DNA demethylation took place in wt ESCs and Mbd4-/- 
ESCs, but only very little in TDG deficient cells [Muller et al., 2014]. This demonstrates that DNA 
demethylation is the cause of the observed gene re-activation. 
To elucidate whether the NEIL glycosylase family contributes to gene reactivation, we measured 
the expression of the modified reporter plasmids in Tdg-/- cells transiently overexpressing NEIL1, 
NEIL2 or NEIL3. Interestingly, we observed a significant increase of pOct4-GFP expression in 
these Tdg-/- rescue cells using oxidized plasmids. Additionally, we isolated genomic DNA from wt 
E14 and Tdg-/- ESCs as well as from the transient rescues with wt TDG and NEIL1, 2 and 3. The 
rescues of Tdg-/- cells resulted in decreased genomic 5fC, and for wt TDG and NEIL1, also in 
decreased 5caC levels [Muller et al., 2014]. These data indicate that the NEIL glycosylases can 
partially compensate for the loss of TDG. 
 
TDG actively processes lesions that result from oxidation, alkylation and deamination of cytosine, 
5mC, and thymine [Hardeland et al., 2003]. TDG also has been shown to remove 5′-halogenated 
derivatives of uracil and cytosine, such as 5-bromouracil [Morgan et al., 2007]. Moreover, TDG 
exhibits highest processing efficiency on lesions opposite guanine within CpG sites, but can also 
remove several bases opposite adenine [Morgan et al., 2011]. This broad range of substrates allows 
TDG to eliminate a variety of mutagenic bases and help to stabilize the genome. Knockout of Tdg 
in mice is embryonic lethal, suggesting that it has an essential function in development [Cortazar et 
al., 2011; Cortellino et al., 2011].  
The rescue with functionally active TDG indicates that this glycosylase is mainly responsible for 
DNA demethylation and the resulting gene-reactivation. Furthermore our APEX assay 
demonstrated that TDG has the highest activity toward 5fC and 5caC containing DNA substrates 
[Muller et al., 2014]. This supports previous finding, which indicated that TDG has robust in vitro 
base excision activity on 5fC and 5caC but not on C, 5mC and 5hmC [He et al., 2011; Maiti and 
Drohat, 2011]. Together with the fact that we identified TDG as a reader for fC and caC and its 
interaction with TET proteins, its essential role in removal of the oxidized bases was manifested. 
Computational studies have further suggested that 5fC and 5caC have destabilized N-glycosidic 
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bonds relative to C, 5mC and 5hmC [Bennett et al., 2006; Williams and Wang, 2012]. TDG also 
seems to have structural features that mediate recognition of these oxidized C bases, including a 
binding pocket that can specifically accommodate the 5-carboxyl substituent [Zhang et al., 2012]. 
Structural data showed that 5caC is flipped out from the double-stranded DNA and is stabilized 
by several hydrogen bonds in the catalytic pocket of the enzyme (Figure 11) [Hashimoto et al., 
2013]. Interestingly, the chemical properties for 5fC recognition seem to differ from 5caC, which 
raises the question of the relative contribution of 5fC compared to 5caC in demethylation and 
gene regulation. 
 
MBD4 is unique from other thymine and uracil-processing glycosylases as it contains two DNA 
binding domains, an MBD and a C-terminal glycosylase domain. MBD4 catalyzes the removal of 
U and T paired with G within CpG sites, which result from deamination of cytosine or 5mC 
[Hendrich et al., 1999; Petronzelli et al., 2000]. Additionally, MBD4 is active on several 
halogenated pyrimidines, including 5-chlorouracil and 5-bromouracil paired with G that are 
produced during peroxidase-mediated inflammatory processes, as well as chemotherapy-induced 
5-Fluorouracil (5FU) [Turner et al., 2006; Valinluck et al., 2005]. In the context of DNA 
demethylation, MBD4 was shown to be active on 5hmU in vitro, initially proposed to be the 
deamination product of 5hmC [Hashimoto et al., 2012c]. Although MBD4 showed an interaction 
with all three TET proteins, it did not contribute to gene re-activation in ESCs but may be 
involved in other regulatory mechanism, which are still unknown. Our data suggest that MBD4 is 
not active on oxidized cytosines in ESCs, which is generated through TET mediated oxidation. 
However, a potential involvement in DNA demethylation during special developmental stages 
such as in zygotes or at specific DNA sequences may still require the presence of MBD4. 
 
The mammalian NEIL glycosylase family consists of three members: NEIL1, NEIL2, and 
NEIL3. The preferred substrates of NEIL1 and NEIL2 are thymine-glycol (Tg), 5-
hydroxycytosine (5hC), FaPyA, and FaPyG [Hazra et al., 2002; Morland et al., 2002], but also 5-
hydroxyuracil (5hU) and 8oxoG in DNA bubble structures [Dou et al., 2003]. NEIL3 excises 
formamidopyrimidines but is inactive on 8oxoG [Liu et al., 2010]. Notably, NEIL1 and NEIL3 
show a higher preference for their substrates in telomeric sequences [Zhou et al., 2013].  
NEIL family members exhibit a distinct two-domain architecture where the N- and C-terminal 
domains are connected by a flexible hinge region [Liu et al., 2013a; Prakash et al., 2012]. The N-
terminal domain comprises a two-layered β-sandwich flanked by α-helices, while the 
predominantly α-helical C-terminal domain contains a conserved helix-two-turn-helix (H2TH) 
motif, as well as two antiparallel β-strands that in the case of NEIL2 and NEIL 3 form a zinc-
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finger motif required for DNA binding [Doublie et al., 2004]. Although they differ in their 
substrate preferences, both NEIL1 and NEIL2 recognize oxidized pyrimidines. They share a 
common catalytic proline at the N-terminal position, whereas NEIL3 has a valine at this position 
[Bandaru et al., 2002].  
One of the main questions regarding NEIL glycosylases is how these enzymes locate and 
recognize a damaged base. The structures of a viral ortholog of human NEIL1 glycosylase 
complexes revealed that the 5hU-lesion is extruded from the DNA helix and inserted in the active 
site of the enzyme (Figure 14) [Imamura et al., 2012; Prakash et al., 2013]. Unexpectedly, very few 
hydrogen bond interactions were observed between the enzyme and either lesion, and mutating 
two of the residues in contact with the lesion did not affect the glycosylase activity. This finding 
suggests that lesion recognition is likely performed before the lesion is flipped out from the DNA 
double helix. It needs to be further investigated whether NEIL glycosylases are also active in the 
presence of TDG and how they are regulated in the context of DNA demethylation. 
 
Figure 13: Crystal structure of a viral ortholog of 
human NEIL1 glycosylase bound to 5hU 
containing DNA. 
NEIL1 is composed of two domains connected by a linker. 
The N-terminal domain comprises an α-helix followed by a 
two-layered β-sandwich, with each layer composed of four 
antiparallel β-strands (yellow). The C-terminal domain 
comprises several α-helices (green), two of which are 
involved in the H2TH motif. The DNA is bound in the 
cleft between the two domains and lies perpendicularly to 
the long axis of NEIL1. The lesion (red) is flipped out of 
the DNA double helix and placed in the active site. 
 
 
 
 
 
 
 
Additional human glycosylases and their involvement in DNA demethylation 
UNG and SMUG glycosylases are highly specific for processing genomic uracil in mouse and 
human cells [Haushalter et al., 1999; Nilsen et al., 1997]. Interactions with PCNA target UNG to 
sites of DNA replication, where its main function is to immediately excise uracil that is 
incorporated opposite from adenine [Otterlei et al., 1999]. SMUG glycosylases appear to serve as a 
back-up for UNG in limiting uracil accumulation in genomic DNA and in preventing C → T 
mutations after cytosine deamination [An et al., 2005]. Notably, SMUG1 has also been shown to 
contribute to rRNA quality control as it regulates 5hmU levels [Jobert et al., 2013]. 
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Recently, UNG was described to be active on uracil after AID mediated cytosine deamination in 
mouse zygotes, contributing to active DNA demethylation [Santos et al., 2013]. In line, 
knockdown of zebrafish Ung causes an increase of global DNA methylation levels together with a 
reduction of overall transcriptional activity [Wu et al., 2014]. However, the AID system is not 
active in zebrafish embryos before zygotic genome activation [Rai et al., 2008] and also UNG itself 
did not display any activity towards 5hmU using in vitro glycosylase assays. However, we found 
UNG as a binder of fC in ESCs, which proposes a potential involvement of this glycosylase in 
DNA demethylation. Interestingly, this finding suggests an additional recognition of oxidized 
cytosines by UNG besides its already known uracil substrates.  
SMUG1 has been implicated in active DNA demethylation as it was shown to excise 5hmU, the 
deamination product of 5hmC. Although we did not observe a direct interaction of TET proteins 
with SMUG1, the excision of 5hmU could still occur in vivo. However, 5hmU is not generated by 
deamination of 5hmC but by TET mediated oxidation of thymine (see chapter 3.2). Nevertheless, 
further biochemical and structural studies are needed to definitely elucidate the role and context of 
the uracil specific glycosylases in DNA demethylation. 
OGG1 serves as the main glycosylase for the excision of 8oxoG opposite cytosine in mammals 
[Radicella et al., 1997]. In addition, it is also active on other oxidized purines or formamido-
guanine (FapyG) [Dherin et al., 1999]. Structural data indicate that the catalytic core of OGG1 is 
very specific for guanine and it is thus unlikely that cytosine derivatives are processed [Banerjee et 
al., 2005; Bjoras et al., 2002]. Although, we did not observe any interaction with the TET proteins 
using F3H [Luitz, 2013], we identified OGG1 as a 5hmC specific reader in brain. Further studies 
are needed to clarify to what extend OGG1 can process oxidized cytosine bases.  
MPG glycosylase excises a variety of alkylated bases, including methylated adenine or guanine, as 
well as ethylated bases in single- and double-stranded DNA [Lee et al., 2009; O'Connor, 1993]. 
Chrystal structures show that the base-flipping mechanism used by MPG can only be applied on 
mutated purine bases [Lau et al., 1998] and its role in removing oxidized cytosines is therefore 
unlikely. Recently, it was shown that UHRF1 interacts with MPG in cancer cells. However, the 
functional linkage between MPG-mediated DNA damage repair and UHRF1/2-mediated DNA 
methylation is not known yet [Liang et al., 2013]. MPG was found as a 5hmC reader in ESCs but 
we did not observe interactions with the TET proteins [Luitz, 2013]. Thus, its involvement in 
DNA demethylation remains unclear. 
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Dynamic regulation of gene expression by TETs and TDG 
We could show that TET-dependent oxidation leads to DNA demethylation via BER, with TDG 
being the main glycosylase involved in this process [Muller et al., 2014]. 
First studies on DNA demethylation were performed in developing chicken embryos, in which 
hormone induced gene reactivation was observed independent of DNA replication [Wilks et al., 
1984]. Further analysis revealed that TDG was contributing to the observed DNA demethylation 
effect and a potential activity against 5mC was proposed [Jost, 1993; Jost et al., 1995]. A more 
detailed screen showed TDG enrichment inside loci at which rapid cycling of C and 5mC is 
associated with hormonal or cytokine-mediated regulation [Kangaspeska et al., 2008; Metivier et 
al., 2008; Thillainadesan et al., 2012]. These initial studies imply that active demethylation via TDG 
may be essential when transcriptional control must be modulated in the absence of DNA 
replication.  
New genome-wide and single-base resolution methods have been developed to discriminate 
between all known cytosine bases. Several studies have demonstrated a probable regulatory role 
for 5hmC with significant enrichment for this modification at transcribed gene bodies, bivalent 
and silent promoters, and distal cis-regulatory elements [Pastor et al., 2011; Williams et al., 2011; 
Wu et al., 2011]. A recent mapping in ESCs has shown the functional relevance of 5fC and 5caC 
together with TDG. In TDG knockout ESCs, a significant enrichment of 5fC and 5caC was 
detected in non-repetitive regions, mainly at distal regulatory elements. However, in wild-type 
ESCs, 5fC or 5caC accumulates at major satellite repeats but not at nonrepetitive loci [Shen et al., 
2013]. Furthermore, 5fC and 5caC are transiently accumulated during lineage specification of 
neural stem cells (NSCs). 5caC is mainly found at the cell-type-specific promoters during 
differentiation of NSCs, and TDG knockdown leads to increased 5fC/5caC levels in these cells 
[Wheldon et al., 2014].  
Other studies further demonstrated 5fC enrichment in enhancer regions and in CpG islands of 
promoters and exons [Song et al., 2013]. In line with our results, CGI promoters in which 5fC was 
relatively more enriched than 5mC or 5hmC corresponded to transcriptionally active genes. 
Accordingly, 5fC-rich promoters had elevated H3K4me3 levels, associated with active 
transcription, and were frequently bound by RNA polymerase II. TDG down-regulation led to 
5fC accumulation in CGIs in ESCs, which correlates with increased methylation in these genomic 
regions during differentiation in wild-type and TDG knockout contexts [Raiber et al., 2012]. Thus, 
5fC excision in ESCs is necessary for the correct establishment of CGI methylation patterns 
during differentiation and hence for appropriate patterns of gene expression during development. 
Another study connecting TET and TDG functions revealed, that TET-deficient MEFs cannot be 
reprogrammed because of a block in the mesenchymal-to-epithelial transition step. Interestingly, 
reprogramming of MEFs deficient in TDG is similarly impaired [Hu et al., 2014]. Thus, oxidative 
  DISCUSSION 
 
 161 
demethylation to promote gene activation appears to be functionally required for reprogramming 
of fibroblasts to pluripotent cells. These findings provide new mechanistic insights into the role of 
epigenetic barriers in cell-lineage conversion. 
Recently, it was indicated that TET proteins can be post-transcriptionally regulated by 
microRNAs. The miR-29-family of microRNAs downregulate TET1 and TDG without affecting 
DNA methylation, possibly because it can also repress DNMT3A and DNMT3B [Morita et al., 
2013]. MiR-26 was shown to inhibit activity of all three TETs and TDG, emphasizing a complex 
regulation of DNA demethylation enzymes by small RNAs [Fu et al., 2013]. 
Concerning cytosine oxidation as a step-wise modification process the key question arises, what 
regulates TET enzymes in stalling at specific intermediates in this pathway or promotes 
progression through all three catalytic oxidation steps? 
As 5hmC levels are higher than 5fC and 5caC and given that TET enzymes can iteratively oxidize 
these bases, it remains elusive what factors control the modification pathway to stop at 5hmC. 
Stalling at the 5hmC modification could be regulated through the accessibility of 5hmC by TET 
proteins or availability of the cofactors 2-OG and Fe(II), which leads to altered enzyme kinetics. 
Other mechanisms could include either post-translational modifications or interaction with other 
factors. The basal reactivity of TET with each of its substrates and regulation of its substrate 
preferences are crucial to investigate. First structural insights into the catalytic domain of TET2 
have already started to give first insights into the underlying mechanisms. However, the role of the 
large N-terminal domain or the insert, which separates the DSBH is unknown yet. 
At the next step of the oxidation pathway, it is still not understood whether 5fC and 5caC have 
different roles, as they can be both excised by TDG. Furthermore, it remains elusive what 
significance they have beyond serving as intermediates in active DNA demethylation. Although 
they are very rare in the genome, we could show that they are both bound by different readers, 
which might indicate additional regulatory roles [Spruijt et al., 2013].  
Finally, when the pathway is viewed as a complete cycle of cytosine methylation, oxidation and 
repair, it immediately begs the question: how does recurrent cycling of this pathway happen? 
However, evidence of multiple cycling events through a methylation-demethylation pathway at a 
single locus needs to be investigated.  
Taken together, TET mediated oxidation and TDG dependent demethylation seems to be highly 
dynamic and a complex regulation ensures the control of gene expression and genomic plasticity. 
 
 
 
 
DISCUSSION  
 
 162 
Conclusion and perspectives 
Since their discovery in 2009, TET enzymes and their mode of action have dramatically changed 
the views about epigenetic regulation and chromatin dynamics. Several key studies showed the 
importance of active or passive TET-mediated demethylation mechanisms in different biological 
processes such as ESC reprogramming, differentiation but also cancer development and 
progression. TET proteins are connected with diverse chromatin-related machineries involved in 
transcriptional regulation or DNA repair. The epigenetic marks they establish can not only act as 
distinctive signals but also serve as DNA-demethylation intermediates. Besides, TET proteins 
have additional functions that do not depend on their catalytic activity, such as the recruitment of 
chromatin associated proteins. Oxidative modifications of 5mC or thymine, generated by TETs 
and DNA demethylation mechanisms have greatly expanded the possibilities by which the 
genome can be flexible while maintaining the integrity of its coding information. TET proteins are 
regulated at various levels including metabolites, miRNAs and post-translational modifications. 
Furthermore, the increasing numbers of identified interactors could contribute to understanding 
how these different complex epigenetic processes are interconnected with each other (Figure 15).  
 
 
 
 
Figure 15: The expanding regulation and functional network of TET proteins and oxidized base derivatives 
The activity and localization of TET proteins can be regulated at different levels. Metabolites such as Vitamin C can increase TET activity, 
whereas 2-HG, generated by mutated IDH can inhibit TET function.  Similarly, miRNAs can also affect TET-mediated oxidation by direct 
downregulation of TET expression or inhibit DNA demethylation by interfering with TDG. TET proteins can be further regulated by PTMs. 
Glycosylation by OGT has been shown to alter TET localization and thus its activity. Several proteins have been shown to interact with TET 
enzymes, some controlling reprogramming or differentiation or modulating chromatin states. Some factors also seem to affect TET activity 
via indirect mechanisms. Readers of oxidized cytosines are highly dynamic and show very little overlap. However, their exact functions still 
need to be investigated. The ability of TET proteins to oxidize thymine into 5hmU expands the epigenetic network and possibilities to fine-
tune gene expression. Active DNA demethylation is mainly achieved by base-excision repair. The main glycosylase initiating this pathway is 
TDG, however NEIL glycosylases and maybe also others can serve as backup. 
 
Future research will shed new light on the role of dynamic regulation of DNA modifications in 
pluripotency, development, gene regulation and genome stability. 
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4.2 Abbreviations 
2-HG  2-hydroxyglutarate 
2-OG  2-oxoglutarate 
5caC  5-carboxylcytosine 
5fC  5-formylcytosine 
5mC  5-methylcytosine 
5hmC  5-hydroxymethylcytosine 
5hmU  5-hydroxymethyluracil 
5fU  5-formyluracil 
8oxoG  8-oxoguanine 
AID  Activation induced cytidine deaminase 
APOBEC Apolipoprotein B mRNA editing enzyme, catalytic polypeptide 
BER  Base excision repair 
CGI  CpG island 
CpG  Cytosine-phosphatidyl-guanine 
DNA  Deoxyribonucleic acid 
DNMT  DNA methyltransferase 
ESC  Embryonic stem cell 
F3H  Fluorescent-three hybrid 
Fe  Iron 
GADD45 Growth arrest and DNA-damage-inducible protein 45 
HDAC  Histone deacetylase 
HP1  Heterochromatin binding protein 1 
IAP  Intracisternal A particle 
IDH  Isocitrate dehydrogenase 
IDAX  Inhibition of the Dvl and axin complex protein 
JBP  J-binding protein 
JGT  J-associated glycosyltransferase 
KLF  Krüppel-like factor 
LIG3  DNA Ligase 3 
MBD  Methyl-CpG binding domain 
MeCP2  Methyl-CpG binding protein 2 
MPG  N-methylpuringe glycosylase 
MLL1  Mixed-lineage leukemia protein 1  
MS  Mass spectrometry 
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NEIL  Nei endonuclease 8-like 
NER  Nucleotide excision repair 
NPC  Neuronal progenitor cell 
OCT4  Octamer binding transcription factor 4 
OGG1  8-oxoguanine glycosylase 1 
O-GlcNAc O-linked N-acetylglucosamine 
OGT  O-linked N-acetylglucosamine transferase 
PARP1  Poly [ADP-ribose] polymerase 1 
PCNA  Proliferating cell nuclear antigen 
PGC  Primordial germ cells 
PRC  Polycomb repressive complex 
RNA  Ribonucleic acid 
SMUG1 Single-strand selective monofunctional uracil DNA glycosylase 
TDG  Thymidine DNA glycosylase 
TET  Ten-eleven translocation 
UHRF  Ubiquitin-like containing PHD and Ring finger domain proteins 
UNG  Uracil-DNA glycosylase 
wt  wildtype 
ZnF  Zinc Finger 
XRCC1 X-ray repair cross-complementing protein 1 
 
